country,term,count
AL,DRUG HYPERSENSITIVITY,5
AL,DYSPNOEA,3
AL,LIP OEDEMA,2
AL,PRURITUS,2
AL,URTICARIA,2
AL,ANAPHYLACTIC REACTION,1
AL,ANGIOEDEMA,1
AL,CHEST DISCOMFORT,1
AL,CILIARY HYPERAEMIA,1
AL,COUGH,1
AL,ERYTHEMA,1
AL,HYPOTENSION,1
AL,ORBITAL OEDEMA,1
AL,RHINORRHOEA,1
DZ,ASTHENIA,2
DZ,CHEST PAIN,2
DZ,HEADACHE,2
DZ,ANAEMIA,1
DZ,ANOREXIA NERVOSA,1
DZ,ARTHRALGIA,1
DZ,BENIGN PROSTATIC HYPERPLASIA,1
DZ,BICYTOPENIA,1
DZ,CARDIO-RESPIRATORY ARREST,1
DZ,COMA,1
DZ,CYANOSIS,1
DZ,DEATH,1
DZ,DECREASED APPETITE,1
DZ,DYSPNOEA,1
DZ,FATIGUE,1
DZ,GENERAL PHYSICAL CONDITION ABNORMAL,1
DZ,LUNG DISORDER,1
DZ,LUNG INFECTION,1
DZ,MUSCULAR WEAKNESS,1
DZ,NIGHT SWEATS,1
DZ,PAIN IN EXTREMITY,1
DZ,PLATELET COUNT DECREASED,1
DZ,PYREXIA,1
DZ,RENAL FAILURE,1
DZ,SYNCOPE,1
DZ,VERTIGO,1
AR,RENAL TUBULAR NECROSIS,33
AR,PAIN,6
AR,PYREXIA,6
AR,ANAEMIA,5
AR,MALIGNANT NEOPLASM PROGRESSION,5
AR,ACUTE KIDNEY INJURY,4
AR,BLOOD PRESSURE INCREASED,4
AR,COMA,4
AR,TUBULOINTERSTITIAL NEPHRITIS,4
AR,ARTHRALGIA,3
AR,ARTHRITIS,3
AR,CELLULITIS,3
AR,DIZZINESS,3
AR,ELECTROCARDIOGRAM QT PROLONGED,3
AR,GENERAL PHYSICAL HEALTH DETERIORATION,3
AR,HEADACHE,3
AR,INTENTIONAL OVERDOSE,3
AR,PAIN IN EXTREMITY,3
AR,PULMONARY OEDEMA,3
AR,RENAL PAPILLARY NECROSIS,3
AR,THROMBOSIS,3
AR,URINARY TRACT INFECTION,3
AR,ATAXIA,2
AR,DEPRESSED MOOD,2
AR,DRUG INEFFECTIVE,2
AR,DRUG-INDUCED LIVER INJURY,2
AR,DYSPNOEA,2
AR,FATIGUE,2
AR,INFECTION,2
AR,MATERNAL EXPOSURE DURING PREGNANCY,2
AR,OVERDOSE,2
AR,RHEUMATOID ARTHRITIS,2
AR,TINNITUS,2
AR,VAGINAL HAEMORRHAGE,2
AR,WHITE BLOOD CELL COUNT DECREASED,2
AR,ABASIA,1
AR,ABDOMINAL PAIN UPPER,1
AR,ACUTE LEUKAEMIA,1
AR,ACUTE RESPIRATORY FAILURE,1
AR,ALANINE AMINOTRANSFERASE INCREASED,1
AR,ANGIOEDEMA,1
AR,APHAGIA,1
AR,APHASIA,1
AR,APPENDICITIS,1
AR,ASCITES,1
AR,ASPARTATE AMINOTRANSFERASE INCREASED,1
AR,ASTHENIA,1
AR,AUTOIMMUNE HEPATITIS,1
AR,BACK PAIN,1
AR,BACTERAEMIA,1
AR,BETA HAEMOLYTIC STREPTOCOCCAL INFECTION,1
AR,BILE DUCT STONE,1
AR,BLOOD CHROMOGRANIN A INCREASED,1
AR,BLOOD CREATININE INCREASED,1
AR,BLOOD PRESSURE ABNORMAL,1
AR,BONE MARROW TUMOUR CELL INFILTRATION,1
AR,BONE PAIN,1
AR,CAESAREAN SECTION,1
AR,CALCIUM METABOLISM DISORDER,1
AR,CARDIO-RESPIRATORY ARREST,1
AR,CARDIOMYOPATHY,1
AR,CATARACT,1
AR,CHEST PAIN,1
AR,CHORIORETINITIS,1
AR,CILIARY HYPERAEMIA,1
AR,COLITIS,1
AR,CRITICAL ILLNESS MYOPATHY,1
AR,CRITICAL ILLNESS POLYNEUROPATHY,1
AR,DEATH,1
AR,DECREASED IMMUNE RESPONSIVENESS,1
AR,DERMATITIS DIAPER,1
AR,DERMATITIS EXFOLIATIVE,1
AR,DISCOMFORT,1
AR,DUODENAL ULCER,1
AR,DYSPHONIA,1
AR,DYSSTASIA,1
AR,EAR DISCOMFORT,1
AR,ECTOPIC PREGNANCY,1
AR,ENCEPHALOPATHY,1
AR,EOSINOPHILIA,1
AR,EXOSTOSIS,1
AR,EYE DISORDER,1
AR,FALL,1
AR,FEELING ABNORMAL,1
AR,FLATULENCE,1
AR,FOETAL EXPOSURE DURING PREGNANCY,1
AR,FOOT DEFORMITY,1
AR,GAIT DISTURBANCE,1
AR,GASTROENTERITIS,1
AR,GASTROINTESTINAL HAEMORRHAGE,1
AR,GENERAL SYMPTOM,1
AR,GENERALISED OEDEMA,1
AR,GLAUCOMA,1
AR,HAEMANGIOMA OF SKIN,1
AR,HAEMARTHROSIS,1
AR,HAEMATOCRIT DECREASED,1
AR,HAEMATOMA,1
AR,HAEMORRHAGE,1
AR,HEPATIC ENZYME INCREASED,1
AR,HEPATIC LESION,1
AR,HEPATIC NEOPLASM,1
AR,HEPATITIS,1
AR,HIP ARTHROPLASTY,1
AR,HISTIOCYTOSIS HAEMATOPHAGIC,1
AR,HYPERSENSITIVITY,1
AR,HYPERTENSION,1
AR,HYPERTENSIVE CRISIS,1
AR,IMMUNOSUPPRESSION,1
AR,IMPLANT SITE INFECTION,1
AR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
AR,INJURY,1
AR,INSOMNIA,1
AR,INTERSTITIAL LUNG DISEASE,1
AR,INTESTINAL METASTASIS,1
AR,INTESTINAL PERFORATION,1
AR,INTRA-ABDOMINAL FLUID COLLECTION,1
AR,INTRAOCULAR PRESSURE INCREASED,1
AR,IRIS ADHESIONS,1
AR,ISCHAEMIA,1
AR,JOINT DISLOCATION,1
AR,KERATIC PRECIPITATES,1
AR,LEUKOCYTOSIS,1
AR,LIGAMENT INJURY,1
AR,LIVER DISORDER,1
AR,LOSS OF CONSCIOUSNESS,1
AR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
AR,LUNG INFILTRATION,1
AR,LYMPHOPENIA,1
AR,MATERNAL DRUGS AFFECTING FOETUS,1
AR,MENSTRUAL DISORDER,1
AR,METASTASES TO BONE,1
AR,METASTASES TO LUNG,1
AR,MOBILITY DECREASED,1
AR,MOUNTAIN SICKNESS ACUTE,1
AR,MOVEMENT DISORDER,1
AR,MUCOSAL INFLAMMATION,1
AR,MULTIPLE SCLEROSIS,1
AR,MULTIPLE SCLEROSIS RELAPSE,1
AR,MUSCULOSKELETAL STIFFNESS,1
AR,MYALGIA,1
AR,MYOCARDIAL INFARCTION,1
AR,NEPHROLITHIASIS,1
AR,NERVOUS SYSTEM DISORDER,1
AR,NEUROENDOCRINE TUMOUR,1
AR,NEUTROPENIA,1
AR,NOSOCOMIAL INFECTION,1
AR,OBSTRUCTIVE UROPATHY,1
AR,OCULAR DISCOMFORT,1
AR,OEDEMA,1
AR,OSTEITIS,1
AR,OSTEONECROSIS OF JAW,1
AR,OVARIAN CYST,1
AR,PERICARDIAL DISEASE,1
AR,PERIPHERAL SWELLING,1
AR,PERITONEAL LESION,1
AR,PHARYNGEAL OEDEMA,1
AR,PLATELET COUNT DECREASED,1
AR,POISONING,1
AR,POST PROCEDURAL COMPLICATION,1
AR,PREMATURE BABY,1
AR,PRODUCT USE ISSUE,1
AR,PSORIATIC ARTHROPATHY,1
AR,PUPILLARY BLOCK,1
AR,RASH,1
AR,RASH MACULO-PAPULAR,1
AR,RED BLOOD CELL COUNT DECREASED,1
AR,RENAL DISORDER,1
AR,RENAL FAILURE,1
AR,RENAL IMPAIRMENT,1
AR,RESPIRATORY DISTRESS,1
AR,RETINAL PIGMENT EPITHELIOPATHY,1
AR,ROTATOR CUFF SYNDROME,1
AR,SCRATCH,1
AR,SENSORY LOSS,1
AR,SEPSIS,1
AR,SKIN CANCER,1
AR,SKIN HYPERPIGMENTATION,1
AR,SKIN NEOPLASM BLEEDING,1
AR,SKIN ULCER,1
AR,SOMNOLENCE,1
AR,SPINAL FRACTURE,1
AR,SUBARACHNOID HAEMORRHAGE,1
AR,SUDDEN DEATH,1
AR,SWELLING FACE,1
AR,TENDONITIS,1
AR,TOXICITY TO VARIOUS AGENTS,1
AR,TREMOR,1
AR,TUBULOINTERSTITIAL NEPHRITIS AND UVEITIS SYNDROME,1
AR,TURBINECTOMY,1
AR,UMBILICAL HERNIA,1
AR,UTERINE HAEMORRHAGE,1
AR,UTERINE INFECTION,1
AR,UTERINE NEOPLASM,1
AR,UTERINE POLYP,1
AR,VISION BLURRED,1
AR,VOMITING,1
AR,VULVAL DISORDER,1
AR,WEIGHT DECREASED,1
AR,WHITE BLOOD CELL COUNT INCREASED,1
AR,WOUND COMPLICATION,1
AM,ANAPHYLACTIC SHOCK,1
AM,FEELING COLD,1
AM,SYNCOPE,1
AW,ANAEMIA,1
AW,BLOOD UREA INCREASED,1
AW,GASTRIC ULCER,1
AW,HAEMATEMESIS,1
AW,HAEMOGLOBIN DECREASED,1
AW,HYPOTENSION,1
AW,UPPER GASTROINTESTINAL HAEMORRHAGE,1
AU,TOXICITY TO VARIOUS AGENTS,53
AU,OVERDOSE,26
AU,CONSTIPATION,16
AU,OBSTRUCTIVE AIRWAYS DISORDER,16
AU,BEZOAR,15
AU,NAUSEA,14
AU,COMPLETED SUICIDE,13
AU,ABNORMAL BEHAVIOUR,12
AU,SEROTONIN SYNDROME,12
AU,DYSPNOEA,11
AU,TACHYCARDIA,11
AU,VOMITING,11
AU,DRUG ABUSE,10
AU,HEADACHE,10
AU,SEIZURE,10
AU,SPLENOMEGALY,10
AU,DECREASED APPETITE,9
AU,PERICARDITIS,9
AU,URINARY INCONTINENCE,9
AU,FATIGUE,8
AU,GASTRIC ULCER,8
AU,RENAL TUBULAR ACIDOSIS,8
AU,VITAMIN D DECREASED,8
AU,ANTIPSYCHOTIC DRUG LEVEL DECREASED,7
AU,C-REACTIVE PROTEIN DECREASED,7
AU,CHEST PAIN,7
AU,INTENTIONAL OVERDOSE,7
AU,LYMPHADENOPATHY MEDIASTINAL,7
AU,MYOCARDITIS,7
AU,SCHIZOPHRENIA,7
AU,SUICIDE ATTEMPT,7
AU,ARTHRALGIA,6
AU,ASTHENIA,6
AU,DIARRHOEA,6
AU,GASTROINTESTINAL DISORDER,6
AU,INFUSION SITE PAIN,6
AU,INTENTIONAL PRODUCT MISUSE,6
AU,INTESTINAL DIAPHRAGM DISEASE,6
AU,MALNUTRITION,6
AU,NEUTROPENIA,6
AU,PAIN,6
AU,PULMONARY EMBOLISM,6
AU,PYREXIA,6
AU,WEIGHT DECREASED,6
AU,ANAPHYLACTIC REACTION,5
AU,COAGULOPATHY,5
AU,CONFUSIONAL STATE,5
AU,CONTUSION,5
AU,DEEP VEIN THROMBOSIS,5
AU,DEHYDRATION,5
AU,DEPRESSED LEVEL OF CONSCIOUSNESS,5
AU,DIZZINESS,5
AU,GASTRIC ULCER HAEMORRHAGE,5
AU,HAEMATEMESIS,5
AU,HISTIOCYTOSIS HAEMATOPHAGIC,5
AU,HYPOALBUMINAEMIA,5
AU,HYPOKALAEMIA,5
AU,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,5
AU,INSOMNIA,5
AU,INTESTINAL ISCHAEMIA,5
AU,IRON DEFICIENCY ANAEMIA,5
AU,MALAISE,5
AU,NEPHROPATHY TOXIC,5
AU,OEDEMA PERIPHERAL,5
AU,PERICARDIAL HAEMORRHAGE,5
AU,PROTEIN-LOSING GASTROENTEROPATHY,5
AU,PULMONARY OEDEMA,5
AU,RASH,5
AU,RESPIRATORY DEPRESSION,5
AU,SQUAMOUS CELL CARCINOMA,5
AU,STEVENS-JOHNSON SYNDROME,5
AU,TOXIC EPIDERMAL NECROLYSIS,5
AU,TREATMENT NONCOMPLIANCE,5
AU,TROPONIN INCREASED,5
AU,BACK PAIN,4
AU,BLOOD CREATINE PHOSPHOKINASE INCREASED,4
AU,CELLULITIS,4
AU,CONDITION AGGRAVATED,4
AU,DEATH,4
AU,DUODENAL STENOSIS,4
AU,DUODENAL ULCER,4
AU,HAEMORRHAGE,4
AU,ISCHAEMIC HEPATITIS,4
AU,LETHARGY,4
AU,MELAENA,4
AU,PNEUMONIA,4
AU,URINARY RETENTION,4
AU,URINARY TRACT INFECTION,4
AU,ABDOMINAL PAIN UPPER,3
AU,ACUTE MYOCARDIAL INFARCTION,3
AU,ALTERED STATE OF CONSCIOUSNESS,3
AU,ANXIETY,3
AU,ASTHMA,3
AU,ATRIAL FIBRILLATION,3
AU,ATRIO-OESOPHAGEAL FISTULA,3
AU,COMA SCALE ABNORMAL,3
AU,DEPRESSED MOOD,3
AU,DRUG INEFFECTIVE,3
AU,ENDOMETRIOSIS,3
AU,HAEMATURIA,3
AU,HYPERTENSION,3
AU,HYPOAESTHESIA,3
AU,HYPONATRAEMIA,3
AU,HYPOTENSION,3
AU,HYPOVOLAEMIA,3
AU,INTESTINAL OBSTRUCTION,3
AU,LIVER FUNCTION TEST ABNORMAL,3
AU,LYMPHADENOPATHY,3
AU,MALIGNANT NEOPLASM PROGRESSION,3
AU,MIGRAINE,3
AU,MUSCULOSKELETAL PAIN,3
AU,MUSCULOSKELETAL STIFFNESS,3
AU,NASOPHARYNGITIS,3
AU,PARAESTHESIA,3
AU,PERICARDIAL EFFUSION,3
AU,PNEUMONIA ASPIRATION,3
AU,POISONING DELIBERATE,3
AU,PRODUCT USE IN UNAPPROVED INDICATION,3
AU,PRURITUS,3
AU,PULMONARY HYPERTENSION,3
AU,RESPIRATORY FAILURE,3
AU,SEDATION,3
AU,SHOCK,3
AU,SUICIDAL IDEATION,3
AU,UPPER RESPIRATORY TRACT INFECTION,3
AU,WEIGHT INCREASED,3
AU,WITHDRAWAL SYNDROME,3
AU,ABDOMINAL DISTENSION,2
AU,ACCIDENTAL POISONING,2
AU,ACUTE KIDNEY INJURY,2
AU,AGRANULOCYTOSIS,2
AU,ARRHYTHMIA,2
AU,ASPIRATION,2
AU,ATELECTASIS,2
AU,BLINDNESS,2
AU,BLOOD PRESSURE DECREASED,2
AU,BONE MARROW FAILURE,2
AU,CARDIAC TAMPONADE,2
AU,CARDIOMEGALY,2
AU,CHROMATURIA,2
AU,COUGH,2
AU,DELIRIUM,2
AU,DISEASE PROGRESSION,2
AU,DRUG ADMINISTRATION ERROR,2
AU,DRUG DEPENDENCE,2
AU,DRUG-INDUCED LIVER INJURY,2
AU,DRY MOUTH,2
AU,ELECTROCARDIOGRAM QT PROLONGED,2
AU,ENTERITIS,2
AU,ESCHERICHIA BACTERAEMIA,2
AU,EXTRAPYRAMIDAL DISORDER,2
AU,EYE PAIN,2
AU,FALL,2
AU,FLUSHING,2
AU,GASTRIC DISORDER,2
AU,GASTRITIS HAEMORRHAGIC,2
AU,GASTRITIS VIRAL,2
AU,GRAND MAL CONVULSION,2
AU,HAEMOGLOBIN DECREASED,2
AU,HALLUCINATION,2
AU,HALLUCINATION_ AUDITORY,2
AU,HYPERHIDROSIS,2
AU,IMPAIRED SELF-CARE,2
AU,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
AU,INFLUENZA,2
AU,INFUSION RELATED REACTION,2
AU,INTENTIONAL DRUG MISUSE,2
AU,JUDGEMENT IMPAIRED,2
AU,LOWER RESPIRATORY TRACT INFECTION,2
AU,METASTASES TO CENTRAL NERVOUS SYSTEM,2
AU,MONOCYTE COUNT DECREASED,2
AU,MOUTH ULCERATION,2
AU,MOVEMENT DISORDER,2
AU,MUSCULAR WEAKNESS,2
AU,MYALGIA,2
AU,NECK PAIN,2
AU,NEUROTOXICITY,2
AU,NICOTINIC ACID DEFICIENCY,2
AU,OESOPHAGEAL STENOSIS,2
AU,ORAL CANDIDIASIS,2
AU,OSTEOARTHRITIS,2
AU,OSTEONECROSIS,2
AU,PAIN IN EXTREMITY,2
AU,PARANOIA,2
AU,PLEURAL EFFUSION,2
AU,PLEURITIC PAIN,2
AU,POOR QUALITY SLEEP,2
AU,RENAL FAILURE ACUTE,2
AU,RESPIRATORY ACIDOSIS,2
AU,RESPIRATORY DISORDER,2
AU,RESPIRATORY TRACT HAEMORRHAGE,2
AU,RESPIRATORY TRACT OEDEMA,2
AU,RHABDOMYOLYSIS,2
AU,SEPSIS,2
AU,SKIN LESION,2
AU,SOMNOLENCE,2
AU,THROMBOCYTOPENIA,2
AU,TOOTH FRACTURE,2
AU,TOOTH INFECTION,2
AU,TRANSAMINASES INCREASED,2
AU,UNEVALUABLE EVENT,2
AU,UPPER AIRWAY OBSTRUCTION,2
AU,UPPER GASTROINTESTINAL HAEMORRHAGE,2
AU,VISION BLURRED,2
AU,VITAMIN B12 DEFICIENCY,2
AU,WHITE BLOOD CELL COUNT DECREASED,2
AU,WOUND INFECTION,2
AU,ABDOMINAL ADHESIONS,1
AU,ABDOMINAL PAIN,1
AU,ABNORMAL SLEEP-RELATED EVENT,1
AU,ACTIVITIES OF DAILY LIVING IMPAIRED,1
AU,ACUTE HEPATIC FAILURE,1
AU,ADJUSTMENT DISORDER WITH ANXIETY,1
AU,AGITATION,1
AU,ALANINE AMINOTRANSFERASE INCREASED,1
AU,ALBUMIN URINE PRESENT,1
AU,ALOPECIA,1
AU,AMNESIA,1
AU,ANAEMIA,1
AU,ANGER,1
AU,ANIMAL BITE,1
AU,AORTIC DISSECTION,1
AU,APATHY,1
AU,ASPARTATE AMINOTRANSFERASE INCREASED,1
AU,AUTOIMMUNE HEPATITIS,1
AU,BASAL CELL CARCINOMA,1
AU,BILE DUCT OBSTRUCTION,1
AU,BILIARY DILATATION,1
AU,BLADDER DYSFUNCTION,1
AU,BLISTER,1
AU,BLOOD ALBUMIN DECREASED,1
AU,BLOOD BILIRUBIN INCREASED,1
AU,BLOOD THYROID STIMULATING HORMONE DECREASED,1
AU,BLOOD UREA INCREASED,1
AU,BONE PAIN,1
AU,BRADYCARDIA,1
AU,BREAST CANCER,1
AU,BRONCHOPNEUMONIA,1
AU,BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC,1
AU,BRUXISM,1
AU,BURNING SENSATION,1
AU,C-REACTIVE PROTEIN INCREASED,1
AU,CALCIFICATION OF MUSCLE,1
AU,CANCER PAIN,1
AU,CANDIDA INFECTION,1
AU,CARDIOVASCULAR DISORDER,1
AU,CAROTID ARTERY OCCLUSION,1
AU,CARPAL TUNNEL SYNDROME,1
AU,CAUDA EQUINA SYNDROME,1
AU,CENTRAL NERVOUS SYSTEM LESION,1
AU,CEREBRAL HAEMORRHAGE,1
AU,CEREBRAL INFARCTION,1
AU,CHEST DISCOMFORT,1
AU,CHEST X-RAY ABNORMAL,1
AU,CHILLS,1
AU,CHOLELITHIASIS,1
AU,CIRCULATORY COLLAPSE,1
AU,CIRRHOSIS ALCOHOLIC,1
AU,CLONIC CONVULSION,1
AU,COLD SWEAT,1
AU,COLITIS ISCHAEMIC,1
AU,COLORECTAL CANCER METASTATIC,1
AU,COMA,1
AU,COMA SCALE,1
AU,COMPULSIVE SHOPPING,1
AU,CORONARY ARTERY DISEASE,1
AU,CREPITATIONS,1
AU,CROHN^S DISEASE,1
AU,CYSTOID MACULAR OEDEMA,1
AU,CYTOMEGALOVIRUS INFECTION,1
AU,DEMENTIA,1
AU,DENTAL CARIES,1
AU,DEPRESSION,1
AU,DERMATITIS,1
AU,DERMATITIS ACNEIFORM,1
AU,DEVICE OCCLUSION,1
AU,DIABETIC KETOACIDOSIS,1
AU,DIAPHRAGMATIC DISORDER,1
AU,DISCOMFORT,1
AU,DIVERTICULUM,1
AU,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
AU,DRUG CLEARANCE DECREASED,1
AU,DRUG EFFECT DECREASED,1
AU,DRUG HYPERSENSITIVITY,1
AU,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
AU,DRUG INTOLERANCE,1
AU,DRUG SPECIFIC ANTIBODY PRESENT,1
AU,DRUG USE DISORDER,1
AU,DYSARTHRIA,1
AU,DYSKINESIA,1
AU,DYSLIPIDAEMIA,1
AU,DYSPHONIA,1
AU,DYSPLASTIC NAEVUS,1
AU,EAR PAIN,1
AU,ELECTROLYTE IMBALANCE,1
AU,EMOTIONAL DISTRESS,1
AU,ENTEROCOLITIS,1
AU,EROSIVE DUODENITIS,1
AU,ERYTHEMA,1
AU,ERYTHEMA MULTIFORME,1
AU,EYE SWELLING,1
AU,FACE OEDEMA,1
AU,FEBRILE NEUTROPENIA,1
AU,FEELING ABNORMAL,1
AU,FIBROSIS,1
AU,FLANK PAIN,1
AU,FOAMING AT MOUTH,1
AU,FOOD INTOLERANCE,1
AU,FOOT FRACTURE,1
AU,GASTRITIS,1
AU,GASTRITIS EROSIVE,1
AU,GASTROENTERITIS VIRAL,1
AU,GASTROINTESTINAL HAEMORRHAGE,1
AU,GASTROINTESTINAL INJURY,1
AU,GASTROINTESTINAL MUCOSAL DISORDER,1
AU,GASTROOESOPHAGEAL REFLUX DISEASE,1
AU,GENERALISED OEDEMA,1
AU,GIANOTTI-CROSTI SYNDROME,1
AU,HAEMATOMA INFECTION,1
AU,HAEMOPTYSIS,1
AU,HAEMORRHOIDS THROMBOSED,1
AU,HALO VISION,1
AU,HEAD DISCOMFORT,1
AU,HEMIPARESIS,1
AU,HEPATIC CIRRHOSIS,1
AU,HEPATIC ENCEPHALOPATHY,1
AU,HEPATIC FAILURE,1
AU,HEPATIC FUNCTION ABNORMAL,1
AU,HEPATIC NECROSIS,1
AU,HEPATITIS,1
AU,HEPATITIS ACUTE,1
AU,HEPATOCELLULAR INJURY,1
AU,HEPATOTOXICITY,1
AU,HERPES ZOSTER,1
AU,HILAR LYMPHADENOPATHY,1
AU,HIP SURGERY,1
AU,HOT FLUSH,1
AU,HYPERBILIRUBINAEMIA,1
AU,HYPERFERRITINAEMIA,1
AU,HYPERPHAGIA,1
AU,HYPERPHOSPHATAEMIA,1
AU,HYPOGLYCAEMIA,1
AU,HYPOPHAGIA,1
AU,HYPOPHOSPHATAEMIA,1
AU,HYPOTHYROIDISM,1
AU,HYPOTONIA,1
AU,HYPOURICAEMIA,1
AU,HYPOXIA,1
AU,IMMUNOSUPPRESSION,1
AU,IMPAIRED HEALING,1
AU,IMPAIRED WORK ABILITY,1
AU,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
AU,INFARCTION,1
AU,INFECTION,1
AU,INFECTION SUSCEPTIBILITY INCREASED,1
AU,INFLUENZA LIKE ILLNESS,1
AU,INFUSION SITE BRUISING,1
AU,INJECTION SITE THROMBOSIS,1
AU,INTENTIONAL SELF-INJURY,1
AU,IRON DEFICIENCY,1
AU,IRRITABILITY,1
AU,JAUNDICE,1
AU,JOINT SWELLING,1
AU,KAWASAKI^S DISEASE,1
AU,LACERATION,1
AU,LACTIC ACIDOSIS,1
AU,LIMB DISCOMFORT,1
AU,LIVER FUNCTION TEST INCREASED,1
AU,LOBAR PNEUMONIA,1
AU,LOSS OF CONSCIOUSNESS,1
AU,LUNG DISORDER,1
AU,LYMPHADENITIS,1
AU,LYMPHOEDEMA,1
AU,MASTOCYTOSIS,1
AU,MENINGITIS,1
AU,MENTAL DISORDER,1
AU,METASTASES TO BONE,1
AU,METASTASES TO GASTROINTESTINAL TRACT,1
AU,MICROCYTIC ANAEMIA,1
AU,MITRAL VALVE INCOMPETENCE,1
AU,MOBILITY DECREASED,1
AU,MOOD ALTERED,1
AU,MOOD SWINGS,1
AU,MUCOCUTANEOUS RASH,1
AU,MULTIPLE FRACTURES,1
AU,MULTIPLE SCLEROSIS RELAPSE,1
AU,MUSCLE CONTUSION,1
AU,MUSCLE SPASMS,1
AU,MUSCLE TWITCHING,1
AU,MYOCARDIAL INFARCTION,1
AU,MYOCARDIAL ISCHAEMIA,1
AU,MYOPATHY,1
AU,NASAL ULCER,1
AU,NERVE COMPRESSION,1
AU,NERVOUS SYSTEM DISORDER,1
AU,NEURALGIA,1
AU,NEUROLOGICAL DECOMPENSATION,1
AU,NEUTROPENIC SEPSIS,1
AU,NIGHT SWEATS,1
AU,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,1
AU,OCULAR ICTERUS,1
AU,OEDEMA,1
AU,OPTIC NEURITIS,1
AU,ORAL HERPES,1
AU,OSTEOPOROSIS,1
AU,OXYGEN SATURATION DECREASED,1
AU,PAIN IN JAW,1
AU,PALPITATIONS,1
AU,PANCYTOPENIA,1
AU,PARAPARESIS,1
AU,PAROTITIS,1
AU,PELVIC PAIN,1
AU,PEPTIC ULCER,1
AU,PERIORBITAL OEDEMA,1
AU,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
AU,PERIPHERAL SWELLING,1
AU,PERITONITIS,1
AU,PETECHIAE,1
AU,PHARYNGITIS,1
AU,PNEUMONIA PNEUMOCOCCAL,1
AU,PNEUMONITIS,1
AU,POLYARTHRITIS,1
AU,POLYMYALGIA RHEUMATICA,1
AU,POLYSUBSTANCE DEPENDENCE,1
AU,POST PROCEDURAL COMPLICATION,1
AU,POSTOPERATIVE WOUND INFECTION,1
AU,POTASSIUM WASTING NEPHROPATHY,1
AU,POTENTIATING DRUG INTERACTION,1
AU,PRODUCT USE ISSUE,1
AU,PROTEIN ALBUMIN RATIO DECREASED,1
AU,PROTEINURIA,1
AU,PSYCHOGENIC SEIZURE,1
AU,PSYCHOTIC DISORDER,1
AU,PULMONARY HAEMORRHAGE,1
AU,PYELONEPHRITIS,1
AU,QUADRIPARESIS,1
AU,RASH MACULO-PAPULAR,1
AU,RASH PRURITIC,1
AU,RECTAL ADENOCARCINOMA,1
AU,RECTAL HAEMORRHAGE,1
AU,REGRESSIVE BEHAVIOUR,1
AU,RENAL DISORDER,1
AU,RENAL FAILURE,1
AU,RENAL IMPAIRMENT,1
AU,RENAL TUBULAR DYSFUNCTION,1
AU,RESTLESS LEGS SYNDROME,1
AU,RESTLESSNESS,1
AU,RETINAL DETACHMENT,1
AU,RHEUMATOID ARTHRITIS,1
AU,SARCOMA OF SKIN,1
AU,SELF INJURIOUS BEHAVIOUR,1
AU,SERUM FERRITIN DECREASED,1
AU,SEVERE INVASIVE STREPTOCOCCAL INFECTION,1
AU,SHOCK HAEMORRHAGIC,1
AU,SINUSITIS,1
AU,SKIN EXFOLIATION,1
AU,SLEEP DISORDER,1
AU,SMALL INTESTINAL STENOSIS,1
AU,SMOOTH MUSCLE ANTIBODY POSITIVE,1
AU,SPINAL COLUMN STENOSIS,1
AU,SPINAL CORD COMPRESSION,1
AU,SPINAL FRACTURE,1
AU,SPINAL FUSION SURGERY,1
AU,SPINAL OSTEOARTHRITIS,1
AU,SPLENIC RUPTURE,1
AU,SQUAMOUS CELL CARCINOMA OF SKIN,1
AU,STATUS ASTHMATICUS,1
AU,STOMATITIS,1
AU,STRESS,1
AU,STRESS CARDIOMYOPATHY,1
AU,SWELLING,1
AU,SWELLING FACE,1
AU,SYNCOPE,1
AU,SYNOVIAL CYST,1
AU,TEMPOROMANDIBULAR JOINT SYNDROME,1
AU,TENDERNESS,1
AU,TENSION,1
AU,THALAMUS HAEMORRHAGE,1
AU,THERAPEUTIC RESPONSE DECREASED,1
AU,THERAPEUTIC RESPONSE UNEXPECTED,1
AU,THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION,1
AU,THROAT TIGHTNESS,1
AU,THROMBOPHLEBITIS SUPERFICIAL,1
AU,TINNITUS,1
AU,TOBACCO USER,1
AU,TREATMENT FAILURE,1
AU,TREMOR,1
AU,TRICUSPID VALVE INCOMPETENCE,1
AU,TUBULOINTERSTITIAL NEPHRITIS,1
AU,TUMOUR HAEMORRHAGE,1
AU,TUNNEL VISION,1
AU,UNRESPONSIVE TO STIMULI,1
AU,URTICARIA,1
AU,UTERINE LEIOMYOMA,1
AU,VENTRICULAR HYPERKINESIA,1
AU,VERTIGO,1
AU,VIRAL MUTATION IDENTIFIED,1
AU,VISUAL IMPAIRMENT,1
AU,VON WILLEBRAND^S DISEASE,1
AU,WALKING AID USER,1
AU,WHEEZING,1
AU,WHITE BLOOD CELL COUNT INCREASED,1
AU,WOUND,1
AU,WOUND SECRETION,1
AU,YELLOW SKIN,1
AT,ACUTE MYOCARDIAL INFARCTION,6
AT,CARDIOGENIC SHOCK,6
AT,PANCREATITIS,5
AT,VOMITING,5
AT,AMYLASE INCREASED,4
AT,LIPASE INCREASED,4
AT,CHEST PAIN,3
AT,HEADACHE,3
AT,OEDEMA PERIPHERAL,3
AT,OPTIC NEURITIS,3
AT,RASH MACULO-PAPULAR,3
AT,THROMBOSIS IN DEVICE,3
AT,WEIGHT DECREASED,3
AT,ACUTE KIDNEY INJURY,2
AT,ANAPHYLACTIC REACTION,2
AT,ARTHRALGIA,2
AT,ASCITES,2
AT,BONE PAIN,2
AT,BRADYCARDIA,2
AT,CARDIOMYOPATHY,2
AT,DIARRHOEA,2
AT,DRUG INEFFECTIVE,2
AT,FALL,2
AT,FATIGUE,2
AT,HEPATOMEGALY,2
AT,HYPERTENSION,2
AT,HYPOCALCAEMIA,2
AT,HYPOKALAEMIA,2
AT,HYPONATRAEMIA,2
AT,JUGULAR VEIN THROMBOSIS,2
AT,MYALGIA,2
AT,NAUSEA,2
AT,PAIN,2
AT,PLEURAL EFFUSION,2
AT,POLYNEUROPATHY,2
AT,PULMONARY CONGESTION,2
AT,PYREXIA,2
AT,RENAL FAILURE,2
AT,SUBCLAVIAN VEIN THROMBOSIS,2
AT,TYPE IV HYPERSENSITIVITY REACTION,2
AT,ACUTE HEPATIC FAILURE,1
AT,ACUTE RESPIRATORY DISTRESS SYNDROME,1
AT,ANAPLASTIC LARGE-CELL LYMPHOMA,1
AT,ANGIOPATHY,1
AT,AORTIC ARTERIOSCLEROSIS,1
AT,ATELECTASIS,1
AT,BILE DUCT STONE,1
AT,BLOOD CHOLESTEROL INCREASED,1
AT,BLOOD PRESSURE INCREASED,1
AT,BLOOD TRIGLYCERIDES INCREASED,1
AT,BONE GIANT CELL TUMOUR MALIGNANT,1
AT,BONE LESION,1
AT,CANDIDURIA,1
AT,CARDIAC ARREST,1
AT,CARDIAC FAILURE,1
AT,CAROTID ARTERY THROMBOSIS,1
AT,CEREBROVASCULAR ACCIDENT,1
AT,CHEST DISCOMFORT,1
AT,CHOLESTASIS,1
AT,COAGULATION TIME SHORTENED,1
AT,CONDITION AGGRAVATED,1
AT,CYTOMEGALOVIRUS COLITIS,1
AT,DELIRIUM,1
AT,DEPRESSION,1
AT,DERMATITIS,1
AT,DIARRHOEA HAEMORRHAGIC,1
AT,DIASTOLIC DYSFUNCTION,1
AT,DILATATION VENTRICULAR,1
AT,DIPLOPIA,1
AT,DIZZINESS,1
AT,DRUG ADMINISTRATION ERROR,1
AT,DRUG DEPENDENCE,1
AT,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
AT,DRUG-INDUCED LIVER INJURY,1
AT,DYSPNOEA,1
AT,ERYSIPELAS,1
AT,FAECES DISCOLOURED,1
AT,FEMUR FRACTURE,1
AT,GAIT DISTURBANCE,1
AT,GASTRITIS,1
AT,GASTROINTESTINAL HAEMORRHAGE,1
AT,GLUTAMATE DEHYDROGENASE INCREASED,1
AT,HAEMOGLOBIN DECREASED,1
AT,HEPATIC FAILURE,1
AT,HEPATIC STEATOSIS,1
AT,HEPATOTOXICITY,1
AT,HIDRADENITIS,1
AT,HYDROCHOLECYSTIS,1
AT,HYPERKALAEMIA,1
AT,HYPERTHYROIDISM,1
AT,HYPOPROTEINAEMIA,1
AT,INFECTION,1
AT,INFLAMMATORY BOWEL DISEASE,1
AT,INFLAMMATORY MARKER INCREASED,1
AT,INTERVERTEBRAL DISC DISORDER,1
AT,LEFT VENTRICULAR DYSFUNCTION,1
AT,LEUKOPENIA,1
AT,LIVER DISORDER,1
AT,LIVER FUNCTION TEST ABNORMAL,1
AT,LIVER FUNCTION TEST INCREASED,1
AT,LYMPHATIC DISORDER,1
AT,MALABSORPTION,1
AT,MALIGNANT NEOPLASM PROGRESSION,1
AT,METASTASES TO MENINGES,1
AT,MUSCULAR WEAKNESS,1
AT,NEPHROPATHY,1
AT,NEUTROPENIA,1
AT,NOSOCOMIAL INFECTION,1
AT,OCULAR ICTERUS,1
AT,OEDEMA,1
AT,OESOPHAGEAL CANDIDIASIS,1
AT,OSTEONECROSIS,1
AT,OVERDOSE,1
AT,PANCREATIC FAILURE,1
AT,PAPILLARY THYROID CANCER,1
AT,PATHOGEN RESISTANCE,1
AT,PERIPHERAL VENOUS DISEASE,1
AT,PNEUMONIA,1
AT,PNEUMONIA KLEBSIELLA,1
AT,POST-TRAUMATIC STRESS DISORDER,1
AT,RENAL CYST,1
AT,SEPSIS,1
AT,SKIN ULCER,1
AT,SOMNOLENCE,1
AT,SPLENOMEGALY,1
AT,SQUAMOUS CELL CARCINOMA OF LUNG,1
AT,SUICIDAL IDEATION,1
AT,SWELLING,1
AT,SYSTOLIC DYSFUNCTION,1
AT,TACHYCARDIA,1
AT,TACHYPNOEA,1
AT,THERAPEUTIC RESPONSE DECREASED,1
AT,TINNITUS,1
AT,TOOTHACHE,1
AT,TRANSAMINASES INCREASED,1
AT,UPPER GASTROINTESTINAL HAEMORRHAGE,1
AT,URINARY TRACT INFECTION,1
AT,URTICARIA,1
AT,VARICES OESOPHAGEAL,1
BH,INJECTION SITE MASS,2
BH,PAIN,2
BH,UPPER RESPIRATORY TRACT INFECTION,2
BD,ARTHRALGIA,1
BD,KWASHIORKOR,1
BD,OEDEMA,1
BD,PURPURA,1
BD,RESPIRATORY DISTRESS,1
BD,RICKETTSIOSIS,1
BD,VISCERAL LEISHMANIASIS,1
BE,AGITATION,18
BE,ACUTE KIDNEY INJURY,16
BE,AGGRESSION,14
BE,CONFUSIONAL STATE,13
BE,MYDRIASIS,13
BE,TOXICITY TO VARIOUS AGENTS,12
BE,POISONING,11
BE,VOMITING,10
BE,DEHYDRATION,8
BE,DIARRHOEA,8
BE,METABOLIC ACIDOSIS,8
BE,NAUSEA,8
BE,PYREXIA,7
BE,COMA,6
BE,FATIGUE,6
BE,HYPERLACTACIDAEMIA,6
BE,HYPOGLYCAEMIA,6
BE,ARTHRALGIA,5
BE,GENERAL PHYSICAL HEALTH DETERIORATION,5
BE,HYPERCALCAEMIA,5
BE,RASH,5
BE,RENAL FAILURE ACUTE,5
BE,ABDOMINAL DISCOMFORT,4
BE,ACUTE RESPIRATORY DISTRESS SYNDROME,4
BE,DECREASED APPETITE,4
BE,ERYTHEMA,4
BE,GASTROINTESTINAL DISORDER,4
BE,HEADACHE,4
BE,HYPOXIA,4
BE,LOSS OF CONSCIOUSNESS,4
BE,OVERDOSE,4
BE,THROMBOCYTOPENIA,4
BE,URTICARIA,4
BE,ACUTE LUNG INJURY,3
BE,ALLERGIC OEDEMA,3
BE,ANAPHYLACTIC REACTION,3
BE,DYSPEPSIA,3
BE,EAR INFECTION,3
BE,ECZEMA,3
BE,ERYTHEMA INFECTIOSUM,3
BE,FEBRILE NEUTROPENIA,3
BE,HAEMORRHAGE,3
BE,HOT FLUSH,3
BE,HYPERGLYCAEMIA,3
BE,HYPERTRIGLYCERIDAEMIA,3
BE,HYPOTENSION,3
BE,JOINT DISLOCATION,3
BE,LIP SWELLING,3
BE,MALIGNANT NEOPLASM PROGRESSION,3
BE,MENTAL DISORDER,3
BE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
BE,MUSCULOSKELETAL PAIN,3
BE,OSTEONECROSIS OF JAW,3
BE,PSORIASIS,3
BE,RESPIRATORY TRACT INFECTION,3
BE,RHABDOMYOLYSIS,3
BE,VERTIGO,3
BE,ABDOMINAL DISTENSION,2
BE,ABDOMINAL PAIN,2
BE,ABDOMINAL PAIN LOWER,2
BE,ANAPHYLACTIC SHOCK,2
BE,ARRHYTHMIA,2
BE,ARTHRITIS,2
BE,BACK PAIN,2
BE,BLOOD UREA INCREASED,2
BE,CONCOMITANT DISEASE AGGRAVATED,2
BE,CONDITION AGGRAVATED,2
BE,DEPRESSED LEVEL OF CONSCIOUSNESS,2
BE,DEPRESSED MOOD,2
BE,DIABETES MELLITUS,2
BE,DISEASE PROGRESSION,2
BE,DRUG INEFFECTIVE,2
BE,DYSPNOEA,2
BE,ENTEROCOLITIS,2
BE,FALL,2
BE,HAEMOGLOBIN DECREASED,2
BE,HEPATIC FAILURE,2
BE,HYPERAMMONAEMIC ENCEPHALOPATHY,2
BE,HYPERREFLEXIA,2
BE,ILEUS,2
BE,INFLUENZA LIKE ILLNESS,2
BE,LEUKOPENIA,2
BE,MENTAL STATUS CHANGES,2
BE,OSTEOARTHRITIS,2
BE,PAIN,2
BE,PANCYTOPENIA,2
BE,PERIORBITAL OEDEMA,2
BE,PROTEINURIA,2
BE,PULMONARY ALVEOLAR HAEMORRHAGE,2
BE,PULMONARY EMBOLISM,2
BE,RESTLESSNESS,2
BE,RHINORRHOEA,2
BE,SEIZURE,2
BE,SEPSIS,2
BE,SHOCK HAEMORRHAGIC,2
BE,SKIN LESION,2
BE,TOXIC EPIDERMAL NECROLYSIS,2
BE,TYPE 2 DIABETES MELLITUS,2
BE,URINARY TRACT INFECTION,2
BE,ABASIA,1
BE,ABSCESS,1
BE,ACIDOSIS,1
BE,ACUTE HEPATIC FAILURE,1
BE,AMENORRHOEA,1
BE,AMMONIA INCREASED,1
BE,ANAEMIA,1
BE,ANGIOEDEMA,1
BE,ANTINUCLEAR ANTIBODY POSITIVE,1
BE,ANXIETY,1
BE,ARTERIAL INSUFFICIENCY,1
BE,ASCITES,1
BE,ASTHENIA,1
BE,ATRIAL FIBRILLATION,1
BE,AVULSION FRACTURE,1
BE,BENIGN BREAST NEOPLASM,1
BE,BLADDER DISORDER,1
BE,BLOOD ALKALINE PHOSPHATASE INCREASED,1
BE,BLOOD CHLORIDE INCREASED,1
BE,BLOOD CHOLESTEROL INCREASED,1
BE,BLOOD GLUCOSE INCREASED,1
BE,BLOOD LACTIC ACID INCREASED,1
BE,BLOOD OSMOLARITY INCREASED,1
BE,BLOOD SODIUM INCREASED,1
BE,BRADYCARDIA,1
BE,BRAIN OEDEMA,1
BE,BREAST CANCER,1
BE,BRONCHITIS,1
BE,BURNING SENSATION,1
BE,BURSITIS,1
BE,C-REACTIVE PROTEIN INCREASED,1
BE,CARDIAC ARREST,1
BE,CARDIAC FAILURE,1
BE,CARDIORENAL SYNDROME,1
BE,CELLULITIS,1
BE,CEREBRAL HAEMORRHAGE,1
BE,CHEST PAIN,1
BE,CHILLS,1
BE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
BE,COMA SCALE ABNORMAL,1
BE,COMPLEX REGIONAL PAIN SYNDROME,1
BE,CONJUNCTIVITIS,1
BE,CORONARY ARTERY DISEASE,1
BE,COUGH,1
BE,CREATININE RENAL CLEARANCE DECREASED,1
BE,CUTANEOUS SARCOIDOSIS,1
BE,DACTYLITIS,1
BE,DEAFNESS,1
BE,DECUBITUS ULCER,1
BE,DEEP VEIN THROMBOSIS,1
BE,DELIRIUM,1
BE,DEPRESSION,1
BE,DERMATITIS BULLOUS,1
BE,DEVICE DISLOCATION,1
BE,DISCOMFORT,1
BE,DIZZINESS,1
BE,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
BE,DYSKINESIA,1
BE,DYSPNOEA EXERTIONAL,1
BE,DYSURIA,1
BE,EAR DISCOMFORT,1
BE,EOSINOPHILIA,1
BE,EXPOSED BONE IN JAW,1
BE,FACIAL PAIN,1
BE,FLUID RETENTION,1
BE,FOLLICULITIS,1
BE,FOOT FRACTURE,1
BE,FRACTURED COCCYX,1
BE,FREEZING PHENOMENON,1
BE,GALLBLADDER ENLARGEMENT,1
BE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
BE,GASTRIC ULCER,1
BE,GASTROENTERITIS ESCHERICHIA COLI,1
BE,GENERALISED OEDEMA,1
BE,GLOMERULONEPHRITIS MINIMAL LESION,1
BE,GRANULOMA,1
BE,GUILLAIN-BARRE SYNDROME,1
BE,HAEMATOCRIT DECREASED,1
BE,HALLUCINATION,1
BE,HEPATITIS,1
BE,HEPATOMEGALY,1
BE,HERPES OESOPHAGITIS,1
BE,HIGH DENSITY LIPOPROTEIN INCREASED,1
BE,HYDROCEPHALUS,1
BE,HYPERHIDROSIS,1
BE,HYPERNATRAEMIA,1
BE,HYPERTENSION,1
BE,HYPERTHYROIDISM,1
BE,HYPERTONIC BLADDER,1
BE,HYPERTRICHOSIS,1
BE,HYPOALBUMINAEMIA,1
BE,HYPOKALAEMIA,1
BE,HYPOKINESIA,1
BE,INCONTINENCE,1
BE,INCORRECT PRODUCT STORAGE,1
BE,INFECTED SKIN ULCER,1
BE,INFLAMMATION,1
BE,INJECTION SITE SWELLING,1
BE,INSOMNIA,1
BE,INTESTINAL OPERATION,1
BE,INTESTINAL PERFORATION,1
BE,LACTIC ACIDOSIS,1
BE,LIVER DISORDER,1
BE,LOCALISED INTRAABDOMINAL FLUID COLLECTION,1
BE,LOW DENSITY LIPOPROTEIN INCREASED,1
BE,LUNG ADENOCARCINOMA,1
BE,LUNG HYPERINFLATION,1
BE,LYMPHADENOPATHY,1
BE,LYMPHOPENIA,1
BE,MALAISE,1
BE,MALIGNANT MELANOMA,1
BE,METASTASES TO CENTRAL NERVOUS SYSTEM,1
BE,METASTASES TO LIVER,1
BE,MULTIPLE SCLEROSIS,1
BE,MULTIPLE SCLEROSIS RELAPSE,1
BE,MUSCLE INJURY,1
BE,MUSCULOSKELETAL DISCOMFORT,1
BE,MUSCULOSKELETAL DISORDER,1
BE,MYALGIA,1
BE,NECROSIS,1
BE,NEOPLASM PROGRESSION,1
BE,NEPHROLITHIASIS,1
BE,NEPHROTIC SYNDROME,1
BE,NEUTROPHIL COUNT INCREASED,1
BE,NIGHT SWEATS,1
BE,ODYNOPHAGIA,1
BE,OEDEMA,1
BE,OEDEMA PERIPHERAL,1
BE,OPTIC NEURITIS,1
BE,OROPHARYNGEAL PAIN,1
BE,OSTEOMA,1
BE,OSTEONECROSIS,1
BE,OSTEOPENIA,1
BE,OSTEOPOROSIS,1
BE,PAIN IN EXTREMITY,1
BE,PAIN IN JAW,1
BE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
BE,PALPITATIONS,1
BE,PANCREATIC DISORDER,1
BE,PELVIC INFLAMMATORY DISEASE,1
BE,PEMPHIGOID,1
BE,PERIARTHRITIS,1
BE,PERICARDIAL EFFUSION,1
BE,PERITONEAL HAEMORRHAGE,1
BE,PLEURAL EFFUSION,1
BE,PLEURAL NEOPLASM,1
BE,PLEURISY,1
BE,PNEUMONIA,1
BE,PNEUMONITIS,1
BE,PNEUMOTHORAX,1
BE,POLYARTHRITIS,1
BE,POOR QUALITY SLEEP,1
BE,POST PROCEDURAL INFECTION,1
BE,PRODUCT USE IN UNAPPROVED INDICATION,1
BE,PROPOFOL INFUSION SYNDROME,1
BE,PRURITUS,1
BE,PSORIATIC ARTHROPATHY,1
BE,PURULENT DISCHARGE,1
BE,PYELONEPHRITIS,1
BE,RENAL IMPAIRMENT,1
BE,RESPIRATORY FAILURE,1
BE,RHINITIS,1
BE,ROTATOR CUFF SYNDROME,1
BE,SALIVARY GLAND CYST,1
BE,SCAB,1
BE,SEPTIC SHOCK,1
BE,SINUS TACHYCARDIA,1
BE,SMALL INTESTINAL HAEMORRHAGE,1
BE,SMALL INTESTINAL OBSTRUCTION,1
BE,SNEEZING,1
BE,SPINAL CORD COMPRESSION,1
BE,SPINAL CORD OEDEMA,1
BE,STAPHYLOCOCCAL BACTERAEMIA,1
BE,STATUS EPILEPTICUS,1
BE,STOMA SITE INFECTION,1
BE,STOMA SITE IRRITATION,1
BE,STRESS FRACTURE,1
BE,SUPRAVENTRICULAR EXTRASYSTOLES,1
BE,SYRINGOMYELIA,1
BE,TENOSYNOVITIS,1
BE,THROMBOTIC MICROANGIOPATHY,1
BE,TOXIC SKIN ERUPTION,1
BE,TRANSAMINASES INCREASED,1
BE,TYPE I HYPERSENSITIVITY,1
BE,ULCER,1
BE,UNRESPONSIVE TO STIMULI,1
BE,UPPER RESPIRATORY TRACT INFECTION,1
BE,URINE OUTPUT DECREASED,1
BE,VAGINAL HAEMORRHAGE,1
BE,VENTRICULAR EXTRASYSTOLES,1
BE,WEIGHT INCREASED,1
BE,WOUND,1
BA,ABDOMINAL PAIN UPPER,1
BA,ASTHENIA,1
BA,RASH,1
BW,VIITH NERVE PARALYSIS,1
BR,PAIN,85
BR,ARTHRALGIA,54
BR,HEADACHE,47
BR,DRUG INEFFECTIVE,43
BR,PYREXIA,43
BR,PAIN IN EXTREMITY,42
BR,MALAISE,41
BR,GAIT DISTURBANCE,36
BR,DYSPNOEA,30
BR,FALL,28
BR,FATIGUE,28
BR,INJECTION SITE ERYTHEMA,26
BR,PERIPHERAL SWELLING,26
BR,DIZZINESS,25
BR,HYPERSENSITIVITY,24
BR,INFLUENZA,21
BR,VOMITING,21
BR,WEIGHT DECREASED,21
BR,HYPOAESTHESIA,20
BR,MULTIPLE SCLEROSIS RELAPSE,20
BR,INJECTION SITE PAIN,19
BR,PNEUMONIA,19
BR,DRUG DOSE OMISSION,18
BR,HYPERTENSION,18
BR,NAUSEA,18
BR,TREMOR,18
BR,URINARY TRACT INFECTION,18
BR,BACK PAIN,16
BR,RHEUMATOID ARTHRITIS,16
BR,SWELLING,16
BR,ARTHROPATHY,15
BR,ERYTHEMA,15
BR,FEELING ABNORMAL,15
BR,MUSCULAR WEAKNESS,15
BR,PRURITUS,15
BR,ASTHENIA,14
BR,DIARRHOEA,14
BR,PRODUCT USE ISSUE,14
BR,ANAEMIA,13
BR,DEPRESSION,13
BR,IMMUNODEFICIENCY,13
BR,INSOMNIA,13
BR,MUSCULOSKELETAL STIFFNESS,13
BR,PARAESTHESIA,13
BR,WEIGHT INCREASED,13
BR,ABDOMINAL PAIN UPPER,12
BR,ANAPHYLACTIC REACTION,12
BR,CHEST PAIN,12
BR,JOINT SWELLING,12
BR,MEMORY IMPAIRMENT,12
BR,BALANCE DISORDER,11
BR,BLOOD CHOLESTEROL INCREASED,11
BR,CHOLELITHIASIS,11
BR,SINUSITIS,11
BR,SOMNOLENCE,11
BR,VISION BLURRED,11
BR,BLOOD PRESSURE INCREASED,10
BR,DIABETES MELLITUS,10
BR,FOOT DEFORMITY,10
BR,ABASIA,9
BR,BURNING SENSATION,9
BR,COUGH,9
BR,DECREASED APPETITE,9
BR,INTERVERTEBRAL DISC PROTRUSION,9
BR,MOBILITY DECREASED,9
BR,SKIN DISCOLOURATION,9
BR,BEDRIDDEN,8
BR,CATARACT,8
BR,CENTRAL NERVOUS SYSTEM LESION,8
BR,INFLAMMATION,8
BR,LIVER DISORDER,8
BR,NEPHROLITHIASIS,8
BR,OSTEOPOROSIS,8
BR,SYNCOPE,8
BR,VISUAL IMPAIRMENT,8
BR,ABDOMINAL DISTENSION,7
BR,CHILLS,7
BR,DENGUE FEVER,7
BR,DYSPHAGIA,7
BR,FEELING HOT,7
BR,INJECTION SITE PRURITUS,7
BR,LOCAL SWELLING,7
BR,MUSCLE SPASMS,7
BR,NASOPHARYNGITIS,7
BR,NERVOUSNESS,7
BR,PSORIASIS,7
BR,SPINAL PAIN,7
BR,SWELLING FACE,7
BR,THROAT IRRITATION,7
BR,VIRAL INFECTION,7
BR,ABDOMINAL DISCOMFORT,6
BR,ABDOMINAL PAIN,6
BR,ALOPECIA,6
BR,BLISTER,6
BR,BONE EROSION,6
BR,BONE PAIN,6
BR,DEPRESSED MOOD,6
BR,DRUG EFFECT INCOMPLETE,6
BR,HAEMORRHAGE,6
BR,INFARCTION,6
BR,INFLUENZA LIKE ILLNESS,6
BR,INJECTION SITE HAEMATOMA,6
BR,LIMB INJURY,6
BR,MOVEMENT DISORDER,6
BR,OROPHARYNGEAL PAIN,6
BR,OSTEOARTHRITIS,6
BR,PHARYNGITIS,6
BR,PLEURAL EFFUSION,6
BR,RENAL DISORDER,6
BR,TUBERCULOSIS,6
BR,WOUND,6
BR,AGITATION,5
BR,AMNESIA,5
BR,ANXIETY,5
BR,ARTHRITIS,5
BR,CEREBROVASCULAR ACCIDENT,5
BR,CONDITION AGGRAVATED,5
BR,CONSTIPATION,5
BR,DRUG HYPERSENSITIVITY,5
BR,DRY MOUTH,5
BR,DYSPHONIA,5
BR,DYSSTASIA,5
BR,EYE PAIN,5
BR,FEMUR FRACTURE,5
BR,FINGER DEFORMITY,5
BR,FOOT FRACTURE,5
BR,FUNGAL INFECTION,5
BR,GASTRITIS,5
BR,INCORRECT DOSE ADMINISTERED,5
BR,INJECTION SITE BRUISING,5
BR,INJECTION SITE NODULE,5
BR,INJECTION SITE SWELLING,5
BR,LUNG DISORDER,5
BR,MUSCULOSKELETAL PAIN,5
BR,MYALGIA,5
BR,NECK PAIN,5
BR,RETCHING,5
BR,SPEECH DISORDER,5
BR,THROAT TIGHTNESS,5
BR,THROMBOSIS,5
BR,ACTIVITIES OF DAILY LIVING IMPAIRED,4
BR,BLINDNESS,4
BR,BLOOD CHOLESTEROL ABNORMAL,4
BR,BLOOD GLUCOSE INCREASED,4
BR,CHEST DISCOMFORT,4
BR,CONFUSIONAL STATE,4
BR,DEATH,4
BR,DISCOMFORT,4
BR,DRUG DEPENDENCE,4
BR,DRUG EFFECT DECREASED,4
BR,DYSGEUSIA,4
BR,EPISTAXIS,4
BR,ERYSIPELAS,4
BR,EYE INFLAMMATION,4
BR,EYE SWELLING,4
BR,FIBROMYALGIA,4
BR,FOREIGN BODY,4
BR,GASTRIC DISORDER,4
BR,HAND DEFORMITY,4
BR,IMPAIRED HEALING,4
BR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
BR,INFECTION,4
BR,INJECTION SITE DISCOLOURATION,4
BR,INJECTION SITE MASS,4
BR,JOINT INJURY,4
BR,LOCALISED INFECTION,4
BR,MENTAL DISORDER,4
BR,MULTIPLE SCLEROSIS,4
BR,PRE-EXISTING CONDITION IMPROVED,4
BR,PROCEDURAL PAIN,4
BR,RASH,4
BR,RASH MACULAR,4
BR,ROAD TRAFFIC ACCIDENT,4
BR,SEIZURE,4
BR,SENSATION OF HEAVINESS,4
BR,SNEEZING,4
BR,SPINAL DISORDER,4
BR,THERAPEUTIC RESPONSE UNEXPECTED,4
BR,THYROID DISORDER,4
BR,UPPER LIMB FRACTURE,4
BR,URINARY INCONTINENCE,4
BR,URTICARIA,4
BR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,4
BR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,4
BR,APPARENT DEATH,3
BR,ARRHYTHMIA,3
BR,ASTHMA,3
BR,BACTERIAL INFECTION,3
BR,BLOOD PRESSURE FLUCTUATION,3
BR,BONE DISORDER,3
BR,BRONCHITIS,3
BR,CARDIAC ARREST,3
BR,CARDIAC FAILURE,3
BR,CARTILAGE INJURY,3
BR,CHONDROPATHY,3
BR,CYANOSIS,3
BR,DYSPEPSIA,3
BR,EMOTIONAL DISORDER,3
BR,EYE DISORDER,3
BR,FEEDING DISORDER,3
BR,FLATULENCE,3
BR,GASTRIC ULCER,3
BR,GASTROINTESTINAL INFECTION,3
BR,GRIP STRENGTH DECREASED,3
BR,HEMIPLEGIA,3
BR,HOSPITALISATION,3
BR,HYPOTENSION,3
BR,ILL-DEFINED DISORDER,3
BR,IMMUNE SYSTEM DISORDER,3
BR,INCORRECT PRODUCT STORAGE,3
BR,INFUSION RELATED REACTION,3
BR,INJECTION SITE HAEMORRHAGE,3
BR,INTESTINAL PERFORATION,3
BR,JOINT LOCK,3
BR,JOINT STIFFNESS,3
BR,LIMB DISCOMFORT,3
BR,LOWER LIMB FRACTURE,3
BR,LUNG INFECTION,3
BR,MIGRAINE,3
BR,NASAL CONGESTION,3
BR,NASAL DISCOMFORT,3
BR,NEUROPATHY PERIPHERAL,3
BR,OEDEMA PERIPHERAL,3
BR,OESOPHAGITIS,3
BR,PATIENT-DEVICE INCOMPATIBILITY,3
BR,PERIPHERAL COLDNESS,3
BR,PLATELET COUNT DECREASED,3
BR,PRODUCT PHYSICAL ISSUE,3
BR,PRURITUS GENERALISED,3
BR,RENAL PAIN,3
BR,RETINAL DISORDER,3
BR,RHEUMATIC DISORDER,3
BR,RHINITIS,3
BR,RHINORRHOEA,3
BR,SCIATICA,3
BR,SERUM FERRITIN DECREASED,3
BR,SKIN EXFOLIATION,3
BR,SKIN MASS,3
BR,STEVENS-JOHNSON SYNDROME,3
BR,TACHYCARDIA,3
BR,TENDONITIS,3
BR,THERAPEUTIC RESPONSE DECREASED,3
BR,UMBILICAL HERNIA,3
BR,URINARY RETENTION,3
BR,VARICOSE VEIN,3
BR,VITAMIN D DEFICIENCY,3
BR,ABORTION SPONTANEOUS,2
BR,ACCIDENTAL EXPOSURE TO PRODUCT,2
BR,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,2
BR,ACUTE CORONARY SYNDROME,2
BR,ACUTE MYOCARDIAL INFARCTION,2
BR,ADVERSE REACTION,2
BR,AGEUSIA,2
BR,AGGRESSION,2
BR,ANAL FISTULA,2
BR,ANAPHYLACTIC SHOCK,2
BR,ANGINA UNSTABLE,2
BR,ANGIOPATHY,2
BR,APATHY,2
BR,APHASIA,2
BR,ASPARTATE AMINOTRANSFERASE ABNORMAL,2
BR,ASPHYXIA,2
BR,ASTHENOPIA,2
BR,ASTIGMATISM,2
BR,BENIGN NEOPLASM OF THYROID GLAND,2
BR,BLINDNESS UNILATERAL,2
BR,BLOOD GLUCOSE FLUCTUATION,2
BR,BLOOD PRESSURE DECREASED,2
BR,BLOOD TEST ABNORMAL,2
BR,BLOOD TRIGLYCERIDES INCREASED,2
BR,BODY HEIGHT DECREASED,2
BR,BONE ATROPHY,2
BR,BREAST CANCER,2
BR,BREAST CANCER METASTATIC,2
BR,CARDIOVASCULAR DISORDER,2
BR,CATARRH,2
BR,CHIKUNGUNYA VIRUS INFECTION,2
BR,CHOLELITHOTOMY,2
BR,COLITIS ULCERATIVE,2
BR,CONTUSION,2
BR,CRYING,2
BR,DECREASED IMMUNE RESPONSIVENESS,2
BR,DEFORMITY,2
BR,DEMYELINATING POLYNEUROPATHY,2
BR,DRUG PRESCRIBING ERROR,2
BR,DRY EYE,2
BR,DRY SKIN,2
BR,DYSENTERY,2
BR,DYSURIA,2
BR,EAR DISCOMFORT,2
BR,EAR PAIN,2
BR,EATING DISORDER,2
BR,EMPHYSEMA,2
BR,ENDOMETRIOSIS,2
BR,ERUCTATION,2
BR,EXOSTOSIS,2
BR,FACIAL PARALYSIS,2
BR,FAECAL INCONTINENCE,2
BR,FEELING COLD,2
BR,FLUSHING,2
BR,FUNCTIONAL GASTROINTESTINAL DISORDER,2
BR,FURUNCLE,2
BR,GAIT INABILITY,2
BR,GENERALISED ERYTHEMA,2
BR,GINGIVITIS,2
BR,GLAUCOMA,2
BR,HAEMATOMA,2
BR,HAEMORRHAGIC OVARIAN CYST,2
BR,HAND FRACTURE,2
BR,HEARING IMPAIRED,2
BR,HEART INJURY,2
BR,HEPATIC PAIN,2
BR,HERNIA,2
BR,HOT FLUSH,2
BR,HYPERHIDROSIS,2
BR,HYPERKERATOSIS,2
BR,HYPERTENSIVE CRISIS,2
BR,HYPOGLYCAEMIA,2
BR,HYPOKINESIA,2
BR,INFREQUENT BOWEL MOVEMENTS,2
BR,INGUINAL HERNIA,2
BR,INJECTION SITE WARMTH,2
BR,INJURY CORNEAL,2
BR,INTENTIONAL PRODUCT MISUSE,2
BR,INTERVERTEBRAL DISC DEGENERATION,2
BR,IRRITABILITY,2
BR,JOINT DISLOCATION,2
BR,JOINT RANGE OF MOTION DECREASED,2
BR,JUVENILE IDIOPATHIC ARTHRITIS,2
BR,KNEE DEFORMITY,2
BR,KNEE OPERATION,2
BR,LABYRINTHITIS,2
BR,LACERATION,2
BR,LIGAMENT SPRAIN,2
BR,LIMB DEFORMITY,2
BR,LIVER FUNCTION TEST ABNORMAL,2
BR,LOSS OF CONSCIOUSNESS,2
BR,LOSS OF CONTROL OF LEGS,2
BR,MALIGNANT NEOPLASM PROGRESSION,2
BR,MASS,2
BR,MATERNAL EXPOSURE DURING PREGNANCY,2
BR,MENSTRUAL DISORDER,2
BR,MICTURITION URGENCY,2
BR,MINERAL DEFICIENCY,2
BR,MITRAL VALVE PROLAPSE,2
BR,MULTI-ORGAN FAILURE,2
BR,MUSCLE RIGIDITY,2
BR,MUSCULOSKELETAL CHEST PAIN,2
BR,NASAL PRURITUS,2
BR,NERVE INJURY,2
BR,NEURALGIA,2
BR,NOCTURNAL DYSPNOEA,2
BR,NODULE,2
BR,ORAL DISCOMFORT,2
BR,OROPHARYNGEAL DISCOMFORT,2
BR,OXYGEN SATURATION DECREASED,2
BR,PALPITATIONS,2
BR,PANCREATIC CYST,2
BR,PANCREATITIS CHRONIC,2
BR,PERIPHERAL VASCULAR DISORDER,2
BR,PETECHIAE,2
BR,POISONING,2
BR,POOR QUALITY DRUG ADMINISTERED,2
BR,POSTOPERATIVE WOUND INFECTION,2
BR,PRESYNCOPE,2
BR,PRODUCT SIZE ISSUE,2
BR,PRURITUS ALLERGIC,2
BR,PULMONARY MASS,2
BR,RASH ERYTHEMATOUS,2
BR,RASH PAPULAR,2
BR,RENAL FAILURE,2
BR,RESPIRATORY FATIGUE,2
BR,RHEUMATOID FACTOR INCREASED,2
BR,SECRETION DISCHARGE,2
BR,SENSORY LOSS,2
BR,SEPSIS,2
BR,SEPTIC SHOCK,2
BR,SERUM FERRITIN INCREASED,2
BR,SKIN LESION,2
BR,SLEEP DISORDER,2
BR,SPINAL OPERATION,2
BR,SYNOVIAL CYST,2
BR,SYSTEMIC LUPUS ERYTHEMATOSUS,2
BR,THERAPY CESSATION,2
BR,THYROID NEOPLASM,2
BR,TOOTH EXTRACTION,2
BR,TOOTH INFECTION,2
BR,TOXIC EPIDERMAL NECROLYSIS,2
BR,TOXICITY TO VARIOUS AGENTS,2
BR,UNEVALUABLE EVENT,2
BR,URINE ABNORMALITY,2
BR,UTERINE LEIOMYOMA,2
BR,UVEITIS,2
BR,VARICELLA,2
BR,VISUAL ACUITY REDUCED,2
BR,VITAMIN B12 DEFICIENCY,2
BR,ABDOMINAL HERNIA,1
BR,ABDOMINAL HERNIA REPAIR,1
BR,ABDOMINAL PAIN LOWER,1
BR,ABDOMINAL SEPSIS,1
BR,ABNORMAL FAECES,1
BR,ABORTION INDUCED,1
BR,ACCIDENT,1
BR,ACNE,1
BR,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
BR,ALANINE AMINOTRANSFERASE INCREASED,1
BR,ALLERGIC COUGH,1
BR,ALLERGIC RESPIRATORY SYMPTOM,1
BR,ANAL ABSCESS,1
BR,ANEURYSM,1
BR,ANGINA PECTORIS,1
BR,ANGIOEDEMA,1
BR,ANKLE FRACTURE,1
BR,ANTI-THYROID ANTIBODY POSITIVE,1
BR,AORTIC ARTERIOSCLEROSIS,1
BR,APHAGIA,1
BR,APHONIA,1
BR,APPENDICITIS,1
BR,APPLICATION SITE ERYTHEMA,1
BR,APPLICATION SITE HYPERSENSITIVITY,1
BR,APPLICATION SITE PRURITUS,1
BR,APPLICATION SITE SWELLING,1
BR,ASPARTATE AMINOTRANSFERASE INCREASED,1
BR,ASTHMATIC CRISIS,1
BR,AUTOIMMUNE DISORDER,1
BR,AUTOIMMUNE THYROIDITIS,1
BR,BACK DISORDER,1
BR,BACK INJURY,1
BR,BACTERAEMIA,1
BR,BENIGN BREAST NEOPLASM,1
BR,BENIGN HYDATIDIFORM MOLE,1
BR,BENIGN MUSCLE NEOPLASM,1
BR,BILIARY COLIC,1
BR,BIPOLAR DISORDER,1
BR,BLADDER DISORDER,1
BR,BLADDER PAIN,1
BR,BLOOD CREATINE INCREASED,1
BR,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
BR,BLOOD GLUCOSE ABNORMAL,1
BR,BLOOD PRESSURE ABNORMAL,1
BR,BLOOD PRESSURE DIASTOLIC INCREASED,1
BR,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
BR,BLOOD THYROID STIMULATING HORMONE INCREASED,1
BR,BLOOD TRIGLYCERIDES ABNORMAL,1
BR,BONE CALLUS EXCESSIVE,1
BR,BONE DENSITY DECREASED,1
BR,BONE FISSURE,1
BR,BONE LOSS,1
BR,BONE NEOPLASM,1
BR,BRADYCARDIA,1
BR,BRAIN DEATH,1
BR,BRAIN OPERATION,1
BR,BREAST CALCIFICATIONS,1
BR,BREATH SOUNDS ABNORMAL,1
BR,BRONCHITIS CHRONIC,1
BR,BRONCHOPULMONARY DYSPLASIA,1
BR,BURN ORAL CAVITY,1
BR,CANDIDA INFECTION,1
BR,CARDIAC DISORDER,1
BR,CARDIAC VALVE RUPTURE,1
BR,CARDIO-RESPIRATORY ARREST,1
BR,CARDIOMEGALY,1
BR,CARTILAGE ATROPHY,1
BR,CATHETERISATION CARDIAC,1
BR,CELLULITIS,1
BR,CEREBRAL DISORDER,1
BR,CEREBRAL HAEMORRHAGE,1
BR,CEREBRAL ISCHAEMIA,1
BR,CEREBRAL MICROHAEMORRHAGE,1
BR,CERVICAL VERTEBRAL FRACTURE,1
BR,CERVIX INFLAMMATION,1
BR,CHEMICAL EYE INJURY,1
BR,CHEST INJURY,1
BR,CHEST X-RAY ABNORMAL,1
BR,CHOKING,1
BR,CHOLECYSTECTOMY,1
BR,CHONDRITIS,1
BR,CHRONIC SINUSITIS,1
BR,COGNITIVE DISORDER,1
BR,COLD SWEAT,1
BR,COMPUTERISED TOMOGRAM THORAX ABNORMAL,1
BR,CONCOMITANT DISEASE AGGRAVATED,1
BR,CONJUNCTIVITIS,1
BR,COORDINATION ABNORMAL,1
BR,CORNEAL PERFORATION,1
BR,CROHN^S DISEASE,1
BR,CRYSTAL URINE,1
BR,CRYSTAL URINE PRESENT,1
BR,CYST,1
BR,CYSTIC FIBROSIS HEPATIC DISEASE,1
BR,DEAFNESS,1
BR,DECREASED ACTIVITY,1
BR,DEEP VEIN THROMBOSIS,1
BR,DEHYDRATION,1
BR,DEMENTIA ALZHEIMER^S TYPE,1
BR,DEMYELINATION,1
BR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
BR,DERMATITIS ALLERGIC,1
BR,DEVICE BREAKAGE,1
BR,DEVICE DIFFICULT TO USE,1
BR,DEVICE FAILURE,1
BR,DEVICE ISSUE,1
BR,DEVICE MALFUNCTION,1
BR,DIABETIC KETOACIDOSIS,1
BR,DIPLEGIA,1
BR,DISEASE PROGRESSION,1
BR,DISORIENTATION,1
BR,DISTURBANCE IN ATTENTION,1
BR,DIVERTICULITIS,1
BR,DRUG ABUSE,1
BR,DRUG ADMINISTRATION ERROR,1
BR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
BR,DRY THROAT,1
BR,DYSARTHRIA,1
BR,DYSMENORRHOEA,1
BR,EAR HAEMORRHAGE,1
BR,EAR INFECTION,1
BR,ECTOPIC PREGNANCY,1
BR,EMOTIONAL DISTRESS,1
BR,ENDOCRINE DISORDER,1
BR,EROSIVE OESOPHAGITIS,1
BR,EXCESSIVE GRANULATION TISSUE,1
BR,EXPIRED PRODUCT ADMINISTERED,1
BR,EXPOSURE DURING PREGNANCY,1
BR,EXPOSURE TO LEAD,1
BR,EXTERNAL EAR INFLAMMATION,1
BR,EYE BURNS,1
BR,EYE MOVEMENT DISORDER,1
BR,EYE OPERATION,1
BR,EYELID OEDEMA,1
BR,FACE INJURY,1
BR,FACIAL BONES FRACTURE,1
BR,FACIAL PAIN,1
BR,FEAR,1
BR,FEELING OF BODY TEMPERATURE CHANGE,1
BR,FEELING OF DESPAIR,1
BR,FLAVIVIRUS INFECTION,1
BR,FLUID RETENTION,1
BR,FOOD INTOLERANCE,1
BR,FULL BLOOD COUNT DECREASED,1
BR,GALLBLADDER DISORDER,1
BR,GALLBLADDER POLYP,1
BR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
BR,GASTRIC MUCOSAL LESION,1
BR,GASTRITIS HAEMORRHAGIC,1
BR,GASTROINTESTINAL DISORDER,1
BR,GASTROINTESTINAL HAEMORRHAGE,1
BR,GASTROINTESTINAL NEOPLASM,1
BR,GASTROINTESTINAL SOUNDS ABNORMAL,1
BR,GENERAL PHYSICAL HEALTH DETERIORATION,1
BR,GINGIVAL PAIN,1
BR,GINGIVAL PRURITUS,1
BR,GLUTEN SENSITIVITY,1
BR,GOUT,1
BR,HAEMANGIOMA,1
BR,HAEMANGIOMA OF BONE,1
BR,HAEMARTHROSIS,1
BR,HAEMATEMESIS,1
BR,HAEMATOCHEZIA,1
BR,HAEMATOCRIT DECREASED,1
BR,HAEMATOSALPINX,1
BR,HAEMOGLOBIN DECREASED,1
BR,HAEMOPTYSIS,1
BR,HAEMORRHAGIC STROKE,1
BR,HAEMORRHOIDS,1
BR,HALLUCINATION_ VISUAL,1
BR,HEAD INJURY,1
BR,HEART RATE ABNORMAL,1
BR,HEART RATE DECREASED,1
BR,HEART RATE INCREASED,1
BR,HEAT STROKE,1
BR,HELICOBACTER GASTRITIS,1
BR,HEMIANAESTHESIA,1
BR,HEMIPARESIS,1
BR,HEPATIC ENZYME INCREASED,1
BR,HEPATIC STEATOSIS,1
BR,HEPATITIS,1
BR,HEPATITIS C VIRUS TEST POSITIVE,1
BR,HEPATOTOXICITY,1
BR,HERPES SIMPLEX,1
BR,HERPES VIRUS INFECTION,1
BR,HERPES ZOSTER,1
BR,HILAR LYMPHADENOPATHY,1
BR,HIP DEFORMITY,1
BR,HYPERAEMIA,1
BR,HYPERCHOLESTEROLAEMIA,1
BR,HYPERSOMNIA,1
BR,HYPERTHYROIDISM,1
BR,HYPOPHAGIA,1
BR,HYPOTHERMIA,1
BR,HYPOTHYROIDISM,1
BR,HYPOVITAMINOSIS,1
BR,IMMUNOSUPPRESSION,1
BR,IMPAIRED WORK ABILITY,1
BR,IMPATIENCE,1
BR,INCISION SITE ERYTHEMA,1
BR,INCISION SITE RASH,1
BR,INCISION SITE VESICLES,1
BR,INCREASED BRONCHIAL SECRETION,1
BR,INGUINAL HERNIA REPAIR,1
BR,INJECTION SITE HYPERSENSITIVITY,1
BR,INJECTION SITE INJURY,1
BR,INJECTION SITE PAPULE,1
BR,INJECTION SITE PARAESTHESIA,1
BR,INJECTION SITE RASH,1
BR,INJECTION SITE VESICLES,1
BR,INJURY,1
BR,INJURY ASSOCIATED WITH DEVICE,1
BR,INTERVERTEBRAL DISC CALCIFICATION,1
BR,INTERVERTEBRAL DISC SPACE NARROWING,1
BR,INTESTINAL FISTULA,1
BR,INTESTINAL HAEMORRHAGE,1
BR,INTESTINAL POLYP,1
BR,INTESTINAL STEATOSIS,1
BR,INTRA-ABDOMINAL FLUID COLLECTION,1
BR,INTRAOCULAR PRESSURE INCREASED,1
BR,INTRAVENTRICULAR HAEMORRHAGE,1
BR,IRON DEFICIENCY ANAEMIA,1
BR,ISCHAEMIA,1
BR,ISCHAEMIC STROKE,1
BR,JOINT ANKYLOSIS,1
BR,JOINT DESTRUCTION,1
BR,JOINT WARMTH,1
BR,KERATITIS,1
BR,KIDNEY INFECTION,1
BR,LABILE HYPERTENSION,1
BR,LABORATORY TEST ABNORMAL,1
BR,LEUKAEMIA,1
BR,LEUKAEMIA RECURRENT,1
BR,LEUKOCYTOSIS,1
BR,LIGAMENT RUPTURE,1
BR,LIMB ASYMMETRY,1
BR,LIP DISCOLOURATION,1
BR,LIPIDS INCREASED,1
BR,LIPOEDEMA,1
BR,LIQUID PRODUCT PHYSICAL ISSUE,1
BR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
BR,LOW DENSITY LIPOPROTEIN INCREASED,1
BR,LOWER RESPIRATORY TRACT CONGESTION,1
BR,LUDWIG ANGINA,1
BR,LUMBAR VERTEBRAL FRACTURE,1
BR,LUNG NEOPLASM MALIGNANT,1
BR,LYMPHADENOPATHY MEDIASTINAL,1
BR,LYMPHOCYTE COUNT DECREASED,1
BR,MALIGNANT MELANOMA,1
BR,MAMMOPLASTY,1
BR,MEASLES,1
BR,MEDIASTINUM NEOPLASM,1
BR,MEDICAL DEVICE PAIN,1
BR,MEDICATION ERROR,1
BR,MENINGIOMA,1
BR,MENINGITIS,1
BR,MENISCAL DEGENERATION,1
BR,MENISCUS INJURY,1
BR,MENORRHAGIA,1
BR,METRORRHAGIA,1
BR,MITRAL VALVE DISEASE,1
BR,MOOD ALTERED,1
BR,MOUTH HAEMORRHAGE,1
BR,MUSCLE DISORDER,1
BR,MUSCLE RUPTURE,1
BR,MUSCLE TWITCHING,1
BR,MUSCULOSKELETAL DISORDER,1
BR,MYASTHENIA GRAVIS,1
BR,MYELITIS,1
BR,MYOCARDIAL INFARCTION,1
BR,MYOCARDITIS,1
BR,NAIL DISORDER,1
BR,NECROTISING COLITIS,1
BR,NEOPLASM,1
BR,NEOPLASM RECURRENCE,1
BR,NERVE COMPRESSION,1
BR,NEUROLOGICAL SYMPTOM,1
BR,NEUTROPENIA,1
BR,NIGHT SWEATS,1
BR,NODULAR MELANOMA,1
BR,NONSPECIFIC REACTION,1
BR,NOSOCOMIAL INFECTION,1
BR,OBSTRUCTIVE AIRWAYS DISORDER,1
BR,OCULAR HYPERAEMIA,1
BR,OESOPHAGEAL DISORDER,1
BR,OESOPHAGEAL STENOSIS,1
BR,OPTIC NEURITIS,1
BR,OSTEITIS,1
BR,OSTEOARTHROPATHY,1
BR,OSTEOMALACIA,1
BR,OSTEOMYELITIS,1
BR,OSTEONECROSIS,1
BR,OSTEOPENIA,1
BR,OSTEOSCLEROSIS,1
BR,OVERDOSE,1
BR,OVERWEIGHT,1
BR,PANCREAS INFECTION,1
BR,PANIC ATTACK,1
BR,PANIC DISORDER,1
BR,PAPILLOEDEMA,1
BR,PARALYSIS,1
BR,PATELLA FRACTURE,1
BR,PERFORMANCE STATUS DECREASED,1
BR,PERIPHERAL ISCHAEMIA,1
BR,PHARYNGEAL OEDEMA,1
BR,PHOTOPHOBIA,1
BR,PLEURISY,1
BR,PNEUMONIA KLEBSIELLA,1
BR,POLLAKIURIA,1
BR,POOR PERIPHERAL CIRCULATION,1
BR,PRODUCT DIFFICULT TO SWALLOW,1
BR,PRODUCT PACKAGING ISSUE,1
BR,PRODUCT QUALITY ISSUE,1
BR,PRODUCT TASTE ABNORMAL,1
BR,PRODUCTIVE COUGH,1
BR,PSORIATIC ARTHROPATHY,1
BR,PULMONARY CALCIFICATION,1
BR,PULMONARY EMBOLISM,1
BR,PULMONARY OEDEMA,1
BR,PULMONARY SEPSIS,1
BR,PURPURA,1
BR,PURULENT DISCHARGE,1
BR,QUADRIPLEGIA,1
BR,RASH MACULO-PAPULAR,1
BR,RASH PUSTULAR,1
BR,RECTAL DISCHARGE,1
BR,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,1
BR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
BR,REGURGITATION,1
BR,RESPIRATORY ARREST,1
BR,RESPIRATORY DISTRESS,1
BR,RETINAL HAEMORRHAGE,1
BR,RETINOPATHY OF PREMATURITY,1
BR,RHEUMATIC FEVER,1
BR,ROTATOR CUFF SYNDROME,1
BR,SCIATIC NERVE NEUROPATHY,1
BR,SENSATION OF BLOOD FLOW,1
BR,SENSATION OF FOREIGN BODY,1
BR,SENSORY DISTURBANCE,1
BR,SHOCK,1
BR,SICKLE CELL ANAEMIA WITH CRISIS,1
BR,SILICOSIS,1
BR,SKIN DEPIGMENTATION,1
BR,SKIN DISORDER,1
BR,SKIN FISSURES,1
BR,SKIN HAEMORRHAGE,1
BR,SKIN HYPERTROPHY,1
BR,SKIN INFECTION,1
BR,SKIN IRRITATION,1
BR,SKIN PAPILLOMA,1
BR,SKIN ULCER,1
BR,SKIN WARM,1
BR,SLUGGISHNESS,1
BR,SPIDER VEIN,1
BR,SPINAL CORD COMPRESSION,1
BR,SPINAL OSTEOARTHRITIS,1
BR,SPINAL SHOCK,1
BR,SPONDYLITIS,1
BR,SPONDYLOLISTHESIS,1
BR,STOMATITIS,1
BR,STRESS,1
BR,SUDDEN DEATH,1
BR,SUFFOCATION FEELING,1
BR,SUICIDAL IDEATION,1
BR,SURGERY,1
BR,SYRINGE ISSUE,1
BR,SYSTEMIC INFECTION,1
BR,TEARFULNESS,1
BR,TEMPERATURE INTOLERANCE,1
BR,TENDON RUPTURE,1
BR,THERAPEUTIC RESPONSE SHORTENED,1
BR,THROAT LESION,1
BR,THYROIDECTOMY,1
BR,THYROIDITIS,1
BR,TONGUE DISORDER,1
BR,TONGUE ERUPTION,1
BR,TOOTH FRACTURE,1
BR,TOOTHACHE,1
BR,TORTICOLLIS,1
BR,TRACHEAL OBSTRUCTION,1
BR,TRACHEAL OEDEMA,1
BR,TRACHEOBRONCHITIS,1
BR,TRACHEOSTOMY,1
BR,TREATMENT NONCOMPLIANCE,1
BR,TRIGEMINAL NEURALGIA,1
BR,TRISMUS,1
BR,TUBERCULOSIS GASTROINTESTINAL,1
BR,TYPE 2 DIABETES MELLITUS,1
BR,UHTHOFF^S PHENOMENON,1
BR,ULCERATIVE KERATITIS,1
BR,UNDERDOSE,1
BR,UNRESPONSIVE TO STIMULI,1
BR,UPPER EXTREMITY MASS,1
BR,URINARY TRACT INFECTION BACTERIAL,1
BR,UTERINE CERVIX ATROPHY,1
BR,UTERINE FIBROSIS,1
BR,VAGINAL HAEMORRHAGE,1
BR,VAGINAL INFECTION,1
BR,VASCULAR RUPTURE,1
BR,VASODILATATION,1
BR,VEIN DISORDER,1
BR,VEIN RUPTURE,1
BR,VENOUS INSUFFICIENCY,1
BR,VERTEBRAL OSTEOPHYTE,1
BR,VIITH NERVE PARALYSIS,1
BR,VITAMIN D DECREASED,1
BR,VOCAL CORD DISORDER,1
BR,VULVOVAGINITIS,1
BR,WEIGHT FLUCTUATION,1
BR,WHEEZING,1
BR,WHITE BLOOD CELL COUNT DECREASED,1
BR,WHITE BLOOD CELL DISORDER,1
BR,WOUND COMPLICATION,1
BR,WOUND HAEMORRHAGE,1
BR,WOUND SECRETION,1
BR,WRIST FRACTURE,1
BR,WRONG DRUG ADMINISTERED,1
BR,YELLOW SKIN,1
BR,ZIKA VIRUS INFECTION,1
BG,ENDOMETRIAL ADENOCARCINOMA,1
BG,TOXIC EPIDERMAL NECROLYSIS,1
CA,DRUG INEFFECTIVE,370
CA,NAUSEA,301
CA,HEADACHE,284
CA,VOMITING,235
CA,PAIN,233
CA,DIZZINESS,203
CA,RHEUMATOID ARTHRITIS,200
CA,WEIGHT DECREASED,196
CA,ARTHRALGIA,179
CA,FATIGUE,173
CA,DECREASED APPETITE,156
CA,EAR INFECTION,135
CA,PHARYNGITIS,134
CA,JOINT SWELLING,128
CA,NASOPHARYNGITIS,115
CA,ABDOMINAL PAIN UPPER,113
CA,PAIN IN EXTREMITY,105
CA,CONDITION AGGRAVATED,104
CA,DIARRHOEA,102
CA,DYSPNOEA,101
CA,ABDOMINAL DISCOMFORT,98
CA,COUGH,96
CA,GASTROINTESTINAL PAIN,95
CA,MALAISE,94
CA,DRUG HYPERSENSITIVITY,93
CA,FALL,93
CA,BACK PAIN,83
CA,SINUSITIS,82
CA,ASTHENIA,81
CA,GAIT DISTURBANCE,77
CA,PERIPHERAL SWELLING,77
CA,DEAFNESS,75
CA,ARTHROPATHY,70
CA,RASH,70
CA,SHOULDER ARTHROPLASTY,70
CA,ABDOMINAL PAIN,69
CA,PNEUMONIA,68
CA,MUSCULOSKELETAL STIFFNESS,67
CA,INFUSION RELATED REACTION,66
CA,BLOOD PRESSURE INCREASED,65
CA,PYREXIA,65
CA,WEIGHT INCREASED,62
CA,HYPOPHAGIA,61
CA,INSOMNIA,61
CA,INFECTION,60
CA,TREATMENT FAILURE,60
CA,ANXIETY,59
CA,DEAFNESS TRANSITORY,58
CA,SWELLING,57
CA,OROPHARYNGEAL PAIN,54
CA,GASTROINTESTINAL DISORDER,53
CA,MUSCULOSKELETAL DISORDER,53
CA,INFLUENZA,47
CA,LOWER RESPIRATORY TRACT INFECTION,47
CA,PRURITUS,47
CA,PSORIATIC ARTHROPATHY,47
CA,HYPERTENSION,46
CA,HYPOAESTHESIA,45
CA,URINARY TRACT INFECTION,45
CA,NEPHROLITHIASIS,44
CA,CHEST PAIN,43
CA,HYPOTENSION,43
CA,MUSCULOSKELETAL PAIN,43
CA,ALANINE AMINOTRANSFERASE INCREASED,42
CA,DRUG INTOLERANCE,42
CA,HYPERSENSITIVITY,42
CA,SYNOVITIS,42
CA,ARTHRITIS,41
CA,FOOT OPERATION,41
CA,PARAESTHESIA,41
CA,URTICARIA,41
CA,HEART RATE INCREASED,40
CA,FEELING ABNORMAL,39
CA,HAEMOGLOBIN DECREASED,39
CA,C-REACTIVE PROTEIN ABNORMAL,38
CA,DRUG EFFECT INCOMPLETE,38
CA,FEEDING DISORDER,38
CA,SOMNOLENCE,37
CA,CHEST DISCOMFORT,36
CA,CHILLS,36
CA,POOR QUALITY DRUG ADMINISTERED,36
CA,RESPIRATORY DISORDER,36
CA,ASPARTATE AMINOTRANSFERASE INCREASED,35
CA,DEPRESSION,35
CA,ERYTHEMA,35
CA,ALOPECIA,34
CA,MOBILITY DECREASED,34
CA,ASTHMA,33
CA,DRUG ADMINISTRATION ERROR,33
CA,PRODUCT QUALITY ISSUE,33
CA,BALANCE DISORDER,32
CA,DRUG EFFECT DECREASED,32
CA,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,32
CA,OVERDOSE,32
CA,PLATELET COUNT DECREASED,32
CA,STRESS,32
CA,SYNCOPE,32
CA,CONTUSION,31
CA,ENTHESOPATHY,31
CA,HYPERHIDROSIS,31
CA,LOSS OF CONSCIOUSNESS,31
CA,DYSPHAGIA,30
CA,PRURITUS GENERALISED,30
CA,SUICIDAL IDEATION,30
CA,MYALGIA,29
CA,TENOSYNOVITIS,29
CA,EAR PAIN,28
CA,GASTROINTESTINAL HAEMORRHAGE,28
CA,NEUTROPENIA,28
CA,OXYGEN SATURATION DECREASED,28
CA,TONGUE DISORDER,28
CA,BODY TEMPERATURE INCREASED,27
CA,BRONCHITIS,27
CA,SLEEP DISORDER,27
CA,CONSTIPATION,26
CA,CYSTITIS,26
CA,JOINT STIFFNESS,26
CA,NASAL CONGESTION,26
CA,NECK PAIN,26
CA,GENERALISED ERYTHEMA,25
CA,HEART RATE DECREASED,25
CA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,25
CA,KIDNEY INFECTION,25
CA,OEDEMA PERIPHERAL,25
CA,PALPITATIONS,25
CA,ADVERSE DRUG REACTION,24
CA,HAEMORRHAGE,24
CA,INFLAMMATION,24
CA,OSTEOARTHRITIS,24
CA,PRODUCT USE ISSUE,24
CA,THROMBOCYTOPENIA,24
CA,TREMOR,24
CA,TYPE 2 DIABETES MELLITUS,24
CA,CHOKING,23
CA,EATING DISORDER,23
CA,FIBROMYALGIA,23
CA,INJECTION SITE REACTION,23
CA,TENDONITIS,23
CA,ADVERSE REACTION,22
CA,C-REACTIVE PROTEIN INCREASED,22
CA,INFLUENZA LIKE ILLNESS,22
CA,MULTIPLE FRACTURES,22
CA,NIGHT SWEATS,22
CA,RECTAL HAEMORRHAGE,22
CA,TOXICITY TO VARIOUS AGENTS,22
CA,AGITATION,21
CA,ANKYLOSING SPONDYLITIS,21
CA,HAEMATOCHEZIA,21
CA,INJECTION SITE SWELLING,21
CA,PULMONARY EMBOLISM,21
CA,BLOOD PRESSURE DECREASED,20
CA,BLOOD PRESSURE FLUCTUATION,20
CA,DEATH,20
CA,DRY MOUTH,20
CA,MIGRAINE,20
CA,MUSCULAR WEAKNESS,20
CA,MYOCARDIAL INFARCTION,20
CA,PRODUCTIVE COUGH,20
CA,PSORIASIS,20
CA,SEIZURE,20
CA,ABDOMINAL DISTENSION,19
CA,ACTIVITIES OF DAILY LIVING IMPAIRED,19
CA,DIABETES MELLITUS,19
CA,INJECTION SITE BRUISING,19
CA,LOCALISED INFECTION,19
CA,SUICIDE ATTEMPT,19
CA,TINNITUS,19
CA,ALANINE AMINOTRANSFERASE ABNORMAL,18
CA,BLOOD ALKALINE PHOSPHATASE INCREASED,18
CA,BLOOD URINE PRESENT,18
CA,DISEASE PROGRESSION,18
CA,HOT FLUSH,18
CA,INTENTIONAL OVERDOSE,18
CA,METABOLIC ACIDOSIS,18
CA,RESPIRATORY TRACT CONGESTION,18
CA,SURGERY,18
CA,THROAT TIGHTNESS,18
CA,UPPER RESPIRATORY TRACT INFECTION,18
CA,DRUG DOSE OMISSION,17
CA,INJECTION SITE ERYTHEMA,17
CA,INJECTION SITE PRURITUS,17
CA,JOINT EFFUSION,17
CA,MOUTH ULCERATION,17
CA,MUSCLE SPASTICITY,17
CA,SWELLING FACE,17
CA,WHEEZING,17
CA,CELLULITIS,16
CA,DEHYDRATION,16
CA,DRUG DEPENDENCE,16
CA,EPISTAXIS,16
CA,HEPATIC ENZYME INCREASED,16
CA,HERPES ZOSTER,16
CA,IMPAIRED HEALING,16
CA,INJECTION SITE PAIN,16
CA,LETHARGY,16
CA,LIVER FUNCTION TEST ABNORMAL,16
CA,LUNG INFECTION,16
CA,MUSCLE SPASMS,16
CA,RENAL IMPAIRMENT,16
CA,ANAEMIA,15
CA,DYSGEUSIA,15
CA,DYSPEPSIA,15
CA,FOOT DEFORMITY,15
CA,IMPAIRED WORK ABILITY,15
CA,LYMPHADENOPATHY,15
CA,CONFUSIONAL STATE,14
CA,DEPRESSED LEVEL OF CONSCIOUSNESS,14
CA,EYE SWELLING,14
CA,JAUNDICE,14
CA,NEOPLASM MALIGNANT,14
CA,SKIN EXFOLIATION,14
CA,SKIN PAPILLOMA,14
CA,TACHYCARDIA,14
CA,TENDON DISORDER,14
CA,THERAPEUTIC RESPONSE DECREASED,14
CA,ATRIAL FIBRILLATION,13
CA,CARDIAC ARREST,13
CA,DEPRESSED MOOD,13
CA,DYSURIA,13
CA,FUNCTIONAL GASTROINTESTINAL DISORDER,13
CA,GASTRIC ULCER,13
CA,GASTROOESOPHAGEAL REFLUX DISEASE,13
CA,HEPATOTOXICITY,13
CA,LUNG DISORDER,13
CA,MEMORY IMPAIRMENT,13
CA,ORAL HERPES,13
CA,WHITE BLOOD CELL COUNT DECREASED,13
CA,BLOOD BILIRUBIN INCREASED,12
CA,BONE PAIN,12
CA,CEREBROVASCULAR ACCIDENT,12
CA,CLOSTRIDIUM DIFFICILE INFECTION,12
CA,EYE DISORDER,12
CA,FEBRILE NEUTROPENIA,12
CA,FLUSHING,12
CA,GENERAL PHYSICAL HEALTH DETERIORATION,12
CA,ILL-DEFINED DISORDER,12
CA,KNEE ARTHROPLASTY,12
CA,RHINORRHOEA,12
CA,SKIN ULCER,12
CA,STOMATITIS,12
CA,VIRAL UPPER RESPIRATORY TRACT INFECTION,12
CA,ANAPHYLACTIC REACTION,11
CA,BLISTER,11
CA,BLOOD CREATININE INCREASED,11
CA,BLOOD PRESSURE DIASTOLIC DECREASED,11
CA,CARDIAC FAILURE CONGESTIVE,11
CA,CHOLELITHIASIS,11
CA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,11
CA,DISORIENTATION,11
CA,ECZEMA,11
CA,EXPOSURE DURING PREGNANCY,11
CA,FEELING HOT,11
CA,HAEMATEMESIS,11
CA,INJECTION SITE RASH,11
CA,KOUNIS SYNDROME,11
CA,MOVEMENT DISORDER,11
CA,RENAL FAILURE,11
CA,RESPIRATORY ARREST,11
CA,SINUS CONGESTION,11
CA,THERAPY NON-RESPONDER,11
CA,URINARY INCONTINENCE,11
CA,UTERINE LEIOMYOMA,11
CA,ACUTE KIDNEY INJURY,10
CA,AGGRESSION,10
CA,AMNESIA,10
CA,ANKLE DEFORMITY,10
CA,BLOOD TEST ABNORMAL,10
CA,BODY TEMPERATURE DECREASED,10
CA,CARDIAC DISORDER,10
CA,CATARACT,10
CA,DEFORMITY,10
CA,GASTROINTESTINAL TOXICITY,10
CA,HEPATIC FAILURE,10
CA,HEPATIC STEATOSIS,10
CA,HYPERTONIC BLADDER,10
CA,HYPOKALAEMIA,10
CA,INCORRECT DOSE ADMINISTERED,10
CA,IRRITABILITY,10
CA,IRRITABLE BOWEL SYNDROME,10
CA,MALIGNANT NEOPLASM PROGRESSION,10
CA,MENOPAUSAL SYMPTOMS,10
CA,NAIL DISORDER,10
CA,NERVE INJURY,10
CA,NEUROPATHY PERIPHERAL,10
CA,PULMONARY TOXICITY,10
CA,SKIN DISCOLOURATION,10
CA,STEVENS-JOHNSON SYNDROME,10
CA,SUBSTANCE ABUSE,10
CA,UNEVALUABLE EVENT,10
CA,VISUAL IMPAIRMENT,10
CA,WHITE BLOOD CELL COUNT INCREASED,10
CA,WRIST DEFORMITY,10
CA,ABORTION SPONTANEOUS,9
CA,AORTIC BRUIT,9
CA,COELIAC DISEASE,9
CA,ENCEPHALITIS VIRAL,9
CA,FEELING COLD,9
CA,HERNIA,9
CA,HUNGER,9
CA,INCORRECT DRUG ADMINISTRATION DURATION,9
CA,JOINT INJURY,9
CA,LIP SWELLING,9
CA,MELAENA,9
CA,MENTAL STATUS CHANGES,9
CA,MUSCULOSKELETAL DISCOMFORT,9
CA,OBESITY,9
CA,PALLOR,9
CA,POLLAKIURIA,9
CA,PULMONARY CONGESTION,9
CA,RENAL DISORDER,9
CA,RENAL FAILURE ACUTE,9
CA,RENAL PAIN,9
CA,RENAL TUBULAR ACIDOSIS,9
CA,ROAD TRAFFIC ACCIDENT,9
CA,SINUS TACHYCARDIA,9
CA,THROMBOSIS,9
CA,UNRESPONSIVE TO STIMULI,9
CA,VIRAL INFECTION,9
CA,BLOOD PRESSURE DIASTOLIC INCREASED,8
CA,BURNING SENSATION,8
CA,CHROMATURIA,8
CA,DIVERTICULITIS,8
CA,DRY SKIN,8
CA,DYSSTASIA,8
CA,ELBOW OPERATION,8
CA,FLUID RETENTION,8
CA,GASTROENTERITIS VIRAL,8
CA,HEAD DISCOMFORT,8
CA,HIP ARTHROPLASTY,8
CA,HYPOTHYROIDISM,8
CA,JUDGEMENT IMPAIRED,8
CA,LIMB DISCOMFORT,8
CA,MULTI-ORGAN FAILURE,8
CA,NEUTROPHIL COUNT DECREASED,8
CA,OEDEMA,8
CA,OSTEOMYELITIS,8
CA,PAIN IN JAW,8
CA,PANIC ATTACK,8
CA,PLEURAL EFFUSION,8
CA,POOR VENOUS ACCESS,8
CA,RETINAL DEPOSITS,8
CA,SCIATICA,8
CA,SENSORY LOSS,8
CA,SEPSIS,8
CA,SHOCK,8
CA,SKIN FISSURES,8
CA,SKIN IRRITATION,8
CA,SMALL INTESTINAL OBSTRUCTION,8
CA,SPINAL FRACTURE,8
CA,THROAT IRRITATION,8
CA,VISION BLURRED,8
CA,ARTHROPOD BITE,7
CA,BLOOD PRESSURE SYSTOLIC INCREASED,7
CA,BREATH SOUNDS ABNORMAL,7
CA,CRYING,7
CA,DEEP VEIN THROMBOSIS,7
CA,FAECES DISCOLOURED,7
CA,FEBRILE CONVULSION,7
CA,FEELING OF BODY TEMPERATURE CHANGE,7
CA,FOOT FRACTURE,7
CA,FREQUENT BOWEL MOVEMENTS,7
CA,FUNGAL INFECTION,7
CA,GASTRIC DISORDER,7
CA,INJECTION SITE HAEMORRHAGE,7
CA,LEUKOPENIA,7
CA,LYMPHOMA,7
CA,MENTAL DISORDER,7
CA,NASAL ULCER,7
CA,PRODUCT SUBSTITUTION ISSUE,7
CA,RASH GENERALISED,7
CA,RASH PRURITIC,7
CA,RESPIRATORY RATE INCREASED,7
CA,RESPIRATORY TRACT INFECTION,7
CA,RIB FRACTURE,7
CA,SKIN BURNING SENSATION,7
CA,SKIN DISORDER,7
CA,SLEEP APNOEA SYNDROME,7
CA,SNEEZING,7
CA,TOOTH ABSCESS,7
CA,ULCER,7
CA,VERTIGO,7
CA,ABDOMINAL PAIN LOWER,6
CA,ACCIDENTAL EXPOSURE TO PRODUCT,6
CA,ANGER,6
CA,ANGINA PECTORIS,6
CA,APHONIA,6
CA,ARTERIOSPASM CORONARY,6
CA,BLOOD CHOLESTEROL INCREASED,6
CA,BLOOD GLUCOSE INCREASED,6
CA,BREAST CANCER,6
CA,BURSITIS,6
CA,CANDIDA INFECTION,6
CA,CARDIO-RESPIRATORY ARREST,6
CA,CARPAL TUNNEL SYNDROME,6
CA,COLITIS,6
CA,CORONARY ARTERY STENOSIS,6
CA,CROHN^S DISEASE,6
CA,DEFAECATION URGENCY,6
CA,DIARRHOEA HAEMORRHAGIC,6
CA,DRY THROAT,6
CA,DYSLIPIDAEMIA,6
CA,DYSPHONIA,6
CA,DYSPNOEA EXERTIONAL,6
CA,EFFUSION,6
CA,EXOSTOSIS,6
CA,EXPOSURE DURING BREAST FEEDING,6
CA,EXPOSURE TO COMMUNICABLE DISEASE,6
CA,GASTROINTESTINAL INFLAMMATION,6
CA,GENERALISED TONIC-CLONIC SEIZURE,6
CA,HEPATITIS,6
CA,HIP FRACTURE,6
CA,HYPERLIPIDAEMIA,6
CA,HYPERSOMNIA,6
CA,HYSTERECTOMY,6
CA,INTERNATIONAL NORMALISED RATIO INCREASED,6
CA,INTERSTITIAL LUNG DISEASE,6
CA,LARYNGITIS,6
CA,LIGAMENT SPRAIN,6
CA,LOCAL SWELLING,6
CA,LYMPHOEDEMA,6
CA,MALLORY-WEISS SYNDROME,6
CA,MASS,6
CA,MIDDLE INSOMNIA,6
CA,MUSCLE STRAIN,6
CA,MUSCULOSKELETAL CHEST PAIN,6
CA,NERVOUSNESS,6
CA,OCULAR HYPERAEMIA,6
CA,ORAL PAIN,6
CA,OSTEONECROSIS OF JAW,6
CA,OSTEOPOROSIS,6
CA,PANCREATITIS,6
CA,PHOTOSENSITIVITY REACTION,6
CA,POOR QUALITY SLEEP,6
CA,PRODUCT SHAPE ISSUE,6
CA,PRODUCT SIZE ISSUE,6
CA,PULSELESS ELECTRICAL ACTIVITY,6
CA,RED BLOOD CELL SEDIMENTATION RATE INCREASED,6
CA,RESPIRATORY RATE DECREASED,6
CA,SCRATCH,6
CA,TENDON RUPTURE,6
CA,THERAPEUTIC RESPONSE UNEXPECTED,6
CA,TOOTH DISORDER,6
CA,TOOTHACHE,6
CA,UVEITIS,6
CA,ABDOMINAL WALL HAEMATOMA,5
CA,ACCIDENTAL OVERDOSE,5
CA,AKATHISIA,5
CA,ASTHENOPIA,5
CA,BACK INJURY,5
CA,BACTERIAL INFECTION,5
CA,BLOOD POTASSIUM DECREASED,5
CA,BLOOD PRESSURE ABNORMAL,5
CA,BONE DENSITY DECREASED,5
CA,BREAST PAIN,5
CA,BUNION OPERATION,5
CA,CHOLECYSTITIS,5
CA,CHONDROPATHY,5
CA,COLITIS MICROSCOPIC,5
CA,COMA,5
CA,CONVULSION,5
CA,DIABETES MELLITUS INADEQUATE CONTROL,5
CA,DIABETIC KETOACIDOSIS,5
CA,DRY EYE,5
CA,EAR DISCOMFORT,5
CA,EYE INFECTION,5
CA,EYE PAIN,5
CA,FOREIGN BODY,5
CA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,5
CA,GASTRIC INFECTION,5
CA,GASTRITIS,5
CA,GOUT,5
CA,HAEMOPTYSIS,5
CA,HAND DEFORMITY,5
CA,HEAD INJURY,5
CA,HEPATIC CANCER,5
CA,HEPATIC CIRRHOSIS,5
CA,HYPERAESTHESIA,5
CA,HYPERGLYCAEMIA,5
CA,HYPOKINESIA,5
CA,IMMUNODEFICIENCY,5
CA,INJECTION SITE MASS,5
CA,INTERVERTEBRAL DISC DISORDER,5
CA,IRITIS,5
CA,JOINT RANGE OF MOTION DECREASED,5
CA,LIP OEDEMA,5
CA,LIVER DISORDER,5
CA,MATERNAL EXPOSURE DURING PREGNANCY,5
CA,MULTIPLE SCLEROSIS RELAPSE,5
CA,MUSCLE TIGHTNESS,5
CA,NEUTROPHIL COUNT INCREASED,5
CA,NIGHTMARE,5
CA,PARALYSIS,5
CA,PHARYNGITIS STREPTOCOCCAL,5
CA,PRESYNCOPE,5
CA,PRODUCT USE COMPLAINT,5
CA,PROSTATE CANCER,5
CA,REACTION TO DRUG EXCIPIENTS,5
CA,RED BLOOD CELL COUNT DECREASED,5
CA,RESPIRATORY DEPRESSION,5
CA,RESPIRATORY FAILURE,5
CA,RESTLESSNESS,5
CA,SPINAL PAIN,5
CA,SQUAMOUS CELL CARCINOMA,5
CA,SUBCUTANEOUS ABSCESS,5
CA,THERAPEUTIC RESPONSE SHORTENED,5
CA,TUBULOINTERSTITIAL NEPHRITIS,5
CA,UPPER LIMB FRACTURE,5
CA,URINARY TRACT OBSTRUCTION,5
CA,VISUAL ACUITY REDUCED,5
CA,ABNORMAL BEHAVIOUR,4
CA,ABSCESS,4
CA,ACCIDENT,4
CA,ACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,4
CA,ACUTE HEPATIC FAILURE,4
CA,APNOEA,4
CA,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,4
CA,BILIRUBIN CONJUGATED INCREASED,4
CA,BLADDER CANCER,4
CA,BLOOD BILIRUBIN UNCONJUGATED,4
CA,BLOOD IRON DECREASED,4
CA,BLOOD LACTATE DEHYDROGENASE INCREASED,4
CA,BLOOD PHOSPHORUS INCREASED,4
CA,BONE DISORDER,4
CA,BONE LOSS,4
CA,BRADYCARDIA,4
CA,BRONCHOSPASM,4
CA,CARDIAC FLUTTER,4
CA,CARDIOVASCULAR DISORDER,4
CA,COLON CANCER,4
CA,CONCUSSION,4
CA,DACTYLITIS,4
CA,DISABILITY,4
CA,DISTURBANCE IN ATTENTION,4
CA,DRUG TOLERANCE,4
CA,DRUG WITHDRAWAL SYNDROME,4
CA,DUODENAL ULCER,4
CA,DUODENITIS,4
CA,DYSKINESIA,4
CA,EMOTIONAL DISTRESS,4
CA,EPILEPSY,4
CA,EYE DISCHARGE,4
CA,FEAR,4
CA,FLATULENCE,4
CA,FOREIGN BODY IN RESPIRATORY TRACT,4
CA,GASTRIC CANCER,4
CA,GASTRIC HAEMORRHAGE,4
CA,GASTROINTESTINAL INJURY,4
CA,GENITAL PAIN,4
CA,GINGIVAL BLEEDING,4
CA,GINGIVAL DISORDER,4
CA,GINGIVITIS,4
CA,HAEMOLYTIC ANAEMIA,4
CA,HALLUCINATION,4
CA,HEART RATE IRREGULAR,4
CA,HEPATIC MASS,4
CA,HYPOCALCAEMIA,4
CA,HYPOVOLAEMIA,4
CA,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,4
CA,INCREASED TENDENCY TO BRUISE,4
CA,INTENTIONAL PRODUCT MISUSE,4
CA,INTESTINAL OBSTRUCTION,4
CA,INTESTINAL RESECTION,4
CA,IRON DEFICIENCY,4
CA,JOINT DISLOCATION,4
CA,LACERATION,4
CA,LIMB INJURY,4
CA,LIVER FUNCTION TEST INCREASED,4
CA,LOWER GASTROINTESTINAL HAEMORRHAGE,4
CA,LOWER LIMB FRACTURE,4
CA,LOWER RESPIRATORY TRACT CONGESTION,4
CA,LUNG NEOPLASM MALIGNANT,4
CA,LYMPHOCYTE COUNT DECREASED,4
CA,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,4
CA,MENORRHAGIA,4
CA,MENTAL IMPAIRMENT,4
CA,MOOD SWINGS,4
CA,MULTIPLE SCLEROSIS,4
CA,MUSCLE INJURY,4
CA,NASAL DRYNESS,4
CA,NON-CARDIAC CHEST PAIN,4
CA,OCULAR ICTERUS,4
CA,ORAL CANDIDIASIS,4
CA,ORAL INFECTION,4
CA,OVARIAN CYST,4
CA,PARANOIA,4
CA,PEMPHIGUS,4
CA,PERIPHERAL VENOUS DISEASE,4
CA,PNEUMONIA ASPIRATION,4
CA,PRODUCT PHYSICAL ISSUE,4
CA,PRODUCT TASTE ABNORMAL,4
CA,PRODUCT USE IN UNAPPROVED INDICATION,4
CA,QUALITY OF LIFE DECREASED,4
CA,RECTAL ADENOCARCINOMA,4
CA,RHINITIS,4
CA,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,4
CA,SPLENOMEGALY,4
CA,STREPTOCOCCAL INFECTION,4
CA,SWOLLEN TONGUE,4
CA,SYSTEMIC LUPUS ERYTHEMATOSUS,4
CA,TENDON PAIN,4
CA,THERAPEUTIC RESPONSE CHANGED,4
CA,THERMAL BURN,4
CA,THINKING ABNORMAL,4
CA,THIRST,4
CA,THYROID DISORDER,4
CA,TIBIA FRACTURE,4
CA,TONGUE OEDEMA,4
CA,TOOTH EXTRACTION,4
CA,TOOTH INFECTION,4
CA,TUBERCULIN TEST POSITIVE,4
CA,URINARY RETENTION,4
CA,URINARY TRACT INFECTION BACTERIAL,4
CA,WOUND,4
CA,WOUND INFECTION,4
CA,YELLOW SKIN,4
CA,ABASIA,3
CA,ABSCESS LIMB,3
CA,ACNE,3
CA,ACUTE MYOCARDIAL INFARCTION,3
CA,ADENOCARCINOMA OF COLON,3
CA,ADVERSE EVENT,3
CA,AGEUSIA,3
CA,ALCOHOL ABUSE,3
CA,ALCOHOLIC HANGOVER,3
CA,ALOPECIA TOTALIS,3
CA,ALOPECIA UNIVERSALIS,3
CA,ARTHRITIS INFECTIVE,3
CA,AZOTAEMIA,3
CA,BACK DISORDER,3
CA,BASAL CELL CARCINOMA,3
CA,BLINDNESS,3
CA,BLOOD ALBUMIN DECREASED,3
CA,BLOOD CALCIUM DECREASED,3
CA,CARDIAC FAILURE,3
CA,CARDIAC VALVE DISEASE,3
CA,CARDIOMYOPATHY,3
CA,CEREBRAL HAEMORRHAGE,3
CA,COAGULOPATHY,3
CA,COLITIS ULCERATIVE,3
CA,COMPLETED SUICIDE,3
CA,COMPRESSION FRACTURE,3
CA,CYST,3
CA,DELIRIUM,3
CA,DERMAL CYST,3
CA,DEVICE DISLOCATION,3
CA,DEVICE ISSUE,3
CA,DIPLOPIA,3
CA,DISCOMFORT,3
CA,DRUG LEVEL INCREASED,3
CA,DRUG TOLERANCE INCREASED,3
CA,DUODENAL ULCER HAEMORRHAGE,3
CA,DUODENAL ULCER PERFORATION,3
CA,ECTOPIC PREGNANCY,3
CA,ELECTROCARDIOGRAM QT PROLONGED,3
CA,EMOTIONAL DISORDER,3
CA,ENTERITIS,3
CA,EPIGASTRIC DISCOMFORT,3
CA,EROSIVE DUODENITIS,3
CA,ERYTHEMA NODOSUM,3
CA,EXERCISE TOLERANCE DECREASED,3
CA,EYE ALLERGY,3
CA,EYE HAEMORRHAGE,3
CA,EYELID OEDEMA,3
CA,FEMUR FRACTURE,3
CA,FLANK PAIN,3
CA,FULL BLOOD COUNT DECREASED,3
CA,GALLBLADDER DISORDER,3
CA,GASTRIC PERFORATION,3
CA,GASTRIC ULCER HAEMORRHAGE,3
CA,GENITAL SWELLING,3
CA,GLAUCOMA,3
CA,GRAND MAL CONVULSION,3
CA,GRIEF REACTION,3
CA,HAEMOGLOBIN INCREASED,3
CA,HAEMORRHOIDS,3
CA,HANGOVER,3
CA,HICCUPS,3
CA,HIP SURGERY,3
CA,HYPERBILIRUBINAEMIA,3
CA,HYPERCHOLESTEROLAEMIA,3
CA,HYPERVENTILATION,3
CA,HYPOMAGNESAEMIA,3
CA,INCONTINENCE,3
CA,INCREASED APPETITE,3
CA,INCREASED UPPER AIRWAY SECRETION,3
CA,INFREQUENT BOWEL MOVEMENTS,3
CA,INGROWING NAIL,3
CA,INTERVERTEBRAL DISC COMPRESSION,3
CA,INTERVERTEBRAL DISC DEGENERATION,3
CA,INTESTINAL PERFORATION,3
CA,LABORATORY TEST ABNORMAL,3
CA,LACRIMATION INCREASED,3
CA,LACTIC ACIDOSIS,3
CA,LIMB OPERATION,3
CA,LOOSE TOOTH,3
CA,METABOLIC ENCEPHALOPATHY,3
CA,MICTURITION URGENCY,3
CA,MILIARIA,3
CA,MOOD ALTERED,3
CA,MOTOR DYSFUNCTION,3
CA,MUCOSAL INFLAMMATION,3
CA,MUSCLE FATIGUE,3
CA,MUSCLE RUPTURE,3
CA,NEOPLASM,3
CA,NERVE COMPRESSION,3
CA,NERVOUS SYSTEM DISORDER,3
CA,NEURALGIA,3
CA,NEURODERMATITIS,3
CA,NICOTINE DEPENDENCE,3
CA,NO THERAPEUTIC RESPONSE,3
CA,NOSOCOMIAL INFECTION,3
CA,OCULAR DISCOMFORT,3
CA,OPTIC NERVE DISORDER,3
CA,OPTIC NEURITIS,3
CA,ORAL FUNGAL INFECTION,3
CA,ORTHOPNOEA,3
CA,OTOTOXICITY,3
CA,PANCREATIC CYST,3
CA,PANCREATIC MASS,3
CA,PANCREATITIS ACUTE,3
CA,PARONYCHIA,3
CA,PEAU D^ORANGE,3
CA,PERICARDIAL EFFUSION,3
CA,PERIPHERAL COLDNESS,3
CA,PHOTOPSIA,3
CA,PILOERECTION,3
CA,PLEURISY,3
CA,POLYARTHRITIS,3
CA,POSTOPERATIVE WOUND INFECTION,3
CA,PREGNANCY,3
CA,PRERENAL FAILURE,3
CA,PROCEDURAL COMPLICATION,3
CA,PROCEDURAL PAIN,3
CA,PROCTALGIA,3
CA,PSYCHOTIC DISORDER,3
CA,PULMONARY HYPERTENSION,3
CA,RALES,3
CA,RASH ERYTHEMATOUS,3
CA,RESPIRATORY DISTRESS,3
CA,RETCHING,3
CA,RETINAL DETACHMENT,3
CA,SALIVA ALTERED,3
CA,SCLERAL DISCOLOURATION,3
CA,SEASONAL ALLERGY,3
CA,SENSORY DISTURBANCE,3
CA,SEPTIC SHOCK,3
CA,SKIN ABRASION,3
CA,SKIN CANCER,3
CA,SKIN HAEMORRHAGE,3
CA,SKIN INFECTION,3
CA,SKIN LESION,3
CA,SKIN REACTION,3
CA,SKIN WARM,3
CA,SOFT TISSUE DISORDER,3
CA,SPEECH DISORDER,3
CA,SPINAL COLUMN STENOSIS,3
CA,SPINAL CORD COMPRESSION,3
CA,STASIS DERMATITIS,3
CA,TENDERNESS,3
CA,TENDON DISCOMFORT,3
CA,TOBACCO ABUSE,3
CA,TONSILLITIS,3
CA,TOXIC EPIDERMAL NECROLYSIS,3
CA,TRANSFUSION,3
CA,TRANSIENT ISCHAEMIC ATTACK,3
CA,TUMOUR MARKER INCREASED,3
CA,UHTHOFF^S PHENOMENON,3
CA,UPPER RESPIRATORY TRACT CONGESTION,3
CA,URINE ABNORMALITY,3
CA,UROSEPSIS,3
CA,VARICOSE VEIN,3
CA,VASCULAR FRAGILITY,3
CA,VASCULITIS,3
CA,WHITE BLOOD CELLS URINE POSITIVE,3
CA,WRIST FRACTURE,3
CA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,3
CA,ABDOMINAL ADHESIONS,2
CA,ABNORMAL DREAMS,2
CA,ABNORMAL LOSS OF WEIGHT,2
CA,ACCIDENT AT HOME,2
CA,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,2
CA,ACIDOSIS HYPERCHLORAEMIC,2
CA,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,2
CA,ACUTE RESPIRATORY DISTRESS SYNDROME,2
CA,ADENOCARCINOMA,2
CA,ADENOCARCINOMA GASTRIC,2
CA,AKINESIA,2
CA,ALCOHOL USE,2
CA,ANALGESIC DRUG LEVEL INCREASED,2
CA,ANAPHYLACTIC SHOCK,2
CA,ANEURYSM,2
CA,ANGINA UNSTABLE,2
CA,ANIMAL SCRATCH,2
CA,ANKLE FRACTURE,2
CA,ANORECTAL DISCOMFORT,2
CA,AORTIC STENOSIS,2
CA,AORTIC VALVE INCOMPETENCE,2
CA,APHASIA,2
CA,APHTHOUS STOMATITIS,2
CA,APHTHOUS ULCER,2
CA,APOPTOSIS,2
CA,APPENDICITIS,2
CA,ARTERIAL OCCLUSIVE DISEASE,2
CA,ARTHRODESIS,2
CA,ASCITES,2
CA,ATAXIA,2
CA,AUTOIMMUNE DISORDER,2
CA,AUTOIMMUNE HEPATITIS,2
CA,AXILLARY PAIN,2
CA,BILE DUCT STENT INSERTION,2
CA,BILEVEL POSITIVE AIRWAY PRESSURE,2
CA,BLADDER DISORDER,2
CA,BLADDER IRRITATION,2
CA,BLADDER PAIN,2
CA,BLISTER INFECTED,2
CA,BLOOD GLUCOSE DECREASED,2
CA,BLOOD MAGNESIUM DECREASED,2
CA,BLOOD PRESSURE DIASTOLIC ABNORMAL,2
CA,BLOOD UREA INCREASED,2
CA,BLOOD URIC ACID INCREASED,2
CA,BONE CYST,2
CA,BRAIN INJURY,2
CA,BRAIN OEDEMA,2
CA,BREAST CANCER METASTATIC,2
CA,BREAST SWELLING,2
CA,CAESAREAN SECTION,2
CA,CAMPYLOBACTER GASTROENTERITIS,2
CA,CARBOHYDRATE ANTIGEN 125 INCREASED,2
CA,CARDIAC PACEMAKER INSERTION,2
CA,CARDIOGENIC SHOCK,2
CA,CARTILAGE INJURY,2
CA,CENTRAL NERVOUS SYSTEM LESION,2
CA,CHOKING SENSATION,2
CA,CHONDROMA,2
CA,CIRCADIAN RHYTHM SLEEP DISORDER,2
CA,COGNITIVE DISORDER,2
CA,COLITIS ISCHAEMIC,2
CA,COLON DYSPLASIA,2
CA,COMPULSIVE LIP BITING,2
CA,CONJUNCTIVITIS,2
CA,CONTRAINDICATED PRODUCT ADMINISTERED,2
CA,CORONARY ARTERY OCCLUSION,2
CA,CRANIOCEREBRAL INJURY,2
CA,CREPITATIONS,2
CA,CYSTITIS KLEBSIELLA,2
CA,CYSTITIS NONINFECTIVE,2
CA,DEAFNESS UNILATERAL,2
CA,DENTAL CARIES,2
CA,DERMATITIS ALLERGIC,2
CA,DERMATITIS CONTACT,2
CA,DEVICE MALFUNCTION,2
CA,DEVICE OCCLUSION,2
CA,DRUG PRESCRIBING ERROR,2
CA,DRUG RESISTANCE,2
CA,DYSARTHRIA,2
CA,DYSCHEZIA,2
CA,EAR SWELLING,2
CA,EATING DISORDER SYMPTOM,2
CA,EJECTION FRACTION DECREASED,2
CA,EMPYEMA,2
CA,ENCEPHALOPATHY,2
CA,ENERGY INCREASED,2
CA,EPICONDYLITIS,2
CA,ERECTILE DYSFUNCTION,2
CA,EUPHORIC MOOD,2
CA,EXPIRED DRUG ADMINISTERED,2
CA,EXPIRED PRODUCT ADMINISTERED,2
CA,EYE INFLAMMATION,2
CA,FAT TISSUE INCREASED,2
CA,FEMORAL NECK FRACTURE,2
CA,FIBULA FRACTURE,2
CA,FINGER DEFORMITY,2
CA,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,2
CA,FOETAL EXPOSURE DURING PREGNANCY,2
CA,FOLLICULITIS,2
CA,FRACTURE,2
CA,FRUSTRATION TOLERANCE DECREASED,2
CA,FURUNCLE,2
CA,GASTROENTERITIS,2
CA,GESTATIONAL DIABETES,2
CA,GROIN ABSCESS,2
CA,GUILLAIN-BARRE SYNDROME,2
CA,HAEMATOCRIT DECREASED,2
CA,HAEMATURIA,2
CA,HAEMOLYSIS,2
CA,HAEMORRHAGE INTRACRANIAL,2
CA,HAEMORRHAGE URINARY TRACT,2
CA,HALLUCINATIONS_ MIXED,2
CA,HEPATIC ENZYME ABNORMAL,2
CA,HEPATITIS ACUTE,2
CA,HEPATOCELLULAR CARCINOMA,2
CA,HIATUS HERNIA,2
CA,HISTRIONIC PERSONALITY DISORDER,2
CA,HOMICIDAL IDEATION,2
CA,HOSPITALISATION,2
CA,HUMAN PAPILLOMA VIRUS TEST POSITIVE,2
CA,HYPERACUSIS,2
CA,HYPERKALAEMIA,2
CA,HYPERTRIGLYCERIDAEMIA,2
CA,HYPONATRAEMIA,2
CA,HYPOPNOEA,2
CA,IMMOBILE,2
CA,IMMUNE SYSTEM DISORDER,2
CA,IMMUNE-MEDIATED NECROTISING MYOPATHY,2
CA,IMPULSE-CONTROL DISORDER,2
CA,INAPPROPRIATE AFFECT,2
CA,INCISION SITE INFECTION,2
CA,INCOHERENT,2
CA,INCORRECT DOSE ADMINISTERED BY DEVICE,2
CA,INFECTED BITE,2
CA,INFECTED SKIN ULCER,2
CA,INFECTION SUSCEPTIBILITY INCREASED,2
CA,INFLAMMATORY BOWEL DISEASE,2
CA,INFUSION SITE HAEMORRHAGE,2
CA,INJECTION SITE DISCOMFORT,2
CA,INJECTION SITE INDURATION,2
CA,INJURY,2
CA,INTENTIONAL DRUG MISUSE,2
CA,INTENTIONAL SELF-INJURY,2
CA,ISCHAEMIC STROKE,2
CA,JEJUNOSTOMY,2
CA,JOINT DESTRUCTION,2
CA,JOINT INSTABILITY,2
CA,JUVENILE IDIOPATHIC ARTHRITIS,2
CA,LARGE INTESTINAL OBSTRUCTION,2
CA,LEFT VENTRICULAR DYSFUNCTION,2
CA,LEUKAEMIA,2
CA,LID SULCUS DEEPENED,2
CA,LIVER ABSCESS,2
CA,LUNG INFILTRATION,2
CA,LUPUS-LIKE SYNDROME,2
CA,LYMPH NODE PAIN,2
CA,MAJOR DEPRESSION,2
CA,MEAN CELL HAEMOGLOBIN DECREASED,2
CA,MEAN CELL VOLUME INCREASED,2
CA,MEAN PLATELET VOLUME DECREASED,2
CA,MEDICATION ERROR,2
CA,MENOPAUSE,2
CA,MENSTRUATION IRREGULAR,2
CA,MESENTERITIS,2
CA,METASTASES TO BONE,2
CA,METASTASES TO CENTRAL NERVOUS SYSTEM,2
CA,METASTASES TO LYMPH NODES,2
CA,MICTURITION DISORDER,2
CA,MONOCYTE COUNT INCREASED,2
CA,MUSCLE DISORDER,2
CA,MUSCLE SWELLING,2
CA,MYDRIASIS,2
CA,MYOGLOBINURIA,2
CA,NAIL OPERATION,2
CA,NASAL DISCHARGE DISCOLOURATION,2
CA,NASAL DISCOMFORT,2
CA,NEEDLE ISSUE,2
CA,NO ADVERSE EVENT,2
CA,NON-ALCOHOLIC STEATOHEPATITIS,2
CA,NONSPECIFIC REACTION,2
CA,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,2
CA,OBSTRUCTIVE AIRWAYS DISORDER,2
CA,OESOPHAGEAL NEOPLASM,2
CA,OLIGOMENORRHOEA,2
CA,ONYCHOCLASIS,2
CA,ONYCHOMYCOSIS,2
CA,OOPHORECTOMY,2
CA,OPHTHALMOPLEGIA,2
CA,OPTIC GLIOMA,2
CA,ORAL ALLERGY SYNDROME,2
CA,OROPHARYNGEAL OEDEMA,2
CA,PAINFUL RESPIRATION,2
CA,PANCREATIC CALCIFICATION,2
CA,PANCYTOPENIA,2
CA,PARANASAL SINUS DISCOMFORT,2
CA,PERIARTHRITIS,2
CA,PERITONITIS,2
CA,PERSONALITY CHANGE,2
CA,PHARYNGEAL MASS,2
CA,PITUITARY TUMOUR,2
CA,PLATELET COUNT INCREASED,2
CA,PLATELET DISORDER,2
CA,PNEUMONIA VIRAL,2
CA,POLYDIPSIA,2
CA,POLYURIA,2
CA,POST PROCEDURAL COMPLICATION,2
CA,POST PROCEDURAL HAEMORRHAGE,2
CA,POST PROCEDURAL INFECTION,2
CA,POSTMENOPAUSAL HAEMORRHAGE,2
CA,PRECANCEROUS CELLS PRESENT,2
CA,PRESCRIBED UNDERDOSE,2
CA,PROSTATE CANCER METASTATIC,2
CA,PROTEIN URINE PRESENT,2
CA,PSYCHOMOTOR HYPERACTIVITY,2
CA,PULMONARY FIBROSIS,2
CA,PULMONARY MASS,2
CA,PULMONARY OEDEMA,2
CA,PULMONARY PAIN,2
CA,PYELONEPHRITIS,2
CA,PYODERMA GANGRENOSUM,2
CA,RADIATION NECROSIS,2
CA,RAYNAUD^S PHENOMENON,2
CL,HEADACHE,3
CL,BACK PAIN,2
CL,NASOPHARYNGITIS,2
CL,VOMITING,2
CL,ADVERSE EVENT,1
CL,ANAEMIA,1
CL,ANKLE FRACTURE,1
CL,ARTHRITIS,1
CL,ASTHENIA,1
CL,ATRIOVENTRICULAR SEPTAL DEFECT,1
CL,CHILLS,1
CL,COUGH,1
CL,DISCOMFORT,1
CL,DIZZINESS,1
CL,DRY MOUTH,1
CL,EAR PAIN,1
CL,ERYTHEMA,1
CL,FACIAL PAIN,1
CL,FALL,1
CL,FATIGUE,1
CL,GASTROINTESTINAL INFECTION,1
CL,GENERALISED TONIC-CLONIC SEIZURE,1
CL,HERPES ZOSTER,1
CL,INFLUENZA,1
CL,INJECTION SITE NECROSIS,1
CL,INJECTION SITE PAIN,1
CL,INTENTIONAL OVERDOSE,1
CL,INTERVERTEBRAL DISC DISORDER,1
CL,INTERVERTEBRAL DISC PROTRUSION,1
CL,JUVENILE IDIOPATHIC ARTHRITIS,1
CL,LACK OF INJECTION SITE ROTATION,1
CL,LIGAMENT DISORDER,1
CL,LIGAMENT INJURY,1
CL,LIGAMENT SPRAIN,1
CL,LIMB DISCOMFORT,1
CL,MEMORY IMPAIRMENT,1
CL,MENINGITIS,1
CL,MENORRHAGIA,1
CL,MOTOR DYSFUNCTION,1
CL,MULTIPLE SCLEROSIS,1
CL,MUSCLE RUPTURE,1
CL,MUSCLE TONE DISORDER,1
CL,NASAL CONGESTION,1
CL,NERVOUS SYSTEM DISORDER,1
CL,OCULAR DISCOMFORT,1
CL,OEDEMA PERIPHERAL,1
CL,OPTIC NEURITIS,1
CL,PAIN IN EXTREMITY,1
CL,PERIPHERAL SWELLING,1
CL,PNEUMONIA,1
CL,PSORIASIS,1
CL,PYELONEPHRITIS,1
CL,PYELONEPHRITIS ACUTE,1
CL,PYREXIA,1
CL,RASH MACULAR,1
CL,SEPSIS,1
CL,SEPTIC SHOCK,1
CL,SINUSITIS,1
CL,SPINAL DEFORMITY,1
CL,SUICIDE ATTEMPT,1
CL,TENDON PAIN,1
CL,TENDONITIS,1
CL,UTERINE LEIOMYOMA,1
CL,VISION BLURRED,1
CL,VISUAL IMPAIRMENT,1
CL,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
CN,PRODUCT USE ISSUE,36
CN,RASH,28
CN,PRURITUS,22
CN,GASTROINTESTINAL HAEMORRHAGE,20
CN,VOMITING,16
CN,INCORRECT ROUTE OF DRUG ADMINISTRATION,15
CN,OLIGURIA,13
CN,HYPERSENSITIVITY,12
CN,PRODUCT USE IN UNAPPROVED INDICATION,12
CN,URTICARIA,12
CN,DRUG INEFFECTIVE,11
CN,HYPERHIDROSIS,11
CN,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,10
CN,DYSPNOEA,10
CN,NAUSEA,10
CN,ANGIOEDEMA,9
CN,ERYTHEMA MULTIFORME,9
CN,PYREXIA,9
CN,LEUKOPENIA,8
CN,RENAL IMPAIRMENT,8
CN,ACCIDENTAL OVERDOSE,7
CN,ACUTE KIDNEY INJURY,7
CN,ASTHMA,7
CN,CHEST DISCOMFORT,7
CN,DIARRHOEA,7
CN,DRUG HYPERSENSITIVITY,7
CN,INTRAVENTRICULAR HAEMORRHAGE,7
CN,OEDEMA PERIPHERAL,7
CN,UPPER GASTROINTESTINAL HAEMORRHAGE,7
CN,ANAPHYLACTIC SHOCK,6
CN,ANAPHYLACTOID REACTION,6
CN,BRONCHITIS,6
CN,HEPATIC FUNCTION ABNORMAL,6
CN,NECROTISING COLITIS,6
CN,NEPHROPATHY TOXIC,6
CN,RASH ERYTHEMATOUS,6
CN,RASH MACULO-PAPULAR,6
CN,SYNCOPE,6
CN,THERAPEUTIC RESPONSE UNEXPECTED,6
CN,ABDOMINAL DISTENSION,5
CN,BODY TEMPERATURE DECREASED,5
CN,COMA,5
CN,DEATH,5
CN,DIZZINESS,5
CN,DRUG-INDUCED LIVER INJURY,5
CN,EYELID OEDEMA,5
CN,GASTRIC HAEMORRHAGE,5
CN,HEADACHE,5
CN,OVERDOSE,5
CN,PNEUMONIA,5
CN,RASH GENERALISED,5
CN,TUBULOINTERSTITIAL NEPHRITIS,5
CN,ABDOMINAL PAIN,4
CN,ARTHRALGIA,4
CN,BLOOD CREATININE INCREASED,4
CN,COUGH,4
CN,CYANOSIS,4
CN,DRUG ERUPTION,4
CN,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,4
CN,FEEDING INTOLERANCE,4
CN,GRANULOCYTOPENIA,4
CN,HAEMATOCHEZIA,4
CN,HYPERBILIRUBINAEMIA,4
CN,INCORRECT DOSE ADMINISTERED,4
CN,LIVER FUNCTION TEST ABNORMAL,4
CN,MYALGIA,4
CN,PLATELET COUNT DECREASED,4
CN,SWELLING FACE,4
CN,TOXICITY TO VARIOUS AGENTS,4
CN,URINARY RETENTION,4
CN,ANAEMIA,3
CN,ARRHYTHMIA,3
CN,BLOOD PRESSURE DECREASED,3
CN,CEREBRAL INFARCTION,3
CN,DECREASED APPETITE,3
CN,DERMATITIS ALLERGIC,3
CN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,3
CN,DYSPHORIA,3
CN,ERYTHEMA,3
CN,FEBRILE CONVULSION,3
CN,FLUSHING,3
CN,GAIT DISTURBANCE,3
CN,HAEMORRHAGE INTRACRANIAL,3
CN,HEPATIC FAILURE,3
CN,HEPATITIS,3
CN,HEPATITIS CHOLESTATIC,3
CN,HYPOTHERMIA,3
CN,HYPOVOLAEMIC SHOCK,3
CN,LIP OEDEMA,3
CN,LUNG INFECTION,3
CN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
CN,OEDEMA,3
CN,PAIN IN EXTREMITY,3
CN,RASH PRURITIC,3
CN,SEIZURE,3
CN,SELF-MEDICATION,3
CN,SHOCK,3
CN,SUSPECTED COUNTERFEIT PRODUCT,3
CN,TINNITUS,3
CN,TRANSAMINASES INCREASED,3
CN,VISION BLURRED,3
CN,WEIGHT DECREASED,3
CN,ACCIDENTAL EXPOSURE TO PRODUCT,2
CN,ALANINE AMINOTRANSFERASE INCREASED,2
CN,AMBLYOPIA,2
CN,ANAPHYLACTIC REACTION,2
CN,ASPARTATE AMINOTRANSFERASE INCREASED,2
CN,BRONCHOPULMONARY DYSPLASIA,2
CN,CARDIOMYOPATHY,2
CN,DEPRESSED LEVEL OF CONSCIOUSNESS,2
CN,DERMATITIS EXFOLIATIVE,2
CN,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,2
CN,DRY MOUTH,2
CN,EATING DISORDER,2
CN,EXTRA DOSE ADMINISTERED,2
CN,FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT,2
CN,GASTROINTESTINAL DISORDER,2
CN,GENERALISED OEDEMA,2
CN,HAEMATEMESIS,2
CN,HAEMATURIA,2
CN,HAEMOGLOBIN DECREASED,2
CN,HEART RATE INCREASED,2
CN,HEPATIC ENZYME INCREASED,2
CN,HEPATITIS ACUTE,2
CN,HEPATOCELLULAR INJURY,2
CN,HEPATOTOXICITY,2
CN,IMPAIRED GASTRIC EMPTYING,2
CN,INCONTINENCE,2
CN,LABORATORY TEST ABNORMAL,2
CN,LARYNGITIS,2
CN,LIP SWELLING,2
CN,LIVER DISORDER,2
CN,LIVER INJURY,2
CN,LOSS OF CONSCIOUSNESS,2
CN,MENTAL STATUS CHANGES,2
CN,MUSCLE TWITCHING,2
CN,NECROTISING ENTEROCOLITIS NEONATAL,2
CN,PALLOR,2
CN,PERIORBITAL OEDEMA,2
CN,PLASMA CELL LEUKAEMIA,2
CN,PLASMA CELL MYELOMA RECURRENT,2
CN,PRODUCT QUALITY ISSUE,2
CN,PRURITUS GENERALISED,2
CN,RASH MORBILLIFORM,2
CN,RENAL FAILURE,2
CN,RESPIRATORY DEPRESSION,2
CN,RESPIRATORY DISORDER,2
CN,RHABDOMYOLYSIS,2
CN,ROSEOLA,2
CN,SINUS TACHYCARDIA,2
CN,STOMATITIS,2
CN,STRABISMUS,2
CN,THROMBOCYTOPENIA,2
CN,TONSILLITIS,2
CN,TREMOR,2
CN,URINE OUTPUT DECREASED,2
CN,VANISHING BILE DUCT SYNDROME,2
CN,VIRAL INFECTION,2
CN,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
CN,ABDOMINAL ADHESIONS,1
CN,ABDOMINAL DISCOMFORT,1
CN,ABNORMAL BEHAVIOUR,1
CN,ACUTE LEFT VENTRICULAR FAILURE,1
CN,ACUTE MYOCARDIAL INFARCTION,1
CN,ACUTE RESPIRATORY DISTRESS SYNDROME,1
CN,AMAUROSIS,1
CN,ANGINA PECTORIS,1
CN,ANGINA UNSTABLE,1
CN,ASTHENIA,1
CN,ATRIOVENTRICULAR BLOCK,1
CN,AUTOIMMUNE HEPATITIS,1
CN,AZOTAEMIA,1
CN,BLINDNESS,1
CN,BLISTER,1
CN,BLOOD COUNT ABNORMAL,1
CN,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
CN,BLOOD POTASSIUM INCREASED,1
CN,BLOOD SODIUM DECREASED,1
CN,BLOOD UREA INCREASED,1
CN,BODY TEMPERATURE FLUCTUATION,1
CN,BODY TEMPERATURE INCREASED,1
CN,BONE MARROW FAILURE,1
CN,BRAIN INJURY,1
CN,BRONCHIECTASIS,1
CN,BRONCHOPNEUMONIA,1
CN,BRONCHOSTENOSIS,1
CN,BURNING SENSATION,1
CN,CATARACT,1
CN,CENTRAL NERVOUS SYSTEM INFECTION,1
CN,CHILLS,1
CN,CHOLANGITIS,1
CN,CHOLECYSTITIS,1
CN,CHOLELITHIASIS,1
CN,CHOLESTATIC LIVER INJURY,1
CN,COAGULATION DISORDER NEONATAL,1
CN,COAGULOPATHY,1
CN,CONJUNCTIVAL HYPERAEMIA,1
CN,CONJUNCTIVITIS,1
CN,CONTINUOUS HAEMODIAFILTRATION,1
CN,CORNEAL OPACITY,1
CN,DEAFNESS NEUROSENSORY,1
CN,DELIRIUM,1
CN,DRUG DOSE OMISSION,1
CN,DRUG EFFECT INCOMPLETE,1
CN,DYSURIA,1
CN,ELECTROENCEPHALOGRAM ABNORMAL,1
CN,ELECTROLYTE IMBALANCE,1
CN,EMPHYSEMA,1
CN,EPIDERMOLYSIS BULLOSA,1
CN,EPIGASTRIC DISCOMFORT,1
CN,EPILEPSY,1
CN,ERYTHEMA OF EYELID,1
CN,EXPIRED PRODUCT ADMINISTERED,1
CN,EXPOSURE DURING PREGNANCY,1
CN,EYE DISORDER,1
CN,EYE INFECTION,1
CN,EYE SWELLING,1
CN,FEELING COLD,1
CN,FREQUENT BOWEL MOVEMENTS,1
CN,FUNGAL INFECTION,1
CN,GALLBLADDER DISORDER,1
CN,GASTRIC ULCER,1
CN,GASTROINTESTINAL OBSTRUCTION,1
CN,GAZE PALSY,1
CN,GENERALISED ERYTHEMA,1
CN,GLAUCOMA,1
CN,GLOMERULAR FILTRATION RATE DECREASED,1
CN,GLOMERULONEPHRITIS MINIMAL LESION,1
CN,HAEMORRHAGIC ANAEMIA,1
CN,HALLUCINATION,1
CN,HAND-FOOT-AND-MOUTH DISEASE,1
CN,HELICOBACTER TEST POSITIVE,1
CN,HEPATORENAL SYNDROME,1
CN,HERBAL INTERACTION,1
CN,HYPERKALAEMIA,1
CN,HYPOAESTHESIA ORAL,1
CN,HYPOPHAGIA,1
CN,HYPOTENSION,1
CN,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
CN,INADEQUATE ANALGESIA,1
CN,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
CN,INCORRECT DRUG ADMINISTRATION DURATION,1
CN,INFECTION,1
CN,INFECTIOUS MONONUCLEOSIS,1
CN,INFECTIOUS THYROIDITIS,1
CN,INFUSION RELATED REACTION,1
CN,INJURY,1
CN,INSOMNIA,1
CN,INTENTIONAL PRODUCT MISUSE,1
CN,INTENTIONAL PRODUCT USE ISSUE,1
CN,INTERNAL INJURY,1
CN,INTESTINAL DIAPHRAGM DISEASE,1
CN,INTESTINAL PERFORATION,1
CN,IRRITABILITY,1
CN,JAUNDICE,1
CN,JAUNDICE CHOLESTATIC,1
CN,KAWASAKI^S DISEASE,1
CN,KERATITIS,1
CN,KIDNEY TRANSPLANT REJECTION,1
CN,LARYNGEAL OEDEMA,1
CN,LUPUS-LIKE SYNDROME,1
CN,LYMPHOPENIA,1
CN,MALAISE,1
CN,MALIGNANT NEOPLASM PROGRESSION,1
CN,MEASLES,1
CN,MELAENA,1
CN,MENTAL DISORDER,1
CN,METABOLIC ACIDOSIS,1
CN,MIOSIS,1
CN,MIXED LIVER INJURY,1
CN,MOUTH SWELLING,1
CN,MOUTH ULCERATION,1
CN,MULTI-ORGAN FAILURE,1
CN,MYOCARDIAL NECROSIS MARKER INCREASED,1
CN,MYOCARDITIS,1
CN,MYOSITIS,1
CN,NEONATAL ANURIA,1
CN,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
CN,NEOPLASM PROGRESSION,1
CN,NEPHRITIC SYNDROME,1
CN,NEUTROPENIA,1
CN,NEUTROPHIL COUNT INCREASED,1
CN,NEUTROPHILIA,1
CN,NYSTAGMUS,1
CN,OCCULT BLOOD POSITIVE,1
CN,OESOPHAGEAL ULCER,1
CN,PAIN,1
CN,PALPITATIONS,1
CN,PAPULE,1
CN,PEPTIC ULCER,1
CN,PEPTIC ULCER HAEMORRHAGE,1
CN,PERFORATION,1
CN,PERIORBITAL CONTUSION,1
CN,PERIPHERAL OEDEMA NEONATAL,1
CN,PERIPHERAL SWELLING,1
CN,PERIPHERAL VASCULAR DISORDER,1
CN,PERIVENTRICULAR LEUKOMALACIA,1
CN,PHARYNGEAL OEDEMA,1
CN,PHARYNGITIS,1
CN,PIGMENTATION DISORDER,1
CN,PLATELET COUNT INCREASED,1
CN,PRESCRIBED UNDERDOSE,1
CN,PRODUCT CONTAMINATION,1
CN,PRODUCT CONTAMINATION MICROBIAL,1
CN,PRODUCT COUNTERFEIT,1
CN,PRODUCT LABEL CONFUSION,1
CN,PRODUCT LABEL ISSUE,1
CN,PROTEINURIA,1
CN,PURPURA,1
CN,RED BLOOD CELL COUNT DECREASED,1
CN,RENAL FAILURE ACUTE,1
CN,RENAL PAPILLARY NECROSIS,1
CN,RESPIRATORY ARREST,1
CN,RESPIRATORY FAILURE,1
CN,RESPIRATORY TRACT CONGESTION,1
CN,RESPIRATORY TRACT INFECTION,1
CN,RETINAL OEDEMA,1
CN,RETINOPATHY OF PREMATURITY,1
CN,RUBELLA,1
CN,SCOLIOSIS,1
CN,SECONDARY HYPOTHYROIDISM,1
CN,SEPSIS,1
CN,SEPTIC SHOCK,1
CN,SHOCK HAEMORRHAGIC,1
CN,SKIN INJURY,1
CN,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,1
CN,SLOW RESPONSE TO STIMULI,1
CN,SOMNOLENCE,1
CN,STATUS EPILEPTICUS,1
CN,STEVENS-JOHNSON SYNDROME,1
CN,STREPTOCOCCAL INFECTION,1
CN,STRESS ULCER,1
CN,SWOLLEN TONGUE,1
CN,TACHYCARDIA,1
CN,TEMPERATURE INTOLERANCE,1
CN,TENDERNESS,1
CN,TIC,1
CN,TOXIC EPIDERMAL NECROLYSIS,1
CN,TRISMUS,1
CN,UNDERDOSE,1
CN,UPPER RESPIRATORY TRACT INFECTION,1
CN,URINARY TRACT INFECTION,1
CN,URINE ABNORMALITY,1
CN,VENTRICULAR ARRHYTHMIA,1
CN,VERTIGO,1
CN,VULVOVAGINAL DISCOMFORT,1
CN,WHEEZING,1
CN,WHITE BLOOD CELL COUNT ABNORMAL,1
CN,WHITE BLOOD CELL COUNT DECREASED,1
CN,WHITE BLOOD CELL COUNT INCREASED,1
CN,WRONG DRUG ADMINISTERED,1
CN,WRONG PATIENT RECEIVED MEDICATION,1
CN,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
CN,XEROPHTHALMIA,1
CN,YELLOW SKIN,1
CO,HEADACHE,15
CO,PAIN IN EXTREMITY,15
CO,ARTHRALGIA,13
CO,MALAISE,13
CO,PYREXIA,11
CO,DIZZINESS,10
CO,VOMITING,9
CO,BONE PAIN,8
CO,PAIN,8
CO,COUGH,7
CO,NAUSEA,7
CO,PLATELET COUNT DECREASED,7
CO,ABDOMINAL PAIN,6
CO,DIARRHOEA,6
CO,DYSPNOEA,6
CO,INFLUENZA,6
CO,PRURITUS,6
CO,VAGINAL HAEMORRHAGE,6
CO,ARTHROPATHY,5
CO,BACK PAIN,5
CO,ENDOMETRIOSIS,5
CO,FATIGUE,5
CO,GENERAL PHYSICAL HEALTH DETERIORATION,5
CO,INSOMNIA,5
CO,PNEUMONIA,5
CO,VISION BLURRED,5
CO,WEIGHT DECREASED,5
CO,ANAEMIA,4
CO,ASTHENIA,4
CO,BLOOD GLUCOSE INCREASED,4
CO,BRONCHITIS,4
CO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
CO,CONDITION AGGRAVATED,4
CO,EYE IRRITATION,4
CO,FALL,4
CO,FEELING ABNORMAL,4
CO,GAIT DISTURBANCE,4
CO,GASTRITIS,4
CO,HYPERTENSION,4
CO,INFLAMMATION,4
CO,MUSCLE SPASMS,4
CO,VAGINAL DISCHARGE,4
CO,ABDOMINAL DISCOMFORT,3
CO,ABDOMINAL PAIN UPPER,3
CO,ANXIETY,3
CO,CARDIO-RESPIRATORY ARREST,3
CO,CEREBROVASCULAR ACCIDENT,3
CO,CHOKING,3
CO,DECREASED APPETITE,3
CO,DRUG INEFFECTIVE,3
CO,HAEMOGLOBIN DECREASED,3
CO,HERPES ZOSTER,3
CO,HYPERSENSITIVITY,3
CO,HYPOAESTHESIA,3
CO,MALIGNANT NEOPLASM PROGRESSION,3
CO,MYOCARDIAL INFARCTION,3
CO,OSTEOPOROSIS,3
CO,PROCEDURAL PAIN,3
CO,RHEUMATOID ARTHRITIS,3
CO,SKIN DISCOLOURATION,3
CO,SYNCOPE,3
CO,URINARY TRACT INFECTION,3
CO,ACUTE RESPIRATORY DISTRESS SYNDROME,2
CO,AMNESIA,2
CO,ARTHRITIS,2
CO,ASPHYXIA,2
CO,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,2
CO,BLINDNESS,2
CO,BLISTER,2
CO,BLOOD PRESSURE DECREASED,2
CO,BREAST CANCER,2
CO,BURNING SENSATION,2
CO,CATARACT,2
CO,CHEST PAIN,2
CO,CHILLS,2
CO,CONSTIPATION,2
CO,DECREASED IMMUNE RESPONSIVENESS,2
CO,DEHYDRATION,2
CO,DELIRIUM,2
CO,DEPRESSED MOOD,2
CO,DIABETES MELLITUS,2
CO,DISEASE RECURRENCE,2
CO,DRUG DEPENDENCE,2
CO,DRUG DOSE OMISSION,2
CO,EPISTAXIS,2
CO,FEELING HOT,2
CO,FLATULENCE,2
CO,FLUSHING,2
CO,FURUNCLE,2
CO,GINGIVAL BLEEDING,2
CO,HAEMORRHAGE,2
CO,HYPERTENSIVE HEART DISEASE,2
CO,IMMUNE SYSTEM DISORDER,2
CO,INCREASED UPPER AIRWAY SECRETION,2
CO,INJECTION SITE MASS,2
CO,INTESTINAL OBSTRUCTION,2
CO,JOINT SWELLING,2
CO,LACRIMATION INCREASED,2
CO,LEUKOPENIA,2
CO,LUNG DISORDER,2
CO,MEMORY IMPAIRMENT,2
CO,METASTASES TO LUNG,2
CO,MOUTH HAEMORRHAGE,2
CO,MOVEMENT DISORDER,2
CO,MUSCULAR WEAKNESS,2
CO,MUSCULOSKELETAL PAIN,2
CO,NECROTISING FASCIITIS,2
CO,NERVOUSNESS,2
CO,OEDEMA PERIPHERAL,2
CO,PERIPHERAL SWELLING,2
CO,PETECHIAE,2
CO,PRURITUS GENERALISED,2
CO,PSYCHIATRIC SYMPTOM,2
CO,RASH,2
CO,RECTAL HAEMORRHAGE,2
CO,RESPIRATORY FAILURE,2
CO,SEPTIC SHOCK,2
CO,SINUSITIS,2
CO,SOMNOLENCE,2
CO,TREMOR,2
CO,UTERINE LEIOMYOMA,2
CO,ABASIA,1
CO,ABORTION SPONTANEOUS,1
CO,ACCIDENT,1
CO,AGITATION,1
CO,ANAL ABSCESS,1
CO,ANAL HAEMORRHAGE,1
CO,ANGER,1
CO,ANOSMIA,1
CO,ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE,1
CO,APATHY,1
CO,APPENDICITIS PERFORATED,1
CO,ASTHMA,1
CO,ASYMPTOMATIC BACTERIURIA,1
CO,BACK INJURY,1
CO,BALANCE DISORDER,1
CO,BLOOD CALCIUM INCREASED,1
CO,BLOOD CHOLESTEROL INCREASED,1
CO,BLOOD GLUCOSE ABNORMAL,1
CO,BLOOD PRESSURE INCREASED,1
CO,BLOOD SODIUM DECREASED,1
CO,BONE DISORDER,1
CO,BOREDOM,1
CO,CARDIAC ARREST,1
CO,CARDIAC DISORDER,1
CO,CARDIAC MURMUR,1
CO,CARPAL TUNNEL SYNDROME,1
CO,CERVICAL DYSPLASIA,1
CO,CHEMOTHERAPY,1
CO,COLITIS,1
CO,CONGESTIVE CARDIOMYOPATHY,1
CO,CONTUSION,1
CO,CYSTITIS,1
CO,DEATH,1
CO,DENGUE FEVER,1
CO,DENTAL CARIES,1
CO,DEPRESSION,1
CO,DISCOMFORT,1
CO,DISORIENTATION,1
CO,DISSEMINATED INTRAVASCULAR COAGULATION,1
CO,DIVERTICULUM,1
CO,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
CO,DRUG EFFECT DECREASED,1
CO,DRUG HYPERSENSITIVITY,1
CO,DRY SKIN,1
CO,DYSKINESIA,1
CO,DYSPEPSIA,1
CO,DYSPHAGIA,1
CO,DYSURIA,1
CO,EAR INFECTION,1
CO,EATING DISORDER,1
CO,ELECTROLYTE IMBALANCE,1
CO,EMOTIONAL DISORDER,1
CO,ENCEPHALITIS,1
CO,ERYTHEMA,1
CO,EYE DISORDER,1
CO,EYE PAIN,1
CO,EYELID OEDEMA,1
CO,FACIAL PAIN,1
CO,FAECALOMA,1
CO,FALLOPIAN TUBE CANCER,1
CO,FLANK PAIN,1
CO,FOOD INTERACTION,1
CO,FOOT DEFORMITY,1
CO,GAIT INABILITY,1
CO,GALLBLADDER OPERATION,1
CO,GASTRIC ULCER,1
CO,GASTROINTESTINAL INJURY,1
CO,HAEMATOMA,1
CO,HAEMOGLOBIN ABNORMAL,1
CO,HAEMORRHOIDS,1
CO,HAND FRACTURE,1
CO,HEAD DISCOMFORT,1
CO,HEAD INJURY,1
CO,HEART RATE INCREASED,1
CO,HEMIPARESIS,1
CO,HEPATIC FAILURE,1
CO,HEPATIC STEATOSIS,1
CO,HERNIA,1
CO,HIATUS HERNIA,1
CO,HIP ARTHROPLASTY,1
CO,HORMONE LEVEL ABNORMAL,1
CO,HOT FLUSH,1
CO,HYPERKERATOSIS,1
CO,HYPOGLYCAEMIA,1
CO,HYPOTENSION,1
CO,HYPOTHERMIA,1
CO,HYPOTHYROIDISM,1
CO,ILEAL PERFORATION,1
CO,IMMUNE THROMBOCYTOPENIC PURPURA,1
CO,IMMUNOSUPPRESSION,1
CO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
CO,INCORRECT DRUG ADMINISTRATION RATE,1
CO,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
CO,INFARCTION,1
CO,INFECTION,1
CO,INFLUENZA LIKE ILLNESS,1
CO,INGUINAL HERNIA,1
CO,INJECTION SITE PAIN,1
CO,INTENTIONAL DRUG MISUSE,1
CO,INTENTIONAL PRODUCT USE ISSUE,1
CO,IRRITABLE BOWEL SYNDROME,1
CO,JAW DISORDER,1
CO,JOINT INJURY,1
CO,LEIOMYOMA,1
CO,LIMB DEFORMITY,1
CO,LIMB INJURY,1
CO,LIVER INJURY,1
CO,LOCALISED INFECTION,1
CO,LOWER RESPIRATORY TRACT INFECTION,1
CO,LYMPHOPENIA,1
CO,MASTECTOMY,1
CO,MENOPAUSE,1
CO,METASTASES TO KIDNEY,1
CO,METASTASES TO LIVER,1
CO,METASTASES TO SPINE,1
CO,MOBILITY DECREASED,1
CO,MONOPLEGIA,1
CO,MOOD ALTERED,1
CO,MULTI-ORGAN FAILURE,1
CO,MUSCULOSKELETAL CHEST PAIN,1
CO,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
CO,MYDRIASIS,1
CO,MYELOFIBROSIS,1
CO,MYOCARDIAL ISCHAEMIA,1
CO,NASAL ADHESIONS,1
CO,NASAL CONGESTION,1
CO,NASAL MUCOSAL DISORDER,1
CO,NASAL SEPTUM DEVIATION,1
CO,NECK PAIN,1
CO,NEOPLASM,1
CO,NEOPLASM PROGRESSION,1
CO,NERVOUS SYSTEM DISORDER,1
CO,NEURALGIA,1
CO,NOSOCOMIAL INFECTION,1
CO,OCULAR DISCOMFORT,1
CO,OEDEMA,1
CO,OROPHARYNGEAL DISCOMFORT,1
CO,OROPHARYNGEAL PAIN,1
CO,OSTEOARTHRITIS,1
CO,OVARIAN MASS,1
CO,OVERDOSE,1
CO,PAIN IN JAW,1
CO,PALPITATIONS,1
CO,PANCREATIC CARCINOMA,1
CO,PELVIC PAIN,1
CO,PERITONITIS,1
CO,PHOTOPHOBIA,1
CO,PHOTOSENSITIVITY REACTION,1
CO,PLATELET COUNT INCREASED,1
CO,POISONING,1
CO,POLLAKIURIA,1
CO,POLYCYTHAEMIA VERA,1
CO,PORPHYRIA,1
CO,POSTOPERATIVE WOUND INFECTION,1
CO,PRESCRIBED OVERDOSE,1
CO,PRODUCT QUALITY ISSUE,1
CO,PRODUCTIVE COUGH,1
CO,PSEUDOMONAS INFECTION,1
CO,PTERYGIUM,1
CO,PULMONARY PAIN,1
CO,RASH GENERALISED,1
CO,RED BLOOD CELL COUNT DECREASED,1
CO,RENAL COLIC,1
CO,RESPIRATORY ARREST,1
CO,SCIATIC NERVE INJURY,1
CO,SCOLIOSIS,1
CO,SCRATCH,1
CO,SECOND PRIMARY MALIGNANCY,1
CO,SEIZURE,1
CO,SENSITISATION,1
CO,SKELETAL INJURY,1
CO,SKIN DISCOMFORT,1
CO,SKIN HAEMORRHAGE,1
CO,SLEEP DISORDER,1
CO,SPINAL FRACTURE,1
CO,SPLEEN DISORDER,1
CO,STRESS,1
CO,SUICIDE ATTEMPT,1
CO,SWELLING,1
CO,SWELLING FACE,1
CO,SYSTEMIC LUPUS ERYTHEMATOSUS,1
CO,THERAPY NON-RESPONDER,1
CO,THROMBOCYTOPENIA,1
CO,THYROID DISORDER,1
CO,TINNITUS,1
CO,TOOTHACHE,1
CO,TRANSAMINASES INCREASED,1
CO,TRAUMATIC LUNG INJURY,1
CO,TUBERCULOSIS,1
CO,UNDERWEIGHT,1
CO,UTERINE MASS,1
CO,UVEITIS,1
CO,VAGINAL CANCER,1
CO,VARICOSE VEIN,1
CO,VENOUS VALVE RUPTURED,1
CO,VERTIGO,1
CO,VIRAL INFECTION,1
CO,VISUAL ACUITY REDUCED,1
CO,VISUAL IMPAIRMENT,1
CO,VULVOVAGINAL INFLAMMATION,1
CO,VULVOVAGINAL PAIN,1
CO,WEIGHT INCREASED,1
CO,WHITE BLOOD CELL COUNT INCREASED,1
CO,WOUND COMPLICATION,1
CO,WOUND INFECTION,1
CO,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
KM,FOOT DEFORMITY,1
CR,ACUTE CORONARY SYNDROME,2
CR,GASTRIC ADENOMA,2
CR,HEADACHE,2
CR,ABASIA,1
CR,ACUTE MYOCARDIAL INFARCTION,1
CR,ASTHENIA,1
CR,CEREBROSPINAL FISTULA,1
CR,CEREBROSPINAL FLUID LEAKAGE,1
CR,CEREBROVASCULAR ACCIDENT,1
CR,DELIRIUM,1
CR,DISCOMFORT,1
CR,DIZZINESS,1
CR,EYE IRRITATION,1
CR,EYE PAIN,1
CR,GASTRIC ULCER,1
CR,GASTROOESOPHAGEAL REFLUX DISEASE,1
CR,HALLUCINATION,1
CR,MIGRAINE,1
CR,MOTOR DYSFUNCTION,1
CR,MUSCLE SPASMS,1
CR,NAUSEA,1
CR,OESOPHAGEAL CANDIDIASIS,1
CR,OPTIC NEURITIS,1
CR,PHOTOPHOBIA,1
CR,PNEUMONIA,1
CR,PYREXIA,1
CR,SCAB,1
CR,SCAR,1
CR,STOMATITIS,1
CR,VOMITING,1
CI,GASTROINTESTINAL HAEMORRHAGE,1
CI,HEPATOCELLULAR INJURY,1
HR,SUICIDE ATTEMPT,13
HR,HYPOTENSION,10
HR,SOMNOLENCE,6
HR,INTENTIONAL OVERDOSE,5
HR,DEHYDRATION,4
HR,LOSS OF CONSCIOUSNESS,4
HR,TACHYCARDIA,4
HR,URINARY RETENTION,4
HR,JOINT SWELLING,3
HR,NAUSEA,3
HR,NO ADVERSE EVENT,3
HR,ACIDOSIS,2
HR,ALANINE AMINOTRANSFERASE INCREASED,2
HR,ARTHRALGIA,2
HR,ASPARTATE AMINOTRANSFERASE INCREASED,2
HR,BACK PAIN,2
HR,BLOOD BILIRUBIN INCREASED,2
HR,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
HR,BLOOD PRESSURE SYSTOLIC INCREASED,2
HR,BLOOD SELENIUM DECREASED,2
HR,C-REACTIVE PROTEIN INCREASED,2
HR,COMA,2
HR,CONJUNCTIVAL HAEMORRHAGE,2
HR,DACTYLITIS,2
HR,DIZZINESS,2
HR,DRUG ABUSE,2
HR,DRUG INEFFECTIVE,2
HR,DRUG INTOLERANCE,2
HR,DUPUYTREN^S CONTRACTURE,2
HR,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
HR,HYPERSENSITIVITY,2
HR,IRON BINDING CAPACITY TOTAL DECREASED,2
HR,JOINT ANKYLOSIS,2
HR,LIVER INJURY,2
HR,MOUTH HAEMORRHAGE,2
HR,MUSCLE INJURY,2
HR,MUSCULOSKELETAL STIFFNESS,2
HR,OEDEMA,2
HR,ORAL MUCOSAL EXFOLIATION,2
HR,PELVIC PAIN,2
HR,PNEUMONIA,2
HR,PRURITUS,2
HR,PYREXIA,2
HR,RASH MACULO-PAPULAR,2
HR,SEIZURE,2
HR,STEVENS-JOHNSON SYNDROME,2
HR,TESTICULAR OEDEMA,2
HR,TOXIC NEUROPATHY,2
HR,ABDOMINAL PAIN,1
HR,ABORTION THREATENED,1
HR,ACCIDENTAL OVERDOSE,1
HR,AGRANULOCYTOSIS,1
HR,ANKYLOSING SPONDYLITIS,1
HR,APPLICATION SITE HYPERSENSITIVITY,1
HR,ARNOLD-CHIARI MALFORMATION,1
HR,ARTHRITIS BACTERIAL,1
HR,ASTHENIA,1
HR,CEREBRAL VENTRICLE DILATATION,1
HR,CHOKING,1
HR,CONTUSION,1
HR,DEAFNESS NEUROSENSORY,1
HR,DEATH,1
HR,DEEP VEIN THROMBOSIS,1
HR,DENTAL NECROSIS,1
HR,DRY SKIN,1
HR,ERYSIPELAS,1
HR,ESCHERICHIA URINARY TRACT INFECTION,1
HR,FEBRILE NEUTROPENIA,1
HR,FOETAL EXPOSURE DURING PREGNANCY,1
HR,GASTRIC ULCER,1
HR,GASTROINTESTINAL DISORDER,1
HR,HAEMORRHAGE,1
HR,HEADACHE,1
HR,HEART RATE IRREGULAR,1
HR,HYDROCEPHALUS,1
HR,HYPERURICAEMIA,1
HR,INTERNATIONAL NORMALISED RATIO INCREASED,1
HR,INTRA-ABDOMINAL HAEMATOMA,1
HR,MALAISE,1
HR,MATERNAL EXPOSURE BEFORE PREGNANCY,1
HR,MENINGITIS ASEPTIC,1
HR,METHAEMOGLOBINAEMIA,1
HR,MUCOSAL HYPERAEMIA,1
HR,NERVOUS SYSTEM DISORDER,1
HR,NORMOCYTIC ANAEMIA,1
HR,OEDEMA PERIPHERAL,1
HR,PAIN IN EXTREMITY,1
HR,PARAESTHESIA,1
HR,PARAPARESIS,1
HR,PERIPHERAL SWELLING,1
HR,PHARYNGITIS STREPTOCOCCAL,1
HR,PNEUMOPERITONEUM,1
HR,POISONING,1
HR,PROCEDURAL COMPLICATION,1
HR,PRURITUS GENERALISED,1
HR,PSOAS ABSCESS,1
HR,RECTAL HAEMORRHAGE,1
HR,RESPIRATORY FAILURE,1
HR,SCIATICA,1
HR,SELECTIVE ABORTION,1
HR,SPINA BIFIDA,1
HR,STILLBIRTH,1
HR,STOMA SITE DISCHARGE,1
HR,TINNITUS,1
HR,VAGINAL HAEMORRHAGE,1
HR,VARICOSE VEIN,1
HR,VESTIBULAR DISORDER,1
HR,VOMITING,1
HR,WHEEZING,1
CZ,STEVENS-JOHNSON SYNDROME,19
CZ,DRUG INEFFECTIVE,11
CZ,PNEUMONIA,8
CZ,STATUS EPILEPTICUS,8
CZ,OVERDOSE,7
CZ,RASH,6
CZ,INTENTIONAL PRODUCT MISUSE,5
CZ,SUICIDE ATTEMPT,5
CZ,INTENTIONAL OVERDOSE,4
CZ,SOMNOLENCE,4
CZ,DEPRESSED LEVEL OF CONSCIOUSNESS,3
CZ,DEPRESSION,3
CZ,DRUG DEPENDENCE,3
CZ,LACERATION,3
CZ,OPTIC NEURITIS,3
CZ,OSTEONECROSIS OF JAW,3
CZ,RENAL IMPAIRMENT,3
CZ,SOPOR,3
CZ,TOXICITY TO VARIOUS AGENTS,3
CZ,ACUTE KIDNEY INJURY,2
CZ,ALTERED STATE OF CONSCIOUSNESS,2
CZ,BREAST CANCER,2
CZ,CEREBROVASCULAR ACCIDENT,2
CZ,DERMATITIS ALLERGIC,2
CZ,DISEASE PROGRESSION,2
CZ,DRUG LEVEL INCREASED,2
CZ,DYSARTHRIA,2
CZ,DYSPNOEA,2
CZ,HYPERBILIRUBINAEMIA,2
CZ,HYPONATRAEMIA,2
CZ,MALAISE,2
CZ,MALIGNANT NEOPLASM PROGRESSION,2
CZ,PYLORIC STENOSIS,2
CZ,TENSION HEADACHE,2
CZ,THIRST,2
CZ,VOMITING,2
CZ,ABDOMINAL PAIN UPPER,1
CZ,ACUTE TONSILLITIS,1
CZ,AGRANULOCYTOSIS,1
CZ,ALKALOSIS,1
CZ,ANAEMIA,1
CZ,APHASIA,1
CZ,ARTHRALGIA,1
CZ,ARTHRITIS,1
CZ,ATRIAL FIBRILLATION,1
CZ,BACK PAIN,1
CZ,BLOOD POTASSIUM INCREASED,1
CZ,BLOOD PRESSURE FLUCTUATION,1
CZ,CARDIAC FAILURE,1
CZ,CENTRAL NERVOUS SYSTEM LESION,1
CZ,CHEST DISCOMFORT,1
CZ,CONSTIPATION,1
CZ,DEATH,1
CZ,DEHYDRATION,1
CZ,DIARRHOEA,1
CZ,DRUG EFFECT INCOMPLETE,1
CZ,DRUG-INDUCED LIVER INJURY,1
CZ,DYSPEPSIA,1
CZ,ERYTHEMA,1
CZ,FATIGUE,1
CZ,FEBRILE NEUTROPENIA,1
CZ,GASTRITIS,1
CZ,GASTROINTESTINAL DISORDER,1
CZ,GASTROINTESTINAL STROMAL TUMOUR,1
CZ,HAEMATOCHEZIA,1
CZ,HEADACHE,1
CZ,HYPERKALAEMIA,1
CZ,HYPOCALCAEMIA,1
CZ,HYPOGLYCAEMIC UNCONSCIOUSNESS,1
CZ,HYPOKALAEMIA,1
CZ,HYPOVENTILATION,1
CZ,ILEUS,1
CZ,INCORRECT DOSE ADMINISTERED,1
CZ,INFECTION,1
CZ,JOINT SWELLING,1
CZ,LEUKOCYTOSIS,1
CZ,METRORRHAGIA,1
CZ,MYALGIA,1
CZ,NEUTROPENIA,1
CZ,OEDEMA,1
CZ,OEDEMA PERIPHERAL,1
CZ,PAIN,1
CZ,PERITONSILLAR ABSCESS,1
CZ,PRODUCT USE ISSUE,1
CZ,PSORIASIS,1
CZ,PUSTULAR PSORIASIS,1
CZ,PYREXIA,1
CZ,RASH GENERALISED,1
CZ,RENAL FAILURE,1
CZ,SEPSIS,1
CZ,SLOW SPEECH,1
CZ,SUBILEUS,1
CZ,SYNCOPE,1
CZ,THERMAL BURN,1
CZ,TONSILLAR HYPERTROPHY,1
CZ,TONSILLITIS,1
CZ,VENTRICULAR FLUTTER,1
CZ,VISUAL ACUITY REDUCED,1
DK,DYSPNOEA,21
DK,FATIGUE,15
DK,HYPERHIDROSIS,15
DK,TOXICITY TO VARIOUS AGENTS,14
DK,VOMITING,14
DK,CARDIAC FAILURE,12
DK,URTICARIA,11
DK,DIZZINESS,9
DK,HYPOPHOSPHATAEMIA,9
DK,MALAISE,9
DK,PALPITATIONS,9
DK,SWOLLEN TONGUE,9
DK,WEIGHT DECREASED,9
DK,ANXIETY,8
DK,HEADACHE,8
DK,NAUSEA,8
DK,PYREXIA,8
DK,RASH,8
DK,TREMOR,8
DK,AMNESIA,7
DK,ANORGASMIA,7
DK,DISTURBANCE IN ATTENTION,7
DK,DYSKINESIA,7
DK,HOT FLUSH,7
DK,INFLUENZA LIKE ILLNESS,7
DK,INSOMNIA,7
DK,INTERNATIONAL NORMALISED RATIO INCREASED,7
DK,NIGHTMARE,7
DK,PLEURAL EFFUSION,7
DK,SUICIDE ATTEMPT,7
DK,ABDOMINAL PAIN UPPER,6
DK,ANAPHYLACTIC REACTION,6
DK,BACK PAIN,6
DK,BURNING MOUTH SYNDROME,6
DK,DRY EYE,6
DK,DYSGEUSIA,6
DK,FOOD INTOLERANCE,6
DK,MEMORY IMPAIRMENT,6
DK,MULTIPLE CHEMICAL SENSITIVITY,6
DK,MUSCLE SPASMS,6
DK,NEUTROPENIC COLITIS,6
DK,OCULAR HYPERAEMIA,6
DK,OVERDOSE,6
DK,PERICARDITIS,6
DK,TINNITUS,6
DK,ABDOMINAL PAIN,5
DK,ANOSMIA,5
DK,FEBRILE NEUTROPENIA,5
DK,GASTRIC ULCER HAEMORRHAGE,5
DK,PNEUMONIA,5
DK,ACUTE RESPIRATORY FAILURE,4
DK,ASTHENIA,4
DK,C-REACTIVE PROTEIN INCREASED,4
DK,CARDIOMEGALY,4
DK,DEATH,4
DK,DIARRHOEA,4
DK,HAEMOGLOBIN DECREASED,4
DK,HAEMORRHAGE,4
DK,HALLUCINATION,4
DK,LIBIDO DECREASED,4
DK,PANCREATITIS ACUTE,4
DK,PNEUMONITIS,4
DK,AGEUSIA,3
DK,ASCITES,3
DK,CONTUSION,3
DK,DRUG INEFFECTIVE,3
DK,GAIT DISTURBANCE,3
DK,HEART RATE INCREASED,3
DK,HEPATIC ENZYME INCREASED,3
DK,INTENTIONAL OVERDOSE,3
DK,INTERSTITIAL LUNG DISEASE,3
DK,LOSS OF LIBIDO,3
DK,MYALGIA,3
DK,NECK PAIN,3
DK,PAIN IN EXTREMITY,3
DK,PARAESTHESIA ORAL,3
DK,PARAINFLUENZAE VIRUS INFECTION,3
DK,PARKINSON^S DISEASE,3
DK,PHARYNGITIS,3
DK,PNEUMOTHORAX,3
DK,PRURITUS,3
DK,RESPIRATORY DISTRESS,3
DK,RHINORRHOEA,3
DK,SEPTIC SHOCK,3
DK,STOMATITIS,3
DK,WHITE BLOOD CELL COUNT DECREASED,3
DK,ABDOMINAL ABSCESS,2
DK,ABDOMINAL TENDERNESS,2
DK,ACUTE KIDNEY INJURY,2
DK,ALANINE AMINOTRANSFERASE INCREASED,2
DK,ARTHRALGIA,2
DK,ASTHMA,2
DK,BASAL CELL CARCINOMA,2
DK,BLOOD LACTIC ACID INCREASED,2
DK,BONE EROSION,2
DK,BRAIN MIDLINE SHIFT,2
DK,BRAIN OEDEMA,2
DK,CHEST DISCOMFORT,2
DK,CHEST PAIN,2
DK,DYSPEPSIA,2
DK,DYSPHAGIA,2
DK,EJECTION FRACTION DECREASED,2
DK,EOSINOPHILIA,2
DK,FAECES DISCOLOURED,2
DK,FALL,2
DK,FEELING OF BODY TEMPERATURE CHANGE,2
DK,FLATULENCE,2
DK,GASTRIC PERFORATION,2
DK,GASTRIC ULCER,2
DK,GASTROINTESTINAL NECROSIS,2
DK,HAEMATOMA,2
DK,HAEMORRHAGE INTRACRANIAL,2
DK,HYPERSENSITIVITY,2
DK,INFECTION,2
DK,INFLAMMATION,2
DK,JOINT STIFFNESS,2
DK,LIMB DISCOMFORT,2
DK,LUNG DISORDER,2
DK,LYMPHADENOPATHY,2
DK,MULTI-ORGAN FAILURE,2
DK,MYOCARDIAL INFARCTION,2
DK,NASAL CONGESTION,2
DK,NASAL POLYPS,2
DK,NECROTISING COLITIS,2
DK,OEDEMA PERIPHERAL,2
DK,PAIN,2
DK,PALLOR,2
DK,PARAESTHESIA,2
DK,PLATELET COUNT DECREASED,2
DK,PURPURA,2
DK,RENAL FAILURE,2
DK,SEPSIS,2
DK,SINUS POLYP,2
DK,SOMNOLENCE,2
DK,SPLENIC INJURY,2
DK,SUBARACHNOID HAEMORRHAGE,2
DK,TACHYCARDIA,2
DK,WOUND INFECTION,2
DK,ABDOMINAL CAVITY DRAINAGE,1
DK,ABDOMINAL DISCOMFORT,1
DK,ABDOMINAL DISTENSION,1
DK,ACTIVITIES OF DAILY LIVING IMPAIRED,1
DK,ACUTE HEPATIC FAILURE,1
DK,ADRENAL INSUFFICIENCY,1
DK,AFFECT LABILITY,1
DK,AGITATION,1
DK,ALTERED STATE OF CONSCIOUSNESS,1
DK,ALVEOLITIS ALLERGIC,1
DK,ANAPHYLACTIC SHOCK,1
DK,APPLICATION SITE PAIN,1
DK,APPLICATION SITE REACTION,1
DK,ARRHYTHMIA,1
DK,ATELECTASIS,1
DK,ATRIAL FIBRILLATION,1
DK,AUTOIMMUNE HEPATITIS,1
DK,BALANCE DISORDER,1
DK,BLOOD PRESSURE INCREASED,1
DK,CARDIAC DISORDER,1
DK,CARDIAC PACEMAKER INSERTION,1
DK,CARDIOMYOPATHY,1
DK,CARDIOVASCULAR DISORDER,1
DK,CEREBRAL HAEMORRHAGE,1
DK,CHOLANGIOSTOMY,1
DK,CHROMATURIA,1
DK,COGNITIVE DISORDER,1
DK,COMA HEPATIC,1
DK,CONDITION AGGRAVATED,1
DK,CONFUSIONAL STATE,1
DK,COUGH,1
DK,CROHN^S DISEASE,1
DK,CYANOSIS,1
DK,DECREASED APPETITE,1
DK,DEHYDRATION,1
DK,DELUSION,1
DK,DEREALISATION,1
DK,DIABETES INSIPIDUS,1
DK,DIAPHRAGMALGIA,1
DK,DIARRHOEA HAEMORRHAGIC,1
DK,DISEASE PROGRESSION,1
DK,DISSEMINATED INTRAVASCULAR COAGULATION,1
DK,DRUG-INDUCED LIVER INJURY,1
DK,DRY SKIN,1
DK,DUODENAL ULCER PERFORATION,1
DK,EATING DISORDER,1
DK,ECCHYMOSIS,1
DK,EMBOLISM ARTERIAL,1
DK,EPIDURAL HAEMORRHAGE,1
DK,EXTRAOCULAR MUSCLE PARESIS,1
DK,FEELING COLD,1
DK,FEELING HOT,1
DK,FOETAL EXPOSURE DURING PREGNANCY,1
DK,FOLLICLE CENTRE LYMPHOMA_ FOLLICULAR GRADE I_ II_ III,1
DK,FOOD ALLERGY,1
DK,GASTRECTOMY,1
DK,GASTRIC PH DECREASED,1
DK,GASTRITIS,1
DK,GASTROINTESTINAL STENOSIS,1
DK,GINGIVAL BLEEDING,1
DK,GINGIVAL PAIN,1
DK,HAEMATEMESIS,1
DK,HAEMODIALYSIS,1
DK,HAEMORRHAGIC DISORDER,1
DK,HAEMORRHAGIC STROKE,1
DK,HEAD DISCOMFORT,1
DK,HEPATIC ENCEPHALOPATHY,1
DK,HEPATITIS TOXIC,1
DK,HEPATORENAL SYNDROME,1
DK,HYPERCALCAEMIA,1
DK,HYPONATRAEMIA,1
DK,HYPOTENSION,1
DK,IMPAIRED WORK ABILITY,1
DK,INTRACRANIAL PRESSURE INCREASED,1
DK,ISCHAEMIC CEREBRAL INFARCTION,1
DK,ISCHAEMIC STROKE,1
DK,LACERATION,1
DK,LARGE INTESTINAL HAEMORRHAGE,1
DK,LEUKOCYTOSIS,1
DK,LEUKOPENIA,1
DK,LIFE SUPPORT,1
DK,LIGAMENT SPRAIN,1
DK,LIVER DISORDER,1
DK,LIVER FUNCTION TEST ABNORMAL,1
DK,LOSS OF CONSCIOUSNESS,1
DK,MALIGNANT PERITONEAL NEOPLASM,1
DK,MELAENA,1
DK,MENTAL DISORDER,1
DK,MENTAL IMPAIRMENT,1
DK,MENTAL STATUS CHANGES,1
DK,METABOLIC ACIDOSIS,1
DK,MOTOR DYSFUNCTION,1
DK,MUCOUS MEMBRANE DISORDER,1
DK,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
DK,MUNCHAUSEN^S SYNDROME,1
DK,MUSCULAR WEAKNESS,1
DK,MUSCULOSKELETAL DISCOMFORT,1
DK,NASOPHARYNGITIS,1
DK,NERVE INJURY,1
DK,OESOPHAGEAL DILATION PROCEDURE,1
DK,OSTEOARTHRITIS,1
DK,OSTEOCHONDROSIS,1
DK,OSTEONECROSIS,1
DK,OSTEONECROSIS OF JAW,1
DK,OXYGEN SATURATION DECREASED,1
DK,PANCREATITIS,1
DK,PAPILLARY CYSTADENOMA LYMPHOMATOSUM,1
DK,PARANASAL SINUS DISCOMFORT,1
DK,PARKINSONISM,1
DK,PELVIC VENOUS THROMBOSIS,1
DK,PERIPANCREATIC FLUID COLLECTION,1
DK,PERIPHERAL SWELLING,1
DK,PERITONITIS,1
DK,PHARYNGEAL OEDEMA,1
DK,PLANTAR FASCIITIS,1
DK,PLATELET COUNT ABNORMAL,1
DK,POISONING,1
DK,POISONING DELIBERATE,1
DK,PROCEDURAL NAUSEA,1
DK,PROCEDURAL VOMITING,1
DK,PRODUCT QUALITY ISSUE,1
DK,PRODUCT USE IN UNAPPROVED INDICATION,1
DK,PULMONARY OEDEMA,1
DK,PUSTULAR PSORIASIS,1
DK,RENAL FAILURE ACUTE,1
DK,RESTLESS LEGS SYNDROME,1
DK,RESTLESSNESS,1
DK,SEASONAL ALLERGY,1
DK,SECOND PRIMARY MALIGNANCY,1
DK,SENSATION OF FOREIGN BODY,1
DK,SINUS TACHYCARDIA,1
DK,SKIN DISCOLOURATION,1
DK,SKIN EXFOLIATION,1
DK,SKIN HAEMORRHAGE,1
DK,SKIN WOUND,1
DK,SNEEZING,1
DK,SPLENECTOMY,1
DK,SQUAMOUS CELL CARCINOMA,1
DK,STEVENS-JOHNSON SYNDROME,1
DK,SUBDURAL HAEMATOMA,1
DK,SUPRAVENTRICULAR TACHYARRHYTHMIA,1
DK,SYNCOPE,1
DK,THROMBOSIS,1
DK,TRISMUS,1
DK,URINARY INCONTINENCE,1
DK,URINARY RETENTION,1
DK,URINARY TRACT INFECTION,1
DK,VENTRICULAR EXTRASYSTOLES,1
DK,VENTRICULAR FIBRILLATION,1
DK,VENTRICULAR TACHYCARDIA,1
DK,WOUND,1
DO,ABDOMINAL DISTENSION,1
DO,ANAL FISSURE,1
DO,ARTHRALGIA,1
DO,CHOLELITHIASIS,1
DO,CRYPTORCHISM,1
DO,DRUG INEFFECTIVE,1
DO,DYSURIA,1
DO,GAIT INABILITY,1
DO,PAINFUL DEFAECATION,1
DO,POST PROCEDURAL COMPLICATION,1
DO,PREMATURE BABY,1
DO,PROCTALGIA,1
DO,RECTAL PROLAPSE,1
EC,ABORTION,1
EC,ANAPHYLACTIC REACTION,1
EC,CARDIO-RESPIRATORY ARREST,1
EC,COMA,1
EC,DIABETIC COMPLICATION,1
EC,DIZZINESS,1
EC,EXPOSURE DURING PREGNANCY,1
EC,GENERAL PHYSICAL HEALTH DETERIORATION,1
EC,HEADACHE,1
EC,PARAESTHESIA,1
EC,SEIZURE,1
EG,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
EG,GASTROENTERITIS,1
EE,AFFECTIVE DISORDER,1
EE,ANGER,1
EE,ANXIETY,1
EE,BALANCE DISORDER,1
EE,DIZZINESS,1
EE,GROIN PAIN,1
EE,HEADACHE,1
EE,IRRITABILITY,1
EE,LABYRINTHITIS,1
EE,LUNG INFILTRATION,1
EE,NAUSEA,1
EE,NIGHTMARE,1
EE,PYREXIA,1
EE,SEPSIS,1
EE,THROMBOSIS,1
EE,VERTIGO,1
EE,VOMITING,1
FI,COMPLETED SUICIDE,8
FI,INTENTIONAL OVERDOSE,6
FI,TOXICITY TO VARIOUS AGENTS,4
FI,OVERDOSE,3
FI,PYREXIA,3
FI,ARRHYTHMIA,2
FI,DELIRIUM,2
FI,HYPERGLYCAEMIA,2
FI,HYPOKALAEMIA,2
FI,LEUKOCYTOSIS,2
FI,METABOLIC ALKALOSIS,2
FI,AGGRESSION,1
FI,ALCOHOL WITHDRAWAL SYNDROME,1
FI,APATHY,1
FI,ASPIRATION,1
FI,ATRIAL FLUTTER,1
FI,ATRIAL TACHYCARDIA,1
FI,CEREBRAL INFARCTION,1
FI,CHEST DISCOMFORT,1
FI,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
FI,COLITIS,1
FI,CUSHING^S SYNDROME,1
FI,CYANOSIS,1
FI,DEAFNESS,1
FI,DEPRESSION,1
FI,DISEASE PROGRESSION,1
FI,DISORIENTATION,1
FI,DIZZINESS,1
FI,DRUG ABUSE,1
FI,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
FI,DRUG INEFFECTIVE,1
FI,DRUG LEVEL INCREASED,1
FI,DYSPHONIA,1
FI,ECTOPIC ACTH SYNDROME,1
FI,EMOTIONAL POVERTY,1
FI,FATIGUE,1
FI,FEELING ABNORMAL,1
FI,FEELING COLD,1
FI,GENERAL PHYSICAL HEALTH DETERIORATION,1
FI,HEPATITIS CHRONIC ACTIVE,1
FI,HEPATOTOXICITY,1
FI,HYPERHIDROSIS,1
FI,HYPERSENSITIVITY,1
FI,HYPOKINESIA,1
FI,INFLUENZA,1
FI,INTENTIONAL SELF-INJURY,1
FI,LABORATORY TEST ABNORMAL,1
FI,LACTIC ACIDOSIS,1
FI,LUPUS-LIKE SYNDROME,1
FI,MALIGNANT HYPERTENSION,1
FI,MENTAL DISORDER,1
FI,METASTASIS,1
FI,MUSCLE SPASMS,1
FI,NASOPHARYNGITIS,1
FI,OROPHARYNGEAL PAIN,1
FI,PAIN,1
FI,PAIN IN EXTREMITY,1
FI,PALPITATIONS,1
FI,PNEUMONIA,1
FI,PNEUMONIA STREPTOCOCCAL,1
FI,PNEUMONITIS,1
FI,PROCTITIS,1
FI,PROSTATE CANCER,1
FI,PSYCHOTIC DISORDER,1
FI,PULSE ABNORMAL,1
FI,RESPIRATORY TRACT INFECTION,1
FI,RETINAL DETACHMENT,1
FI,SALIVARY HYPERSECRETION,1
FI,SEPSIS,1
FI,SINUSITIS,1
FI,SOCIAL AVOIDANT BEHAVIOUR,1
FI,STRESS,1
FI,SYNCOPE,1
FI,TIBIA FRACTURE,1
FI,TORTICOLLIS,1
FI,TUMOUR MARKER INCREASED,1
FI,TUNNEL VISION,1
FI,UROSEPSIS,1
FI,URTICARIA,1
FI,VISUAL FIELD DEFECT,1
FI,VISUAL IMPAIRMENT,1
FI,WEIGHT INCREASED,1
FR,ACUTE KIDNEY INJURY,68
FR,PYREXIA,56
FR,VOMITING,51
FR,CONDITION AGGRAVATED,43
FR,OVERDOSE,38
FR,RENAL FAILURE ACUTE,37
FR,HEADACHE,36
FR,THROMBOCYTOPENIA,36
FR,TOXICITY TO VARIOUS AGENTS,34
FR,HEPATOCELLULAR INJURY,32
FR,ANAEMIA,30
FR,NAUSEA,30
FR,INTENTIONAL OVERDOSE,28
FR,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,27
FR,ANGIOEDEMA,26
FR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,26
FR,MALAISE,26
FR,COMA,25
FR,HYPOTENSION,25
FR,ASTHENIA,24
FR,DIARRHOEA,23
FR,HEPATITIS,23
FR,CELLULITIS,22
FR,ABDOMINAL PAIN,21
FR,AGRANULOCYTOSIS,21
FR,DYSPNOEA,20
FR,URTICARIA,20
FR,GENERAL PHYSICAL HEALTH DETERIORATION,19
FR,RENAL FAILURE,18
FR,STEVENS-JOHNSON SYNDROME,18
FR,FACE OEDEMA,17
FR,FATIGUE,17
FR,MYALGIA,17
FR,PANCREATITIS ACUTE,17
FR,PNEUMONIA,17
FR,PRURITUS,17
FR,RASH MACULO-PAPULAR,17
FR,TACHYCARDIA,17
FR,TUBULOINTERSTITIAL NEPHRITIS,17
FR,RASH,16
FR,INFECTION,15
FR,MEDICATION ERROR,15
FR,NEUTROPENIA,15
FR,RHABDOMYOLYSIS,15
FR,SEIZURE,15
FR,ANXIETY,14
FR,CHOLESTASIS,14
FR,DYSPHAGIA,14
FR,EOSINOPHILIA,14
FR,ERYTHEMA,14
FR,LACTIC ACIDOSIS,14
FR,RESPIRATORY DISTRESS,14
FR,SUICIDE ATTEMPT,14
FR,WEIGHT DECREASED,14
FR,DEHYDRATION,13
FR,DRUG INEFFECTIVE,13
FR,HAEMATEMESIS,13
FR,LOSS OF CONSCIOUSNESS,13
FR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,13
FR,SOMNOLENCE,13
FR,TRANSAMINASES INCREASED,13
FR,BACK PAIN,12
FR,DECREASED APPETITE,12
FR,GASTROINTESTINAL HAEMORRHAGE,12
FR,HEPATITIS ACUTE,12
FR,RENAL TUBULAR NECROSIS,12
FR,SEPSIS,12
FR,ABDOMINAL PAIN UPPER,11
FR,HYPERKALAEMIA,11
FR,HYPONATRAEMIA,11
FR,POISONING DELIBERATE,11
FR,SEPTIC SHOCK,11
FR,TOXIC SKIN ERUPTION,11
FR,CARDIOGENIC SHOCK,10
FR,ELECTROCARDIOGRAM QT PROLONGED,10
FR,ERYTHEMA MULTIFORME,10
FR,LUNG DISORDER,10
FR,ODYNOPHAGIA,10
FR,SINUSITIS,10
FR,BRAIN EMPYEMA,9
FR,CARDIAC FAILURE,9
FR,CONFUSIONAL STATE,9
FR,CONJUNCTIVITIS,9
FR,DRUG-INDUCED LIVER INJURY,9
FR,EPISTAXIS,9
FR,FALL,9
FR,FOETAL EXPOSURE DURING PREGNANCY,9
FR,GASTRITIS,9
FR,LEUKOCYTOSIS,9
FR,LYMPHADENOPATHY,9
FR,MENINGITIS ASEPTIC,9
FR,MENINGOENCEPHALITIS BACTERIAL,9
FR,METABOLIC ACIDOSIS,9
FR,OEDEMA PERIPHERAL,9
FR,OLIGURIA,9
FR,PAIN IN EXTREMITY,9
FR,PALPITATIONS,9
FR,PARAESTHESIA,9
FR,PLEURAL EFFUSION,9
FR,PRODUCT USE IN UNAPPROVED INDICATION,9
FR,RASH PUSTULAR,9
FR,TACHYCARDIA FOETAL,9
FR,TOXIC EPIDERMAL NECROLYSIS,9
FR,ABNORMAL LOSS OF WEIGHT,8
FR,ACUTE RESPIRATORY FAILURE,8
FR,AGITATION,8
FR,ARTHRALGIA,8
FR,CHROMATURIA,8
FR,COUGH,8
FR,DIZZINESS,8
FR,DRUG DEPENDENCE,8
FR,DRUG HYPERSENSITIVITY,8
FR,DRUG LEVEL INCREASED,8
FR,HAEMORRHAGE,8
FR,HYPERTENSION,8
FR,HYPERTHERMIA,8
FR,HYPOXIA,8
FR,INCORRECT DOSE ADMINISTERED,8
FR,INTENTIONAL PRODUCT MISUSE,8
FR,KERATITIS,8
FR,MELAENA,8
FR,MOUTH ULCERATION,8
FR,PANCYTOPENIA,8
FR,POST-TRAUMATIC STRESS DISORDER,8
FR,SUICIDAL IDEATION,8
FR,TREMOR,8
FR,VISUAL IMPAIRMENT,8
FR,ACUTE RESPIRATORY DISTRESS SYNDROME,7
FR,BRONCHOSPASM,7
FR,CELL DEATH,7
FR,CHILLS,7
FR,DUCTUS ARTERIOSUS PREMATURE CLOSURE,7
FR,DYSURIA,7
FR,HAEMATOMA,7
FR,HAEMOLYTIC ANAEMIA,7
FR,HEPATITIS CHOLESTATIC,7
FR,HYPERSENSITIVITY,7
FR,INFLAMMATION,7
FR,INSOMNIA,7
FR,LUNG ABSCESS,7
FR,MATERNAL EXPOSURE DURING PREGNANCY,7
FR,MIOSIS,7
FR,MYOCARDITIS,7
FR,OEDEMA,7
FR,PANIC ATTACK,7
FR,PNEUMONIA ASPIRATION,7
FR,THROMBOCYTOPENIC PURPURA,7
FR,VERTIGO,7
FR,ALOPECIA AREATA,6
FR,ALTERED STATE OF CONSCIOUSNESS,6
FR,ANAPHYLACTIC SHOCK,6
FR,CHEST DISCOMFORT,6
FR,DERMATITIS BULLOUS,6
FR,DISSEMINATED INTRAVASCULAR COAGULATION,6
FR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,6
FR,GASTRIC ULCER,6
FR,HYPERHIDROSIS,6
FR,HYPERSENSITIVITY VASCULITIS,6
FR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,6
FR,JAUNDICE,6
FR,LIVER INJURY,6
FR,MUSCULOSKELETAL PAIN,6
FR,MYOCARDIAL INFARCTION,6
FR,PAIN,6
FR,PANCREATITIS,6
FR,PRODUCT USE ISSUE,6
FR,PULMONARY EMBOLISM,6
FR,RASH ERYTHEMATOUS,6
FR,RASH MACULAR,6
FR,RASH PRURITIC,6
FR,RESPIRATORY DISORDER,6
FR,SHOCK,6
FR,STOMATITIS,6
FR,SYNCOPE,6
FR,TINNITUS,6
FR,TONSILLITIS,6
FR,TOOTH ABSCESS,6
FR,WEIGHT INCREASED,6
FR,ALANINE AMINOTRANSFERASE INCREASED,5
FR,BLISTER,5
FR,BLOOD CREATINE PHOSPHOKINASE INCREASED,5
FR,BLOOD PRESSURE INCREASED,5
FR,CARDIO-RESPIRATORY ARREST,5
FR,COLONIC ABSCESS,5
FR,DEATH,5
FR,DRUG INTOLERANCE,5
FR,ENCEPHALITIS,5
FR,GASTRIC ULCER HAEMORRHAGE,5
FR,HALLUCINATION_ AUDITORY,5
FR,HEMIPLEGIA,5
FR,HEPATIC ENZYME INCREASED,5
FR,HOT FLUSH,5
FR,HYPERTENSIVE CRISIS,5
FR,IRRITABILITY,5
FR,LIP OEDEMA,5
FR,LIPASE INCREASED,5
FR,MUSCULAR WEAKNESS,5
FR,MYDRIASIS,5
FR,OROPHARYNGEAL PAIN,5
FR,OXYGEN SATURATION DECREASED,5
FR,PHOTOPHOBIA,5
FR,RENAL IMPAIRMENT,5
FR,SELF-MEDICATION,5
FR,SHOCK HAEMORRHAGIC,5
FR,SWELLING FACE,5
FR,ACCIDENTAL OVERDOSE,4
FR,ADVERSE EVENT,4
FR,AGORAPHOBIA,4
FR,ANURIA,4
FR,APHASIA,4
FR,ASCITES,4
FR,ASPARTATE AMINOTRANSFERASE INCREASED,4
FR,BRAIN DEATH,4
FR,CIRCULATORY COLLAPSE,4
FR,COMPLETED SUICIDE,4
FR,CONVULSION,4
FR,DECREASED IMMUNE RESPONSIVENESS,4
FR,DEEP VEIN THROMBOSIS,4
FR,DEPRESSION,4
FR,DERMATITIS EXFOLIATIVE,4
FR,DRUG ABUSE,4
FR,DRUG WITHDRAWAL SYNDROME,4
FR,DRY MOUTH,4
FR,EMPYEMA,4
FR,ERECTILE DYSFUNCTION,4
FR,FOETAL GROWTH RESTRICTION,4
FR,GENERALISED TONIC-CLONIC SEIZURE,4
FR,HAEMATURIA,4
FR,HALLUCINATION,4
FR,HYPERTONIA,4
FR,HYPOACUSIS,4
FR,HYPOKALAEMIA,4
FR,HYPOTHERMIA,4
FR,ILEUS PARALYTIC,4
FR,INTERVERTEBRAL DISC DISORDER,4
FR,LARYNGEAL OEDEMA,4
FR,MALIGNANT NEOPLASM PROGRESSION,4
FR,MEMORY IMPAIRMENT,4
FR,MUCOSAL INFLAMMATION,4
FR,MULTI-ORGAN FAILURE,4
FR,MUSCULOSKELETAL STIFFNESS,4
FR,MYCOPLASMA INFECTION,4
FR,NECROTISING FASCIITIS,4
FR,NEUROSIS,4
FR,NEUTROPHILIA,4
FR,PERICARDIAL EFFUSION,4
FR,PERICHONDRITIS,4
FR,PERITONITIS,4
FR,PERSONAL RELATIONSHIP ISSUE,4
FR,PNEUMONITIS,4
FR,PSORIASIS,4
FR,PSYCHOTIC DISORDER,4
FR,PULMONARY OEDEMA,4
FR,SINUS TACHYCARDIA,4
FR,STATUS EPILEPTICUS,4
FR,SUPERINFECTION,4
FR,ABDOMINAL DISTENSION,3
FR,ACUTE HEPATIC FAILURE,3
FR,ALCOHOL WITHDRAWAL SYNDROME,3
FR,ALOPECIA,3
FR,ANTINUCLEAR ANTIBODY POSITIVE,3
FR,ASTHMA,3
FR,AUTOIMMUNE DISORDER,3
FR,BLOOD CREATININE INCREASED,3
FR,BLOOD PRESSURE DECREASED,3
FR,BONE MARROW FAILURE,3
FR,BRADYCARDIA,3
FR,BRAIN HERNIATION,3
FR,BRAIN OEDEMA,3
FR,BRONCHIECTASIS,3
FR,C-REACTIVE PROTEIN INCREASED,3
FR,CEREBRAL HAEMATOMA,3
FR,CEREBRAL VENOUS THROMBOSIS,3
FR,CEREBROVASCULAR ACCIDENT,3
FR,CHEST PAIN,3
FR,CHEST X-RAY ABNORMAL,3
FR,CONSTIPATION,3
FR,DISORIENTATION,3
FR,DISTURBANCE IN ATTENTION,3
FR,DIVERTICULAR PERFORATION,3
FR,DRUG ERUPTION,3
FR,EPILEPSY,3
FR,EPSTEIN-BARR VIRUS INFECTION,3
FR,EYE PRURITUS,3
FR,EYELID OEDEMA,3
FR,FAECES DISCOLOURED,3
FR,FASCIITIS,3
FR,FORMICATION,3
FR,GAIT DISTURBANCE,3
FR,GASTROENTERITIS,3
FR,GENERALISED ERYTHEMA,3
FR,GINGIVAL BLEEDING,3
FR,GINGIVITIS,3
FR,HAEMARTHROSIS,3
FR,HEPATIC FAILURE,3
FR,HERPES VIRUS INFECTION,3
FR,HYPERTROPHIC SCAR,3
FR,HYPOKINESIA,3
FR,HYPOVOLAEMIA,3
FR,INJECTION SITE PAIN,3
FR,INTERNATIONAL NORMALISED RATIO INCREASED,3
FR,JUGULAR VEIN THROMBOSIS,3
FR,LEUKOPENIA,3
FR,LIP SWELLING,3
FR,LOCALISED OEDEMA,3
FR,LYMPHOPENIA,3
FR,MACULE,3
FR,MENORRHAGIA,3
FR,MOUTH HAEMORRHAGE,3
FR,MUCOSAL EROSION,3
FR,MULTIPLE SCLEROSIS RELAPSE,3
FR,MUSCLE HAEMORRHAGE,3
FR,MUSCLE SPASMS,3
FR,NASOPHARYNGITIS,3
FR,NECK PAIN,3
FR,NYSTAGMUS,3
FR,PAROTITIS,3
FR,PHARYNGITIS,3
FR,PHONOPHOBIA,3
FR,PNEUMONIA STAPHYLOCOCCAL,3
FR,POISONING,3
FR,PROTHROMBIN TIME SHORTENED,3
FR,PULMONARY HYPERTENSION,3
FR,PULMONARY INFARCTION,3
FR,RASH GENERALISED,3
FR,RASH PAPULAR,3
FR,RECTAL HAEMORRHAGE,3
FR,RENAL ABSCESS,3
FR,RHINORRHOEA,3
FR,SKIN EXFOLIATION,3
FR,SKIN HYPERPIGMENTATION,3
FR,SKIN HYPOPIGMENTATION,3
FR,STAPHYLOCOCCUS TEST POSITIVE,3
FR,STREPTOCOCCAL INFECTION,3
FR,SUBSTANCE ABUSE,3
FR,URINARY RETENTION,3
FR,WITHDRAWAL SYNDROME,3
FR,XERODERMA,3
FR,ABDOMINAL ABSCESS,2
FR,ABORTION SPONTANEOUS,2
FR,ABSCESS,2
FR,ACCIDENTAL EXPOSURE TO PRODUCT,2
FR,ACUTE CORONARY SYNDROME,2
FR,ADRENAL HAEMATOMA,2
FR,ADRENAL HAEMORRHAGE,2
FR,ALCOHOL ABUSE,2
FR,ALVEOLITIS ALLERGIC,2
FR,ANAPHYLACTIC REACTION,2
FR,ANGINA PECTORIS,2
FR,APHAGIA,2
FR,APHONIA,2
FR,ARTHRITIS,2
FR,ASPIRATION,2
FR,AUTOIMMUNE THROMBOCYTOPENIA,2
FR,BACTERAEMIA,2
FR,BICYTOPENIA,2
FR,BLINDNESS,2
FR,BLOOD BILIRUBIN INCREASED,2
FR,BLOOD PRESSURE SYSTOLIC INCREASED,2
FR,BRONCHIOLITIS,2
FR,CANDIDA INFECTION,2
FR,CARDIOMEGALY,2
FR,CELLULITIS ORBITAL,2
FR,CELLULITIS PHARYNGEAL,2
FR,CHEILITIS,2
FR,COLITIS,2
FR,COLITIS MICROSCOPIC,2
FR,CONJUNCTIVAL HYPERAEMIA,2
FR,CONSCIOUSNESS FLUCTUATING,2
FR,CONTRAINDICATED PRODUCT ADMINISTERED,2
FR,CORNEAL NEOVASCULARISATION,2
FR,DEAFNESS,2
FR,DELIRIUM,2
FR,DELUSION,2
FR,DEPRESSED LEVEL OF CONSCIOUSNESS,2
FR,DEPRESSIVE SYMPTOM,2
FR,DERMO-HYPODERMITIS,2
FR,DIPLOPIA,2
FR,DISEASE RECURRENCE,2
FR,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,2
FR,DUODENAL ULCER,2
FR,DYSPHONIA,2
FR,EAR PAIN,2
FR,ECCHYMOSIS,2
FR,ECZEMA,2
FR,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,2
FR,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,2
FR,ERYSIPELAS,2
FR,EXPOSURE DURING PREGNANCY,2
FR,EXTENSOR PLANTAR RESPONSE,2
FR,EYE INFECTION,2
FR,EYE PAIN,2
FR,FEEDING DISORDER,2
FR,FOETAL HEART RATE DISORDER,2
FR,GASTROINTESTINAL DISORDER,2
FR,HAEMATOCHEZIA,2
FR,HAEMODYNAMIC INSTABILITY,2
FR,HAEMOPTYSIS,2
FR,HEAD INJURY,2
FR,HEART DISEASE CONGENITAL,2
FR,HEMIANOPIA HOMONYMOUS,2
FR,HEPATIC NECROSIS,2
FR,HEPATITIS C,2
FR,HEPATO-LENTICULAR DEGENERATION,2
FR,HYPERBILIRUBINAEMIA,2
FR,HYPOALBUMINAEMIA,2
FR,HYPOPROTEINAEMIA,2
FR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
FR,INFLUENZA,2
FR,INFLUENZA LIKE ILLNESS,2
FR,INJECTION SITE INFLAMMATION,2
FR,INTESTINAL ISCHAEMIA,2
FR,INTESTINAL PERFORATION,2
FR,INTRACRANIAL PRESSURE INCREASED,2
FR,KIDNEY ENLARGEMENT,2
FR,LIVER DISORDER,2
FR,LUNG INFECTION,2
FR,LYMPHADENITIS,2
FR,MEDICATION OVERUSE HEADACHE,2
FR,MENINGITIS,2
FR,METRORRHAGIA,2
FR,MOBILITY DECREASED,2
FR,NECROTISING ENTEROCOLITIS NEONATAL,2
FR,NEOVASCULARISATION,2
FR,NEPHRITIS ALLERGIC,2
FR,NEPHROPATHY,2
FR,NERVOUS SYSTEM DISORDER,2
FR,NERVOUSNESS,2
FR,NEUROTOXICITY,2
FR,NO ADVERSE EVENT,2
FR,OCULAR VASCULAR DISORDER,2
FR,OESOPHAGEAL ULCER,2
FR,OESOPHAGITIS,2
FR,ORAL HERPES,2
FR,OTITIS MEDIA,2
FR,PERITONSILLAR ABSCESS,2
FR,PERITONSILLITIS,2
FR,PHARYNGEAL ABSCESS,2
FR,PHARYNGEAL ERYTHEMA,2
FR,PLATELET COUNT DECREASED,2
FR,PLEURISY,2
FR,PNEUMONIA PNEUMOCOCCAL,2
FR,PNEUMOPERITONEUM,2
FR,PNEUMOTHORAX,2
FR,POLYURIA,2
FR,PORPHYRIA NON-ACUTE,2
FR,PROTEINURIA,2
FR,PSEUDOMONAS INFECTION,2
FR,PULMONARY CAVITATION,2
FR,PURPURA,2
FR,PURPURA FULMINANS,2
FR,PYELONEPHRITIS,2
FR,PYELONEPHRITIS ACUTE,2
FR,REITER^S SYNDROME,2
FR,RESPIRATORY FAILURE,2
FR,RETINAL PIGMENT EPITHELIOPATHY,2
FR,ROTATOR CUFF SYNDROME,2
FR,SCAR,2
FR,SEROLOGY POSITIVE,2
FR,SKIN HAEMORRHAGE,2
FR,SKIN NECROSIS,2
FR,SPHEROCYTIC ANAEMIA,2
FR,STAPHYLOCOCCAL SEPSIS,2
FR,STREPTOCOCCUS TEST POSITIVE,2
FR,SUBARACHNOID HAEMORRHAGE,2
FR,SUPERIOR SAGITTAL SINUS THROMBOSIS,2
FR,SWELLING,2
FR,SYSTEMIC LUPUS ERYTHEMATOSUS,2
FR,TENDON DISORDER,2
FR,TENSION HEADACHE,2
FR,THROMBOPHLEBITIS SEPTIC,2
FR,THROMBOTIC MICROANGIOPATHY,2
FR,TORTICOLLIS,2
FR,ULTRASOUND KIDNEY ABNORMAL,2
FR,URINARY TRACT INFECTION,2
FR,VACCINATION SITE VESICLES,2
FR,VANISHING BILE DUCT SYNDROME,2
FR,VENTRICULAR DYSFUNCTION,2
FR,VIRAL INFECTION,2
FR,VIRAL PERICARDITIS,2
FR,VISION BLURRED,2
FR,VISUAL ACUITY REDUCED,2
FR,WHEEZING,2
FR,WHITE BLOOD CELL COUNT INCREASED,2
FR,ABASIA,1
FR,ACCOMMODATION DISORDER,1
FR,ACINETOBACTER INFECTION,1
FR,ACQUIRED HAEMOPHILIA,1
FR,ACUTE PRERENAL FAILURE,1
FR,ACUTE PULMONARY OEDEMA,1
FR,ADENOCARCINOMA GASTRIC,1
FR,ADMINISTRATION SITE REACTION,1
FR,AGEUSIA,1
FR,AGGRESSION,1
FR,AKINESIA,1
FR,ALVEOLAR LUNG DISEASE,1
FR,AMNESIA,1
FR,AMYOTROPHIC LATERAL SCLEROSIS,1
FR,ANAPHYLACTOID SHOCK,1
FR,ANEURYSM RUPTURED,1
FR,ANOSMIA,1
FR,ANTICONVULSANT DRUG LEVEL INCREASED,1
FR,APLASTIC ANAEMIA,1
FR,APNOEA,1
FR,APPENDICECTOMY,1
FR,ARTHRITIS BACTERIAL,1
FR,ARTHROPOD BITE,1
FR,ASPHYXIA,1
FR,ASTERIXIS,1
FR,ASTHMATIC CRISIS,1
FR,ATELECTASIS,1
FR,ATELECTASIS NEONATAL,1
FR,ATRIAL FIBRILLATION,1
FR,ATRIAL FLUTTER,1
FR,AUTOIMMUNE HEPATITIS,1
FR,AZOTAEMIA,1
FR,BACK DISORDER,1
FR,BACTERIAL SEPSIS,1
FR,BACTERIAL TEST POSITIVE,1
FR,BENIGN OESOPHAGEAL NEOPLASM,1
FR,BIOPSY SKIN ABNORMAL,1
FR,BLADDER DILATATION,1
FR,BLADDER IRRITATION,1
FR,BLADDER PAIN,1
FR,BLEPHARITIS,1
FR,BLOOD CALCIUM DECREASED,1
FR,BLOOD GLUCOSE INCREASED,1
FR,BLOOD IMMUNOGLOBULIN A INCREASED,1
FR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
FR,BLOOD LACTIC ACID INCREASED,1
FR,BLOOD PARATHYROID HORMONE INCREASED,1
FR,BLOOD POTASSIUM DECREASED,1
FR,BLOOD PRESSURE ABNORMAL,1
FR,BLOOD PRESSURE DIASTOLIC DECREASED,1
FR,BLOOD SODIUM DECREASED,1
FR,BLOOD THYROID STIMULATING HORMONE DECREASED,1
FR,BLOOD THYROID STIMULATING HORMONE INCREASED,1
FR,BONE MARROW TOXICITY,1
FR,BORRELIA TEST POSITIVE,1
FR,BREAST ABSCESS,1
FR,BREAST CANCER FEMALE,1
FR,BREAST CANCER METASTATIC,1
FR,BREAST PAIN,1
FR,BRONCHOSCOPY ABNORMAL,1
FR,BRUGADA SYNDROME,1
FR,CAESAREAN SECTION,1
FR,CANDIDA SEPSIS,1
FR,CARDIAC FAILURE ACUTE,1
FR,CARDIAC FAILURE CHRONIC,1
FR,CARDIOMYOPATHY,1
FR,CATARRH,1
FR,CELLULITIS GANGRENOUS,1
FR,CENTRAL OBESITY,1
FR,CEREBRAL ARTERY EMBOLISM,1
FR,CEREBRAL DISORDER,1
FR,CEREBRAL HAEMORRHAGE,1
FR,CHILLBLAINS,1
FR,CHOKING,1
FR,CHOLECYSTECTOMY,1
FR,CHOLESTATIC LIVER INJURY,1
FR,CHRONIC GASTRITIS,1
FR,CLINODACTYLY,1
FR,CLOSTRIDIUM DIFFICILE COLITIS,1
FR,COAGULATION FACTOR V LEVEL DECREASED,1
FR,COAGULOPATHY,1
FR,COELIAC DISEASE,1
FR,COLITIS ISCHAEMIC,1
FR,COLITIS ULCERATIVE,1
FR,COMA URAEMIC,1
FR,CONGENITAL CYTOMEGALOVIRUS INFECTION,1
FR,CONJUNCTIVAL ABRASION,1
FR,CONTINUOUS HAEMODIAFILTRATION,1
FR,CONVERSION DISORDER,1
FR,COOMBS POSITIVE HAEMOLYTIC ANAEMIA,1
FR,CRANIAL NERVE INJURY,1
FR,CROHN^S DISEASE,1
FR,CSF TEST ABNORMAL,1
FR,CUTANEOUS LUPUS ERYTHEMATOSUS,1
FR,CUTANEOUS VASCULITIS,1
FR,CYSTITIS,1
FR,CYSTITIS INTERSTITIAL,1
FR,CYTOMEGALOVIRUS TEST POSITIVE,1
FR,DECEREBRATION,1
FR,DENTAL CARIES,1
FR,DERMATITIS ALLERGIC,1
FR,DERMATITIS CONTACT,1
FR,DEVICE OCCLUSION,1
FR,DIABETES INSIPIDUS,1
FR,DIABETES MELLITUS,1
FR,DIABETES MELLITUS INADEQUATE CONTROL,1
FR,DIARRHOEA HAEMORRHAGIC,1
FR,DIASTOLIC DYSFUNCTION,1
FR,DIFFUSE ALOPECIA,1
FR,DISCOMFORT,1
FR,DISEASE PROGRESSION,1
FR,DIZZINESS POSTURAL,1
FR,DRUG ADMINISTRATION ERROR,1
FR,DRUG DOSE OMISSION,1
FR,DRUG EFFECT INCOMPLETE,1
FR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
FR,DRUG LEVEL ABOVE THERAPEUTIC,1
FR,DRUG LEVEL CHANGED,1
FR,DRUG WITHDRAWAL CONVULSIONS,1
FR,DRY AGE-RELATED MACULAR DEGENERATION,1
FR,DRY EYE,1
FR,DUODENAL ULCER HAEMORRHAGE,1
FR,DUODENITIS,1
FR,DYSGEUSIA,1
FR,DYSPNOEA EXERTIONAL,1
FR,DYSSOMNIA,1
FR,DYSSTASIA,1
FR,EAR PRURITUS,1
FR,EJECTION FRACTION DECREASED,1
FR,ELECTROCARDIOGRAM ABNORMAL,1
FR,EMPHYSEMA,1
FR,ENCEPHALOPATHY,1
FR,ENDOCARDITIS,1
FR,ENDOMETRIAL CANCER METASTATIC,1
FR,ENDOTRACHEAL INTUBATION COMPLICATION,1
FR,ENTEROCOCCAL BACTERAEMIA,1
FR,ENTEROCOCCAL INFECTION,1
FR,EOSINOPHILIC MYOCARDITIS,1
FR,EOSINOPHILIC PNEUMONIA,1
FR,EPIGLOTTITIS,1
FR,EPSTEIN-BARR VIRAEMIA,1
FR,ERYSIPELOID,1
FR,ESCHERICHIA SEPSIS,1
FR,EVANS SYNDROME,1
FR,EXTRAPYRAMIDAL DISORDER,1
FR,EXTRASYSTOLES,1
FR,EYE DISORDER,1
FR,EYE OEDEMA,1
FR,FEBRILE NEUTROPENIA,1
FR,FEELING COLD,1
FR,FILARIASIS,1
FR,FLATULENCE,1
FR,FLUID INTAKE REDUCED,1
FR,FLUID OVERLOAD,1
FR,FOETAL ARRHYTHMIA,1
FR,FOLLICULITIS,1
FR,FUNGAL SKIN INFECTION,1
FR,GASTRITIS EROSIVE,1
FR,GASTROINTESTINAL INJURY,1
FR,GASTROINTESTINAL ULCER,1
FR,GAZE PALSY,1
FR,GENERAL PHYSICAL CONDITION ABNORMAL,1
FR,GENITAL INFECTION,1
FR,GENOTYPE DRUG RESISTANCE TEST POSITIVE,1
FR,GINGIVAL INFLAMMATION,1
FR,GOUT,1
FR,GRANULOMA SKIN,1
FR,HAEMATOCRIT INCREASED,1
FR,HAEMODIALYSIS,1
FR,HAEMOGLOBIN DECREASED,1
FR,HAEMOGLOBIN INCREASED,1
FR,HAEMOLYTIC URAEMIC SYNDROME,1
FR,HAEMORRHAGE INTRACRANIAL,1
FR,HALLUCINATION_ VISUAL,1
FR,HEART RATE DECREASED,1
FR,HEART RATE INCREASED,1
FR,HEAT STROKE,1
FR,HEMIANOPIA,1
FR,HEMIPARESIS,1
FR,HEPARIN-INDUCED THROMBOCYTOPENIA TEST POSITIVE,1
FR,HEPATIC ENCEPHALOPATHY,1
FR,HEPATIC FIBROSIS,1
FR,HEPATIC LESION,1
FR,HEPATIC PAIN,1
FR,HEPATIC STEATOSIS,1
FR,HEPATITIS FULMINANT,1
FR,HEPATITIS TOXIC,1
FR,HEPATOCELLULAR CARCINOMA,1
FR,HEPATOMEGALY,1
FR,HERNIAL EVENTRATION,1
FR,HERPES SIMPLEX,1
FR,HERPES ZOSTER,1
FR,HIDRADENITIS,1
FR,HILAR LYMPHADENOPATHY,1
FR,HISTIOCYTIC NECROTISING LYMPHADENITIS,1
FR,HUMAN HERPESVIRUS 6 INFECTION,1
FR,HYPERCAPNIC COMA,1
FR,HYPERLIPASAEMIA,1
FR,HYPERTENSIVE EMERGENCY,1
FR,HYPOGAMMAGLOBULINAEMIA,1
FR,HYPOGLOSSAL NERVE DISORDER,1
FR,HYPOGLYCAEMIA,1
FR,HYPOGLYCAEMIA NEONATAL,1
FR,HYPOGLYCAEMIC COMA,1
FR,HYPOPHAGIA,1
FR,HYPOREFLEXIA,1
FR,HYPOTONIA,1
FR,HYPOTRICHOSIS,1
FR,HYPOVOLAEMIC SHOCK,1
FR,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,1
FR,IMMUNE THROMBOCYTOPENIC PURPURA,1
FR,IMPLANT SITE HAEMORRHAGE,1
FR,IMPLANT SITE PAIN,1
FR,IMPLANT SITE PRURITUS,1
FR,INCORRECT DRUG ADMINISTRATION RATE,1
FR,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
FR,INFECTIOUS PLEURAL EFFUSION,1
FR,INJECTION SITE CELLULITIS,1
FR,INJECTION SITE ERYTHEMA,1
FR,INJECTION SITE INDURATION,1
FR,INJECTION SITE REACTION,1
FR,INJECTION SITE SWELLING,1
FR,INJECTION SITE VESICLES,1
FR,INJURY CORNEAL,1
FR,INTENTIONAL DRUG MISUSE,1
FR,INTERSTITIAL LUNG DISEASE,1
FR,INVASIVE DUCTAL BREAST CARCINOMA,1
FR,IRON DEFICIENCY,1
FR,ISCHAEMIC STROKE,1
FR,JOINT DISLOCATION,1
FR,JOINT STIFFNESS,1
FR,KLEBSIELLA INFECTION,1
FR,LARYNGEAL DISCOMFORT,1
FR,LARYNGEAL DYSPNOEA,1
FR,LARYNGEAL PAIN,1
FR,LEFT VENTRICULAR DYSFUNCTION,1
FR,LEFT VENTRICULAR FAILURE,1
FR,LEG AMPUTATION,1
FR,LEMIERRE SYNDROME,1
FR,LEUKOCYTURIA,1
FR,LEUKOSTASIS SYNDROME,1
FR,LIMB DISCOMFORT,1
FR,LINEAR IGA DISEASE,1
FR,LIP HAEMORRHAGE,1
FR,LIVER FUNCTION TEST ABNORMAL,1
FR,LIVER TENDERNESS,1
FR,LOWER RESPIRATORY TRACT INFECTION,1
FR,LYMPHANGITIS,1
FR,LYMPHOCYTE PERCENTAGE INCREASED,1
FR,LYMPHOMA,1
FR,MADAROSIS,1
FR,MALIGNANT MELANOMA,1
FR,MALNUTRITION,1
FR,MASS,1
FR,MASTOIDITIS,1
FR,MEDIASTINITIS,1
FR,MENINGITIS VIRAL,1
FR,MENINGORRHAGIA,1
FR,MICROANGIOPATHIC HAEMOLYTIC ANAEMIA,1
FR,MICROCEPHALY,1
FR,MIXED LIVER INJURY,1
FR,MONOCYTOPENIA,1
FR,MOOD ALTERED,1
FR,MORAXELLA INFECTION,1
FR,MOTOR DYSFUNCTION,1
FR,MOVEMENT DISORDER,1
FR,MUCOSAL ULCERATION,1
FR,MUSCLE ABSCESS,1
FR,MUSCLE CONTRACTIONS INVOLUNTARY,1
FR,MUSCULOSKELETAL DISORDER,1
FR,MYELOCYTOSIS,1
FR,MYOCARDIAL ISCHAEMIA,1
FR,MYOSITIS OSSIFICANS,1
FR,NASAL MUCOSAL ULCER,1
FR,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
FR,NEPHRITIS,1
FR,NEPHROLITHIASIS,1
FR,NEPHROPATHY TOXIC,1
FR,NEPHROTIC SYNDROME,1
FR,NEUROLOGICAL DECOMPENSATION,1
FR,NIKOLSKY^S SIGN,1
FR,OBLITERATIVE BRONCHIOLITIS,1
FR,OBSTRUCTIVE AIRWAYS DISORDER,1
FR,OCULAR ICTERUS,1
FR,OEDEMA MOUTH,1
FR,OESOPHAGEAL RUPTURE,1
FR,OESOPHAGEAL ULCER HAEMORRHAGE,1
FR,OLIGOHYDRAMNIOS,1
FR,OPHTHALMOPLEGIA,1
FR,OPTIC ISCHAEMIC NEUROPATHY,1
FR,ORAL DISCOMFORT,1
FR,ORAL DISORDER,1
FR,ORAL PRURITUS,1
FR,ORGANISING PNEUMONIA,1
FR,ORTHOSTATIC HYPOTENSION,1
FR,OSTEITIS,1
FR,OSTEONECROSIS,1
FR,PACHYMENINGITIS,1
FR,PALATAL OEDEMA,1
FR,PALLOR,1
FR,PANCREATIC INSUFFICIENCY,1
FR,PAPILLOEDEMA,1
FR,PARAESTHESIA ORAL,1
FR,PARTIAL SEIZURES,1
FR,PELVIC PAIN,1
FR,PEPTIC ULCER,1
FR,PERIPHERAL VENOUS DISEASE,1
FR,PERITONEAL HAEMORRHAGE,1
FR,PETECHIAE,1
FR,PETIT MAL EPILEPSY,1
FR,PHALANGEAL HYPOPLASIA,1
FR,PHARYNGEAL INFLAMMATION,1
FR,PHARYNGOTONSILLITIS,1
FR,PHLEBITIS,1
FR,PHOBIA,1
FR,PHOTOSENSITIVITY REACTION,1
FR,PLACENTAL INFARCTION,1
FR,PLACENTAL INSUFFICIENCY,1
FR,PLATELET COUNT ABNORMAL,1
FR,PNEUMATOSIS INTESTINALIS,1
FR,PNEUMOCOCCAL INFECTION,1
FR,PNEUMOCOCCAL SEPSIS,1
FR,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
FR,PNEUMONIA CHLAMYDIAL,1
FR,POLYARTHRITIS,1
FR,POST PROCEDURAL HAEMATOMA,1
FR,POSTPARTUM HAEMORRHAGE,1
FR,PREGNANCY,1
FR,PREMATURE BABY,1
FR,PRERENAL FAILURE,1
FR,PRESYNCOPE,1
FR,PRODUCT QUALITY ISSUE,1
FR,PRODUCTIVE COUGH,1
FR,PROSTATITIS ESCHERICHIA COLI,1
FR,PROTHROMBIN TIME ABNORMAL,1
FR,PROTHROMBIN TIME PROLONGED,1
FR,PRURIGO,1
FR,PRURITUS ALLERGIC,1
FR,PRURITUS GENERALISED,1
FR,PSEUDOMONAL SEPSIS,1
FR,PSOAS ABSCESS,1
FR,PSYCHIATRIC SYMPTOM,1
FR,PULMONARY ARTERIAL HYPERTENSION,1
FR,PUNCTURE SITE HAEMORRHAGE,1
FR,PURULENT DISCHARGE,1
FR,RALES,1
FR,RASH MORBILLIFORM,1
FR,RASH SCARLATINIFORM,1
FR,RASH VESICULAR,1
FR,RENAL TUBULAR DISORDER,1
FR,RESPIRATION ABNORMAL,1
FR,RESPIRATORY ALKALOSIS,1
FR,RETINAL ARTERY OCCLUSION,1
FR,RETINOPATHY HYPERTENSIVE,1
FR,REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME,1
FR,RHEUMATIC DISORDER,1
FR,RHINITIS,1
FR,ROTAVIRUS INFECTION,1
FR,SCIATICA,1
FR,SCLERODERMA,1
FR,SCLERODERMA RENAL CRISIS,1
FR,SECOND PRIMARY MALIGNANCY,1
FR,SELF INJURIOUS BEHAVIOUR,1
FR,SEPTIC ARTHRITIS STREPTOCOCCAL,1
FR,SERRATIA INFECTION,1
FR,SHOCK SYMPTOM,1
FR,SIALOADENITIS,1
FR,SINUS BRADYCARDIA,1
FR,SJOGREN^S SYNDROME,1
FR,SKIN BACTERIAL INFECTION,1
FR,SKIN EROSION,1
FR,SKIN REACTION,1
FR,SKIN TEST POSITIVE,1
FR,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,1
FR,SOCIAL PROBLEM,1
FR,SPEECH DISORDER,1
FR,SPHINCTER OF ODDI DYSFUNCTION,1
FR,SPINAL COLUMN INJURY,1
FR,SPINAL CORD COMPRESSION,1
FR,SQUAMOUS CELL CARCINOMA,1
FR,STAPHYLOCOCCAL BACTERAEMIA,1
FR,STAPHYLOCOCCAL INFECTION,1
FR,STREPTOCOCCAL SEPSIS,1
FR,STRESS,1
FR,STRESS FRACTURE,1
FR,SUBCUTANEOUS ABSCESS,1
FR,SUBDURAL HAEMATOMA,1
FR,SUDDEN DEATH,1
FR,SUPRAVENTRICULAR TACHYCARDIA,1
FR,SUSPICIOUSNESS,1
FR,SWOLLEN TONGUE,1
FR,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
FR,SYSTEMIC SCLEROSIS,1
FR,SYSTOLIC DYSFUNCTION,1
FR,TACHYPNOEA,1
FR,THERAPEUTIC RESPONSE DECREASED,1
FR,THROAT IRRITATION,1
FR,THROMBOCYTOSIS,1
FR,TOBACCO WITHDRAWAL SYMPTOMS,1
FR,TONGUE PARALYSIS,1
FR,TONSILLITIS STREPTOCOCCAL,1
FR,TOOTHACHE,1
FR,TOXOPLASMOSIS,1
FR,TRANSFERRIN DECREASED,1
FR,TRANSVERSE SINUS THROMBOSIS,1
FR,TREATMENT FAILURE,1
FR,TRICUSPID VALVE INCOMPETENCE,1
FR,TRISMUS,1
FR,TROPONIN INCREASED,1
FR,TUBERCULOSIS,1
FR,TYPE 1 DIABETES MELLITUS,1
FR,TYPE 2 DIABETES MELLITUS,1
FR,ULCER,1
FR,UMBILICAL CORD VASCULAR DISORDER,1
FR,UNDERDOSE,1
FR,UPPER GASTROINTESTINAL HAEMORRHAGE,1
FR,URINARY TRACT DISORDER,1
FR,URINE FLOW DECREASED,1
FR,VAGINAL HAEMORRHAGE,1
FR,VAGINAL INFLAMMATION,1
FR,VARICELLA,1
FR,VARICES OESOPHAGEAL,1
FR,VASCULAR COMPLICATION ASSOCIATED WITH DEVICE,1
FR,VASCULAR PURPURA,1
FR,VASCULITIS,1
FR,VENTRICULAR EXTRASYSTOLES,1
FR,VENTRICULAR HYPOKINESIA,1
FR,VIITH NERVE PARALYSIS,1
FR,VIRAL RASH,1
FR,VITAMIN B12 INCREASED,1
FR,VITAMIN D DECREASED,1
FR,VULVAL OEDEMA,1
FR,VULVAR EROSION,1
FR,WOUND,1
FR,WRIST FRACTURE,1
FR,WRONG PATIENT RECEIVED MEDICATION,1
GA,ENCEPHALOPATHY,1
DE,NAUSEA,135
DE,FATIGUE,134
DE,SUICIDE ATTEMPT,112
DE,DYSPNOEA,102
DE,FOETAL EXPOSURE DURING PREGNANCY,102
DE,ACUTE KIDNEY INJURY,99
DE,DIARRHOEA,99
DE,PYREXIA,98
DE,ARTHRALGIA,94
DE,GENERAL PHYSICAL HEALTH DETERIORATION,93
DE,PNEUMONIA,93
DE,TOXICITY TO VARIOUS AGENTS,90
DE,VOMITING,85
DE,INTENTIONAL OVERDOSE,77
DE,DIZZINESS,76
DE,HEADACHE,76
DE,ANAEMIA,75
DE,PAIN,71
DE,SOMNOLENCE,68
DE,PAIN IN EXTREMITY,66
DE,FALL,65
DE,OVERDOSE,64
DE,THROMBOCYTOPENIA,58
DE,TACHYCARDIA,57
DE,WEIGHT DECREASED,56
DE,BACK PAIN,54
DE,EXPOSURE DURING PREGNANCY,54
DE,ABDOMINAL PAIN,47
DE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,47
DE,LEUKOPENIA,47
DE,PRURITUS,47
DE,ALANINE AMINOTRANSFERASE INCREASED,46
DE,DRUG INEFFECTIVE,46
DE,HYPERTENSION,46
DE,HAEMOGLOBIN DECREASED,44
DE,MYALGIA,44
DE,RESPIRATORY FAILURE,44
DE,DECREASED APPETITE,42
DE,DEPRESSION,42
DE,GASTROINTESTINAL HAEMORRHAGE,42
DE,RASH,42
DE,ASTHENIA,40
DE,CONSTIPATION,40
DE,MULTIPLE SCLEROSIS RELAPSE,40
DE,URTICARIA,40
DE,DRUG-INDUCED LIVER INJURY,39
DE,GAIT DISTURBANCE,38
DE,HYPOTENSION,38
DE,MATERNAL EXPOSURE DURING PREGNANCY,38
DE,SEPSIS,38
DE,ABDOMINAL PAIN UPPER,37
DE,ASPARTATE AMINOTRANSFERASE INCREASED,37
DE,C-REACTIVE PROTEIN INCREASED,37
DE,DYSPHAGIA,37
DE,NASOPHARYNGITIS,36
DE,ANGIOEDEMA,35
DE,HEPATIC ENZYME INCREASED,35
DE,PANCYTOPENIA,35
DE,SYNCOPE,35
DE,TUBULOINTERSTITIAL NEPHRITIS,35
DE,CARDIAC FAILURE,34
DE,DEATH,34
DE,HAEMORRHAGE,34
DE,MALIGNANT NEOPLASM PROGRESSION,34
DE,ATRIAL SEPTAL DEFECT,33
DE,PULMONARY EMBOLISM,33
DE,ALOPECIA,32
DE,LOSS OF CONSCIOUSNESS,32
DE,PLEURAL EFFUSION,32
DE,AGRANULOCYTOSIS,31
DE,CHILLS,31
DE,INSOMNIA,31
DE,OEDEMA PERIPHERAL,31
DE,INTERVERTEBRAL DISC PROTRUSION,30
DE,JAUNDICE,30
DE,ACUTE HEPATIC FAILURE,29
DE,COUGH,29
DE,RENAL FAILURE,29
DE,RHEUMATOID ARTHRITIS,29
DE,BLOOD CREATINE PHOSPHOKINASE INCREASED,28
DE,INFECTION,28
DE,BLOOD CREATININE INCREASED,27
DE,COMA,27
DE,GASTRITIS,27
DE,HYPOKALAEMIA,27
DE,URINARY TRACT INFECTION,27
DE,CEREBROVASCULAR ACCIDENT,26
DE,PARAESTHESIA,26
DE,RHABDOMYOLYSIS,26
DE,EPISTAXIS,25
DE,POLYNEUROPATHY,25
DE,SLEEP DISORDER,25
DE,BLOOD BILIRUBIN INCREASED,24
DE,CIRCULATORY COLLAPSE,24
DE,HAEMATOMA,24
DE,INFLUENZA LIKE ILLNESS,24
DE,MALAISE,24
DE,RESTLESSNESS,24
DE,VENTRICULAR SEPTAL DEFECT,24
DE,VERTIGO,24
DE,CHEST PAIN,23
DE,HAEMATURIA,23
DE,HYPONATRAEMIA,23
DE,TRANSAMINASES INCREASED,23
DE,VISUAL IMPAIRMENT,23
DE,BRONCHITIS,22
DE,DYSPNOEA EXERTIONAL,22
DE,HAEMATOCHEZIA,22
DE,HYPERHIDROSIS,22
DE,HYPERSENSITIVITY,22
DE,HYPOAESTHESIA,22
DE,MUSCLE SPASMS,22
DE,MUSCULAR WEAKNESS,22
DE,NEUTROPENIA,22
DE,RENAL FAILURE ACUTE,22
DE,ANXIETY,21
DE,EPILEPSY,21
DE,ERYTHEMA,21
DE,HYPERTENSIVE CRISIS,21
DE,METABOLIC ACIDOSIS,21
DE,MYOCARDIAL INFARCTION,21
DE,PERIPHERAL SWELLING,21
DE,PSORIASIS,21
DE,SEIZURE,21
DE,ARRHYTHMIA,20
DE,ATRIAL FIBRILLATION,20
DE,DEEP VEIN THROMBOSIS,20
DE,DEHYDRATION,20
DE,OSTEOARTHRITIS,20
DE,BLOOD GLUCOSE INCREASED,19
DE,CHOLELITHIASIS,19
DE,CONDITION AGGRAVATED,19
DE,CONFUSIONAL STATE,19
DE,DELIRIUM,19
DE,IMPAIRED HEALING,19
DE,LACTIC ACIDOSIS,19
DE,MUSCULOSKELETAL PAIN,19
DE,RENAL IMPAIRMENT,19
DE,TREMOR,19
DE,BLOOD PRESSURE INCREASED,18
DE,COMPLETED SUICIDE,18
DE,HERPES ZOSTER,18
DE,PALPITATIONS,18
DE,SPINAL PAIN,18
DE,STOMATITIS,18
DE,UPPER GASTROINTESTINAL HAEMORRHAGE,18
DE,ABDOMINAL DISCOMFORT,17
DE,DRY MOUTH,17
DE,JOINT SWELLING,17
DE,SUICIDAL IDEATION,17
DE,TINNITUS,17
DE,WEIGHT INCREASED,17
DE,ANAPHYLACTIC REACTION,16
DE,ARTHROPATHY,16
DE,DRY SKIN,16
DE,HYPOXIA,16
DE,LYMPHADENOPATHY,16
DE,PATENT DUCTUS ARTERIOSUS,16
DE,VISION BLURRED,16
DE,AGGRESSION,15
DE,AGITATION,15
DE,ANURIA,15
DE,APATHY,15
DE,BLOOD ALKALINE PHOSPHATASE INCREASED,15
DE,CARDIOVASCULAR DISORDER,15
DE,CONTUSION,15
DE,ERYSIPELAS,15
DE,LIVER FUNCTION TEST ABNORMAL,15
DE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,15
DE,OPTIC NEURITIS,15
DE,PREMATURE BABY,15
DE,THROMBOSIS,15
DE,BASAL CELL CARCINOMA,14
DE,CARDIAC ARREST,14
DE,CHOLESTASIS,14
DE,CHROMATURIA,14
DE,COLITIS,14
DE,CONJUNCTIVITIS,14
DE,DYSPEPSIA,14
DE,GASTROINTESTINAL DISORDER,14
DE,HAEMANGIOMA,14
DE,HEPATIC FAILURE,14
DE,INFLUENZA,14
DE,PRODUCT USE ISSUE,14
DE,RENAL CYST,14
DE,SKIN DISORDER,14
DE,SMALL FOR DATES BABY,14
DE,TRANSPOSITION OF THE GREAT VESSELS,14
DE,ACUTE RESPIRATORY DISTRESS SYNDROME,13
DE,APPENDICITIS,13
DE,BRAIN OEDEMA,13
DE,CHEST DISCOMFORT,13
DE,DYSGEUSIA,13
DE,FAECES DISCOLOURED,13
DE,GASTRIC ULCER,13
DE,HAEMOPTYSIS,13
DE,HEPATITIS,13
DE,MOBILITY DECREASED,13
DE,MUCOSAL INFLAMMATION,13
DE,OEDEMA,13
DE,OROPHARYNGEAL PAIN,13
DE,PERICARDIAL EFFUSION,13
DE,PLATELET COUNT DECREASED,13
DE,SKIN EXFOLIATION,13
DE,SPEECH DISORDER,13
DE,STAPHYLOCOCCAL INFECTION,13
DE,ANGINA PECTORIS,12
DE,BALANCE DISORDER,12
DE,BLOOD LACTATE DEHYDROGENASE INCREASED,12
DE,BONE PAIN,12
DE,CEREBRAL HAEMORRHAGE,12
DE,COMA SCALE ABNORMAL,12
DE,DRUG WITHDRAWAL SYNDROME NEONATAL,12
DE,HAEMANGIOMA CONGENITAL,12
DE,HAEMORRHAGIC ANAEMIA,12
DE,HEART RATE INCREASED,12
DE,HYPERTHYROIDISM,12
DE,HYPOTONIA NEONATAL,12
DE,INTERNATIONAL NORMALISED RATIO INCREASED,12
DE,MELAENA,12
DE,NASAL CONGESTION,12
DE,PANCREATITIS,12
DE,PREMATURE LABOUR,12
DE,PREMATURE RUPTURE OF MEMBRANES,12
DE,RESPIRATORY DISTRESS,12
DE,TENDON PAIN,12
DE,TOXIC EPIDERMAL NECROLYSIS,12
DE,UROSEPSIS,12
DE,WHITE BLOOD CELL COUNT INCREASED,12
DE,ACIDOSIS,11
DE,AUTOIMMUNE HEPATITIS,11
DE,CATARACT,11
DE,CYSTITIS,11
DE,DEPRESSED MOOD,11
DE,DERMATITIS ALLERGIC,11
DE,DIVERTICULITIS,11
DE,GASTROOESOPHAGEAL REFLUX DISEASE,11
DE,HYPERBILIRUBINAEMIA NEONATAL,11
DE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,11
DE,INTRACRANIAL PRESSURE INCREASED,11
DE,MENISCUS INJURY,11
DE,NEONATAL RESPIRATORY DISTRESS SYNDROME,11
DE,OSTEONECROSIS OF JAW,11
DE,OXYGEN SATURATION DECREASED,11
DE,PANCREATITIS ACUTE,11
DE,PROTEINURIA,11
DE,PYELONEPHRITIS,11
DE,RESPIRATORY TRACT INFECTION,11
DE,TRANSIENT ISCHAEMIC ATTACK,11
DE,ACUTE MYOCARDIAL INFARCTION,10
DE,BREAST CANCER,10
DE,CARDIO-RESPIRATORY ARREST,10
DE,DRUG INTOLERANCE,10
DE,GASTROENTERITIS,10
DE,GESTATIONAL DIABETES,10
DE,HAEMATEMESIS,10
DE,HERPES VIRUS INFECTION,10
DE,LEUKOCYTOSIS,10
DE,LOW BIRTH WEIGHT BABY,10
DE,LUMBAR VERTEBRAL FRACTURE,10
DE,MENORRHAGIA,10
DE,MUCOUS STOOLS,10
DE,MUSCLE TIGHTNESS,10
DE,NECK PAIN,10
DE,PERITONITIS,10
DE,POST PROCEDURAL HAEMORRHAGE,10
DE,RESPIRATORY DISORDER NEONATAL,10
DE,SKIN BURNING SENSATION,10
DE,STRESS,10
DE,SWELLING FACE,10
DE,TENDON RUPTURE,10
DE,TREMOR NEONATAL,10
DE,ABSCESS,9
DE,ACCIDENT,9
DE,ACCIDENTAL EXPOSURE TO PRODUCT,9
DE,ALTERED STATE OF CONSCIOUSNESS,9
DE,ANKLE FRACTURE,9
DE,ASCITES,9
DE,BLINDNESS UNILATERAL,9
DE,BLISTER,9
DE,BRADYCARDIA,9
DE,BRAIN HERNIATION,9
DE,CAESAREAN SECTION,9
DE,CORONARY ARTERY DISEASE,9
DE,DISORIENTATION,9
DE,DRUG ERUPTION,9
DE,FEBRILE NEUTROPENIA,9
DE,FEELING ABNORMAL,9
DE,FOOT DEFORMITY,9
DE,HAEMATOCRIT DECREASED,9
DE,HALLUCINATION,9
DE,HEPATIC FUNCTION ABNORMAL,9
DE,HEPATITIS ACUTE,9
DE,INTESTINAL PERFORATION,9
DE,MUSCULOSKELETAL STIFFNESS,9
DE,MYOGLOBIN URINE,9
DE,NECROTISING RETINITIS,9
DE,OLIGOHYDRAMNIOS,9
DE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,9
DE,PREMATURE SEPARATION OF PLACENTA,9
DE,PRODUCT USE IN UNAPPROVED INDICATION,9
DE,PULMONARY HAEMORRHAGE,9
DE,PULMONARY OEDEMA,9
DE,SENSORY DISTURBANCE,9
DE,TRICUSPID VALVE INCOMPETENCE,9
DE,WHITE BLOOD CELL COUNT DECREASED,9
DE,ABDOMINAL PAIN LOWER,8
DE,AMNESIA,8
DE,ANAPHYLACTIC SHOCK,8
DE,ASTHMA,8
DE,BRADYCARDIA NEONATAL,8
DE,CARDIAC DISORDER,8
DE,CEREBRAL INFARCTION,8
DE,CROHN^S DISEASE,8
DE,CUTANEOUS SYMPTOM,8
DE,DIABETES MELLITUS,8
DE,DISTURBANCE IN ATTENTION,8
DE,DRUG DEPENDENCE,8
DE,DRUG EFFECT DECREASED,8
DE,DUCTUS ARTERIOSUS PREMATURE CLOSURE,8
DE,EAR PAIN,8
DE,FACIAL PARESIS,8
DE,FOOD INTOLERANCE,8
DE,HEPATITIS CHOLESTATIC,8
DE,HYPERBILIRUBINAEMIA,8
DE,HYPERKALAEMIA,8
DE,HYPERKINESIA,8
DE,HYPOGLYCAEMIA,8
DE,HYPOTHYROIDISM,8
DE,INCORRECT DOSE ADMINISTERED,8
DE,IRON DEFICIENCY,8
DE,ISCHAEMIC STROKE,8
DE,JOINT RANGE OF MOTION DECREASED,8
DE,LIGAMENT RUPTURE,8
DE,MATERNAL DRUGS AFFECTING FOETUS,8
DE,METABOLIC MYOPATHY,8
DE,MOTOR DYSFUNCTION,8
DE,MOUTH HAEMORRHAGE,8
DE,MULTIPLE SCLEROSIS,8
DE,MUSCLE ATROPHY,8
DE,NON-CARDIAC CHEST PAIN,8
DE,OSTEONECROSIS,8
DE,PLACENTAL INSUFFICIENCY,8
DE,PLEURISY,8
DE,PNEUMONITIS,8
DE,PREMATURE DELIVERY,8
DE,PRERENAL FAILURE,8
DE,REHABILITATION THERAPY,8
DE,RENAL DISORDER,8
DE,RETINAL DETACHMENT,8
DE,RETROPLACENTAL HAEMATOMA,8
DE,SPINAL OSTEOARTHRITIS,8
DE,TENOSYNOVITIS,8
DE,ABORTION LATE,7
DE,ABORTION SPONTANEOUS,7
DE,ACCIDENTAL OVERDOSE,7
DE,ARTERIAL THROMBOSIS,7
DE,ARTHRITIS,7
DE,BLOOD CHOLESTEROL INCREASED,7
DE,BLOOD URINE PRESENT,7
DE,BURNING SENSATION,7
DE,BURSITIS,7
DE,CONCUSSION,7
DE,CONGENITAL SKIN DIMPLES,7
DE,CONJUNCTIVAL HAEMORRHAGE,7
DE,DEVICE RELATED INFECTION,7
DE,DYSARTHRIA,7
DE,ECZEMA,7
DE,EXPOSURE DURING BREAST FEEDING,7
DE,FEELING COLD,7
DE,FLUID RETENTION,7
DE,FOETAL HEART RATE DECELERATION ABNORMALITY,7
DE,FOETAL HYPOKINESIA,7
DE,FUNGAL INFECTION,7
DE,GASTROINTESTINAL INFECTION,7
DE,HAEMOLYTIC ANAEMIA,7
DE,HEPATIC CYST,7
DE,HEPATIC STEATOSIS,7
DE,HYPOACUSIS,7
DE,INFLAMMATION,7
DE,INJECTION SITE ERYTHEMA,7
DE,INTERSTITIAL LUNG DISEASE,7
DE,IRRITABILITY,7
DE,LABORATORY TEST ABNORMAL,7
DE,LACERATION,7
DE,LACRIMATION INCREASED,7
DE,LOWER GASTROINTESTINAL HAEMORRHAGE,7
DE,LYMPHOCYTE COUNT DECREASED,7
DE,MACROCEPHALY,7
DE,MENTAL DISORDER,7
DE,NEPHROPATHY TOXIC,7
DE,NIGHT SWEATS,7
DE,NIGHTMARE,7
DE,PRURITUS GENERALISED,7
DE,PULMONARY ARTERY STENOSIS CONGENITAL,7
DE,RASH GENERALISED,7
DE,RED BLOOD CELL COUNT DECREASED,7
DE,RIGHT AORTIC ARCH,7
DE,SALIVARY HYPERSECRETION,7
DE,SCIATICA,7
DE,SENSORY LOSS,7
DE,SINUS TACHYCARDIA,7
DE,SKIN DISCOLOURATION,7
DE,SPINAL FRACTURE,7
DE,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,7
DE,VIRAL INFECTION,7
DE,WOUND,7
DE,WOUND INFECTION,7
DE,ABNORMAL FAECES,6
DE,AKINESIA,6
DE,AUTOIMMUNE THYROIDITIS,6
DE,BLADDER DISORDER,6
DE,BLOOD PRESSURE DECREASED,6
DE,BLOOD UREA INCREASED,6
DE,BRAIN STEM INFARCTION,6
DE,CARDIOVASCULAR INSUFFICIENCY,6
DE,CHRONIC KIDNEY DISEASE,6
DE,COGNITIVE DISORDER,6
DE,CORONARY ARTERY STENOSIS,6
DE,CREATININE RENAL CLEARANCE DECREASED,6
DE,DERMAL CYST,6
DE,DEVICE DISLOCATION,6
DE,DISCOMFORT,6
DE,DRUG ABUSE,6
DE,DRUG EFFECT INCOMPLETE,6
DE,DRUG HYPERSENSITIVITY,6
DE,DRUG LEVEL INCREASED,6
DE,ERUCTATION,6
DE,EXTRASYSTOLES,6
DE,FEELING HOT,6
DE,FEMUR FRACTURE,6
DE,FOETAL GROWTH RESTRICTION,6
DE,GASTROINTESTINAL ANGIECTASIA,6
DE,GINGIVAL BLEEDING,6
DE,GOITRE,6
DE,HAEMORRHOIDS,6
DE,HEPATITIS TOXIC,6
DE,HEPATOBILIARY DISEASE,6
DE,HEPATOTOXICITY,6
DE,HOT FLUSH,6
DE,HYPOKINESIA,6
DE,INJECTION SITE REACTION,6
DE,INTERVERTEBRAL DISC DISORDER,6
DE,INTRAOCULAR PRESSURE INCREASED,6
DE,JOINT DISLOCATION,6
DE,LARYNGEAL OEDEMA,6
DE,LIP SWELLING,6
DE,LIVER DISORDER,6
DE,METASTASES TO BONE,6
DE,METASTASES TO LIVER,6
DE,METASTATIC MALIGNANT MELANOMA,6
DE,MIGRAINE,6
DE,MOOD SWINGS,6
DE,MYOSITIS,6
DE,NEOPLASM PROGRESSION,6
DE,NEUROPATHY PERIPHERAL,6
DE,OESOPHAGEAL DISCOMFORT,6
DE,OESOPHAGITIS,6
DE,OVARIAN CYST,6
DE,PHARYNGEAL OEDEMA,6
DE,PREGNANCY,6
DE,PRESYNCOPE,6
DE,PROCEDURAL PAIN,6
DE,RADIUS FRACTURE,6
DE,RENAL COLIC,6
DE,RESPIRATORY ARREST,6
DE,RHEUMATIC DISORDER,6
DE,ROTATOR CUFF SYNDROME,6
DE,SECOND PRIMARY MALIGNANCY,6
DE,SELF-MEDICATION,6
DE,SKELETAL DYSPLASIA,6
DE,SKIN HAEMORRHAGE,6
DE,SPLENOMEGALY,6
DE,TACHYCARDIA FOETAL,6
DE,URINARY INCONTINENCE,6
DE,VISUAL ACUITY REDUCED,6
DE,ABDOMINAL DISTENSION,5
DE,ABDOMINAL TENDERNESS,5
DE,ACUTE RESPIRATORY FAILURE,5
DE,ALCOHOL ABUSE,5
DE,ALCOHOL POISONING,5
DE,ANKYLOSING SPONDYLITIS,5
DE,ANTI-THYROID ANTIBODY POSITIVE,5
DE,APHASIA,5
DE,APNOEA,5
DE,BLOOD SODIUM DECREASED,5
DE,BLOOD TEST ABNORMAL,5
DE,BLOOD URIC ACID INCREASED,5
DE,BODY HEIGHT DECREASED,5
DE,BODY TEMPERATURE INCREASED,5
DE,BONE EROSION,5
DE,BONE MARROW OEDEMA,5
DE,BREAST CANCER METASTATIC,5
DE,BRONCHIAL CARCINOMA,5
DE,BUNDLE BRANCH BLOCK RIGHT,5
DE,CAROTID ARTERY STENOSIS,5
DE,CARPAL TUNNEL SYNDROME,5
DE,CEREBRAL ISCHAEMIA,5
DE,CERVICAL INCOMPETENCE,5
DE,CHOLECYSTITIS,5
DE,COAGULOPATHY,5
DE,COARCTATION OF THE AORTA,5
DE,CYST,5
DE,DERMATITIS,5
DE,DIALYSIS,5
DE,DIPLOPIA,5
DE,DISEASE PROGRESSION,5
DE,DIVERTICULAR PERFORATION,5
DE,DRUG ADMINISTRATION ERROR,5
DE,DUCTUS ARTERIOSUS STENOSIS FOETAL,5
DE,DUODENAL ULCER,5
DE,DYSKINESIA,5
DE,DYSPHONIA,5
DE,DYSURIA,5
DE,EXOSTOSIS,5
DE,FAECES PALE,5
DE,FEBRILE INFECTION,5
DE,FOETAL MONITORING ABNORMAL,5
DE,FRACTURED SACRUM,5
DE,GASTRIC PERFORATION,5
DE,GASTRITIS BACTERIAL,5
DE,GASTROENTERITIS NOROVIRUS,5
DE,GASTROINTESTINAL ULCER,5
DE,GLAUCOMA,5
DE,HAEMARTHROSIS,5
DE,HALLUCINATION_ VISUAL,5
DE,HEMIPARESIS,5
DE,HIATUS HERNIA,5
DE,HOSPITALISATION,5
DE,HYPERGLYCAEMIA,5
DE,HYPOAESTHESIA ORAL,5
DE,HYPOCHROMIC ANAEMIA,5
DE,INFECTION SUSCEPTIBILITY INCREASED,5
DE,INFLAMMATORY MARKER INCREASED,5
DE,INFUSION RELATED REACTION,5
DE,INJECTION SITE PAIN,5
DE,INTERVERTEBRAL DISCITIS,5
DE,LIVE BIRTH,5
DE,MELANOCYTIC NAEVUS,5
DE,MUSCLE SPASTICITY,5
DE,NEOPLASM,5
DE,NERVE INJURY,5
DE,NEURALGIA,5
DE,ONYCHOMYCOSIS,5
DE,ORAL CANDIDIASIS,5
DE,OSTEOPOROSIS,5
DE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,5
DE,PERSISTENT LEFT SUPERIOR VENA CAVA,5
DE,PHARYNGITIS,5
DE,PNEUMONIA ASPIRATION,5
DE,PNEUMOTHORAX SPONTANEOUS,5
DE,POST PROCEDURAL COMPLICATION,5
DE,PRODUCTIVE COUGH,5
DE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,5
DE,PROSTATE CANCER METASTATIC,5
DE,PROTHROMBIN TIME SHORTENED,5
DE,PSORIATIC ARTHROPATHY,5
DE,PSYCHOTIC DISORDER,5
DE,PULMONARY HYPERTENSION,5
DE,PULPITIS DENTAL,5
DE,RASH PRURITIC,5
DE,RASH PUSTULAR,5
DE,RESTLESS LEGS SYNDROME,5
DE,RHINITIS,5
DE,RIB FRACTURE,5
DE,RIGHT VENTRICULAR FAILURE,5
DE,SHOCK HAEMORRHAGIC,5
DE,SKIN LESION,5
DE,SKIN ULCER,5
DE,SUBACUTE HEPATIC FAILURE,5
DE,SUBARACHNOID HAEMORRHAGE,5
DE,SUBDURAL HAEMATOMA,5
DE,SWELLING,5
DE,SWOLLEN TONGUE,5
DE,SYNOVIAL CYST,5
DE,TREATMENT NONCOMPLIANCE,5
DE,TYPE 2 DIABETES MELLITUS,5
DE,UPPER LIMB FRACTURE,5
DE,URINARY SEDIMENT PRESENT,5
DE,UTERINE LEIOMYOMA,5
DE,VAGINAL HAEMORRHAGE,5
DE,VENOUS THROMBOSIS,5
DE,ABORTION INDUCED,4
DE,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,4
DE,ACUTE ABDOMEN,4
DE,ACUTE MYELOID LEUKAEMIA,4
DE,ACUTE PRERENAL FAILURE,4
DE,AORTIC ARTERIOSCLEROSIS,4
DE,ARTERIOSCLEROSIS,4
DE,ASPIRATION,4
DE,AUTOIMMUNE HAEMOLYTIC ANAEMIA,4
DE,BACTERIAL INFECTION,4
DE,BACTERIAL TEST,4
DE,BEDRIDDEN,4
DE,BLOOD CALCIUM DECREASED,4
DE,BLOOD URINE,4
DE,BORDERLINE PERSONALITY DISORDER,4
DE,CELLULITIS,4
DE,CENTRAL NERVOUS SYSTEM LESION,4
DE,CHOLANGITIS,4
DE,CLEFT LIP AND PALATE,4
DE,COLITIS ULCERATIVE,4
DE,CONGENITAL CYSTIC LUNG,4
DE,CONVULSION,4
DE,DEPRESSED LEVEL OF CONSCIOUSNESS,4
DE,DEPRESSIVE SYMPTOM,4
DE,DIVERTICULUM INTESTINAL,4
DE,DOUBLE OUTLET RIGHT VENTRICLE,4
DE,DROOLING,4
DE,DRUG RESISTANCE,4
DE,DRUG USE DISORDER,4
DE,DYSSTASIA,4
DE,EAR DISCOMFORT,4
DE,ELECTROCARDIOGRAM QT PROLONGED,4
DE,ENTERITIS,4
DE,ENTEROCOCCAL INFECTION,4
DE,ERYTHEMA MULTIFORME,4
DE,EYE OEDEMA,4
DE,EYELID OEDEMA,4
DE,FALLOPIAN TUBE CYST,4
DE,FIBRIN D DIMER INCREASED,4
DE,FISTULA,4
DE,FLUSHING,4
DE,GASTRIC HAEMORRHAGE,4
DE,GASTRITIS EROSIVE,4
DE,GASTROINTESTINAL VASCULAR MALFORMATION HAEMORRHAGIC,4
DE,GENERAL PHYSICAL CONDITION ABNORMAL,4
DE,GENERALISED ERYTHEMA,4
DE,GROIN PAIN,4
DE,HEARING IMPAIRED,4
DE,HEPATIC ENCEPHALOPATHY,4
DE,HEPATIC LESION,4
DE,HISTIOCYTOSIS HAEMATOPHAGIC,4
DE,HYPERAESTHESIA,4
DE,HYPERTHERMIA,4
DE,HYPERTONIA NEONATAL,4
DE,ILEUS,4
DE,INDUCED LABOUR,4
DE,INTENTIONAL DRUG MISUSE,4
DE,IRON OVERLOAD,4
DE,JUVENILE IDIOPATHIC ARTHRITIS,4
DE,KNEE ARTHROPLASTY,4
DE,LARGE INTESTINE PERFORATION,4
DE,LETHARGY,4
DE,LIMB DISCOMFORT,4
DE,LIPASE INCREASED,4
DE,LIVER FUNCTION TEST INCREASED,4
DE,LIVER INJURY,4
DE,LOCALISED INFECTION,4
DE,LUNG INFECTION,4
DE,LUNG INFILTRATION,4
DE,LUNG NEOPLASM MALIGNANT,4
DE,LYMPHADENITIS,4
DE,METASTASES TO CENTRAL NERVOUS SYSTEM,4
DE,METASTASES TO LYMPH NODES,4
DE,MICROCEPHALY,4
DE,MICTURITION URGENCY,4
DE,MIDDLE INSOMNIA,4
DE,MONOCYTE COUNT INCREASED,4
DE,MUSCLE DISORDER,4
DE,MUSCLE HAEMORRHAGE,4
DE,NAIL BED INFLAMMATION,4
DE,NECROSIS,4
DE,NEONATAL HYPOXIA,4
DE,NEPHROLITHIASIS,4
DE,NODULE,4
DE,OCULAR ICTERUS,4
DE,ORAL HERPES,4
DE,OSTEOCHONDROSIS,4
DE,OTITIS MEDIA,4
DE,PANIC ATTACK,4
DE,PARKINSON^S DISEASE,4
DE,PERFORMANCE STATUS DECREASED,4
DE,PETECHIAE,4
DE,PILONIDAL CYST,4
DE,PLASMA CELL MYELOMA,4
DE,POLLAKIURIA,4
DE,POLYDACTYLY,4
DE,POSTOPERATIVE WOUND INFECTION,4
DE,PRODUCT SUBSTITUTION ISSUE,4
DE,PROSTATE CANCER,4
DE,PSEUDARTHROSIS,4
DE,PULMONARY FIBROSIS,4
DE,PUSTULAR PSORIASIS,4
DE,RECTAL HAEMORRHAGE,4
DE,RENAL FUNCTION TEST ABNORMAL,4
DE,RESPIRATORY DISORDER,4
DE,RHEUMATOID NODULE,4
DE,SEPTIC SHOCK,4
DE,SERUM FERRITIN INCREASED,4
DE,SKIN TOXICITY,4
DE,SLOW RESPONSE TO STIMULI,4
DE,SOPOR,4
DE,SPINAL COLUMN STENOSIS,4
DE,SPINAL DISORDER,4
DE,SUDDEN CARDIAC DEATH,4
DE,SYNOVITIS,4
DE,THORACIC VERTEBRAL FRACTURE,4
DE,THYROID MASS,4
DE,THYROXINE FREE INCREASED,4
DE,TONGUE HAEMORRHAGE,4
DE,TOOTH ABSCESS,4
DE,TOOTHACHE,4
DE,UNRESPONSIVE TO STIMULI,4
DE,UPPER RESPIRATORY TRACT INFECTION,4
DE,URINARY RETENTION,4
DE,URINARY TRACT DISORDER,4
DE,VASCULITIS,4
DE,VISUAL FIELD DEFECT,4
DE,WALKING AID USER,4
DE,WITHDRAWAL SYNDROME,4
DE,WOUND HAEMORRHAGE,4
DE,YELLOW SKIN,4
DE,ABDOMINAL HERNIA,3
DE,ABDOMINAL RIGIDITY,3
DE,ABDOMINAL WOUND DEHISCENCE,3
DE,ABSCESS LIMB,3
DE,ACNE,3
DE,ACTIVITIES OF DAILY LIVING IMPAIRED,3
DE,ACUTE DISSEMINATED ENCEPHALOMYELITIS,3
DE,ADVERSE EVENT,3
DE,AGEUSIA,3
DE,ALVEOLITIS ALLERGIC,3
DE,ANAEMIA POSTOPERATIVE,3
DE,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,3
DE,ANXIETY DISORDER,3
DE,APHTHOUS STOMATITIS,3
DE,ARTHROSCOPY,3
DE,ATELECTASIS,3
DE,ATYPICAL PNEUMONIA,3
DE,AZOTAEMIA,3
DE,BASILAR ARTERY THROMBOSIS,3
DE,BLADDER CANCER,3
DE,BLOOD BRAIN BARRIER DEFECT,3
DE,BLOOD CREATININE ABNORMAL,3
DE,BLOOD DISORDER,3
DE,BONE GIANT CELL TUMOUR,3
DE,BONE LOSS,3
DE,BREAST PAIN,3
DE,CANDIDA INFECTION,3
DE,CARDIAC FAILURE ACUTE,3
DE,CARDIAC HYPERTROPHY,3
DE,CATARACT CONGENITAL,3
DE,CEREBRAL MICROANGIOPATHY,3
DE,CHRONIC GASTRITIS,3
DE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
DE,COLITIS MICROSCOPIC,3
DE,COLON ADENOMA,3
DE,COMPARTMENT SYNDROME,3
DE,CONCOMITANT DISEASE AGGRAVATED,3
DE,CONGENITAL HYDRONEPHROSIS,3
DE,CONTRAINDICATED PRODUCT ADMINISTERED,3
DE,COORDINATION ABNORMAL,3
DE,CRYPTORCHISM,3
DE,CYANOSIS,3
DE,DEAFNESS,3
DE,DEMYELINATION,3
DE,DEPENDENCE,3
DE,DERMATITIS BULLOUS,3
DE,DIARRHOEA HAEMORRHAGIC,3
DE,DRUG DOSE OMISSION,3
DE,DYSAESTHESIA,3
DE,EAR SWELLING,3
DE,EJECTION FRACTION DECREASED,3
DE,EMPHYSEMA,3
DE,EPIGASTRIC DISCOMFORT,3
DE,EYE PAIN,3
DE,EYE SWELLING,3
DE,FAECALOMA,3
DE,FEMORAL NECK FRACTURE,3
DE,FIBROMYALGIA,3
DE,FLANK PAIN,3
DE,FOLATE DEFICIENCY,3
DE,FOOT FRACTURE,3
DE,FRACTURE,3
DE,FRACTURE DELAYED UNION,3
DE,GASTRIC DISORDER,3
DE,GASTRIC ULCER HAEMORRHAGE,3
DE,GASTROINTESTINAL INFLAMMATION,3
DE,GASTROINTESTINAL PAIN,3
DE,GENERALISED OEDEMA,3
DE,GENERALISED TONIC-CLONIC SEIZURE,3
DE,GINGIVITIS,3
DE,GLOMERULAR FILTRATION RATE DECREASED,3
DE,GLOMERULONEPHRITIS CHRONIC,3
DE,GLYCOSYLATED HAEMOGLOBIN INCREASED,3
DE,HAEMODIALYSIS,3
DE,HAEMOLYSIS,3
DE,HAEMORRHAGE IN PREGNANCY,3
DE,HAEMORRHAGIC DIATHESIS,3
DE,HEART RATE IRREGULAR,3
DE,HELICOBACTER GASTRITIS,3
DE,HIP ARTHROPLASTY,3
DE,HUMERUS FRACTURE,3
DE,HYDROCEPHALUS,3
DE,HYPERCHOLESTEROLAEMIA,3
DE,HYPERKERATOSIS,3
DE,HYPERSENSITIVITY VASCULITIS,3
DE,HYPERVENTILATION,3
DE,HYPOALBUMINAEMIA,3
DE,HYPOPHAGIA,3
DE,HYPOTONIA,3
DE,HYPOVENTILATION,3
DE,HYPOVOLAEMIC SHOCK,3
DE,HYSTERECTOMY,3
DE,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,3
DE,IMMUNE SYSTEM DISORDER,3
DE,IMMUNE THROMBOCYTOPENIC PURPURA,3
DE,INCISIONAL HERNIA,3
DE,INCORRECT DRUG ADMINISTRATION DURATION,3
DE,INCORRECT ROUTE OF DRUG ADMINISTRATION,3
DE,INFECTED DERMAL CYST,3
DE,INFERTILITY,3
DE,INJECTION SITE HAEMORRHAGE,3
DE,INJECTION SITE PRURITUS,3
DE,INJECTION SITE SWELLING,3
DE,INTENTIONAL PRODUCT MISUSE,3
DE,INTERNATIONAL NORMALISED RATIO DECREASED,3
DE,INTESTINAL HAEMORRHAGE,3
DE,INTRADUCTAL PROLIFERATIVE BREAST LESION,3
DE,INVASIVE DUCTAL BREAST CARCINOMA,3
DE,IRITIS,3
DE,IRON DEFICIENCY ANAEMIA,3
DE,JOINT DESTRUCTION,3
DE,JOINT INJURY,3
DE,JOINT INSTABILITY,3
DE,JOINT STIFFNESS,3
DE,KNEE OPERATION,3
DE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,3
DE,LIMB INJURY,3
DE,LISTERIA SEPSIS,3
DE,LUNG ADENOCARCINOMA,3
DE,LUNG DISORDER,3
DE,LYMPHOCYTOSIS,3
DE,MALIGNANT MELANOMA,3
DE,MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE,3
DE,MALNUTRITION,3
DE,MECONIUM IN AMNIOTIC FLUID,3
DE,MEDICAL INDUCTION OF COMA,3
DE,MEDICATION ERROR,3
DE,MEMORY IMPAIRMENT,3
DE,MENSTRUATION IRREGULAR,3
DE,METABOLIC DISORDER,3
DE,METASTASES TO SPINE,3
DE,MITRAL VALVE INCOMPETENCE,3
DE,MIXED LIVER INJURY,3
DE,MOOD ALTERED,3
DE,MUCOSAL NECROSIS,3
DE,MUSCLE STRAIN,3
DE,MUSCULOSKELETAL DISORDER,3
DE,MYELODYSPLASTIC SYNDROME,3
DE,MYOSCLEROSIS,3
DE,NAIL DISORDER,3
DE,NERVOUSNESS,3
DE,NEURITIS,3
DE,NEURODERMATITIS,3
DE,NEUTROPENIC SEPSIS,3
DE,NEUTROPHIL COUNT INCREASED,3
DE,NOCTURIA,3
DE,NORMOCHROMIC NORMOCYTIC ANAEMIA,3
DE,OBSTRUCTED LABOUR,3
DE,OCULAR HYPERAEMIA,3
DE,OEDEMA MUCOSAL,3
DE,OLIGURIA,3
DE,ORAL PAIN,3
DE,OSTEITIS,3
DE,OSTEOPENIA,3
DE,PALLOR,3
DE,PANCREATITIS CHRONIC,3
DE,PARONYCHIA,3
DE,PELVIC PAIN,3
DE,PEPTIC ULCER PERFORATION,3
DE,PERICARDITIS,3
DE,PERIODONTITIS,3
DE,PNEUMOTHORAX,3
DE,POISONING,3
DE,POLYURIA,3
DE,POST PROCEDURAL HAEMATOMA,3
DE,PRE-ECLAMPSIA,3
DE,PRESCRIBED OVERDOSE,3
DE,PRETERM PREMATURE RUPTURE OF MEMBRANES,3
DE,PRODUCT QUALITY ISSUE,3
DE,PROSTATITIS,3
DE,PROTHROMBIN TIME PROLONGED,3
DE,PULMONARY SARCOIDOSIS,3
DE,PURULENCE,3
DE,RAPID CORRECTION OF HYPONATRAEMIA,3
DE,RED BLOOD CELLS URINE POSITIVE,3
DE,RETINAL HAEMORRHAGE,3
DE,SEDATION,3
DE,SKIN EROSION,3
DE,SKIN FISSURES,3
DE,SKIN REACTION,3
DE,STRESS FRACTURE,3
DE,SUDDEN HEARING LOSS,3
DE,SYSTEMIC LUPUS ERYTHEMATOSUS,3
DE,TACHYPNOEA,3
DE,TEMPERATURE INTOLERANCE,3
DE,TENDERNESS,3
DE,TENDON DISORDER,3
DE,TENDONITIS,3
DE,THIRST,3
DE,THROAT IRRITATION,3
DE,THROMBOPHLEBITIS,3
DE,THROMBOPHLEBITIS SUPERFICIAL,3
DE,THYROID STIMULATING IMMUNOGLOBULIN INCREASED,3
DE,TOOTH DISORDER,3
DE,UHTHOFF^S PHENOMENON,3
DE,URINARY BLADDER HAEMORRHAGE,3
DE,VERTIGO POSITIONAL,3
DE,VIITH NERVE PARALYSIS,3
DE,VIRAL UPPER RESPIRATORY TRACT INFECTION,3
DE,VITAMIN D DEFICIENCY,3
DE,WHITE BLOOD CELLS URINE POSITIVE,3
DE,WOUND COMPLICATION,3
DE,ABDOMINAL ABSCESS,2
DE,ABNORMAL BEHAVIOUR,2
DE,ABORTION MISSED,2
DE,ACUTE CORONARY SYNDROME,2
DE,ACUTE PSYCHOSIS,2
DE,ADRENAL ADENOMA,2
DE,AGITATION NEONATAL,2
DE,ALCOHOLIC LIVER DISEASE,2
DE,ALCOHOLISM,2
DE,ALPHA-1 ANTI-TRYPSIN DECREASED,2
DE,ALVEOLITIS,2
DE,ANAL FISSURE,2
DE,ANAL PRURITUS,2
DE,ANEURYSM,2
DE,ANGINA UNSTABLE,2
DE,AORTIC ANEURYSM,2
DE,APPARENT DEATH,2
DE,ARTERIAL OCCLUSIVE DISEASE,2
DE,ARTHROPOD BITE,2
DE,AXILLARY PAIN,2
DE,BACTERIAL TEST POSITIVE,2
DE,BASAL GANGLIA HAEMORRHAGE,2
DE,BASILAR ARTERY OCCLUSION,2
DE,BILIRUBIN CONJUGATED INCREASED,2
DE,BLADDER CYST,2
DE,BLADDER SPASM,2
DE,BLOOD ALCOHOL INCREASED,2
DE,BLOOD ALKALINE PHOSPHATASE ABNORMAL,2
DE,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,2
DE,BLOOD POTASSIUM DECREASED,2
DE,BLOOD POTASSIUM INCREASED,2
DE,BLOOD PROLACTIN INCREASED,2
DE,BLOOD THYROID STIMULATING HORMONE INCREASED,2
DE,BLOOD TRIGLYCERIDES INCREASED,2
DE,BLOOD UREA DECREASED,2
DE,BONE DISORDER,2
DE,BONE MARROW FAILURE,2
DE,BRCA2 GENE MUTATION,2
DE,BREAST ADENOMA,2
DE,BREAST CALCIFICATIONS,2
DE,BRONCHITIS CHRONIC,2
DE,BRONCHOSPASM,2
DE,BULIMIA NERVOSA,2
DE,CALCULUS URINARY,2
DE,CAMPYLOBACTER INFECTION,2
DE,CARDIAC DEATH,2
DE,CARDIOMEGALY,2
DE,CARDIOPULMONARY FAILURE,2
DE,CAUDA EQUINA SYNDROME,2
DE,CERVICAL DYSPLASIA,2
DE,CERVICOBRACHIAL SYNDROME,2
DE,CHEILITIS,2
DE,CHOLANGIOCARCINOMA,2
DE,CHOLECYSTITIS ACUTE,2
DE,CHOLECYSTITIS CHRONIC,2
DE,CHONDROPATHY,2
DE,CHRONIC TONSILLITIS,2
DE,CLAUSTROPHOBIA,2
DE,COATING IN MOUTH,2
DE,COLITIS ISCHAEMIC,2
DE,COLON CANCER,2
DE,CONGENITAL PULMONARY HYPERTENSION,2
DE,CONJUNCTIVITIS BACTERIAL,2
DE,CRANIOCEREBRAL INJURY,2
DE,CRYING,2
DE,CYTOMEGALOVIRUS CHORIORETINITIS,2
DE,CYTOPENIA,2
DE,DEFAECATION URGENCY,2
DE,DERMATITIS EXFOLIATIVE,2
DE,DEVICE ISSUE,2
DE,DIVERTICULUM,2
DE,DIVERTICULUM INTESTINAL HAEMORRHAGIC,2
DE,DRUG EFFECT INCREASED,2
DE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
DE,DRUG LEVEL ABOVE THERAPEUTIC,2
DE,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
DE,DRUG WITHDRAWAL SYNDROME,2
DE,DRY EYE,2
DE,DRY THROAT,2
DE,DUODENAL ULCER HAEMORRHAGE,2
DE,DYSTONIA,2
DE,ECZEMA WEEPING,2
DE,EMBOLISM ARTERIAL,2
GR,HYPERKALAEMIA,5
GR,MYOCARDIAL ISCHAEMIA,2
GR,ABDOMINAL PAIN,1
GR,AFFECTIVE DISORDER,1
GR,AORTIC VALVE INCOMPETENCE,1
GR,CARDIAC TAMPONADE,1
GR,CONDITION AGGRAVATED,1
GR,CONSTIPATION,1
GR,CORONARY ARTERY ANEURYSM,1
GR,CORONARY ARTERY DILATATION,1
GR,CUSHING^S SYNDROME,1
GR,DERMATITIS PSORIASIFORM,1
GR,DRUG INEFFECTIVE,1
GR,DYSPNOEA,1
GR,DYSPNOEA EXERTIONAL,1
GR,GASTRIC HAEMORRHAGE,1
GR,GASTRIC ULCER,1
GR,HAEMATEMESIS,1
GR,HAEMOGLOBIN DECREASED,1
GR,INFECTION,1
GR,METABOLIC ACIDOSIS,1
GR,MITRAL VALVE INCOMPETENCE,1
GR,MUSCULAR WEAKNESS,1
GR,OEDEMA PERIPHERAL,1
GR,PERICARDITIS CONSTRICTIVE,1
GR,PYREXIA,1
GR,RASH,1
GR,SKIN EXFOLIATION,1
GR,THERAPEUTIC RESPONSE DECREASED,1
GR,TONSILLAR HYPERTROPHY,1
GR,TONSILLITIS,1
GR,TUBULOINTERSTITIAL NEPHRITIS,1
GT,HEAD DISCOMFORT,2
GT,NAUSEA,2
GT,SEIZURE,2
GT,VOMITING,2
GT,ABDOMINAL PAIN UPPER,1
GT,ALANINE AMINOTRANSFERASE INCREASED,1
GT,ALOPECIA,1
GT,ANAEMIA,1
GT,ANAL INCONTINENCE,1
GT,APHONIA,1
GT,ARTHROPATHY,1
GT,ASPARTATE AMINOTRANSFERASE INCREASED,1
GT,ASTHENIA,1
GT,BILIRUBIN CONJUGATED INCREASED,1
GT,BLOOD GLUCOSE DECREASED,1
GT,CHEST PAIN,1
GT,COUGH,1
GT,DECREASED APPETITE,1
GT,DENGUE FEVER,1
GT,DEPRESSION,1
GT,DIPLOPIA,1
GT,DIZZINESS,1
GT,DYSPHONIA,1
GT,DYSPNOEA,1
GT,FAECES SOFT,1
GT,FEELING ABNORMAL,1
GT,FEELING DRUNK,1
GT,GAIT DISTURBANCE,1
GT,HAEMATOCHEZIA,1
GT,HEPATIC FAILURE,1
GT,JOINT STIFFNESS,1
GT,LIMB DISCOMFORT,1
GT,LIVER DISORDER,1
GT,MALAISE,1
GT,MULTIPLE SCLEROSIS,1
GT,MUSCULAR WEAKNESS,1
GT,NERVOUSNESS,1
GT,PYREXIA,1
GT,RENAL DISORDER,1
GT,SECRETION DISCHARGE,1
GT,SENSORY DISTURBANCE,1
GT,SYNCOPE,1
GT,TINNITUS,1
GT,TONSILLITIS,1
GT,URINARY INCONTINENCE,1
GT,URINE OUTPUT DECREASED,1
GT,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
HT,HEPATOTOXICITY,1
HT,IDIOPATHIC INTERSTITIAL PNEUMONIA,1
HN,TOXIC EPIDERMAL NECROLYSIS,1
HK,PEPTIC ULCER,5
HK,RENAL IMPAIRMENT,5
HK,SECONDARY ADRENOCORTICAL INSUFFICIENCY,5
HK,TOXICITY TO VARIOUS AGENTS,4
HK,CUSHING^S SYNDROME,3
HK,OSTEOPOROTIC FRACTURE,3
HK,MEDICATION ERROR,2
HK,POISONING,2
HK,RENAL FAILURE ACUTE,2
HK,AGRANULOCYTOSIS,1
HK,HERBAL INTERACTION,1
HK,LIVER FUNCTION TEST ABNORMAL,1
HK,SYNCOPE,1
HU,APPENDICITIS,1
HU,CHOKING,1
HU,DEHYDRATION,1
HU,ERYTHEMA MULTIFORME,1
HU,GASTRIC DISORDER,1
HU,MUSCULOSKELETAL CHEST PAIN,1
HU,POST PROCEDURAL INFLAMMATION,1
HU,PRODUCTIVE COUGH,1
HU,STEVENS-JOHNSON SYNDROME,1
HU,TOXIC EPIDERMAL NECROLYSIS,1
IS,EYELID OEDEMA,1
IS,HYPERSENSITIVITY,1
IS,LIP OEDEMA,1
IS,SWELLING FACE,1
IN,INTESTINAL OBSTRUCTION,6
IN,LARGE INTESTINE PERFORATION,6
IN,DUODENAL OBSTRUCTION,4
IN,FAECALOMA,4
IN,HISTIOCYTOSIS HAEMATOPHAGIC,4
IN,RESPIRATORY DISORDER,4
IN,SELF-MEDICATION,4
IN,VENTRICULAR FIBRILLATION,3
IN,CARDIAC ARREST,2
IN,CONSTIPATION,2
IN,EXTRAPYRAMIDAL DISORDER,2
IN,HEADACHE,2
IN,HYPOMANIA,2
IN,PRURITUS,2
IN,RASH MACULO-PAPULAR,2
IN,SEROTONIN SYNDROME,2
IN,SUPRAVENTRICULAR TACHYCARDIA,2
IN,VENTRICULAR TACHYCARDIA,2
IN,ABDOMINAL PAIN,1
IN,ABDOMINAL PAIN UPPER,1
IN,ABNORMAL BEHAVIOUR,1
IN,AGITATION,1
IN,ASTHENIA,1
IN,BLINDNESS,1
IN,BODY TEMPERATURE INCREASED,1
IN,BRADYKINESIA,1
IN,CHEST PAIN,1
IN,CHOLESTASIS,1
IN,CHOLESTATIC LIVER INJURY,1
IN,CONJUNCTIVALISATION,1
IN,DISTURBANCE IN ATTENTION,1
IN,DIZZINESS,1
IN,DRUG DEPENDENCE,1
IN,DRUG INEFFECTIVE,1
IN,DRUG LEVEL INCREASED,1
IN,DRUG WITHDRAWAL SYNDROME,1
IN,DRUG-INDUCED LIVER INJURY,1
IN,EATING DISORDER,1
IN,EJECTION FRACTION DECREASED,1
IN,EUPHORIC MOOD,1
IN,EYE HAEMORRHAGE,1
IN,FAECES HARD,1
IN,FATIGUE,1
IN,GASTROINTESTINAL NECROSIS,1
IN,GASTROINTESTINAL STROMAL TUMOUR,1
IN,HAEMANGIOMA OF LIVER,1
IN,HAEMOGLOBIN DECREASED,1
IN,HERPES ZOSTER,1
IN,HYPERTONIA,1
IN,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
IN,INSOMNIA,1
IN,INTENTIONAL OVERDOSE,1
IN,INTENTIONAL PRODUCT USE ISSUE,1
IN,INTESTINAL PERFORATION,1
IN,INTRAOCULAR PRESSURE INCREASED,1
IN,LOGORRHOEA,1
IN,MALAISE,1
IN,MENINGITIS EOSINOPHILIC,1
IN,MESENTERIC ARTERIAL OCCLUSION,1
IN,MUSCULOSKELETAL STIFFNESS,1
IN,NEOPLASM,1
IN,NUCHAL RIGIDITY,1
IN,OVARIAN CYST,1
IN,OVERCONFIDENCE,1
IN,PAIN,1
IN,PHOTOPHOBIA,1
IN,PSYCHOMOTOR RETARDATION,1
IN,PYLORIC STENOSIS,1
IN,SALIVARY HYPERSECRETION,1
IN,SLEEP DISORDER,1
IN,STEVENS-JOHNSON SYNDROME,1
IN,TACHYCARDIA,1
IN,TRANSFUSION,1
IN,TREMOR,1
IN,VENTRICULAR EXTRASYSTOLES,1
IN,VISUAL ACUITY REDUCED,1
IN,VOMITING PROJECTILE,1
IR,ANAPHYLACTIC SHOCK,2
IR,ARRHYTHMIA,2
IR,DIZZINESS,2
IR,DYSPNOEA,2
IR,HEADACHE,2
IR,HYPERTENSION,2
IR,PALLOR,2
IR,PALPITATIONS,2
IR,PERIORBITAL HAEMORRHAGE,2
IR,PRURITUS,2
IR,URTICARIA,2
IR,DEATH,1
IR,DRUG INEFFECTIVE,1
IR,ERYTHEMA MULTIFORME,1
IR,EYE HAEMORRHAGE,1
IR,HAEMATOMA,1
IQ,BLOOD BILIRUBIN INCREASED,1
IQ,CHROMATURIA,1
IQ,FAECES DISCOLOURED,1
IQ,FATIGUE,1
IQ,HAEMATOCHEZIA,1
IQ,HELMINTHIC INFECTION,1
IQ,JAUNDICE,1
IQ,LIVER FUNCTION TEST INCREASED,1
IQ,MENINGITIS,1
IE,ACUTE KIDNEY INJURY,10
IE,DUODENAL ULCER PERFORATION,9
IE,GASTRITIS,9
IE,IRON DEFICIENCY ANAEMIA,8
IE,DIARRHOEA,7
IE,DIAPHRAGMATIC DISORDER,6
IE,FATIGUE,6
IE,FLUSHING,6
IE,ILEAL STENOSIS,6
IE,INTESTINAL OBSTRUCTION,6
IE,LOWER RESPIRATORY TRACT INFECTION,6
IE,ANGIOEDEMA,5
IE,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,5
IE,INFLAMMATORY BOWEL DISEASE,5
IE,PERIORBITAL OEDEMA,5
IE,PRODUCT USE IN UNAPPROVED INDICATION,5
IE,PRODUCT USE ISSUE,5
IE,RHINORRHOEA,5
IE,THROAT TIGHTNESS,5
IE,WHEEZING,5
IE,ALLERGIC RESPIRATORY DISEASE,4
IE,CHEST DISCOMFORT,4
IE,CONJUNCTIVITIS,4
IE,DEATH,4
IE,DRUG HYPERSENSITIVITY,4
IE,FALL,4
IE,INFLUENZA LIKE ILLNESS,4
IE,INTESTINAL DIAPHRAGM DISEASE,4
IE,PARAESTHESIA ORAL,4
IE,ABDOMINAL PAIN,3
IE,BLISTER,3
IE,DEPRESSED MOOD,3
IE,HYPERSENSITIVITY,3
IE,LETHARGY,3
IE,LIP OEDEMA,3
IE,OESOPHAGITIS,3
IE,PAIN,3
IE,PAIN IN EXTREMITY,3
IE,ABDOMINAL DISTENSION,2
IE,ARTHRALGIA,2
IE,BACK PAIN,2
IE,COLITIS,2
IE,COUGH,2
IE,DIABETIC KETOACIDOSIS,2
IE,DRUG ABUSE,2
IE,DRUG INEFFECTIVE,2
IE,DRUG WITHDRAWAL SYNDROME,2
IE,DUODENITIS,2
IE,DYSPEPSIA,2
IE,EMOTIONAL DISTRESS,2
IE,ERYTHEMA,2
IE,EYE INFECTION,2
IE,EYE SWELLING,2
IE,FACIAL PARALYSIS,2
IE,FOOD AVERSION,2
IE,FORMICATION,2
IE,HAEMOGLOBIN DECREASED,2
IE,HYPERTENSION,2
IE,INFECTION,2
IE,INFLUENZA,2
IE,INSOMNIA,2
IE,INTENTIONAL OVERDOSE,2
IE,INTENTIONAL SELF-INJURY,2
IE,INTESTINAL PERFORATION,2
IE,MUSCLE TWITCHING,2
IE,NAUSEA,2
IE,NEUTROPHIL COUNT DECREASED,2
IE,PALLOR,2
IE,PANCREATITIS ACUTE,2
IE,PLATELET COUNT DECREASED,2
IE,PYREXIA,2
IE,RENAL FAILURE ACUTE,2
IE,RENAL IMPAIRMENT,2
IE,RESPIRATORY TRACT INFECTION,2
IE,RESTLESSNESS,2
IE,SENSATION OF FOREIGN BODY,2
IE,WEIGHT DECREASED,2
IE,ABDOMINAL PAIN UPPER,1
IE,AGGRESSION,1
IE,ALOPECIA,1
IE,ANTICONVULSANT DRUG LEVEL DECREASED,1
IE,ASCITES,1
IE,BILIARY COLIC,1
IE,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
IE,BLOOD GLUCOSE INCREASED,1
IE,BLOOD POTASSIUM INCREASED,1
IE,BODY TEMPERATURE INCREASED,1
IE,BONE PAIN,1
IE,BRAIN OEDEMA,1
IE,BURNING SENSATION,1
IE,C-REACTIVE PROTEIN INCREASED,1
IE,CELLULITIS,1
IE,CEREBRAL HAEMORRHAGE,1
IE,CHEST PAIN,1
IE,CHILLS,1
IE,COLON ADENOMA,1
IE,CONDITION AGGRAVATED,1
IE,CONSTIPATION,1
IE,CONTUSION,1
IE,CORONAVIRUS TEST POSITIVE,1
IE,CRANIOCEREBRAL INJURY,1
IE,CYANOSIS,1
IE,CYST,1
IE,DERMATITIS BULLOUS,1
IE,DIZZINESS,1
IE,DRUG DEPENDENCE,1
IE,DRUG DISPENSING ERROR,1
IE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
IE,DYSPHAGIA,1
IE,EAR TUBE INSERTION,1
IE,ENDOMETRIAL HYPERTROPHY,1
IE,EPISTAXIS,1
IE,EXPIRED DRUG ADMINISTERED,1
IE,EYE INFLAMMATION,1
IE,EYE PAIN,1
IE,EYE PRURITUS,1
IE,GASTRIC ULCER HAEMORRHAGE,1
IE,GASTROINTESTINAL INFLAMMATION,1
IE,GENERAL PHYSICAL HEALTH DETERIORATION,1
IE,GINGIVAL ABSCESS,1
IE,GLOMERULAR FILTRATION RATE DECREASED,1
IE,GRUNTING,1
IE,HAEMATOCRIT DECREASED,1
IE,HAEMOGLOBIN ABNORMAL,1
IE,HAEMORRHOIDS,1
IE,HAIR TEXTURE ABNORMAL,1
IE,HEADACHE,1
IE,HUMAN RHINOVIRUS TEST POSITIVE,1
IE,HYPERHIDROSIS,1
IE,HYPERTENSIVE CRISIS,1
IE,HYPOTENSION,1
IE,IMPAIRED GASTRIC EMPTYING,1
IE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
IE,INFLAMMATORY MARKER INCREASED,1
IE,INFUSION RELATED REACTION,1
IE,INJURY,1
IE,INTESTINAL POLYP,1
IE,JOINT SWELLING,1
IE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
IE,LARGE INTESTINE POLYP,1
IE,LOCAL SWELLING,1
IE,LOWER LIMB FRACTURE,1
IE,LUNG CONSOLIDATION,1
IE,LYMPHOMA,1
IE,LYMPHOMATOID PAPULOSIS,1
IE,MALAISE,1
IE,MASS,1
IE,MOBILITY DECREASED,1
IE,MONARTHRITIS,1
IE,MYALGIA,1
IE,MYOCARDIAL INFARCTION,1
IE,MYOCARDIAL ISCHAEMIA,1
IE,NASAL CONGESTION,1
IE,NEOPLASM MALIGNANT,1
IE,OEDEMA PERIPHERAL,1
IE,ORAL HERPES,1
IE,OROPHARYNGEAL PAIN,1
IE,PERFORATED ULCER,1
IE,PERIPHERAL SWELLING,1
IE,PLEURISY,1
IE,POSTMENOPAUSAL HAEMORRHAGE,1
IE,PRODUCT SUBSTITUTION ISSUE,1
IE,PROSTATE CANCER,1
IE,PULMONARY CONGESTION,1
IE,RALES,1
IE,RASH,1
IE,RASH MACULAR,1
IE,RASH PRURITIC,1
IE,RED BLOOD CELL COUNT DECREASED,1
IE,REHABILITATION THERAPY,1
IE,RESPIRATORY RATE INCREASED,1
IE,RESPIRATORY SYMPTOM,1
IE,RETINAL EXUDATES,1
IE,RETINAL HAEMORRHAGE,1
IE,RETINOPATHY HYPERTENSIVE,1
IE,RHEUMATOID ARTHRITIS,1
IE,ROAD TRAFFIC ACCIDENT,1
IE,SCHIZOPHRENIA,1
IE,SCLERODERMA RENAL CRISIS,1
IE,SKIN DISCOLOURATION,1
IE,SKIN FISSURES,1
IE,SKIN ULCER,1
IE,SKULL FRACTURE,1
IE,SUBARACHNOID HAEMORRHAGE,1
IE,SUBDURAL HAEMORRHAGE,1
IE,SUDDEN DEATH,1
IE,SUPRAVENTRICULAR TACHYCARDIA,1
IE,SWELLING FACE,1
IE,SYNOVIAL CYST,1
IE,THERAPY CHANGE,1
IE,THYROXINE FREE INCREASED,1
IE,TONSILLITIS,1
IE,TOOTH ABSCESS,1
IE,TRIGEMINAL NEURALGIA,1
IE,URINARY TRACT INFECTION,1
IE,URTICARIA,1
IE,VISION BLURRED,1
IE,VITAMIN D DEFICIENCY,1
IE,WHITE BLOOD CELL COUNT DECREASED,1
IE,WHITE BLOOD CELL COUNT INCREASED,1
IL,CONDITION AGGRAVATED,3
IL,GASTRITIS EROSIVE,3
IL,HYPERTENSION,3
IL,HYPOALBUMINAEMIA,3
IL,DEHYDRATION,2
IL,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
IL,FEBRILE NEUTROPENIA,2
IL,PSYCHOTIC DISORDER,2
IL,VOMITING,2
IL,WEIGHT DECREASED,2
IL,ABASIA,1
IL,ABDOMINAL DISCOMFORT,1
IL,ABDOMINAL PAIN UPPER,1
IL,ABDOMINAL TENDERNESS,1
IL,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,1
IL,ACCIDENTAL OVERDOSE,1
IL,ACTIVITIES OF DAILY LIVING IMPAIRED,1
IL,ACUTE KIDNEY INJURY,1
IL,ACUTE LEUKAEMIA,1
IL,ANAPHYLACTIC SHOCK,1
IL,ARTHRALGIA,1
IL,ASCITES,1
IL,ASPARTATE AMINOTRANSFERASE INCREASED,1
IL,ASTHENIA,1
IL,BRONCHIOLITIS,1
IL,BRONCHITIS,1
IL,C-REACTIVE PROTEIN INCREASED,1
IL,CARDIAC ARREST,1
IL,CARDIAC FAILURE,1
IL,CARDIOVASCULAR DISORDER,1
IL,CELLULITIS,1
IL,CEREBROVASCULAR ACCIDENT,1
IL,CHEST PAIN,1
IL,CHEST X-RAY ABNORMAL,1
IL,COELIAC DISEASE,1
IL,DIARRHOEA,1
IL,DRUG INEFFECTIVE,1
IL,DRUG-INDUCED LIVER INJURY,1
IL,DYSPNOEA,1
IL,ENDOCARDITIS,1
IL,ERYTHEMA,1
IL,FACIAL PARALYSIS,1
IL,FAECAL INCONTINENCE,1
IL,FOETAL EXPOSURE DURING PREGNANCY,1
IL,GAIT DISTURBANCE,1
IL,GASTROINTESTINAL OEDEMA,1
IL,GASTROOESOPHAGEAL REFLUX DISEASE,1
IL,HAEMATEMESIS,1
IL,HAEMATURIA,1
IL,HAEMORRHAGE,1
IL,HEART RATE INCREASED,1
IL,HEPATIC ENZYME INCREASED,1
IL,HYPERCOAGULATION,1
IL,HYPERSENSITIVITY,1
IL,HYPOTHERMIA,1
IL,HYPOTONIA,1
IL,INCONTINENCE,1
IL,INFUSION RELATED REACTION,1
IL,INTENTIONAL PRODUCT MISUSE,1
IL,INTERNATIONAL NORMALISED RATIO INCREASED,1
IL,ISCHAEMIC STROKE,1
IL,LIVER INJURY,1
IL,LOSS OF CONSCIOUSNESS,1
IL,LUNG HYPERINFLATION,1
IL,LYMPHADENOPATHY,1
IL,MUSCULAR WEAKNESS,1
IL,NAUSEA,1
IL,OVERDOSE,1
IL,PALATAL OEDEMA,1
IL,PARALYSIS,1
IL,PERICARDIAL EFFUSION,1
IL,PERICARDITIS,1
IL,PLEURAL EFFUSION,1
IL,PNEUMONIA,1
IL,PROTEIN-LOSING GASTROENTEROPATHY,1
IL,PRURITUS GENERALISED,1
IL,PSORIATIC ARTHROPATHY,1
IL,PULMONARY CONGESTION,1
IL,PYREXIA,1
IL,RENAL FAILURE,1
IL,RENAL INJURY,1
IL,RESPIRATORY DISTRESS,1
IL,RESPIRATORY RATE INCREASED,1
IL,RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE,1
IL,RESTRICTIVE CARDIOMYOPATHY,1
IL,SARCOIDOSIS,1
IL,SPEECH DISORDER,1
IL,SUBARACHNOID HAEMORRHAGE,1
IL,SUDDEN DEATH,1
IL,SUFFOCATION FEELING,1
IL,SWELLING FACE,1
IL,SWOLLEN TONGUE,1
IL,THROMBOCYTOPENIA,1
IL,THYROIDITIS,1
IL,VENTRICULAR SEPTAL DEFECT,1
IT,DRUG ABUSE,126
IT,HYPOTHERMIA,118
IT,SOPOR,62
IT,TOXICITY TO VARIOUS AGENTS,52
IT,LIP OEDEMA,51
IT,OVERDOSE,50
IT,ANAEMIA,48
IT,ERYTHEMA,48
IT,VOMITING,47
IT,ASTHENIA,46
IT,URTICARIA,44
IT,DYSPNOEA,43
IT,ABDOMINAL PAIN UPPER,41
IT,SUICIDE ATTEMPT,39
IT,MELAENA,38
IT,PRURITUS,38
IT,HYPERSENSITIVITY,36
IT,ABDOMINAL PAIN,31
IT,NAUSEA,31
IT,ANGIOEDEMA,30
IT,ACUTE KIDNEY INJURY,28
IT,HAEMATEMESIS,27
IT,INTENTIONAL SELF-INJURY,26
IT,HYPOTENSION,25
IT,FACE OEDEMA,24
IT,ACUTE HEPATIC FAILURE,22
IT,DRUG-INDUCED LIVER INJURY,22
IT,GASTRITIS EROSIVE,22
IT,DRUG HYPERSENSITIVITY,20
IT,HYPERHIDROSIS,20
IT,INTENTIONAL OVERDOSE,20
IT,RASH,20
IT,BRADYCARDIA,19
IT,METABOLIC ACIDOSIS,19
IT,RASH MACULO-PAPULAR,19
IT,DRUG USE DISORDER,18
IT,GASTROINTESTINAL HAEMORRHAGE,18
IT,PRESYNCOPE,18
IT,ANGULAR CHEILITIS,17
IT,GASTRIC ULCER,17
IT,MEDICATION ERROR,17
IT,EYELID OEDEMA,16
IT,GASTRITIS,16
IT,HEADACHE,15
IT,INTERNATIONAL NORMALISED RATIO INCREASED,15
IT,PARAESTHESIA,15
IT,GASTRITIS HAEMORRHAGIC,14
IT,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,14
IT,PRURITUS GENERALISED,14
IT,RASH GENERALISED,13
IT,TUBULOINTERSTITIAL NEPHRITIS,13
IT,PULMONARY EMBOLISM,12
IT,PYREXIA,12
IT,RECTAL HAEMORRHAGE,12
IT,DECREASED APPETITE,11
IT,DIARRHOEA,11
IT,HEPATITIS ACUTE,11
IT,PAIN,11
IT,STEVENS-JOHNSON SYNDROME,11
IT,ALCOHOL INTERACTION,10
IT,CHOLESTASIS,10
IT,CONTRAINDICATED PRODUCT ADMINISTERED,10
IT,DYSPHONIA,10
IT,PERICARDITIS,10
IT,COMA,9
IT,CONDITION AGGRAVATED,9
IT,CRYING,9
IT,HAEMATURIA,9
IT,HYPERTENSIVE CRISIS,9
IT,OEDEMA PERIPHERAL,9
IT,PALATAL OEDEMA,9
IT,PARAESTHESIA ORAL,9
IT,PRODUCT USE ISSUE,9
IT,PSYCHOMOTOR SKILLS IMPAIRED,9
IT,AGITATION,8
IT,ARTHRALGIA,8
IT,COUGH,8
IT,ELECTROCARDIOGRAM QT PROLONGED,8
IT,HYPERTRANSAMINASAEMIA,8
IT,INTENTIONAL PRODUCT MISUSE,8
IT,JAUNDICE,8
IT,LARGE INTESTINAL ULCER,8
IT,PALLOR,8
IT,PROTHROMBIN TIME ABNORMAL,8
IT,RENAL FAILURE,8
IT,RETCHING,8
IT,RHABDOMYOLYSIS,8
IT,TACHYCARDIA,8
IT,ABDOMINAL DISTENSION,7
IT,CHEST PAIN,7
IT,CHOLELITHIASIS,7
IT,DUODENAL ULCER,7
IT,EROSIVE OESOPHAGITIS,7
IT,HYPERCHOLESTEROLAEMIA,7
IT,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,7
IT,LOSS OF CONSCIOUSNESS,7
IT,PERIORBITAL OEDEMA,7
IT,SELF INJURIOUS BEHAVIOUR,7
IT,SWELLING FACE,7
IT,THROMBOCYTOPENIA,7
IT,TONGUE OEDEMA,7
IT,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,6
IT,ANAPHYLACTIC REACTION,6
IT,ASTHMA,6
IT,BLOOD THYROID STIMULATING HORMONE INCREASED,6
IT,CHROMATURIA,6
IT,DRUG PRESCRIBING ERROR,6
IT,DUODENAL ULCER HAEMORRHAGE,6
IT,DYSPEPSIA,6
IT,LARYNGEAL OEDEMA,6
IT,MALAISE,6
IT,NECROTISING COLITIS,6
IT,NEPHROLITHIASIS,6
IT,OXYGEN SATURATION DECREASED,6
IT,PRODUCT USE IN UNAPPROVED INDICATION,6
IT,SINUS BRADYCARDIA,6
IT,SUPRAVENTRICULAR TACHYCARDIA,6
IT,TOXIC EPIDERMAL NECROLYSIS,6
IT,VERTIGO,6
IT,BONE MARROW FAILURE,5
IT,BRADYARRHYTHMIA,5
IT,DERMATITIS BULLOUS,5
IT,DRUG INEFFECTIVE,5
IT,EPISTAXIS,5
IT,FEELING HOT,5
IT,INCORRECT DRUG ADMINISTRATION DURATION,5
IT,LIP SWELLING,5
IT,MYALGIA,5
IT,MYCOPLASMA INFECTION,5
IT,MYCOPLASMA TEST POSITIVE,5
IT,OEDEMA,5
IT,PLEURAL EFFUSION,5
IT,PORTAL VEIN THROMBOSIS,5
IT,PROTEINURIA,5
IT,PULMONARY OEDEMA,5
IT,RHINITIS,5
IT,SENSATION OF FOREIGN BODY,5
IT,SYNCOPE,5
IT,TACHYPNOEA,5
IT,ACCIDENTAL OVERDOSE,4
IT,ANAL INCONTINENCE,4
IT,ATRIAL FIBRILLATION,4
IT,BLOOD CREATININE INCREASED,4
IT,CARDIAC ARREST,4
IT,CHILLS,4
IT,CHRONIC GASTRITIS,4
IT,CONFUSIONAL STATE,4
IT,CONJUNCTIVITIS,4
IT,DIVERTICULUM INTESTINAL HAEMORRHAGIC,4
IT,HAEMATOCHEZIA,4
IT,IRON DEFICIENCY ANAEMIA,4
IT,MUSCLE HAEMORRHAGE,4
IT,OBSTRUCTION GASTRIC,4
IT,OSTEONECROSIS OF JAW,4
IT,PANCYTOPENIA,4
IT,PHARYNGITIS,4
IT,POLYP,4
IT,PURPURA,4
IT,SOMNOLENCE,4
IT,THROAT TIGHTNESS,4
IT,THROMBOSIS MESENTERIC VESSEL,4
IT,TREMOR,4
IT,VULVOVAGINITIS TRICHOMONAL,4
IT,ACUTE MYOCARDIAL INFARCTION,3
IT,ADVERSE DRUG REACTION,3
IT,ALANINE AMINOTRANSFERASE INCREASED,3
IT,ALLERGIC OEDEMA,3
IT,ASPARTATE AMINOTRANSFERASE INCREASED,3
IT,ASTHMATIC CRISIS,3
IT,BLISTER,3
IT,BLOOD CREATINE INCREASED,3
IT,CARDIOVASCULAR DISORDER,3
IT,CHRONIC KIDNEY DISEASE,3
IT,COLITIS,3
IT,COMPLETED SUICIDE,3
IT,DEATH,3
IT,DUODENITIS,3
IT,EROSIVE DUODENITIS,3
IT,FATIGUE,3
IT,GASTROINTESTINAL ULCER,3
IT,GENERALISED ERYTHEMA,3
IT,HAEMATOMA,3
IT,HAEMORRHAGE,3
IT,HYPERTENSION,3
IT,HYPOAESTHESIA ORAL,3
IT,HYPOCOAGULABLE STATE,3
IT,HYPONATRAEMIA,3
IT,NEPHROPATHY,3
IT,NO ADVERSE EVENT,3
IT,PANIC ATTACK,3
IT,PERICARDIAL EFFUSION,3
IT,POISONING,3
IT,POLYPECTOMY,3
IT,PREPYLORIC STENOSIS,3
IT,RENAL FAILURE ACUTE,3
IT,RESPIRATORY DEPRESSION,3
IT,SKIN LESION,3
IT,STOMATITIS,3
IT,STOMATITIS HAEMORRHAGIC,3
IT,SWOLLEN TONGUE,3
IT,THERAPY NON-RESPONDER,3
IT,TRANSAMINASES INCREASED,3
IT,TREATMENT NONCOMPLIANCE,3
IT,UPPER GASTROINTESTINAL HAEMORRHAGE,3
IT,ADVERSE EVENT,2
IT,ANAEMIA MACROCYTIC,2
IT,ANAPHYLACTIC SHOCK,2
IT,ANXIETY,2
IT,APHTHOUS ULCER,2
IT,ATRIOVENTRICULAR BLOCK FIRST DEGREE,2
IT,BRAIN OEDEMA,2
IT,BRONCHOSPASM,2
IT,BURNING SENSATION,2
IT,CEREBROVASCULAR ACCIDENT,2
IT,CHAPPED LIPS,2
IT,CONJUNCTIVAL HYPERAEMIA,2
IT,CONTRAINDICATED DRUG ADMINISTERED,2
IT,CONTRAINDICATED DRUG PRESCRIBED,2
IT,CORONARY ARTERY ANEURYSM,2
IT,DIVERTICULAR PERFORATION,2
IT,DRUG ERUPTION,2
IT,FAECES PALE,2
IT,FIBRIN D DIMER INCREASED,2
IT,FLUID RETENTION,2
IT,GASTRIC ULCER HAEMORRHAGE,2
IT,GASTRIC ULCER PERFORATION,2
IT,GASTROINTESTINAL PERFORATION,2
IT,HAEMOGLOBIN DECREASED,2
IT,HAEMOLYSIS,2
IT,HAEMOLYTIC URAEMIC SYNDROME,2
IT,HEART RATE INCREASED,2
IT,HEPATIC CONGESTION,2
IT,HEPATITIS,2
IT,HEPATITIS CHOLESTATIC,2
IT,HEPATOCELLULAR INJURY,2
IT,HISTAMINE LEVEL INCREASED,2
IT,HYPERAEMIA,2
IT,INCORRECT DOSE ADMINISTERED,2
IT,INJURY,2
IT,INTESTINAL OBSTRUCTION,2
IT,IRRITABILITY,2
IT,KAWASAKI^S DISEASE,2
IT,LIVER INJURY,2
IT,LYMPHADENOPATHY,2
IT,MAJOR DEPRESSION,2
IT,MALIGNANT NEOPLASM PROGRESSION,2
IT,MOOD ALTERED,2
IT,MYOCARDIAL INFARCTION,2
IT,NASAL CONGESTION,2
IT,NEPHRITIS,2
IT,OEDEMA GENITAL,2
IT,PEPTIC ULCER,2
IT,PHARYNGEAL DISORDER,2
IT,PNEUMONIA,2
IT,PNEUMONITIS,2
IT,PULMONARY CONGESTION,2
IT,PULMONARY EOSINOPHILIA,2
IT,RASH ERYTHEMATOUS,2
IT,RESPIRATORY DISORDER,2
IT,RESTLESSNESS,2
IT,SEIZURE,2
IT,SLUGGISHNESS,2
IT,SUDDEN DEATH,2
IT,TONIC CLONIC MOVEMENTS,2
IT,VULVAL OEDEMA,2
IT,WHEEZING,2
IT,WHITE BLOOD CELL COUNT INCREASED,2
IT,ABDOMINAL DISCOMFORT,1
IT,ABDOMINAL TENDERNESS,1
IT,ABDOMINAL WALL HAEMATOMA,1
IT,ACQUIRED HYDROCELE,1
IT,ACUTE PSYCHOSIS,1
IT,ALCOHOL ABUSE,1
IT,ALCOHOL USE,1
IT,ALOPECIA,1
IT,ANGINA PECTORIS,1
IT,ANURIA,1
IT,APHASIA,1
IT,APPENDICITIS,1
IT,ASCITES,1
IT,ATAXIA,1
IT,ATELECTASIS,1
IT,AURICULAR SWELLING,1
IT,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
IT,BACK PAIN,1
IT,BACTERIAL INFECTION,1
IT,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
IT,BLOOD GASES ABNORMAL,1
IT,BLOOD IRON DECREASED,1
IT,BLOOD PRESSURE DECREASED,1
IT,C-REACTIVE PROTEIN INCREASED,1
IT,CAESAREAN SECTION,1
IT,CARDIAC FAILURE,1
IT,CARDIAC TAMPONADE,1
IT,CARDIOACTIVE DRUG LEVEL INCREASED,1
IT,CARDIOMYOPATHY,1
IT,CELLULITIS,1
IT,CEREBRAL HAEMORRHAGE,1
IT,CLUSTER HEADACHE,1
IT,COAGULOPATHY,1
IT,COMA SCALE ABNORMAL,1
IT,CONGENITAL ANOMALY,1
IT,CUTANEOUS SYMPTOM,1
IT,CYSTITIS,1
IT,DEHYDRATION,1
IT,DEPRESSION,1
IT,DERMATITIS CONTACT,1
IT,DIPLOPIA,1
IT,DISABILITY,1
IT,DISSEMINATED INTRAVASCULAR COAGULATION,1
IT,DIZZINESS,1
IT,DRUG ADMINISTRATION ERROR,1
IT,DRUG EFFECT DECREASED,1
IT,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
IT,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
IT,DRY SKIN,1
IT,DYSARTHRIA,1
IT,DYSPHAGIA,1
IT,EJECTION FRACTION DECREASED,1
IT,EMPYEMA,1
IT,ENCEPHALOPATHY,1
IT,EPIGASTRIC DISCOMFORT,1
IT,EPILEPSY,1
IT,EUPHORIC MOOD,1
IT,EXCESSIVE GRANULATION TISSUE,1
IT,EXOPHTHALMOS,1
IT,EYE PAIN,1
IT,EYE SWELLING,1
IT,EYELID PTOSIS,1
IT,FACIAL PAIN,1
IT,FAECES DISCOLOURED,1
IT,FALSE POSITIVE INVESTIGATION RESULT,1
IT,FEELING JITTERY,1
IT,FIBROSIS,1
IT,FOETAL EXPOSURE DURING PREGNANCY,1
IT,GAIT DISTURBANCE,1
IT,GASTRIC CANCER,1
IT,GASTRIC HAEMORRHAGE,1
IT,GASTRIC MUCOSAL LESION,1
IT,GASTRODUODENAL ULCER,1
IT,GASTROENTERITIS,1
IT,GASTROINTESTINAL DISORDER,1
IT,GASTROINTESTINAL INFLAMMATION,1
IT,GASTROINTESTINAL OBSTRUCTION,1
IT,GASTROINTESTINAL TOXICITY,1
IT,GASTROINTESTINAL TUBE INSERTION,1
IT,GINGIVAL PAIN,1
IT,GRAND MAL CONVULSION,1
IT,GRAVITATIONAL OEDEMA,1
IT,HAEMOPTYSIS,1
IT,HAEMORRHAGIC EROSIVE GASTRITIS,1
IT,HALLUCINATION,1
IT,HEART TRANSPLANT REJECTION,1
IT,HEMIPARESIS,1
IT,HENOCH-SCHONLEIN PURPURA,1
IT,HEPATIC CIRRHOSIS,1
IT,HEPATIC FUNCTION ABNORMAL,1
IT,HEPATIC NECROSIS,1
IT,HERPES ZOSTER DISSEMINATED,1
IT,HYDROCELE,1
IT,HYDROTHORAX,1
IT,HYPERKALAEMIA,1
IT,HYPOAESTHESIA,1
IT,HYPOCALCAEMIA,1
IT,HYPOPHAGIA,1
IT,HYPOTONIA,1
IT,HYPOVENTILATION,1
IT,HYPOXIA,1
IT,IMMUNOSUPPRESSION,1
IT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
IT,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
IT,INFECTION,1
IT,INFLAMMATORY PAIN,1
IT,INJECTION SITE ATROPHY,1
IT,INJECTION SITE NECROSIS,1
IT,INTENTIONAL DRUG MISUSE,1
IT,INTENTIONAL PRODUCT USE ISSUE,1
IT,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
IT,INTERSTITIAL LUNG DISEASE,1
IT,INTESTINAL STENOSIS,1
IT,KIDNEY CONGESTION,1
IT,KOUNIS SYNDROME,1
IT,LACRIMATION INCREASED,1
IT,LACTIC ACIDOSIS,1
IT,LETHARGY,1
IT,LEUKOCYTOSIS,1
IT,LEUKOPENIA,1
IT,LIVE BIRTH,1
IT,LIVER DISORDER,1
IT,LOCALISED OEDEMA,1
IT,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
IT,LOWER GASTROINTESTINAL HAEMORRHAGE,1
IT,MALIGNANT HYPERTENSION,1
IT,MASTITIS FUNGAL,1
IT,MENINGITIS ASEPTIC,1
IT,MESENTERIC VEIN THROMBOSIS,1
IT,MONONUCLEOSIS SYNDROME,1
IT,MUCOSAL INFLAMMATION,1
IT,MULTI-ORGAN FAILURE,1
IT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
IT,MULTIPLE SCLEROSIS RELAPSE,1
IT,MUSCULAR WEAKNESS,1
IT,MYOCARDIAL OEDEMA,1
IT,MYOCLONUS,1
IT,NASOPHARYNGITIS,1
IT,NECROSIS,1
IT,NERVOUSNESS,1
IT,NEUROMUSCULAR BLOCK PROLONGED,1
IT,NON-ALCOHOLIC FATTY LIVER,1
IT,NON-HODGKIN^S LYMPHOMA,1
IT,OBSTRUCTIVE AIRWAYS DISORDER,1
IT,ODYNOPHAGIA,1
IT,OESOPHAGITIS,1
IT,OROPHARYNGEAL DISCOMFORT,1
IT,OVARIAN CYST,1
IT,PACKED RED BLOOD CELL TRANSFUSION,1
IT,PAIN IN EXTREMITY,1
IT,PANCREATITIS ACUTE,1
IT,PARTIAL SEIZURES,1
IT,PERIPHERAL SWELLING,1
IT,PERIPHERAL VENOUS DISEASE,1
IT,PETECHIAE,1
IT,PHARYNGEAL ERYTHEMA,1
IT,PHARYNGEAL OEDEMA,1
IT,PHOTOPHOBIA,1
IT,PHOTOSENSITIVITY REACTION,1
IT,POLLAKIURIA,1
IT,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,1
IT,PREGNANCY ON CONTRACEPTIVE,1
IT,PREMATURE DELIVERY,1
IT,PREMATURE RUPTURE OF MEMBRANES,1
IT,PRODUCTIVE COUGH,1
IT,PROSTATE CANCER,1
IT,PROTHROMBIN TIME PROLONGED,1
IT,PSEUDOMONAL SEPSIS,1
IT,PULMONARY HYPERTENSION,1
IT,RASH PUSTULAR,1
IT,RASH VESICULAR,1
IT,RENAL HAEMORRHAGE,1
IT,RENAL VENOUS CONGESTION,1
IT,RHINORRHOEA,1
IT,SELF-MEDICATION,1
IT,SENSORY DISTURBANCE,1
IT,SEPSIS,1
IT,SEPTIC ARTHRITIS STAPHYLOCOCCAL,1
IT,SEPTIC SHOCK,1
IT,SHOCK HAEMORRHAGIC,1
IT,SKIN BURNING SENSATION,1
IT,SKIN EROSION,1
IT,SKIN HAEMORRHAGE,1
IT,SKIN WARM,1
IT,SMALL INTESTINAL HAEMORRHAGE,1
IT,SMALL INTESTINAL OBSTRUCTION,1
IT,SPEECH DISORDER,1
IT,SPINAL FRACTURE,1
IT,SUBDURAL HAEMATOMA,1
IT,SUBDURAL HAEMATOMA EVACUATION,1
IT,TENSION HEADACHE,1
IT,TESTICULAR SWELLING,1
IT,THERAPEUTIC RESPONSE DECREASED,1
IT,THORACIC CAVITY DRAINAGE,1
IT,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
IT,TONGUE DRY,1
IT,TOOTH ABSCESS,1
IT,TRANSFUSION,1
IT,TRANSIENT ISCHAEMIC ATTACK,1
IT,TRANSITIONAL CELL CARCINOMA,1
IT,TYPE IV HYPERSENSITIVITY REACTION,1
IT,URTICARIA CHRONIC,1
IT,URTICARIA PAPULAR,1
IT,UTERINE LEIOMYOMA,1
IT,VARICELLA,1
IT,VASCULITIS NECROTISING,1
IT,VENTRICULAR DYSFUNCTION,1
IT,VIRAEMIA,1
IT,VIRAL OESOPHAGITIS,1
IT,VISION BLURRED,1
IT,WOUND HAEMORRHAGE,1
JP,PYREXIA,10
JP,RASH,8
JP,VANISHING BILE DUCT SYNDROME,8
JP,DECREASED APPETITE,6
JP,DRUG-INDUCED LIVER INJURY,6
JP,PLEURAL EFFUSION,5
JP,ASCITES,4
JP,ERYTHEMA,4
JP,HEPATIC FUNCTION ABNORMAL,4
JP,HYPOGLYCAEMIA,4
JP,HYPONATRAEMIA,4
JP,OVERDOSE,4
JP,TOXIC EPIDERMAL NECROLYSIS,4
JP,ACUTE RESPIRATORY FAILURE,3
JP,ASTHMA,3
JP,DISSEMINATED INTRAVASCULAR COAGULATION,3
JP,DIZZINESS,3
JP,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,3
JP,DYSPNOEA,3
JP,EXPOSURE DURING PREGNANCY,3
JP,FEBRILE NEUTROPENIA,3
JP,HEADACHE,3
JP,LYMPHADENOPATHY,3
JP,NECROSIS,3
JP,PALPITATIONS,3
JP,RENAL IMPAIRMENT,3
JP,RHABDOMYOLYSIS,3
JP,STEVENS-JOHNSON SYNDROME,3
JP,SUICIDE ATTEMPT,3
JP,TOXIC SHOCK SYNDROME STREPTOCOCCAL,3
JP,TOXICITY TO VARIOUS AGENTS,3
JP,TUBULOINTERSTITIAL NEPHRITIS,3
JP,TUMOUR LYSIS SYNDROME,3
JP,ACUTE KIDNEY INJURY,2
JP,ALTERED STATE OF CONSCIOUSNESS,2
JP,ARTHRALGIA,2
JP,BLISTER,2
JP,BLOOD CREATININE INCREASED,2
JP,CHEST X-RAY ABNORMAL,2
JP,CHOLESTASIS,2
JP,COMA BLISTER,2
JP,DRUG EFFECT INCREASED,2
JP,DUODENAL PERFORATION,2
JP,EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE),2
JP,EXTRAPYRAMIDAL DISORDER,2
JP,FATIGUE,2
JP,GASTROINTESTINAL DISORDER,2
JP,HERPES ZOSTER MENINGITIS,2
JP,HYPERHIDROSIS,2
JP,INFLAMMATION,2
JP,INSOMNIA,2
JP,INTENTIONAL OVERDOSE,2
JP,LEUKOCYTOSIS,2
JP,NAUSEA,2
JP,NEUTROPENIA,2
JP,PAIN,2
JP,PANCREATITIS ACUTE,2
JP,PERICARDIAL EFFUSION,2
JP,PERIPORTAL OEDEMA,2
JP,PNEUMONIA,2
JP,PREMATURE BABY,2
JP,PROCALCITONIN INCREASED,2
JP,PRODUCT USE ISSUE,2
JP,RASH VESICULAR,2
JP,RENAL FAILURE ACUTE,2
JP,SEPSIS,2
JP,SOMNOLENCE,2
JP,SYNCOPE,2
JP,TRANSITIONAL CELL CARCINOMA,2
JP,XANTHOMA,2
JP,ABASIA,1
JP,ABORTION,1
JP,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,1
JP,ANAEMIA HAEMOLYTIC AUTOIMMUNE,1
JP,ANGINA PECTORIS,1
JP,ANURIA,1
JP,ARTHRITIS,1
JP,ASPARTATE AMINOTRANSFERASE INCREASED,1
JP,ASTHENIA,1
JP,ATONIC SEIZURES,1
JP,BACK INJURY,1
JP,BK VIRUS INFECTION,1
JP,BLADDER TRANSITIONAL CELL CARCINOMA,1
JP,BLOOD PRESSURE DECREASED,1
JP,BLOOD PRESSURE INCREASED,1
JP,BONE LOSS,1
JP,BREAST CANCER,1
JP,BREAST CANCER RECURRENT,1
JP,BRONCHITIS,1
JP,CAESAREAN SECTION,1
JP,CARDIAC DISORDER,1
JP,CD4 LYMPHOCYTES DECREASED,1
JP,CHILLS,1
JP,CHROMATURIA,1
JP,CONCOMITANT DISEASE AGGRAVATED,1
JP,CONDITION AGGRAVATED,1
JP,CONJUNCTIVAL HYPERAEMIA,1
JP,COUGH,1
JP,CYTOMEGALOVIRUS INFECTION,1
JP,CYTOMEGALOVIRUS VIRAEMIA,1
JP,DELIRIUM,1
JP,DEPRESSED LEVEL OF CONSCIOUSNESS,1
JP,DERMATITIS,1
JP,DERMATITIS ATOPIC,1
JP,DERMATITIS BULLOUS,1
JP,DRUG ERUPTION,1
JP,DRUG INEFFECTIVE,1
JP,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
JP,DYSPHONIA,1
JP,DYSURIA,1
JP,EAR NEOPLASM,1
JP,EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED,1
JP,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
JP,ENCEPHALOPATHY,1
JP,ENTEROCOLITIS HAEMORRHAGIC,1
JP,EOSINOPHILIA,1
JP,EPILEPSY,1
JP,EXCORIATION,1
JP,EYE SWELLING,1
JP,FACE OEDEMA,1
JP,FOETAL EXPOSURE DURING PREGNANCY,1
JP,GALLBLADDER DISORDER,1
JP,GASTRIC MUCOSAL LESION,1
JP,GASTRODUODENAL ULCER,1
JP,GENERALISED ERYTHEMA,1
JP,GENERALISED TONIC-CLONIC SEIZURE,1
JP,GINGIVAL EROSION,1
JP,HAEMOGLOBIN INCREASED,1
JP,HEPATIC ENZYME INCREASED,1
JP,HEPATIC NECROSIS,1
JP,HEPATITIS,1
JP,HEPATITIS FULMINANT,1
JP,HICCUPS,1
JP,HUMAN HERPESVIRUS 6 INFECTION,1
JP,HYPERGLYCAEMIA,1
JP,HYPERKALAEMIA,1
JP,HYPERMAGNESAEMIA,1
JP,HYPERTHYROIDISM,1
JP,HYPOALBUMINAEMIA,1
JP,HYPOGAMMAGLOBULINAEMIA,1
JP,HYPOGLYCAEMIC COMA,1
JP,HYPOGLYCAEMIC SEIZURE,1
JP,ILEAL ULCER,1
JP,IMMUNE SYSTEM DISORDER,1
JP,INCARCERATED INCISIONAL HERNIA,1
JP,JAUNDICE,1
JP,JOINT ANKYLOSIS,1
JP,LEUKOPENIA,1
JP,LIVER FUNCTION TEST ABNORMAL,1
JP,LIVIDITY,1
JP,LOW BIRTH WEIGHT BABY,1
JP,LUNG DISORDER,1
JP,LYMPH NODE PAIN,1
JP,LYMPHOCYTE STIMULATION TEST POSITIVE,1
JP,MALAISE,1
JP,MALIGNANT PLEURAL EFFUSION,1
JP,MATERNAL DRUGS AFFECTING FOETUS,1
JP,MEDICATION OVERUSE HEADACHE,1
JP,MENINGITIS ASEPTIC,1
JP,MENINGITIS LISTERIA,1
JP,METASTASES TO LYMPH NODES,1
JP,MIGRAINE WITHOUT AURA,1
JP,MUSCLE SPASMS,1
JP,NASAL CONGESTION,1
JP,NASOPHARYNGITIS,1
JP,NIGHTMARE,1
JP,OBESITY,1
JP,OLIGURIA,1
JP,OSTEONECROSIS,1
JP,PERICARDITIS,1
JP,PERICHONDRITIS,1
JP,PERICORONITIS,1
JP,PLATELET COUNT INCREASED,1
JP,PNEUMONITIS,1
JP,POISONING,1
JP,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,1
JP,PREMATURE DELIVERY,1
JP,PRESCRIBED UNDERDOSE,1
JP,PROTEIN URINE,1
JP,PROTHROMBIN TIME PROLONGED,1
JP,RASH GENERALISED,1
JP,RENAL FAILURE,1
JP,RHABDOMYOSARCOMA,1
JP,ROAD TRAFFIC ACCIDENT,1
JP,SEIZURE,1
JP,SEROTONIN SYNDROME,1
JP,SKIN LESION,1
JP,SMALL INTESTINAL STENOSIS,1
JP,SPASTIC PARALYSIS,1
JP,SPEECH DISORDER,1
JP,STEM CELL TRANSPLANT,1
JP,STOMATITIS,1
JP,SUBCUTANEOUS ABSCESS,1
JP,SWEAT GLAND DISORDER,1
JP,SWELLING,1
JP,SWELLING FACE,1
JP,THROMBOCYTOPENIA,1
JP,THROMBOSIS,1
JP,THYROIDITIS,1
JP,TINNITUS,1
JP,TOXIC SKIN ERUPTION,1
JP,TREMOR,1
JP,VARICOSE VEIN,1
JP,VIRAL INFECTION,1
JP,VOMITING,1
JP,WATER INTOXICATION,1
JP,WHEEZING,1
JP,WHITE BLOOD CELL COUNT INCREASED,1
KE,ABORTION SPONTANEOUS,3
KE,ASPARTATE AMINOTRANSFERASE INCREASED,1
KE,BLOOD BILIRUBIN INCREASED,1
KE,EXPOSURE DURING PREGNANCY,1
KP,DRUG INEFFECTIVE,1
KP,DUODENAL OBSTRUCTION,1
KP,DYSPHAGIA,1
KP,NEUROLEPTIC MALIGNANT SYNDROME,1
KP,PYREXIA,1
KP,RASH,1
KP,TOXIC EPIDERMAL NECROLYSIS,1
KP,VANISHING BILE DUCT SYNDROME,1
KR,PULMONARY ARTERIAL HYPERTENSION,20
KR,TOXIC EPIDERMAL NECROLYSIS,6
KR,VANISHING BILE DUCT SYNDROME,6
KR,BRONCHOPULMONARY DYSPLASIA,3
KR,PYREXIA,3
KR,ANALGESIC ASTHMA SYNDROME,2
KR,BLISTER,2
KR,DRUG DEPENDENCE,2
KR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
KR,EPISTAXIS,2
KR,HAEMORRHAGE INTRACRANIAL,2
KR,OVERDOSE,2
KR,RASH MACULAR,2
KR,RESPIRATORY FAILURE,2
KR,RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED,2
KR,ABDOMINAL DISCOMFORT,1
KR,ABDOMINAL PAIN,1
KR,ALANINE AMINOTRANSFERASE ABNORMAL,1
KR,ALOPECIA,1
KR,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
KR,BLOOD ALKALINE PHOSPHATASE ABNORMAL,1
KR,CARDIO-RESPIRATORY ARREST NEONATAL,1
KR,CEREBRAL HAEMORRHAGE,1
KR,CHOLECYSTITIS,1
KR,CHOLESTASIS,1
KR,COAGULOPATHY,1
KR,CONSTIPATION,1
KR,DETACHMENT OF RETINAL PIGMENT EPITHELIUM,1
KR,DIARRHOEA,1
KR,DIZZINESS,1
KR,DRUG ADMINISTRATION ERROR,1
KR,DRUG ERUPTION,1
KR,DRUG INEFFECTIVE,1
KR,DYSPNOEA,1
KR,EOSINOPHILIC PNEUMONIA,1
KR,FOETAL EXPOSURE DURING PREGNANCY,1
KR,GASTRIC PERFORATION,1
KR,GUILLAIN-BARRE SYNDROME,1
KR,HAEMATOMA,1
KR,HAEMOPTYSIS,1
KR,HEADACHE,1
KR,HEPATITIS ALCOHOLIC,1
KR,HYDRONEPHROSIS,1
KR,HYPERTENSION,1
KR,HYPOTENSION,1
KR,HYPOXIA,1
KR,INFLUENZA LIKE ILLNESS,1
KR,INTENTIONAL PRODUCT MISUSE,1
KR,INTERNATIONAL NORMALISED RATIO INCREASED,1
KR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
KR,LIVER FUNCTION TEST INCREASED,1
KR,LOCALISED OEDEMA,1
KR,LOSS OF CONSCIOUSNESS,1
KR,LUNG INFECTION,1
KR,METASTASIS,1
KR,MUSCLE HAEMORRHAGE,1
KR,NASOPHARYNGITIS,1
KR,NAUSEA,1
KR,NEUTROPHIL COUNT DECREASED,1
KR,NEUTROPHILIC PANNICULITIS,1
KR,NO THERAPEUTIC RESPONSE,1
KR,ORTHOSTATIC HYPOTENSION,1
KR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
KR,PANCREATITIS,1
KR,PANCYTOPENIA,1
KR,PELVI-URETERIC OBSTRUCTION,1
KR,PELVIC NEOPLASM,1
KR,PERITONEAL HAEMORRHAGE,1
KR,PERSISTENT FOETAL CIRCULATION,1
KR,PLEURITIC PAIN,1
KR,PULMONARY EMBOLISM,1
KR,PYELOCALIECTASIS,1
KR,RASH ERYTHEMATOUS,1
KR,RENAL DYSPLASIA,1
KR,SKIN LESION,1
KR,THROMBOCYTOPENIA,1
KR,THYROID CANCER,1
KR,TOXICITY TO VARIOUS AGENTS,1
KR,VOMITING,1
LA,DUODENAL ULCER HAEMORRHAGE,1
LA,GASTRIC ULCER HAEMORRHAGE,1
LV,CHOLELITHIASIS,3
LV,COAGULOPATHY,3
LV,HEPATIC FAILURE,3
LV,POLYNEUROPATHY,3
LV,DRUG INEFFECTIVE,2
LV,DRUG-INDUCED LIVER INJURY,2
LV,INSOMNIA,2
LV,JAUNDICE,2
LV,OEDEMA PERIPHERAL,2
LV,PALMAR ERYTHEMA,2
LV,RASH,2
LV,ALTERED STATE OF CONSCIOUSNESS,1
LV,BURNING SENSATION,1
LV,CHILLS,1
LV,CONDITION AGGRAVATED,1
LV,DRY MOUTH,1
LV,ELECTROCARDIOGRAM ST-T CHANGE,1
LV,EMOTIONAL DISORDER,1
LV,FALL,1
LV,GAIT DISTURBANCE,1
LV,HAEMORRHAGE SUBCUTANEOUS,1
LV,HEADACHE,1
LV,HEPATITIS TOXIC,1
LV,HEPATOMEGALY,1
LV,HYPERBILIRUBINAEMIA,1
LV,HYPERHIDROSIS,1
LV,INFUSION SITE PAIN,1
LV,LIGAMENT RUPTURE,1
LV,LIGAMENT SPRAIN,1
LV,NAUSEA,1
LV,OSTEOARTHRITIS,1
LV,PAIN,1
LV,PAIN IN EXTREMITY,1
LV,PALLOR,1
LV,PARAESTHESIA,1
LV,PETECHIAE,1
LV,POISONING,1
LV,SMALL FIBRE NEUROPATHY,1
LV,SOMNOLENCE,1
LV,SUPRAVENTRICULAR EXTRASYSTOLES,1
LV,SYNOVITIS,1
LV,TEARFULNESS,1
LV,TELANGIECTASIA,1
LB,FATIGUE,10
LB,INFLUENZA,9
LB,HEADACHE,7
LB,PYREXIA,7
LB,WEIGHT DECREASED,7
LB,ABDOMINAL PAIN UPPER,6
LB,ANAEMIA,6
LB,COUGH,6
LB,DIARRHOEA,6
LB,ABDOMINAL PAIN,5
LB,ARTHRALGIA,5
LB,HYPERGLYCAEMIA,5
LB,NAUSEA,5
LB,ANXIETY,4
LB,CHILLS,4
LB,DIZZINESS,4
LB,DRY SKIN,4
LB,GASTROENTERITIS,4
LB,HAEMORRHOIDS,4
LB,HYPERSENSITIVITY,4
LB,HYPERTENSION,4
LB,LEUKOCYTOSIS,4
LB,MYALGIA,4
LB,NECK PAIN,4
LB,PAIN IN EXTREMITY,4
LB,VOMITING,4
LB,ABDOMINAL DISTENSION,3
LB,ALOPECIA,3
LB,BACK PAIN,3
LB,BONE PAIN,3
LB,CYTOGENETIC ANALYSIS ABNORMAL,3
LB,DECREASED APPETITE,3
LB,DYSLIPIDAEMIA,3
LB,ERYTHEMA,3
LB,HYPEROXALURIA,3
LB,INSOMNIA,3
LB,NEPHROPATHY,3
LB,RASH,3
LB,SINUSITIS,3
LB,SKIN DISORDER,3
LB,THROMBOCYTOPENIA,3
LB,TOOTH ABSCESS,3
LB,TOOTHACHE,3
LB,URINARY TRACT INFECTION,3
LB,VAGINAL HAEMORRHAGE,3
LB,WEIGHT INCREASED,3
LB,CONSTIPATION,2
LB,DEPRESSION,2
LB,DERMATITIS ALLERGIC,2
LB,DYSPNOEA,2
LB,DYSURIA,2
LB,EAR PAIN,2
LB,EPISTAXIS,2
LB,FEELING COLD,2
LB,HAEMATOCHEZIA,2
LB,HOT FLUSH,2
LB,HYPOGLYCAEMIA,2
LB,INFECTION,2
LB,MATERNAL EXPOSURE DURING PREGNANCY,2
LB,MENSTRUAL DISORDER,2
LB,OLIGURIA,2
LB,PARAESTHESIA,2
LB,PELVIC PAIN,2
LB,POLYMERASE CHAIN REACTION POSITIVE,2
LB,SECRETION DISCHARGE,2
LB,SWELLING,2
LB,SWELLING FACE,2
LB,THROMBOCYTOSIS,2
LB,TOOTH INFECTION,2
LB,TUBULOINTERSTITIAL NEPHRITIS,2
LB,ABORTION SPONTANEOUS,1
LB,ADENOIDAL HYPERTROPHY,1
LB,ALLERGIC COUGH,1
LB,AMNESIA,1
LB,ARTHROPOD STING,1
LB,BENIGN NEOPLASM OF THYROID GLAND,1
LB,BLOOD IRON DECREASED,1
LB,BLOOD POTASSIUM INCREASED,1
LB,BRONCHITIS,1
LB,CHEST PAIN,1
LB,COLON CANCER,1
LB,CONJUNCTIVAL HAEMORRHAGE,1
LB,CRYSTAL NEPHROPATHY,1
LB,CYANOSIS,1
LB,DIABETES MELLITUS,1
LB,DRY MOUTH,1
LB,DYSPEPSIA,1
LB,DYSPHONIA,1
LB,EAR DISORDER,1
LB,EAR INFECTION,1
LB,EPHELIDES,1
LB,ERECTILE DYSFUNCTION,1
LB,EXPOSURE VIA FATHER,1
LB,EYE ALLERGY,1
LB,EYE PRURITUS,1
LB,FLUID RETENTION,1
LB,FUNGAL INFECTION,1
LB,FURUNCLE,1
LB,GASTRITIS,1
LB,GASTROOESOPHAGEAL REFLUX DISEASE,1
LB,GENERAL PHYSICAL HEALTH DETERIORATION,1
LB,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
LB,GRANULOMA SKIN,1
LB,GUILLAIN-BARRE SYNDROME,1
LB,HAEMATEMESIS,1
LB,HAEMATOCRIT DECREASED,1
LB,HELICOBACTER INFECTION,1
LB,HELMINTHIC INFECTION,1
LB,HYPERHIDROSIS,1
LB,HYPOACUSIS,1
LB,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
LB,INTENTIONAL PRODUCT MISUSE,1
LB,INTERVERTEBRAL DISC CALCIFICATION,1
LB,IRON DEFICIENCY,1
LB,IRRITABLE BOWEL SYNDROME,1
LB,JOINT SWELLING,1
LB,LIBIDO DECREASED,1
LB,LIMB DISCOMFORT,1
LB,LIMB INJURY,1
LB,LOCALISED OEDEMA,1
LB,MALARIA,1
LB,MASTITIS,1
LB,MELANOCYTIC NAEVUS,1
LB,MEMORY IMPAIRMENT,1
LB,MUSCLE SPASMS,1
LB,MUSCULAR WEAKNESS,1
LB,MUSCULOSKELETAL CHEST PAIN,1
LB,MUSCULOSKELETAL PAIN,1
LB,NERVOUSNESS,1
LB,NIGHT SWEATS,1
LB,NOCTURIA,1
LB,OEDEMA,1
LB,OEDEMA PERIPHERAL,1
LB,OROPHARYNGEAL PAIN,1
LB,OVARIAN CYST,1
LB,PAIN,1
LB,PALPITATIONS,1
LB,PATERNAL EXPOSURE DURING PREGNANCY,1
LB,PERIPHERAL SWELLING,1
LB,PHLEBITIS,1
LB,PLATELET COUNT INCREASED,1
LB,POLYP,1
LB,POLYURIA,1
LB,PRURITUS,1
LB,PRURITUS GENITAL,1
LB,RECTAL HAEMORRHAGE,1
LB,RENAL PAIN,1
LB,ROAD TRAFFIC ACCIDENT,1
LB,SALIVARY GLAND PAIN,1
LB,SECOND PRIMARY MALIGNANCY,1
LB,SEPSIS,1
LB,SKIN INFECTION,1
LB,SKIN PAPILLOMA,1
LB,SOMNOLENCE,1
LB,STENOSIS,1
LB,STRESS,1
LB,TACHYCARDIA,1
LB,THERMAL BURN,1
LB,THYROIDITIS,1
LB,TOOTH DISORDER,1
LB,TREMOR,1
LB,TUMOUR MARKER INCREASED,1
LB,TYPHOID FEVER,1
LB,VISION BLURRED,1
LB,VITAMIN B12 DECREASED,1
LB,VITAMIN D DECREASED,1
LB,WHEEZING,1
LB,WOUND,1
LB,WOUND COMPLICATION,1
LT,ABDOMINAL PAIN UPPER,1
LT,DIARRHOEA,1
LT,DRUG INEFFECTIVE,1
LT,DYSPNOEA,1
LT,HEART RATE INCREASED,1
LT,LOSS OF CONSCIOUSNESS,1
LT,PROCTITIS,1
LT,PROCTITIS INFECTIOUS,1
LT,PRURITUS,1
LU,ABASIA,1
LU,BURNING SENSATION,1
LU,DEEP VEIN THROMBOSIS,1
LU,PAIN IN EXTREMITY,1
LU,UPPER RESPIRATORY TRACT INFECTION,1
MK,ANGINA PECTORIS,1
MK,CHEST PAIN,1
MK,DYSLIPIDAEMIA,1
MK,HYPERTENSION,1
MK,LIPIDS ABNORMAL,1
MK,SINUS TACHYCARDIA,1
MW,ACROCHORDON,2
MW,BLOOD PHOSPHORUS DECREASED,2
MW,FOETAL EXPOSURE DURING PREGNANCY,2
MW,GASTROENTERITIS,2
MW,PREMATURE BABY,2
MW,ACCESSORY AURICLE,1
MW,ARTHRALGIA,1
MW,BACTERIAL INFECTION,1
MW,EXPOSURE DURING BREAST FEEDING,1
MW,LOW BIRTH WEIGHT BABY,1
MW,OSTEONECROSIS,1
MW,PAIN IN EXTREMITY,1
MY,HENOCH-SCHONLEIN PURPURA NEPHRITIS,4
MY,HENOCH-SCHONLEIN PURPURA,1
MY,HYPERTENSION,1
MY,OEDEMA PERIPHERAL,1
MY,PURPURA,1
MY,URINE ABNORMALITY,1
MX,ACUTE KIDNEY INJURY,6
MX,PERIPHERAL SWELLING,5
MX,URINARY TRACT INFECTION,5
MX,BLOOD PRESSURE INCREASED,4
MX,FATIGUE,4
MX,FEELING ABNORMAL,4
MX,HEADACHE,4
MX,PYREXIA,4
MX,WEIGHT DECREASED,4
MX,ANXIETY,3
MX,ARTHRALGIA,3
MX,ASTHENIA,3
MX,COUGH,3
MX,DECREASED APPETITE,3
MX,DIZZINESS,3
MX,FAECES DISCOLOURED,3
MX,INSOMNIA,3
MX,MOBILITY DECREASED,3
MX,MYALGIA,3
MX,PAIN,3
MX,PAIN IN EXTREMITY,3
MX,ANAPHYLACTIC SHOCK,2
MX,BLINDNESS,2
MX,BLOOD PRESSURE DECREASED,2
MX,BONE PAIN,2
MX,CARDIO-RESPIRATORY ARREST,2
MX,DRY SKIN,2
MX,GAIT DISTURBANCE,2
MX,GASTRIC ULCER,2
MX,GASTRITIS,2
MX,HYPOAESTHESIA,2
MX,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
MX,INFLUENZA,2
MX,MATERNAL EXPOSURE DURING PREGNANCY,2
MX,PRODUCT USE IN UNAPPROVED INDICATION,2
MX,RESPIRATORY TRACT INFECTION,2
MX,SWELLING FACE,2
MX,THROAT TIGHTNESS,2
MX,VOMITING,2
MX,WEIGHT INCREASED,2
MX,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
MX,ABASIA,1
MX,ABDOMINAL PAIN,1
MX,ABDOMINAL PAIN UPPER,1
MX,ACCIDENTAL EXPOSURE TO PRODUCT,1
MX,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,1
MX,ACCIDENTAL OVERDOSE,1
MX,ADMINISTRATION SITE EXTRAVASATION,1
MX,ADRENAL GLAND INJURY,1
MX,ALOPECIA,1
MX,ANAEMIA,1
MX,ANGER,1
MX,ARRHYTHMIA,1
MX,BLOOD GLUCOSE INCREASED,1
MX,BLOOD TEST ABNORMAL,1
MX,BLOOD TRIGLYCERIDES INCREASED,1
MX,BRONCHIAL HYPERREACTIVITY,1
MX,CALCULUS URINARY,1
MX,CARDIAC DISORDER,1
MX,CARDIOMEGALY,1
MX,CENTRAL NERVOUS SYSTEM LESION,1
MX,CHEST PAIN,1
MX,CHOKING SENSATION,1
MX,CHOLECYSTITIS,1
MX,CHONDROPATHY,1
MX,CONJUNCTIVAL ULCER,1
MX,CONSTIPATION,1
MX,CONTRAINDICATED PRODUCT ADMINISTERED,1
MX,CONVULSION,1
MX,DEATH,1
MX,DEPENDENCE,1
MX,DEPRESSED MOOD,1
MX,DEPRESSION,1
MX,DIARRHOEA,1
MX,DIARRHOEA HAEMORRHAGIC,1
MX,DISORIENTATION,1
MX,DIVERTICULITIS,1
MX,DRUG DEPENDENCE,1
MX,DRUG HYPERSENSITIVITY,1
MX,DRUG INEFFECTIVE,1
MX,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
MX,DRUG PRESCRIBING ERROR,1
MX,DRUG USE DISORDER,1
MX,DRUG-INDUCED LIVER INJURY,1
MX,DYSPEPSIA,1
MX,DYSSTASIA,1
MX,DYSURIA,1
MX,ECZEMA,1
MX,ELECTROENCEPHALOGRAM ABNORMAL,1
MX,EPILEPSY,1
MX,EPISTAXIS,1
MX,EXPOSURE DURING PREGNANCY,1
MX,EXTRA DOSE ADMINISTERED,1
MX,EYE DISORDER,1
MX,EYE IRRITATION,1
MX,EYE PRURITUS,1
MX,FALL,1
MX,FEAR,1
MX,FEELING HOT,1
MX,GASTROINTESTINAL DISORDER,1
MX,GASTROINTESTINAL HAEMORRHAGE,1
MX,GASTROINTESTINAL NEOPLASM,1
MX,GASTROOESOPHAGEAL REFLUX DISEASE,1
MX,GENERAL PHYSICAL HEALTH DETERIORATION,1
MX,HAEMORRHOIDS,1
MX,HEMIPARESIS,1
MX,HEPATIC ATROPHY,1
MX,HEPATIC PAIN,1
MX,HOSPITALISATION,1
MX,HYPERKERATOSIS,1
MX,HYPERSENSITIVITY,1
MX,HYPERSOMNIA,1
MX,HYPERTENSION,1
MX,HYPOKINESIA,1
MX,HYPOTHERMIA,1
MX,JEJUNAL ULCER,1
MX,JOINT SWELLING,1
MX,LIP SWELLING,1
MX,LIVER INJURY,1
MX,LOCAL SWELLING,1
MX,MALAISE,1
MX,MIGRAINE,1
MX,MONOPARESIS,1
MX,MOOD ALTERED,1
MX,MUSCLE FATIGUE,1
MX,MUSCULAR WEAKNESS,1
MX,MUSCULOSKELETAL CHEST PAIN,1
MX,MUSCULOSKELETAL DISORDER,1
MX,MUSCULOSKELETAL STIFFNESS,1
MX,NASAL DISCOMFORT,1
MX,NASOPHARYNGITIS,1
MX,NECK PAIN,1
MX,NEOPLASM MALIGNANT,1
MX,NEPHROLITHIASIS,1
MX,NERVOUSNESS,1
MX,ONYCHOMADESIS,1
MX,OSTEOPENIA,1
MX,OVERLAP SYNDROME,1
MX,PANCREATIC DISORDER,1
MX,PARAPLEGIA,1
MX,PHARYNGITIS,1
MX,PLATELET COUNT DECREASED,1
MX,POISONING,1
MX,POST PROCEDURAL DISCHARGE,1
MX,PRODUCT SUBSTITUTION,1
MX,PRODUCT USE ISSUE,1
MX,PRURITUS,1
MX,PRURITUS GENERALISED,1
MX,RASH,1
MX,RASH ERYTHEMATOUS,1
MX,RENAL ABSCESS,1
MX,RENAL IMPAIRMENT,1
MX,RENAL PAIN,1
MX,RETINAL TEAR,1
MX,RHEUMATOID ARTHRITIS,1
MX,SEIZURE,1
MX,SERUM FERRITIN INCREASED,1
MX,SKIN BURNING SENSATION,1
MX,SKIN DISCOLOURATION,1
MX,SPINAL COLUMN INJURY,1
MX,STRESS,1
MX,SUICIDAL BEHAVIOUR,1
MX,TEARFULNESS,1
MX,THERAPEUTIC RESPONSE UNEXPECTED,1
MX,TONGUE DISORDER,1
MX,TOXICITY TO VARIOUS AGENTS,1
MX,TREATMENT FAILURE,1
MX,ULCER,1
MX,UMBILICAL HERNIA,1
MX,VISUAL IMPAIRMENT,1
MX,WOUND COMPLICATION,1
MX,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
MA,TOXIC EPIDERMAL NECROLYSIS,5
MA,HYPOKALAEMIA,4
MA,HYPONATRAEMIA,4
MA,ASTHENIA,2
MA,CONJUNCTIVAL ADHESION,2
MA,CONJUNCTIVAL HYPERAEMIA,2
MA,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
MA,ORAL DISORDER,2
MA,PYREXIA,2
MA,ADHESION,1
MA,ANGULAR CHEILITIS,1
MA,CHEILITIS,1
MA,CONJUNCTIVAL DISORDER,1
MA,EPIDERMAL NECROSIS,1
MA,GENITAL LABIAL ADHESIONS,1
MA,MACULE,1
MA,RASH,1
MA,RASH ERYTHEMATOUS,1
MA,RASH MACULAR,1
MA,SKIN EXFOLIATION,1
NP,BRONCHOSPASM,1
NP,CONDITION AGGRAVATED,1
NP,CONVULSION NEONATAL,1
NP,GASTROINTESTINAL HAEMORRHAGE,1
NP,HYPONATRAEMIA,1
NP,PSEUDOMONAS INFECTION,1
NP,STAPHYLOCOCCAL INFECTION,1
NP,STEVENS-JOHNSON SYNDROME,1
NP,TOXIC EPIDERMAL NECROLYSIS,1
NL,ACUTE KIDNEY INJURY,10
NL,DYSPNOEA,8
NL,HEADACHE,8
NL,DIARRHOEA,7
NL,FATIGUE,7
NL,NAUSEA,7
NL,RENAL TUBULAR DISORDER,7
NL,ABDOMINAL PAIN UPPER,6
NL,HAEMATOCHEZIA,6
NL,TUBULOINTERSTITIAL NEPHRITIS,6
NL,WEIGHT INCREASED,6
NL,GASTROINTESTINAL DISORDER,5
NL,HYPERKALAEMIA,5
NL,INFLUENZA LIKE ILLNESS,5
NL,MUSCLE RUPTURE,5
NL,PNEUMONIA,5
NL,PYREXIA,5
NL,THERAPY CESSATION,5
NL,TOXICITY TO VARIOUS AGENTS,5
NL,BACK PAIN,4
NL,DEATH,4
NL,ERYTHEMA,4
NL,GASTROENTERITIS,4
NL,MALAISE,4
NL,MYOCARDIAL INFARCTION,4
NL,OEDEMA,4
NL,PRURITUS,4
NL,RENAL TUBULAR NECROSIS,4
NL,THROMBOCYTOPENIA,4
NL,VOMITING,4
NL,ARTHRALGIA,3
NL,CHEST DISCOMFORT,3
NL,CHEST PAIN,3
NL,COMA,3
NL,CONVULSION,3
NL,DEPRESSION,3
NL,DRUG INEFFECTIVE,3
NL,ENTEROCOLITIS HAEMORRHAGIC,3
NL,FALL,3
NL,FLUID RETENTION,3
NL,HAEMOGLOBIN DECREASED,3
NL,HAEMOLYTIC ANAEMIA,3
NL,HYPERSENSITIVITY,3
NL,HYPONATRAEMIA,3
NL,INFLAMMATION,3
NL,PAIN,3
NL,PAIN IN EXTREMITY,3
NL,SUICIDAL IDEATION,3
NL,SWELLING,3
NL,THROAT IRRITATION,3
NL,ANAPHYLACTIC SHOCK,2
NL,ANGIOEDEMA,2
NL,BLINDNESS,2
NL,BLOOD GLUCOSE INCREASED,2
NL,BONE DISORDER,2
NL,BRONCHOSPASM,2
NL,CARDIAC ARREST,2
NL,CARDIAC FAILURE,2
NL,CELLULITIS,2
NL,CEREBRAL VENOUS THROMBOSIS,2
NL,CHILLS,2
NL,CONSTIPATION,2
NL,DEEP VEIN THROMBOSIS,2
NL,DIZZINESS,2
NL,DYSPHAGIA,2
NL,EAR PRURITUS,2
NL,EYE DISORDER,2
NL,FOOT FRACTURE,2
NL,HAEMORRHAGE,2
NL,HOT FLUSH,2
NL,HYPERTENSION,2
NL,HYPOGLYCAEMIA,2
NL,HYPOTENSION,2
NL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
NL,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
NL,INFECTED BITES,2
NL,INJECTION SITE ERYTHEMA,2
NL,INTESTINAL DIAPHRAGM DISEASE,2
NL,LEUKOPENIA,2
NL,LOSS OF CONSCIOUSNESS,2
NL,MENINGITIS,2
NL,MOUTH SWELLING,2
NL,MYALGIA,2
NL,ORAL PRURITUS,2
NL,OROPHARYNGEAL PAIN,2
NL,PALPITATIONS,2
NL,PARALYSIS,2
NL,PERICARDIAL EFFUSION,2
NL,PROSTATE CANCER,2
NL,PRURITUS GENERALISED,2
NL,RENAL TUBULAR DYSFUNCTION,2
NL,SEASONAL ALLERGY,2
NL,SWELLING FACE,2
NL,TENDON DISORDER,2
NL,THROAT TIGHTNESS,2
NL,TUMOUR EXCISION,2
NL,WEIGHT DECREASED,2
NL,ABDOMINAL MASS,1
NL,ABDOMINAL PAIN,1
NL,ABSCESS,1
NL,ACCIDENT,1
NL,ACTIVITIES OF DAILY LIVING IMPAIRED,1
NL,ACUTE HEPATIC FAILURE,1
NL,ACUTE MYOCARDIAL INFARCTION,1
NL,ADVERSE DRUG REACTION,1
NL,AGGRESSION,1
NL,ANAEMIA,1
NL,ANGINA BULLOSA HAEMORRHAGICA,1
NL,ANKYLOSING SPONDYLITIS,1
NL,AORTIC ANEURYSM,1
NL,ARRHYTHMIA,1
NL,ARTERIAL THROMBOSIS,1
NL,ARTHROPATHY,1
NL,ASTHMA,1
NL,ATRIAL FIBRILLATION,1
NL,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
NL,BAND SENSATION,1
NL,BLISTER,1
NL,BLOOD GLUCOSE FLUCTUATION,1
NL,BLOOD IRON DECREASED,1
NL,BONE PAIN,1
NL,BONE SCAN ABNORMAL,1
NL,BREAST CANCER FEMALE,1
NL,BREAST OPERATION,1
NL,BREAST RECONSTRUCTION,1
NL,BUDD-CHIARI SYNDROME,1
NL,BURSITIS,1
NL,BURSITIS INFECTIVE,1
NL,CANDIDA INFECTION,1
NL,CARDIAC DISORDER,1
NL,CARDIAC FAILURE CONGESTIVE,1
NL,CARDIAC FIBRILLATION,1
NL,CARDIAC MURMUR,1
NL,CARPAL TUNNEL SYNDROME,1
NL,CARTILAGE ATROPHY,1
NL,CAUDA EQUINA SYNDROME,1
NL,CEREBROVASCULAR ACCIDENT,1
NL,CERVICAL VERTEBRAL FRACTURE,1
NL,CHOKING SENSATION,1
NL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
NL,CONDITION AGGRAVATED,1
NL,COUGH,1
NL,CYANOSIS,1
NL,DECREASED APPETITE,1
NL,DEHYDRATION,1
NL,DEPRESSED LEVEL OF CONSCIOUSNESS,1
NL,DEPRESSED MOOD,1
NL,DERMATITIS BULLOUS,1
NL,DEVICE RELATED SEPSIS,1
NL,DIABETES MELLITUS,1
NL,DISABILITY,1
NL,DISEASE RECURRENCE,1
NL,DRUG ERUPTION,1
NL,DRY EYE,1
NL,EAR DISORDER,1
NL,EMBOLISM ARTERIAL,1
NL,ENTEROSTOMY,1
NL,EPILEPSY,1
NL,EPISTAXIS,1
NL,ERECTILE DYSFUNCTION,1
NL,ERYSIPELAS,1
NL,EXPOSURE VIA FATHER,1
NL,FACE OEDEMA,1
NL,FEBRILE NEUTROPENIA,1
NL,FEELING ABNORMAL,1
NL,FEELING HOT,1
NL,GALLBLADDER DISORDER,1
NL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
NL,GASTRIC DISORDER,1
NL,GASTRIC PERFORATION,1
NL,GASTRIC ULCER PERFORATION,1
NL,GASTROINTESTINAL PERFORATION,1
NL,GASTROINTESTINAL TOXICITY,1
NL,GASTROOESOPHAGEAL SPHINCTER INSUFFICIENCY,1
NL,GENERALISED ERYTHEMA,1
NL,GENOTYPE DRUG RESISTANCE TEST POSITIVE,1
NL,GINGIVAL BLEEDING,1
NL,GRANULOMATOSIS WITH POLYANGIITIS,1
NL,GROIN PAIN,1
NL,GYNAECOMASTIA,1
NL,HAEMATOMA,1
NL,HAEMORRHAGE INTRACRANIAL,1
NL,HALLUCINATION_ AUDITORY,1
NL,HEART RATE INCREASED,1
NL,HEPATIC ENZYME INCREASED,1
NL,HEPATITIS C,1
NL,HEPATOMEGALY,1
NL,HERPES ZOSTER,1
NL,HYMENOLEPIASIS,1
NL,HYPERHIDROSIS,1
NL,HYPERLIPIDAEMIA,1
NL,HYPOMAGNESAEMIA,1
NL,HYPOPLASTIC RIGHT HEART SYNDROME,1
NL,HYSTERECTOMY,1
NL,IMMEDIATE POST-INJECTION REACTION,1
NL,IMMUNE THROMBOCYTOPENIC PURPURA,1
NL,INCONTINENCE,1
NL,INCREASED TENDENCY TO BRUISE,1
NL,INFECTION,1
NL,INFECTIOUS MONONUCLEOSIS,1
NL,INFLAMMATORY PAIN,1
NL,INJECTION SITE BRUISING,1
NL,INJECTION SITE DISCOLOURATION,1
NL,INJECTION SITE INDURATION,1
NL,INJECTION SITE INFLAMMATION,1
NL,INJECTION SITE MASS,1
NL,INJECTION SITE PAIN,1
NL,INJECTION SITE WARMTH,1
NL,INTERVERTEBRAL DISC DISORDER,1
NL,INTESTINAL ULCER,1
NL,IRON DEFICIENCY ANAEMIA,1
NL,JOINT INJURY,1
NL,JOINT STIFFNESS,1
NL,LARGE INTESTINE PERFORATION,1
NL,LARYNGEAL INFLAMMATION,1
NL,LIMB DISCOMFORT,1
NL,LIP SWELLING,1
NL,LIVER DISORDER,1
NL,LUNG DISORDER,1
NL,LUNG INFECTION,1
NL,LYMPHADENOPATHY,1
NL,LYMPHOEDEMA,1
NL,MAJOR DEPRESSION,1
NL,MALIGNANT NEOPLASM PROGRESSION,1
NL,MENTAL DISORDER,1
NL,MICTURITION URGENCY,1
NL,MOOD SWINGS,1
NL,MULTIMORBIDITY,1
NL,MUSCLE SPASMS,1
NL,MUSCULAR WEAKNESS,1
NL,MUSCULOSKELETAL STIFFNESS,1
NL,NASAL DISORDER,1
NL,NASOPHARYNGITIS,1
NL,NECROSIS ISCHAEMIC,1
NL,NEPHRITIS,1
NL,NEURALGIA,1
NL,NIGHT SWEATS,1
NL,OBESITY,1
NL,OBSTRUCTIVE AIRWAYS DISORDER,1
NL,OCCULT BLOOD POSITIVE,1
NL,ONYCHOMYCOSIS,1
NL,OOPHORECTOMY,1
NL,OSTEOARTHRITIS,1
NL,OSTEONECROSIS,1
NL,OVARIAN CYST,1
NL,OXYGEN SATURATION DECREASED,1
NL,PAIN IN JAW,1
NL,PANIC REACTION,1
NL,PENILE CURVATURE,1
NL,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
NL,PERIPHERAL COLDNESS,1
NL,PERIPHERAL MOTOR NEUROPATHY,1
NL,PHARYNGEAL DISORDER,1
NL,PHARYNGITIS,1
NL,PHLEBITIS INFECTIVE,1
NL,PITUITARY TUMOUR BENIGN,1
NL,PLEURAL EFFUSION,1
NL,POLYARTERITIS NODOSA,1
NL,POLYARTHRITIS,1
NL,PORTAL VEIN THROMBOSIS,1
NL,PRODUCT SUBSTITUTION ISSUE,1
NL,PROSTATOMEGALY,1
NL,PROTEIN DEFICIENCY,1
NL,PSEUDOMEMBRANOUS COLITIS,1
NL,PULMONARY EMBOLISM,1
NL,RASH ERYTHEMATOUS,1
NL,RENAL CANCER,1
NL,RENAL FAILURE,1
NL,RENAL FAILURE ACUTE,1
NL,RESPIRATORY ARREST,1
NL,RESPIRATORY TRACT OEDEMA,1
NL,RETINAL TELANGIECTASIA,1
NL,REYE^S SYNDROME,1
NL,RHINORRHOEA,1
NL,SCROTAL PAIN,1
NL,SEIZURE,1
NL,SEPTIC SHOCK,1
NL,SKIN REACTION,1
NL,SMALL INTESTINAL OBSTRUCTION,1
NL,SOMNOLENCE,1
NL,SPINAL FRACTURE,1
NL,SPLENOMEGALY,1
NL,STAPHYLOCOCCAL SEPSIS,1
NL,STEVENS-JOHNSON SYNDROME,1
NL,STRIDOR,1
NL,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,1
NL,SUDDEN DEATH,1
NL,SYNCOPE,1
NL,TERMINAL STATE,1
NL,THERAPEUTIC RESPONSE UNEXPECTED,1
NL,THROMBOCYTOPENIC PURPURA,1
NL,TINNITUS,1
NL,TOXIC EPIDERMAL NECROLYSIS,1
NL,TRANSIENT ISCHAEMIC ATTACK,1
NL,TRANSITIONAL CELL CARCINOMA,1
NL,TREATMENT FAILURE,1
NL,TREMOR,1
NL,UHTHOFF^S PHENOMENON,1
NL,URINARY BLADDER POLYP,1
NL,URINARY RETENTION,1
NL,UROSEPSIS,1
NL,URTICARIA,1
NL,VEIN DISORDER,1
NL,VESICOURETERAL REFLUX SURGERY,1
NL,VULVOVAGINAL MYCOTIC INFECTION,1
NL,WOUND,1
NZ,SLEEP DISORDER,6
NZ,HALLUCINATION,5
NZ,PAIN,4
NZ,ACUTE KIDNEY INJURY,3
NZ,ARTHRALGIA,3
NZ,DEATH,3
NZ,FALL,3
NZ,NAUSEA,3
NZ,RENAL FAILURE ACUTE,3
NZ,ACUTE MYOCARDIAL INFARCTION,2
NZ,ACUTE RESPIRATORY DISTRESS SYNDROME,2
NZ,BACK PAIN,2
NZ,COMA HEPATIC,2
NZ,DIZZINESS,2
NZ,DYSPNOEA,2
NZ,EXPOSURE DURING PREGNANCY,2
NZ,GOUT,2
NZ,HAEMATEMESIS,2
NZ,HEADACHE,2
NZ,HYPOAESTHESIA,2
NZ,INCORRECT DOSE ADMINISTERED,2
NZ,LARGE INTESTINE POLYP,2
NZ,NECROTISING FASCIITIS,2
NZ,NEUTROPHIL COUNT DECREASED,2
NZ,PARAESTHESIA,2
NZ,PERIPHERAL SWELLING,2
NZ,PYREXIA,2
NZ,UNEVALUABLE EVENT,2
NZ,UROSEPSIS,2
NZ,VOMITING,2
NZ,WEIGHT BEARING DIFFICULTY,2
NZ,WEIGHT DECREASED,2
NZ,ABDOMINAL DISTENSION,1
NZ,ABDOMINAL PAIN,1
NZ,ABDOMINAL PAIN UPPER,1
NZ,ABDOMINAL RIGIDITY,1
NZ,ANAEMIA,1
NZ,ANAPHYLACTIC REACTION,1
NZ,ANKLE FRACTURE,1
NZ,ANXIETY,1
NZ,ARTHRITIS,1
NZ,ARTHROPATHY,1
NZ,BASAL CELL CARCINOMA,1
NZ,BLADDER DISORDER,1
NZ,BRACHIAL PLEXUS INJURY,1
NZ,BRADYCARDIA,1
NZ,C-REACTIVE PROTEIN ABNORMAL,1
NZ,C-REACTIVE PROTEIN INCREASED,1
NZ,CARDIAC ARREST,1
NZ,CARDIAC FAILURE,1
NZ,CARDIAC TAMPONADE,1
NZ,CARDIOGENIC SHOCK,1
NZ,CAUDA EQUINA SYNDROME,1
NZ,CEREBRAL HAEMORRHAGE,1
NZ,CHILLS,1
NZ,CHOLECYSTITIS,1
NZ,CHONDROCALCINOSIS PYROPHOSPHATE,1
NZ,CHONDROPATHY,1
NZ,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
NZ,COLORECTAL CANCER,1
NZ,COMA,1
NZ,COMA SCALE ABNORMAL,1
NZ,COMPLEX REGIONAL PAIN SYNDROME,1
NZ,CONFUSIONAL STATE,1
NZ,COUGH,1
NZ,CRYSTAL ARTHROPATHY,1
NZ,DECREASED APPETITE,1
NZ,DIABETES MELLITUS INADEQUATE CONTROL,1
NZ,DIARRHOEA,1
NZ,DIARRHOEA HAEMORRHAGIC,1
NZ,DISEASE PROGRESSION,1
NZ,DISSEMINATED INTRAVASCULAR COAGULATION,1
NZ,DISTURBANCE IN ATTENTION,1
NZ,DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT,1
NZ,DRUG DOSE OMISSION,1
NZ,DRUG INEFFECTIVE,1
NZ,DRUG LEVEL INCREASED,1
NZ,DUODENAL ULCER,1
NZ,EMOTIONAL DISORDER,1
NZ,EXPIRED PRODUCT ADMINISTERED,1
NZ,EYE IRRITATION,1
NZ,FATIGUE,1
NZ,FEBRILE NEUTROPENIA,1
NZ,FEELING COLD,1
NZ,FEMORAL NERVE INJURY,1
NZ,GAIT DISTURBANCE,1
NZ,GASTRIC MUCOSAL LESION,1
NZ,GASTRIC ULCER HAEMORRHAGE,1
NZ,GASTRITIS EROSIVE,1
NZ,GLOMERULONEPHRITIS MEMBRANOUS,1
NZ,GRIP STRENGTH DECREASED,1
NZ,HEMIPARESIS,1
NZ,HEPATIC FAILURE,1
NZ,HEPATIC STEATOSIS,1
NZ,HEPATITIS CHOLESTATIC,1
NZ,HOT FLUSH,1
NZ,HYPOTENSION,1
NZ,INCORRECT DRUG ADMINISTRATION DURATION,1
NZ,INCORRECT DRUG DOSAGE FORM ADMINISTERED,1
NZ,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
NZ,INFLUENZA LIKE ILLNESS,1
NZ,INFREQUENT BOWEL MOVEMENTS,1
NZ,INJECTION SITE PAIN,1
NZ,INTERVERTEBRAL DISC PROTRUSION,1
NZ,JOINT SWELLING,1
NZ,LETHARGY,1
NZ,LIVER FUNCTION TEST ABNORMAL,1
NZ,LIVER FUNCTION TEST INCREASED,1
NZ,LOBAR PNEUMONIA,1
NZ,LYMPH NODE PAIN,1
NZ,MALAISE,1
NZ,MALIGNANT MELANOMA,1
NZ,MEDICATION ERROR,1
NZ,METASTASES TO LIVER,1
NZ,MIDDLE INSOMNIA,1
NZ,MULTI-ORGAN FAILURE,1
NZ,MUSCLE ATROPHY,1
NZ,MUSCLE NECROSIS,1
NZ,MUSCLE SPASMS,1
NZ,MUSCLE TWITCHING,1
NZ,MUSCULAR WEAKNESS,1
NZ,MUSCULOSKELETAL PAIN,1
NZ,MUSCULOSKELETAL STIFFNESS,1
NZ,MYOCARDITIS,1
NZ,NEOPLASM MALIGNANT,1
NZ,NEPHROLITHIASIS,1
NZ,NEPHROTIC SYNDROME,1
NZ,NERVOUS SYSTEM DISORDER,1
NZ,NEURALGIA,1
NZ,NEUTROPENIA,1
NZ,NEUTROPHIL COUNT INCREASED,1
NZ,OEDEMA PERIPHERAL,1
NZ,OESOPHAGEAL SPASM,1
NZ,ORAL HERPES,1
NZ,OROPHARYNGEAL PAIN,1
NZ,OSTEOARTHRITIS,1
NZ,OSTEOPOROSIS,1
NZ,PARAESTHESIA ORAL,1
NZ,PERICARDITIS,1
NZ,PERIORBITAL OEDEMA,1
NZ,PLACENTA PRAEVIA,1
NZ,POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME,1
NZ,PRODUCT LABEL ISSUE,1
NZ,PRODUCT PACKAGING ISSUE,1
NZ,PRODUCTIVE COUGH,1
NZ,PROSTATOMEGALY,1
NZ,PSORIASIS,1
NZ,PSORIATIC ARTHROPATHY,1
NZ,REACTION TO DRUG EXCIPIENTS,1
NZ,RENAL COLIC,1
NZ,RENAL FAILURE,1
NZ,RENAL IMPAIRMENT,1
NZ,RESPIRATORY ARREST,1
NZ,RETINAL VASCULITIS,1
NZ,RHEUMATOID ARTHRITIS,1
NZ,SCIATICA,1
NZ,SCOLIOSIS,1
NZ,SENSORY LOSS,1
NZ,SEPSIS,1
NZ,SHOCK,1
NZ,SHOULDER OPERATION,1
NZ,SINUS TACHYCARDIA,1
NZ,SPEECH DISORDER,1
NZ,SQUAMOUS CELL CARCINOMA OF SKIN,1
NZ,STREPTOCOCCAL INFECTION,1
NZ,SYNCOPE,1
NZ,TENDERNESS,1
NZ,THERAPY CESSATION,1
NZ,THROMBOSIS,1
NZ,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
NZ,TROPONIN INCREASED,1
NZ,ULCERATIVE KERATITIS,1
NZ,UPPER GASTROINTESTINAL HAEMORRHAGE,1
NZ,URINARY RETENTION,1
NZ,VASOGENIC CEREBRAL OEDEMA,1
NZ,VIITH NERVE PARALYSIS,1
NZ,VIRAL INFECTION,1
NZ,WHITE BLOOD CELL COUNT DECREASED,1
NZ,WHITE BLOOD CELL COUNT INCREASED,1
NZ,WRONG DRUG ADMINISTERED,1
NZ,WRONG PATIENT RECEIVED MEDICATION,1
NZ,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
NG,ABDOMINAL DISCOMFORT,1
NG,ABDOMINAL PAIN UPPER,1
NG,BLOOD URINE PRESENT,1
NG,DEAFNESS,1
NG,GASTROINTESTINAL DISORDER,1
NG,GASTROINTESTINAL PAIN,1
NG,MALAISE,1
NG,OTOTOXICITY,1
NG,RESTLESSNESS,1
NO,NEUROLEPTIC MALIGNANT SYNDROME,12
NO,TOXICITY TO VARIOUS AGENTS,12
NO,MUSCULOSKELETAL STIFFNESS,11
NO,BLOOD CREATINE PHOSPHOKINASE INCREASED,9
NO,CONFUSIONAL STATE,9
NO,DYSPHAGIA,9
NO,HYPERHIDROSIS,9
NO,LEUKOCYTOSIS,9
NO,MUSCLE RIGIDITY,9
NO,NEUTROPHILIA,9
NO,PYREXIA,9
NO,TRANSAMINASES INCREASED,9
NO,DEATH,5
NO,DIARRHOEA,5
NO,HYPERTENSION,5
NO,HYPOKALAEMIA,5
NO,ALTERED STATE OF CONSCIOUSNESS,4
NO,HYPERNATRAEMIA,4
NO,METABOLIC ACIDOSIS,4
NO,MUTISM,4
NO,TACHYCARDIA,4
NO,DYSPNOEA,3
NO,ASTHMA,2
NO,DEPRESSION,2
NO,HEADACHE,2
NO,INFLAMMATION,2
NO,OSTEONECROSIS,2
NO,PERIPHERAL SWELLING,2
NO,ABDOMINAL PAIN UPPER,1
NO,ACIDOSIS,1
NO,ACUTE MYOCARDIAL INFARCTION,1
NO,AGITATION,1
NO,ANAEMIA,1
NO,APPENDICITIS,1
NO,ARTHRALGIA,1
NO,ARTHRITIS BACTERIAL,1
NO,BLOOD PRESSURE DECREASED,1
NO,CHEST PAIN,1
NO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
NO,CIRCULATORY COLLAPSE,1
NO,CONDITION AGGRAVATED,1
NO,CONTUSION,1
NO,DEATH NEONATAL,1
NO,DECREASED APPETITE,1
NO,DEPRESSIVE SYMPTOM,1
NO,DISTURBANCE IN ATTENTION,1
NO,DRY MOUTH,1
NO,DYSKINESIA,1
NO,ECLAMPSIA,1
NO,ENDOMETRIAL HYPERPLASIA,1
NO,EPISTAXIS,1
NO,EXPOSURE DURING PREGNANCY,1
NO,FEELING HOT,1
NO,FOETAL EXPOSURE DURING PREGNANCY,1
NO,GAIT DISTURBANCE,1
NO,GENERALISED TONIC-CLONIC SEIZURE,1
NO,HAIR GROWTH ABNORMAL,1
NO,HEAD TITUBATION,1
NO,HOSPITALISATION,1
NO,INFLUENZA LIKE ILLNESS,1
NO,INTENTIONAL OVERDOSE,1
NO,LOSS OF CONSCIOUSNESS,1
NO,MECHANICAL VENTILATION,1
NO,MEDICATION ERROR,1
NO,MENINGITIS VIRAL,1
NO,MUSCLE TIGHTNESS,1
NO,MUSCULAR WEAKNESS,1
NO,MYALGIA,1
NO,NAUSEA,1
NO,OVERWEIGHT,1
NO,PANCREATITIS,1
NO,PELVIC FLUID COLLECTION,1
NO,PHOTOPHOBIA,1
NO,POSTPARTUM HAEMORRHAGE,1
NO,PRE-ECLAMPSIA,1
NO,PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS,1
NO,PROCEDURAL PAIN,1
NO,PROTEINURIA,1
NO,PRURITUS,1
NO,PUSTULAR PSORIASIS,1
NO,PYELONEPHRITIS,1
NO,RESPIRATORY ARREST,1
NO,RESPIRATORY DISTRESS,1
NO,SLEEP DISORDER,1
NO,SUICIDE ATTEMPT,1
NO,SWELLING,1
NO,SYNCOPE,1
NO,TARDIVE DYSKINESIA,1
NO,TREMOR,1
NO,URINARY TRACT INFECTION,1
NO,VAGINAL HAEMORRHAGE,1
NO,VARICELLA,1
NO,VERTIGO,1
NO,VOMITING,1
NO,WOUND,1
OM,ANGIOEDEMA,3
OM,GASTRITIS,3
OM,HEADACHE,1
OM,HYPERSENSITIVITY,1
OM,HYPOAESTHESIA ORAL,1
OM,PRURITUS,1
OM,VOMITING,1
PS,BACK PAIN,1
PS,COUGH,1
PS,FATIGUE,1
PS,MYOCARDIAL INFARCTION,1
PA,HYPERTENSION,1
PA,HYPERTENSIVE CRISIS,1
PA,ISCHAEMIC STROKE,1
PY,DRUG INEFFECTIVE,1
PY,MENSTRUATION DELAYED,1
PY,PREGNANCY ON ORAL CONTRACEPTIVE,1
PY,PREMATURE LABOUR,1
PY,UREAPLASMA INFECTION,1
PE,IRON DEFICIENCY ANAEMIA,4
PE,CEREBROVASCULAR ACCIDENT,2
PE,RESPIRATORY FAILURE,2
PE,ACUTE MYOCARDIAL INFARCTION,1
PE,ACUTE RESPIRATORY FAILURE,1
PE,ANGINA UNSTABLE,1
PE,ARRHYTHMIA,1
PE,BLOOD CREATININE INCREASED,1
PE,CARDIOMEGALY,1
PE,CEREBRAL INFARCTION,1
PE,DEATH,1
PE,DIABETES MELLITUS,1
PE,DIARRHOEA,1
PE,DIZZINESS,1
PE,EMPHYSEMA,1
PE,EPISTAXIS,1
PE,GASTROINTESTINAL HAEMORRHAGE,1
PE,HAEMOGLOBIN DECREASED,1
PE,HEADACHE,1
PE,HIV TEST POSITIVE,1
PE,HYPERGLYCAEMIA,1
PE,HYPERTENSION,1
PE,HYPOGLYCAEMIA,1
PE,INSOMNIA,1
PE,KERATITIS,1
PE,LOSS OF CONSCIOUSNESS,1
PE,PAIN,1
PE,PANCREATIC CYST,1
PE,PNEUMONIA,1
PE,PSYCHIATRIC SYMPTOM,1
PE,PULMONARY FIBROSIS,1
PE,SOMNOLENCE,1
PE,SYNCOPE,1
PE,TRANSAMINASES INCREASED,1
PE,VIRAL MUTATION IDENTIFIED,1
PE,VOMITING,1
PH,BLOOD LACTATE DEHYDROGENASE INCREASED,3
PH,CHILLS,3
PH,GENERAL PHYSICAL HEALTH DETERIORATION,3
PH,HEADACHE,3
PH,INFLUENZA LIKE ILLNESS,3
PH,MYALGIA,3
PH,PAIN IN EXTREMITY,3
PH,PRODUCTIVE COUGH,3
PH,PYREXIA,3
PH,RASH,3
PH,SPUTUM DISCOLOURED,3
PH,TROPICAL INFECTIOUS DISEASE,3
PH,DYSPNOEA,2
PH,GASTRIC ULCER,2
PH,GASTRITIS EROSIVE,2
PH,ANAEMIA,1
PH,CHRONIC GASTRITIS,1
PH,COLITIS,1
PH,EYE SWELLING,1
PH,EYELID OEDEMA,1
PH,HELICOBACTER GASTRITIS,1
PH,HYPERSENSITIVITY,1
PH,HYPERTENSION,1
PH,HYPERTENSIVE CRISIS,1
PH,IRON DEFICIENCY ANAEMIA,1
PH,OESOPHAGITIS,1
PH,PSYCHOTIC DISORDER,1
PH,TRANSIENT ISCHAEMIC ATTACK,1
PL,C-REACTIVE PROTEIN INCREASED,7
PL,ANAEMIA,6
PL,OVERDOSE,5
PL,SEPTIC SHOCK,5
PL,URTICARIA,5
PL,ASTHENIA,4
PL,BENIGN FAMILIAL PEMPHIGUS,4
PL,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,4
PL,GASTRIC ULCER,4
PL,INTERLEUKIN LEVEL INCREASED,4
PL,PYREXIA,4
PL,SUICIDE ATTEMPT,4
PL,TOXIC EPIDERMAL NECROLYSIS,4
PL,TOXICITY TO VARIOUS AGENTS,4
PL,ANGIOEDEMA,3
PL,BLOOD CREATININE INCREASED,3
PL,BLOOD PRESSURE INCREASED,3
PL,CONDITION AGGRAVATED,3
PL,DRUG INEFFECTIVE,3
PL,DYSPNOEA,3
PL,HEMIPARESIS,3
PL,HYPERTENSION,3
PL,HYPOALDOSTERONISM,3
PL,MULTI-ORGAN FAILURE,3
PL,NEUROLEPTIC MALIGNANT SYNDROME,3
PL,SKIN LESION,3
PL,STREPTOCOCCAL INFECTION,3
PL,TUBULOINTERSTITIAL NEPHRITIS,3
PL,UPPER RESPIRATORY TRACT INFECTION,3
PL,ARTHRALGIA,2
PL,BLISTER,2
PL,BLOOD CHOLESTEROL INCREASED,2
PL,BLOOD TRIGLYCERIDES INCREASED,2
PL,BLOOD UREA INCREASED,2
PL,BRADYCARDIA,2
PL,BRAIN ABSCESS,2
PL,BURNING SENSATION,2
PL,CHOLESTASIS,2
PL,DRUG ERUPTION,2
PL,FACE OEDEMA,2
PL,GASTRIC HAEMORRHAGE,2
PL,GASTROINTESTINAL DISORDER,2
PL,GENERAL PHYSICAL HEALTH DETERIORATION,2
PL,HAEMATURIA,2
PL,HEPATIC ENZYME INCREASED,2
PL,HEPATIC FAILURE,2
PL,HYPOALBUMINAEMIA,2
PL,HYPOPROTEINAEMIA,2
PL,INTENTIONAL OVERDOSE,2
PL,LEUKOPENIA,2
PL,LUNG ABSCESS,2
PL,MALAISE,2
PL,MEDICATION ERROR,2
PL,MUSCULOSKELETAL STIFFNESS,2
PL,NECROTISING FASCIITIS,2
PL,NEUROPATHY PERIPHERAL,2
PL,NEUTROPENIA,2
PL,OEDEMA,2
PL,PLEURAL EFFUSION,2
PL,PNEUMONIA,2
PL,RASH,2
PL,RENAL FAILURE,2
PL,SOMNOLENCE,2
PL,ABDOMINAL PAIN,1
PL,ABSCESS,1
PL,ACCIDENTAL POISONING,1
PL,ACUTE ABDOMEN,1
PL,ACUTE HEPATIC FAILURE,1
PL,ADVERSE EVENT,1
PL,AKINESIA,1
PL,ALTERED STATE OF CONSCIOUSNESS,1
PL,ANAL FISSURE,1
PL,ANAPHYLACTIC REACTION,1
PL,ANAPHYLACTOID REACTION,1
PL,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,1
PL,ATOPY,1
PL,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
PL,BALANCE DISORDER,1
PL,BLOOD BILIRUBIN INCREASED,1
PL,BLOOD URIC ACID INCREASED,1
PL,BODY TEMPERATURE INCREASED,1
PL,BREATH SOUNDS ABNORMAL,1
PL,BRONCHOSPASM,1
PL,CEREBROVASCULAR ACCIDENT,1
PL,CHEILITIS,1
PL,CHRONIC KIDNEY DISEASE,1
PL,COGNITIVE DISORDER,1
PL,COMPLEMENT DEFICIENCY DISEASE,1
PL,COMPLEMENT FACTOR DECREASED,1
PL,CORNEAL DISORDER,1
PL,COUGH,1
PL,DEATH,1
PL,DECREASED APPETITE,1
PL,DEFICIENCY ANAEMIA,1
PL,DEHYDRATION,1
PL,DELIRIUM,1
PL,DEPRESSED MOOD,1
PL,DERMATITIS ALLERGIC,1
PL,DERMATITIS EXFOLIATIVE,1
PL,DIARRHOEA,1
PL,DRUG ABUSE,1
PL,DRUG ADMINISTRATION ERROR,1
PL,DRUG EFFECT DECREASED,1
PL,DYSPHAGIA,1
PL,ELECTROCARDIOGRAM QT SHORTENED,1
PL,ELECTROCARDIOGRAM T WAVE PEAKED,1
PL,EMPYEMA,1
PL,ENCEPHALOPATHY,1
PL,ERYTHEMA,1
PL,FEMORAL NECK FRACTURE,1
PL,GASTRIC ULCER HAEMORRHAGE,1
PL,GASTRITIS,1
PL,GASTROINTESTINAL EROSION,1
PL,GASTROINTESTINAL HAEMORRHAGE,1
PL,GASTROINTESTINAL MUCOSAL NECROSIS,1
PL,GASTROINTESTINAL NECROSIS,1
PL,GENERALISED OEDEMA,1
PL,HAEMATEMESIS,1
PL,HAEMOPTYSIS,1
PL,HAEMORRHAGIC DIATHESIS,1
PL,HEADACHE,1
PL,HEPATIC FUNCTION ABNORMAL,1
PL,HIGH DENSITY LIPOPROTEIN DECREASED,1
PL,HYPERCHOLESTEROLAEMIA,1
PL,HYPERKALAEMIA,1
PL,HYPERSENSITIVITY,1
PL,HYPERURICAEMIA,1
PL,HYPONATRAEMIA,1
PL,HYPOTENSION,1
PL,HYPOTONIA,1
PL,HYPOXIA,1
PL,INFECTIOUS PLEURAL EFFUSION,1
PL,INFLAMMATION,1
PL,INSOMNIA,1
PL,INTERCOSTAL NEURALGIA,1
PL,ISCHAEMIA,1
PL,JAUNDICE,1
PL,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
PL,LEUKOCYTURIA,1
PL,LIP SWELLING,1
PL,LIVER INJURY,1
PL,LOW DENSITY LIPOPROTEIN INCREASED,1
PL,MALIGNANT MELANOMA IN SITU,1
PL,MELAENA,1
PL,MULTI-ORGAN DISORDER,1
PL,MULTIPLE SCLEROSIS,1
PL,MUSCLE SPASMS,1
PL,NASAL POLYPS,1
PL,NAUSEA,1
PL,OBSTRUCTION GASTRIC,1
PL,OCCULT BLOOD POSITIVE,1
PL,ORAL DISORDER,1
PL,ORGAN FAILURE,1
PL,OROPHARYNGEAL DISCOMFORT,1
PL,PAIN,1
PL,PAIN IN EXTREMITY,1
PL,PARAESTHESIA,1
PL,PARAESTHESIA ORAL,1
PL,PERICARDITIS,1
PL,PERIORBITAL OEDEMA,1
PL,PERIPHERAL SWELLING,1
PL,PETECHIAE,1
PL,PNEUMONIA BACTERIAL,1
PL,PNEUMONIA NECROTISING,1
PL,POLYMYALGIA RHEUMATICA,1
PL,PRURITUS,1
PL,PRURITUS GENERALISED,1
PL,PULMONARY OEDEMA,1
PL,PURPURA,1
PL,PYLORIC STENOSIS,1
PL,PYURIA,1
PL,QUALITY OF LIFE DECREASED,1
PL,RASH MACULAR,1
PL,RECTAL ABSCESS,1
PL,RESPIRATORY FAILURE,1
PL,RHEUMATOID ARTHRITIS,1
PL,RHINITIS,1
PL,SALIVARY GLAND DISORDER,1
PL,SEPSIS,1
PL,SKIN EXFOLIATION,1
PL,SOFT TISSUE INFECTION,1
PL,SPEECH DISORDER,1
PL,SYNCOPE,1
PL,SYNOVITIS,1
PL,TENDERNESS,1
PL,TENDON DISORDER,1
PL,TRANSFUSION-RELATED ACUTE LUNG INJURY,1
PL,URINARY TRACT INFECTION,1
PL,URINE ANALYSIS ABNORMAL,1
PL,VENOUS THROMBOSIS,1
PL,VITREOUS HAEMORRHAGE,1
PL,VOMITING,1
PL,WEIGHT DECREASED,1
PL,YELLOW SKIN,1
PT,ANGIOEDEMA,58
PT,URTICARIA,38
PT,DRUG HYPERSENSITIVITY,19
PT,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,19
PT,ANAPHYLACTIC REACTION,18
PT,FACE OEDEMA,18
PT,LIP OEDEMA,11
PT,PERIORBITAL OEDEMA,10
PT,PRURITUS,10
PT,DYSPNOEA,9
PT,RASH GENERALISED,9
PT,GENERALISED ERYTHEMA,8
PT,OEDEMA PERIPHERAL,8
PT,PRODUCT USE IN UNAPPROVED INDICATION,8
PT,PYREXIA,8
PT,ALLERGY TEST POSITIVE,7
PT,COUGH,7
PT,HYPOAESTHESIA,7
PT,RASH,7
PT,RASH MACULO-PAPULAR,7
PT,BRONCHOSPASM,6
PT,DERMATITIS BULLOUS,6
PT,FLUSHING,6
PT,PALMAR ERYTHEMA,6
PT,PRURITUS GENERALISED,6
PT,RASH PRURITIC,6
PT,TUBULOINTERSTITIAL NEPHRITIS,6
PT,TYPE IV HYPERSENSITIVITY REACTION,6
PT,WHEEZING,6
PT,ERYTHEMA,5
PT,MATERNAL EXPOSURE DURING PREGNANCY,5
PT,POST PROCEDURAL HAEMORRHAGE,5
PT,RESPIRATORY DISTRESS,5
PT,DRUG INEFFECTIVE,4
PT,DYSPHAGIA,4
PT,EXPOSURE DURING PREGNANCY,4
PT,FATIGUE,4
PT,GENERALISED OEDEMA,4
PT,HYPERSENSITIVITY,4
PT,MENINGITIS ASEPTIC,4
PT,PHARYNGEAL OEDEMA,4
PT,PLASMA CELL MYELOMA,4
PT,PNEUMONIA,4
PT,STRIDOR,4
PT,SYNCOPE,4
PT,TOXICITY TO VARIOUS AGENTS,4
PT,VOMITING,4
PT,ABDOMINAL PAIN,3
PT,ABDOMINAL PAIN UPPER,3
PT,ACUTE KIDNEY INJURY,3
PT,CHEST PAIN,3
PT,CONTUSION,3
PT,DUODENAL ULCER,3
PT,DYSPHONIA,3
PT,EOSINOPHILIA,3
PT,HEPATIC ENZYME ABNORMAL,3
PT,HYPERHIDROSIS,3
PT,INTERMITTENT CLAUDICATION,3
PT,LEUKOPENIA,3
PT,LOSS OF CONSCIOUSNESS,3
PT,MATERNAL EXPOSURE BEFORE PREGNANCY,3
PT,MYALGIA,3
PT,NAUSEA,3
PT,PAIN,3
PT,PURPURA,3
PT,SEPSIS,3
PT,ADENOCARCINOMA OF COLON,2
PT,AGRANULOCYTOSIS,2
PT,ARTHRALGIA,2
PT,CARDIAC ANEURYSM,2
PT,CHEST DISCOMFORT,2
PT,CONGENITAL CYSTIC KIDNEY DISEASE,2
PT,CORONARY ARTERY DISEASE,2
PT,DECREASED APPETITE,2
PT,DIZZINESS,2
PT,DRUG DEPENDENCE,2
PT,DYSPEPSIA,2
PT,ECCHYMOSIS,2
PT,GASTRIC ULCER,2
PT,GINGIVAL BLEEDING,2
PT,HEADACHE,2
PT,HUNGER,2
PT,HYPERTENSION,2
PT,INTENTIONAL PRODUCT MISUSE,2
PT,JAUNDICE,2
PT,KOUNIS SYNDROME,2
PT,MOUTH ULCERATION,2
PT,MUSCLE HAEMORRHAGE,2
PT,ODYNOPHAGIA,2
PT,OVERDOSE,2
PT,PARAESTHESIA,2
PT,PRODUCT USE ISSUE,2
PT,RASH ERYTHEMATOUS,2
PT,REACTION TO DRUG EXCIPIENTS,2
PT,RENAL FAILURE CHRONIC,2
PT,RESPIRATORY TRACT INFECTION,2
PT,RHINITIS,2
PT,TRANSAMINASES INCREASED,2
PT,UPPER GASTROINTESTINAL HAEMORRHAGE,2
PT,ABDOMINAL DISTENSION,1
PT,ALLERGY TO METALS,1
PT,ALOPECIA,1
PT,ALTERED STATE OF CONSCIOUSNESS,1
PT,ANAEMIA,1
PT,ANAPHYLACTIC SHOCK,1
PT,ANORECTAL DISCOMFORT,1
PT,ARTHRITIS,1
PT,ASTHENIA,1
PT,ASTHMA,1
PT,ATRIAL FIBRILLATION,1
PT,BACK PAIN,1
PT,BALANCE DISORDER,1
PT,BLISTER,1
PT,BLOOD ALKALINE PHOSPHATASE INCREASED,1
PT,BLOOD BILIRUBIN INCREASED,1
PT,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
PT,BLOOD LACTATE DEHYDROGENASE INCREASED,1
PT,BLOOD POTASSIUM ABNORMAL,1
PT,BLOOD PRESSURE INCREASED,1
PT,BODY TEMPERATURE DECREASED,1
PT,C-REACTIVE PROTEIN INCREASED,1
PT,CHEILITIS,1
PT,CHOLURIA,1
PT,CHROMATURIA,1
PT,COLON CANCER METASTATIC,1
PT,COLON CANCER STAGE II,1
PT,COMPLICATIONS OF BONE MARROW TRANSPLANT,1
PT,CONTRAINDICATED PRODUCT ADMINISTERED,1
PT,DEPRESSION,1
PT,DIARRHOEA,1
PT,DRUG CROSS-REACTIVITY,1
PT,DRUG-INDUCED LIVER INJURY,1
PT,DUODENAL ULCER HAEMORRHAGE,1
PT,DYSAESTHESIA,1
PT,DYSGEUSIA,1
PT,DYSURIA,1
PT,EAR PAIN,1
PT,ELECTROCARDIOGRAM ABNORMAL,1
PT,EPIGASTRIC DISCOMFORT,1
PT,ERYSIPELAS,1
PT,EYE DISORDER,1
PT,EYE IRRITATION,1
PT,EYE MOVEMENT DISORDER,1
PT,EYE PAIN,1
PT,EYE PRURITUS,1
PT,EYELID OEDEMA,1
PT,FANCONI SYNDROME ACQUIRED,1
PT,FEELING HOT,1
PT,FOAMING AT MOUTH,1
PT,FORMICATION,1
PT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
PT,GASTROINTESTINAL HAEMORRHAGE,1
PT,GASTROINTESTINAL INFECTION,1
PT,GLYCOSURIA,1
PT,GROIN PAIN,1
PT,HAEMATOTOXICITY,1
PT,HAEMOGLOBIN DECREASED,1
PT,HAEMOLYTIC ANAEMIA,1
PT,HAEMORRHAGE,1
PT,HEART RATE DECREASED,1
PT,HENOCH-SCHONLEIN PURPURA,1
PT,HEPATITIS,1
PT,HEPATITIS CHOLESTATIC,1
PT,HEPATITIS TOXIC,1
PT,HOT FLUSH,1
PT,HYPOCHROMIC ANAEMIA,1
PT,HYPOTENSION,1
PT,INABILITY TO CRAWL,1
PT,INCORRECT DRUG ADMINISTRATION DURATION,1
PT,INFECTIOUS PLEURAL EFFUSION,1
PT,INJECTION SITE HAEMATOMA,1
PT,INJECTION SITE HAEMORRHAGE,1
PT,INTENTIONAL PRODUCT USE ISSUE,1
PT,JOINT STIFFNESS,1
PT,LARYNGEAL OEDEMA,1
PT,LEUKOCYTOSIS,1
PT,LEUKOCYTURIA,1
PT,LYMPHADENOPATHY,1
PT,MALIGNANT NEOPLASM PROGRESSION,1
PT,MUSCLE SPASMS,1
PT,MUSCULOSKELETAL PAIN,1
PT,MYOCARDIAL INFARCTION,1
PT,NO ADVERSE EVENT,1
PT,OEDEMA,1
PT,OESOPHAGEAL VARICEAL LIGATION,1
PT,OROPHARYNGEAL DISCOMFORT,1
PT,OXYGEN SATURATION DECREASED,1
PT,PACKED RED BLOOD CELL TRANSFUSION,1
PT,PALATAL OEDEMA,1
PT,PARAPARESIS,1
PT,PERICARDIAL EFFUSION,1
PT,PHARYNGEAL INFLAMMATION,1
PT,PLATELET COUNT INCREASED,1
PT,PLEURAL EFFUSION,1
PT,PNEUMONITIS CHEMICAL,1
PT,PORTAL HYPERTENSIVE GASTROPATHY,1
PT,POTENTIATING DRUG INTERACTION,1
PT,PRESYNCOPE,1
PT,PROTEINURIA,1
PT,PYELONEPHRITIS,1
PT,RASH MORBILLIFORM,1
PT,RASH VESICULAR,1
PT,RENAL IMPAIRMENT,1
PT,RENAL INJURY,1
PT,RENAL TUBULAR NECROSIS,1
PT,SALMONELLOSIS,1
PT,SEIZURE,1
PT,SELF-MEDICATION,1
PT,SEPTIC SHOCK,1
PT,SERUM SICKNESS-LIKE REACTION,1
PT,SKIN NECROSIS,1
PT,SKIN REACTION,1
PT,SKIN TEST POSITIVE,1
PT,SPLENIC ABSCESS,1
PT,STAPHYLOCOCCUS TEST POSITIVE,1
PT,STEVENS-JOHNSON SYNDROME,1
PT,SUICIDAL IDEATION,1
PT,SUPERINFECTION,1
PT,THROAT IRRITATION,1
PT,THROMBOCYTOPENIA,1
PT,TONGUE OEDEMA,1
PT,VARICES OESOPHAGEAL,1
PT,VISION BLURRED,1
PT,WHITE BLOOD CELL COUNT INCREASED,1
PR,PAIN,10
PR,INJECTION SITE PAIN,9
PR,ARTHRALGIA,6
PR,DRUG INEFFECTIVE,6
PR,DRUG HYPERSENSITIVITY,5
PR,HEADACHE,5
PR,ASTHMA,4
PR,DIARRHOEA,4
PR,LOCAL SWELLING,4
PR,NASOPHARYNGITIS,4
PR,URINARY TRACT INFECTION,4
PR,ABDOMINAL PAIN UPPER,3
PR,BURNING SENSATION,3
PR,DIZZINESS,3
PR,GAIT DISTURBANCE,3
PR,INFLAMMATION,3
PR,INJECTION SITE ERYTHEMA,3
PR,INJECTION SITE RASH,3
PR,PAIN IN EXTREMITY,3
PR,PHARYNGITIS,3
PR,PSORIASIS,3
PR,RASH,3
PR,ABSCESS LIMB,2
PR,ANXIETY,2
PR,ARTHRITIS,2
PR,BACK PAIN,2
PR,CELLULITIS,2
PR,CHIKUNGUNYA VIRUS INFECTION,2
PR,EYE SWELLING,2
PR,FALL,2
PR,FATIGUE,2
PR,FEELING ABNORMAL,2
PR,FEELING HOT,2
PR,GINGIVITIS,2
PR,HYPERSENSITIVITY,2
PR,IMMUNODEFICIENCY,2
PR,INFECTION,2
PR,JOINT SWELLING,2
PR,MALAISE,2
PR,NAUSEA,2
PR,NECK PAIN,2
PR,PRODUCT USE ISSUE,2
PR,VAGINAL INFECTION,2
PR,VOMITING,2
PR,WEIGHT INCREASED,2
PR,ABDOMINAL DISCOMFORT,1
PR,ABDOMINAL DISTENSION,1
PR,ACCIDENT AT WORK,1
PR,ACNE,1
PR,ALCOHOL ABUSE,1
PR,ALOPECIA,1
PR,ANAEMIA,1
PR,ANKLE FRACTURE,1
PR,ARTHROPOD BITE,1
PR,ASTHENIA,1
PR,BACK INJURY,1
PR,BACTERIAL INFECTION,1
PR,BALANCE DISORDER,1
PR,BEDRIDDEN,1
PR,BLINDNESS,1
PR,BLOOD IRON DECREASED,1
PR,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
PR,BLOOD TESTOSTERONE DECREASED,1
PR,BREAST CANCER FEMALE,1
PR,CANDIDA INFECTION,1
PR,CARDIAC DISORDER,1
PR,CARDIO-RESPIRATORY ARREST,1
PR,CARDIOMEGALY,1
PR,CARDIOVASCULAR DISORDER,1
PR,CELLULITIS STAPHYLOCOCCAL,1
PR,CHEMICAL POISONING,1
PR,CHEST PAIN,1
PR,CHILLS,1
PR,CHRONIC GASTRITIS,1
PR,CIRRHOSIS ALCOHOLIC,1
PR,CONSTIPATION,1
PR,CONTUSION,1
PR,CYST,1
PR,DECREASED APPETITE,1
PR,DEHYDRATION,1
PR,DISCOMFORT,1
PR,DRUG ADMINISTRATION ERROR,1
PR,DRUG DISPENSING ERROR,1
PR,DRUG EFFECT DECREASED,1
PR,DRUG EFFECT INCOMPLETE,1
PR,DRUG PRESCRIBING ERROR,1
PR,DYSGEUSIA,1
PR,EAR DISORDER,1
PR,EAR INFECTION,1
PR,EAR INFECTION FUNGAL,1
PR,ERYTHEMA,1
PR,EXOSTOSIS,1
PR,EXPIRED PRODUCT ADMINISTERED,1
PR,EYE HAEMORRHAGE,1
PR,EYE INFECTION,1
PR,EYE INFLAMMATION,1
PR,EYE PRURITUS,1
PR,FAECES DISCOLOURED,1
PR,FEAR,1
PR,GASTRIC ULCER,1
PR,GASTROINTESTINAL INFLAMMATION,1
PR,GLUCOSE TOLERANCE IMPAIRED,1
PR,HAEMATOCHEZIA,1
PR,HAEMOGLOBIN DECREASED,1
PR,HALLUCINATION,1
PR,HEPATIC ENZYME INCREASED,1
PR,HEPATIC FAILURE,1
PR,HYPERCHOLESTEROLAEMIA,1
PR,HYPERTENSION,1
PR,HYPOPHAGIA,1
PR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PR,INCREASED APPETITE,1
PR,INITIAL INSOMNIA,1
PR,INJECTION SITE HAEMATOMA,1
PR,INJECTION SITE PRURITUS,1
PR,INJURY ASSOCIATED WITH DEVICE,1
PR,INSOMNIA,1
PR,INTENTIONAL PRODUCT MISUSE,1
PR,JAUNDICE,1
PR,JOINT ABSCESS,1
PR,JOINT DESTRUCTION,1
PR,JOINT DISLOCATION,1
PR,KNEE ARTHROPLASTY,1
PR,LACRIMATION INCREASED,1
PR,LIMB DISCOMFORT,1
PR,LIVER INJURY,1
PR,LUNG DISORDER,1
PR,LYMPHOMA,1
PR,MIGRAINE,1
PR,MOBILITY DECREASED,1
PR,MUSCULOSKELETAL DISORDER,1
PR,MUSCULOSKELETAL STIFFNESS,1
PR,NERVOUSNESS,1
PR,NEURITIS,1
PR,OCULAR HYPERAEMIA,1
PR,OVARIAN CANCER,1
PR,PALPITATIONS,1
PR,PERIORBITAL OEDEMA,1
PR,PERIPHERAL SWELLING,1
PR,PRURITUS,1
PR,PRURITUS GENERALISED,1
PR,PULMONARY HYPERTENSION,1
PR,PYREXIA,1
PR,RASH MACULAR,1
PR,RECTAL HAEMORRHAGE,1
PR,RENAL DISORDER,1
PR,RENAL FAILURE,1
PR,RHEUMATOID ARTHRITIS,1
PR,SCAR,1
PR,SCIATICA,1
PR,SOMNOLENCE,1
PR,SUBCUTANEOUS ABSCESS,1
PR,TENDON RUPTURE,1
PR,THERMAL BURN,1
PR,THROAT IRRITATION,1
PR,TOOTHACHE,1
PR,UNEVALUABLE EVENT,1
PR,UTERINE CANCER,1
PR,VENOUS OCCLUSION,1
PR,WEIGHT DECREASED,1
PR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
QA,ANAPHYLACTIC REACTION,1
QA,DUODENAL ULCER HAEMORRHAGE,1
QA,DUODENAL ULCER PERFORATION,1
RO,EROSIVE OESOPHAGITIS,38
RO,OESOPHAGEAL STENOSIS,15
RO,RHABDOMYOLYSIS,7
RO,HYPERURICAEMIA,4
RO,OVULATION DISORDER,4
RO,ACIDOSIS,3
RO,BRONCHIAL OBSTRUCTION,3
RO,COMMUNICATION DISORDER,3
RO,HYPONATRAEMIA,3
RO,NASAL CONGESTION,3
RO,OEDEMA PERIPHERAL,3
RO,RHINORRHOEA,3
RO,SOMNOLENCE,3
RO,TOXICITY TO VARIOUS AGENTS,3
RO,ACUTE KIDNEY INJURY,2
RO,ANURIA,2
RO,ANXIETY,2
RO,BLOOD LACTATE DEHYDROGENASE INCREASED,2
RO,CARDIAC ARREST,2
RO,CHROMATURIA,2
RO,CONFUSIONAL STATE,2
RO,DEHYDRATION,2
RO,DRUG INEFFECTIVE,2
RO,DYSPNOEA,2
RO,GASTROINTESTINAL HAEMORRHAGE,2
RO,HAEMORRHAGIC PNEUMONIA,2
RO,HEPATIC CONGESTION,2
RO,HYPOCALCAEMIA,2
RO,LOSS OF CONSCIOUSNESS,2
RO,MALAISE,2
RO,OLIGURIA,2
RO,PAIN IN EXTREMITY,2
RO,PSYCHOMOTOR RETARDATION,2
RO,RENAL FAILURE ACUTE,2
RO,SELF-MEDICATION,2
RO,SUICIDE ATTEMPT,2
RO,TRANSAMINASES INCREASED,2
RO,TUBULOINTERSTITIAL NEPHRITIS,2
RO,WHEEZING,2
RO,ABASIA,1
RO,ABDOMINAL PAIN,1
RO,ANAEMIA,1
RO,ANAPHYLACTIC REACTION,1
RO,CONDITION AGGRAVATED,1
RO,DEAFNESS,1
RO,DRUG ABUSE,1
RO,DRUG HYPERSENSITIVITY,1
RO,DYSPHAGIA,1
RO,EPISTAXIS,1
RO,ERYTHEMA,1
RO,EXTRA DOSE ADMINISTERED,1
RO,FACE OEDEMA,1
RO,FOETAL EXPOSURE DURING PREGNANCY,1
RO,GAIT DISTURBANCE,1
RO,GASTRIC ULCER HAEMORRHAGE,1
RO,GASTROSCHISIS,1
RO,GENITAL ULCERATION,1
RO,HAEMOPTYSIS,1
RO,HYPOTENSION,1
RO,INTENTIONAL OVERDOSE,1
RO,INTENTIONAL PRODUCT MISUSE,1
RO,MOUTH ULCERATION,1
RO,MUCOSAL PAIN,1
RO,MYALGIA,1
RO,NASOPHARYNGEAL CANCER,1
RO,NAUSEA,1
RO,OESOPHAGEAL ULCER,1
RO,PANIC REACTION,1
RO,PATHOGEN RESISTANCE,1
RO,PERIPHERAL SWELLING,1
RO,POLYNEUROPATHY,1
RO,PRODUCT USE ISSUE,1
RO,PRURITUS,1
RO,PSYCHOMOTOR SKILLS IMPAIRED,1
RO,PULMONARY EMBOLISM,1
RO,PYREXIA,1
RO,RASH GENERALISED,1
RO,RASH MACULO-PAPULAR,1
RO,RESPIRATORY DISORDER,1
RO,STEVENS-JOHNSON SYNDROME,1
RO,SUFFOCATION FEELING,1
RO,SUICIDAL BEHAVIOUR,1
RO,THERAPEUTIC RESPONSE DECREASED,1
RO,TONGUE OEDEMA,1
RO,TYPE I HYPERSENSITIVITY,1
RU,DRUG INEFFECTIVE,2
RU,PNEUMONIA,2
RU,RASH,2
RU,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
RU,STEVENS-JOHNSON SYNDROME,2
RU,ACUTE KIDNEY INJURY,1
RU,ALANINE AMINOTRANSFERASE INCREASED,1
RU,ANAEMIA,1
RU,ANKYLOSING SPONDYLITIS,1
RU,ARTHRALGIA,1
RU,ASPARTATE AMINOTRANSFERASE INCREASED,1
RU,ASTHENIA,1
RU,BACTERIAL TEST,1
RU,BODY TEMPERATURE INCREASED,1
RU,C-REACTIVE PROTEIN INCREASED,1
RU,CARDIOPULMONARY FAILURE,1
RU,CHOLECYSTITIS CHRONIC,1
RU,CONDITION AGGRAVATED,1
RU,CONTRAINDICATED PRODUCT ADMINISTERED,1
RU,DEHYDRATION,1
RU,DIABETES MELLITUS,1
RU,DIARRHOEA,1
RU,DISSEMINATED TUBERCULOSIS,1
RU,DIZZINESS,1
RU,EXPOSURE DURING PREGNANCY,1
RU,EYE IRRITATION,1
RU,HEPATIC FAILURE,1
RU,HERPES ZOSTER,1
RU,LIP DRY,1
RU,LYMPHADENOPATHY,1
RU,MENINGIOMA,1
RU,OROPHARYNGEAL PAIN,1
RU,PAIN,1
RU,PRODUCT USE ISSUE,1
RU,PRURITUS,1
RU,PSORIASIS,1
RU,PSORIATIC ARTHROPATHY,1
RU,PYREXIA,1
RU,SCIATICA,1
RU,SKIN BURNING SENSATION,1
RU,THROMBOCYTOPENIA,1
RU,TINNITUS,1
RU,URINARY RETENTION,1
VC,PULMONARY EMBOLISM,1
VC,TREATMENT NONCOMPLIANCE,1
SA,HYPERGLYCAEMIA,2
SA,ACUTE CORONARY SYNDROME,1
SA,ACUTE RESPIRATORY DISTRESS SYNDROME,1
SA,AGITATION,1
SA,ALBUMINURIA,1
SA,CONSCIOUSNESS FLUCTUATING,1
SA,CONVULSION,1
SA,HYPOCALCAEMIA,1
SA,HYPOMAGNESAEMIA,1
SA,METABOLIC ACIDOSIS,1
SA,NYSTAGMUS,1
SA,OVERDOSE,1
SA,PRODUCT USE ISSUE,1
SA,RENAL FAILURE ACUTE,1
SA,SOMNOLENCE,1
SA,TACHYPNOEA,1
SN,DUCTUS ARTERIOSUS PREMATURE CLOSURE,3
SN,FOETAL EXPOSURE DURING PREGNANCY,3
SN,CARDIAC FAILURE,2
SN,EXPOSURE DURING PREGNANCY,2
SN,GENERALISED OEDEMA,2
SN,PREMATURE BABY,2
SN,ASCITES,1
SN,PREMATURE DELIVERY,1
SN,RIGHT VENTRICULAR DILATATION,1
RS,AMYLASE INCREASED,2
RS,ARTHRALGIA,2
RS,DIZZINESS,2
RS,DYSPNOEA,2
RS,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,2
RS,PAIN,2
RS,PANCREATIC ATROPHY,2
RS,PANCREATIC DISORDER,2
RS,PULMONARY PAIN,2
RS,RENAL PAIN,2
RS,SLEEP DISORDER,2
RS,VERTIGO,2
RS,ARTHROPATHY,1
RS,BLOOD CHOLESTEROL DECREASED,1
RS,C-REACTIVE PROTEIN INCREASED,1
RS,CHOLECYSTITIS ACUTE,1
RS,CONDITION AGGRAVATED,1
RS,DISTRIBUTIVE SHOCK,1
RS,DRUG-INDUCED LIVER INJURY,1
RS,GRANULOCYTE COUNT INCREASED,1
RS,HIGH DENSITY LIPOPROTEIN DECREASED,1
RS,INSOMNIA,1
RS,MYOCARDIAL INFARCTION,1
RS,NECROTISING FASCIITIS STREPTOCOCCAL,1
RS,PNEUMONIA,1
RS,RED BLOOD CELL COUNT INCREASED,1
RS,SCHIZOPHRENIA,1
RS,SEPSIS,1
RS,TOXIC EPIDERMAL NECROLYSIS,1
RS,VERY LOW DENSITY LIPOPROTEIN DECREASED,1
SG,DRUG CROSS-REACTIVITY,20
SG,ANGIOEDEMA,14
SG,DRUG HYPERSENSITIVITY,14
SG,EYE SWELLING,8
SG,PERIORBITAL OEDEMA,7
SG,FACE OEDEMA,4
SG,RASH,4
SG,DYSPNOEA,3
SG,LIP SWELLING,3
SG,ANAPHYLACTIC REACTION,2
SG,ARTHRALGIA,2
SG,JOINT SWELLING,2
SG,LIP BLISTER,2
SG,ADVERSE DRUG REACTION,1
SG,ANKLE FRACTURE,1
SG,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,1
SG,BALANCE DISORDER,1
SG,BURNING SENSATION,1
SG,CAMPYLOBACTER GASTROENTERITIS,1
SG,CHEILITIS,1
SG,CHRONIC MYELOID LEUKAEMIA,1
SG,CONDITION AGGRAVATED,1
SG,CONJUNCTIVITIS,1
SG,DRUG INEFFECTIVE,1
SG,DYSPEPSIA,1
SG,FOOD POISONING,1
SG,GASTRODUODENITIS,1
SG,GASTROENTERITIS VIRAL,1
SG,HYPOAESTHESIA,1
SG,MALIGNANT NEOPLASM PROGRESSION,1
SG,MOUTH ULCERATION,1
SG,NAUSEA,1
SG,NIKOLSKY^S SIGN,1
SG,PNEUMONIA INFLUENZAL,1
SG,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
SG,PRODUCT QUALITY ISSUE,1
SG,PYREXIA,1
SG,RENAL FAILURE ACUTE,1
SG,SKIN LESION,1
SG,STEVENS-JOHNSON SYNDROME,1
SG,THERAPEUTIC RESPONSE DECREASED,1
SG,TOXIC EPIDERMAL NECROLYSIS,1
SG,UPPER LIMB FRACTURE,1
SK,SUICIDE ATTEMPT,7
SK,OVERDOSE,5
SK,VOMITING,5
SK,SOMNOLENCE,4
SK,EROSIVE OESOPHAGITIS,3
SK,TRANSAMINASES INCREASED,3
SK,BRONCHOPNEUMONIA,2
SK,DISSEMINATED INTRAVASCULAR COAGULATION,2
SK,DRUG DEPENDENCE,2
SK,HAEMOLYTIC ANAEMIA,2
SK,HYPOTENSION,2
SK,INTENTIONAL OVERDOSE,2
SK,METHAEMOGLOBINAEMIA,2
SK,RENAL FAILURE ACUTE,2
SK,SEPSIS,2
SK,ANURIA,1
SK,ASPHYXIA,1
SK,BLOOD LACTIC ACID INCREASED,1
SK,BLOOD PRESSURE INCREASED,1
SK,BODY TEMPERATURE DECREASED,1
SK,BURN OF INTERNAL ORGANS,1
SK,CYANOSIS,1
SK,DEPRESSED LEVEL OF CONSCIOUSNESS,1
SK,DUODENAL ULCER,1
SK,ELECTROCARDIOGRAM T WAVE PEAKED,1
SK,FAECAL INCONTINENCE,1
SK,FALL,1
SK,GASTRIC MUCOSAL LESION,1
SK,GASTRIC ULCER,1
SK,GASTROINTESTINAL DISORDER,1
SK,GASTROINTESTINAL EROSION,1
SK,GASTROOESOPHAGEAL REFLUX DISEASE,1
SK,HEART RATE INCREASED,1
SK,HEPATIC ENZYME INCREASED,1
SK,HYPERKALAEMIA,1
SK,INCORRECT DOSE ADMINISTERED,1
SK,METABOLIC ACIDOSIS,1
SK,OEDEMA MUCOSAL,1
SK,OESOPHAGEAL ULCER,1
SK,PLATELET COUNT DECREASED,1
SK,SLOW RESPONSE TO STIMULI,1
SK,TOXICITY TO VARIOUS AGENTS,1
SK,TREATMENT NONCOMPLIANCE,1
SK,URINARY INCONTINENCE,1
SI,SUICIDE ATTEMPT,14
SI,HYPOTENSION,12
SI,METABOLIC ACIDOSIS,12
SI,LOSS OF CONSCIOUSNESS,11
SI,LEFT VENTRICULAR DYSFUNCTION,9
SI,BRADYCARDIA,8
SI,OVERDOSE,8
SI,TOXICITY TO VARIOUS AGENTS,5
SI,SINUS BRADYCARDIA,4
SI,BLOOD CREATININE INCREASED,3
SI,EJECTION FRACTION DECREASED,3
SI,C-REACTIVE PROTEIN INCREASED,2
SI,CIRCULATORY COLLAPSE,2
SI,NASOPHARYNGITIS,2
SI,PYREXIA,2
SI,ABDOMINAL PAIN UPPER,1
SI,ACUTE HEPATIC FAILURE,1
SI,ACUTE RESPIRATORY FAILURE,1
SI,AMNESIA,1
SI,ASTHENIA,1
SI,AUTOIMMUNE DISORDER,1
SI,BREATH SOUNDS,1
SI,CARDIAC ARREST,1
SI,CONFUSIONAL STATE,1
SI,COUGH,1
SI,CRYSTAL URINE PRESENT,1
SI,DYSARTHRIA,1
SI,DYSPNOEA,1
SI,ELECTROCARDIOGRAM QT PROLONGED,1
SI,FATIGUE,1
SI,FEBRILE CONVULSION,1
SI,FEELING ABNORMAL,1
SI,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
SI,HEADACHE,1
SI,HEPATIC STEATOSIS,1
SI,HYPEROXALURIA,1
SI,HYPOCITRATURIA,1
SI,HYPOKALAEMIA,1
SI,INFLUENZA,1
SI,INFLUENZA LIKE ILLNESS,1
SI,INFUSION RELATED REACTION,1
SI,INTENTIONAL OVERDOSE,1
SI,LIVER FUNCTION TEST INCREASED,1
SI,METASTASES TO MENINGES,1
SI,MOOD ALTERED,1
SI,MULTIPLE SCLEROSIS RELAPSE,1
SI,NEPHROLITHIASIS,1
SI,OROPHARYNGEAL PAIN,1
SI,PAIN IN EXTREMITY,1
SI,PERSONALITY CHANGE,1
SI,PNEUMONIA STREPTOCOCCAL,1
SI,RENAL FAILURE,1
SI,RHABDOMYOLYSIS,1
SI,RHEUMATIC DISORDER,1
SI,SEPSIS,1
SI,SINUS ARRHYTHMIA,1
SI,SYSTOLIC DYSFUNCTION,1
SI,TESTIS CANCER,1
SI,VARICELLA,1
ZA,RENAL FAILURE,5
ZA,ANGIOEDEMA,4
ZA,ASTHENIA,2
ZA,CAESAREAN SECTION,2
ZA,CONVULSION,2
ZA,DRUG HYPERSENSITIVITY,2
ZA,HEADACHE,2
ZA,PRODUCT USE IN UNAPPROVED INDICATION,2
ZA,TREMOR,2
ZA,WOUND SEPSIS,2
ZA,ABDOMINAL PAIN UPPER,1
ZA,ASTERIXIS,1
ZA,AUTOIMMUNE HEPATITIS,1
ZA,CEREBELLAR ATAXIA,1
ZA,COMA,1
ZA,CONFUSIONAL STATE,1
ZA,DEATH,1
ZA,DYSKINESIA,1
ZA,EATING DISORDER,1
ZA,EXPOSURE DURING PREGNANCY,1
ZA,FOETAL DISTRESS SYNDROME,1
ZA,FOETAL EXPOSURE DURING PREGNANCY,1
ZA,GASTRITIS,1
ZA,HYPOGLYCAEMIA,1
ZA,INTENTIONAL OVERDOSE,1
ZA,LIVE BIRTH,1
ZA,MATERNAL EXPOSURE DURING PREGNANCY,1
ZA,NAUSEA,1
ZA,NON-HODGKIN^S LYMPHOMA,1
ZA,NYSTAGMUS,1
ZA,PREGNANCY,1
ZA,PRODUCT USE ISSUE,1
ZA,PSYCHOTIC DISORDER,1
ZA,PYELONEPHRITIS ACUTE,1
ZA,RASH,1
ZA,RENAL IMPAIRMENT,1
ZA,SOMNOLENCE,1
ZA,SUICIDE ATTEMPT,1
ZA,THROAT IRRITATION,1
ZA,THROMBOCYTOSIS,1
ZA,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
ES,ANGIOEDEMA,224
ES,URTICARIA,118
ES,ASTHMA,100
ES,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,93
ES,EYE DISORDER,73
ES,NASAL DISORDER,71
ES,ANAPHYLACTIC REACTION,63
ES,DRUG HYPERSENSITIVITY,41
ES,PYREXIA,40
ES,ACUTE KIDNEY INJURY,38
ES,PRODUCT USE ISSUE,38
ES,HYPERSENSITIVITY,35
ES,TOXIC EPIDERMAL NECROLYSIS,35
ES,TUBULOINTERSTITIAL NEPHRITIS,33
ES,RENAL FAILURE ACUTE,31
ES,PRURITUS,24
ES,DRUG-INDUCED LIVER INJURY,23
ES,TOXICITY TO VARIOUS AGENTS,22
ES,ASTHENIA,21
ES,HAEMATEMESIS,21
ES,CONJUNCTIVITIS,20
ES,DYSPNOEA,20
ES,PRURITUS GENERALISED,19
ES,OVERDOSE,18
ES,ANAEMIA,17
ES,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,16
ES,MENINGITIS ASEPTIC,16
ES,RENAL FAILURE,16
ES,STEVENS-JOHNSON SYNDROME,15
ES,ANAPHYLACTIC SHOCK,14
ES,SEPTIC SHOCK,14
ES,VOMITING,14
ES,HYPOGLYCAEMIA,13
ES,NAUSEA,13
ES,PANCYTOPENIA,13
ES,RASH,13
ES,COMA,12
ES,PNEUMONIA,12
ES,URINARY TRACT INFECTION,12
ES,BRAIN DEATH,11
ES,BRAIN OEDEMA,11
ES,CARDIO-RESPIRATORY ARREST,11
ES,DIARRHOEA,11
ES,GASTRIC DISORDER,11
ES,GASTROINTESTINAL HAEMORRHAGE,11
ES,HEADACHE,11
ES,RESPIRATORY FAILURE,11
ES,ARTHRALGIA,10
ES,CONDITION AGGRAVATED,10
ES,HYPOTENSION,10
ES,PLEURAL EFFUSION,10
ES,THROMBOCYTOPENIA,10
ES,ABDOMINAL PAIN,9
ES,DEATH,9
ES,DRUG ERUPTION,9
ES,DRUG INEFFECTIVE,9
ES,DYSPEPSIA,9
ES,FEBRILE NEUTROPENIA,9
ES,INTENTIONAL OVERDOSE,9
ES,MALAISE,9
ES,METABOLIC ACIDOSIS,9
ES,MUCOSAL INFLAMMATION,9
ES,PULMONARY HYPERTENSION,9
ES,UPPER GASTROINTESTINAL HAEMORRHAGE,9
ES,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,8
ES,COMPLETED SUICIDE,8
ES,ERYTHEMA,8
ES,FACE OEDEMA,8
ES,NEUTROPENIA,8
ES,OEDEMA PERIPHERAL,8
ES,RESPIRATORY TRACT INFECTION,8
ES,SUICIDE ATTEMPT,8
ES,ACUTE CORONARY SYNDROME,7
ES,ACUTE HEPATIC FAILURE,7
ES,ADVERSE EVENT,7
ES,BACK PAIN,7
ES,CARDIAC FAILURE,7
ES,DECREASED APPETITE,7
ES,DIFFUSE ALVEOLAR DAMAGE,7
ES,DIZZINESS,7
ES,DRUG ABUSE,7
ES,HEPATOTOXICITY,7
ES,TYPE I HYPERSENSITIVITY,7
ES,AGRANULOCYTOSIS,6
ES,BONE MARROW FAILURE,6
ES,BRONCHOSPASM,6
ES,CONFUSIONAL STATE,6
ES,GASTRITIS EROSIVE,6
ES,HEPATIC FAILURE,6
ES,HYPERKALAEMIA,6
ES,JAUNDICE,6
ES,LOWER GASTROINTESTINAL HAEMORRHAGE,6
ES,PAIN,6
ES,POISONING,6
ES,RASH PRURITIC,6
ES,SKIN ULCER,6
ES,TINNITUS,6
ES,ABDOMINAL PAIN UPPER,5
ES,ACUTE MYOCARDIAL INFARCTION,5
ES,ALANINE AMINOTRANSFERASE INCREASED,5
ES,ASPARTATE AMINOTRANSFERASE INCREASED,5
ES,BLISTER,5
ES,BRAIN INJURY,5
ES,COAGULOPATHY,5
ES,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,5
ES,HEPATIC ENCEPHALOPATHY,5
ES,HEPATITIS,5
ES,HEPATITIS CHOLESTATIC,5
ES,HEPATOMEGALY,5
ES,INFLAMMATION,5
ES,INJECTION SITE ERYTHEMA,5
ES,LEUKOPENIA,5
ES,LIP OEDEMA,5
ES,NECROTISING COLITIS,5
ES,PAIN IN EXTREMITY,5
ES,PRODUCT USE IN UNAPPROVED INDICATION,5
ES,RETINOPATHY OF PREMATURITY,5
ES,RHINITIS,5
ES,TOXIC SKIN ERUPTION,5
ES,TRANSAMINASES INCREASED,5
ES,ATRIAL FIBRILLATION,4
ES,CHEST PAIN,4
ES,CHILLS,4
ES,COUGH,4
ES,DEPRESSED LEVEL OF CONSCIOUSNESS,4
ES,DYSPHAGIA,4
ES,ERYTHEMA MULTIFORME,4
ES,EYE ULCER,4
ES,FOETAL EXPOSURE DURING PREGNANCY,4
ES,GASTROENTERITIS,4
ES,GASTROINTESTINAL DISORDER,4
ES,GENERAL PHYSICAL HEALTH DETERIORATION,4
ES,HAEMOLYTIC ANAEMIA,4
ES,HYPERTENSION,4
ES,HYPONATRAEMIA,4
ES,INJECTION SITE PAIN,4
ES,ISCHAEMIC STROKE,4
ES,MALIGNANT NEOPLASM PROGRESSION,4
ES,MULTIPLE SCLEROSIS RELAPSE,4
ES,MUSCLE SPASMS,4
ES,MYALGIA,4
ES,NASOPHARYNGITIS,4
ES,NEUTROPHIL COUNT DECREASED,4
ES,OEDEMA,4
ES,PALATAL OEDEMA,4
ES,PSORIASIS,4
ES,PUNCTATE KERATITIS,4
ES,RASH GENERALISED,4
ES,RECTAL HAEMORRHAGE,4
ES,RENAL IMPAIRMENT,4
ES,RHABDOMYOLYSIS,4
ES,STOMATITIS,4
ES,TRICHIASIS,4
ES,ALOPECIA,3
ES,ALTERED STATE OF CONSCIOUSNESS,3
ES,ARTHRITIS,3
ES,BLOOD BILIRUBIN INCREASED,3
ES,BLOOD CREATININE ABNORMAL,3
ES,BLOOD PRESSURE DECREASED,3
ES,BRONCHOPULMONARY DYSPLASIA,3
ES,CEREBROVASCULAR ACCIDENT,3
ES,CHEST DISCOMFORT,3
ES,DEAFNESS BILATERAL,3
ES,DEAFNESS NEUROSENSORY,3
ES,DISEASE PROGRESSION,3
ES,DRUG INTOLERANCE,3
ES,DUODENAL ULCER HAEMORRHAGE,3
ES,DYSGEUSIA,3
ES,DYSPHONIA,3
ES,EOSINOPHILIA,3
ES,EPISTAXIS,3
ES,EYE PENETRATION,3
ES,FANCONI SYNDROME ACQUIRED,3
ES,FATIGUE,3
ES,FLANK PAIN,3
ES,FOOD INTERACTION,3
ES,GAIT DISTURBANCE,3
ES,GASTRIC ULCER,3
ES,GASTRIC ULCER HAEMORRHAGE,3
ES,HAEMATOCHEZIA,3
ES,HAEMOGLOBIN DECREASED,3
ES,HEPATIC FUNCTION ABNORMAL,3
ES,HYPERHIDROSIS,3
ES,HYPOAESTHESIA,3
ES,HYPOKALAEMIA,3
ES,INCORRECT DOSE ADMINISTERED,3
ES,INJECTION SITE HAEMATOMA,3
ES,INTERSTITIAL LUNG DISEASE,3
ES,INTESTINAL PERFORATION,3
ES,LACTIC ACIDOSIS,3
ES,LYMPHOEDEMA,3
ES,MALLORY-WEISS SYNDROME,3
ES,MATERNAL DRUGS AFFECTING FOETUS,3
ES,MOUTH ULCERATION,3
ES,MUSCULAR WEAKNESS,3
ES,MUSCULOSKELETAL STIFFNESS,3
ES,ODYNOPHAGIA,3
ES,OSTEONECROSIS OF JAW,3
ES,OSTEOPOROSIS,3
ES,OTOTOXICITY,3
ES,PANCREATITIS ACUTE,3
ES,PARAESTHESIA,3
ES,PERICARDIAL EFFUSION,3
ES,PHLEBITIS,3
ES,PNEUMONITIS,3
ES,PSYCHOTIC DISORDER,3
ES,RASH MACULAR,3
ES,RASH MACULO-PAPULAR,3
ES,RENAL FAILURE CHRONIC,3
ES,RESPIRATORY DISORDER,3
ES,RHEUMATOID ARTHRITIS,3
ES,SKIN LESION,3
ES,TACHYCARDIA,3
ES,TONGUE OEDEMA,3
ES,UNRESPONSIVE TO STIMULI,3
ES,WEIGHT INCREASED,3
ES,WHEEZING,3
ES,ABDOMINAL DISCOMFORT,2
ES,ABORTION SPONTANEOUS,2
ES,ACUTE PSYCHOSIS,2
ES,ACUTE PULMONARY OEDEMA,2
ES,ANGINA UNSTABLE,2
ES,ARTHRITIS BACTERIAL,2
ES,ASCITES,2
ES,ATOPY,2
ES,BENIGN PROSTATIC HYPERPLASIA,2
ES,BENIGN SALIVARY GLAND NEOPLASM,2
ES,BLOOD ALKALINE PHOSPHATASE INCREASED,2
ES,BLOOD CHOLESTEROL INCREASED,2
ES,BLOOD CREATININE INCREASED,2
ES,BLOOD PRESSURE DIASTOLIC INCREASED,2
ES,BLOOD PRESSURE INCREASED,2
ES,BONE PAIN,2
ES,BRADYCARDIA,2
ES,BREAST CANCER,2
ES,CARDIAC ARREST,2
ES,CELLULITIS,2
ES,CENTRAL NERVOUS SYSTEM LESION,2
ES,CHOLELITHIASIS,2
ES,CHOLESTASIS,2
ES,CHRONIC KIDNEY DISEASE,2
ES,COLITIS,2
ES,COMA SCALE ABNORMAL,2
ES,CONJUNCTIVAL HYPERAEMIA,2
ES,CONSTIPATION,2
ES,CORNEAL EROSION,2
ES,CRYPTORCHISM,2
ES,CUSHING^S SYNDROME,2
ES,CUTANEOUS VASCULITIS,2
ES,DEAFNESS,2
ES,DEEP VEIN THROMBOSIS,2
ES,DENTAL CARIES,2
ES,DISORIENTATION,2
ES,DISTRIBUTIVE SHOCK,2
ES,DRUG ADMINISTERED AT INAPPROPRIATE SITE,2
ES,DRUG ADMINISTRATION ERROR,2
ES,DUODENAL ULCER PERFORATION,2
ES,DUODENITIS,2
ES,DYSKINESIA,2
ES,DYSURIA,2
ES,ENTEROCOLITIS,2
ES,EYE PAIN,2
ES,EYELID DISORDER,2
ES,FEELING HOT,2
ES,FIBROMYALGIA,2
ES,FUNGAL RHINITIS,2
ES,GASTRITIS,2
ES,GENERALISED OEDEMA,2
ES,GENITAL EROSION,2
ES,GENITAL LESION,2
ES,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
ES,GROWTH RETARDATION,2
ES,HAEMATOCRIT DECREASED,2
ES,HAEMATURIA,2
ES,HALLUCINATION_ VISUAL,2
ES,HEART INJURY,2
ES,HIATUS HERNIA,2
ES,HYPERBILIRUBINAEMIA,2
ES,HYPERSENSITIVITY VASCULITIS,2
ES,HYPERTRANSAMINASAEMIA,2
ES,HYPOCALCAEMIA,2
ES,HYPOKINESIA,2
ES,HYPOTHERMIA,2
ES,HYPOVENTILATION,2
ES,HYPOVOLAEMIC SHOCK,2
ES,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
ES,INFECTION,2
ES,INFLUENZA,2
ES,INJECTION SITE DISCOLOURATION,2
ES,INSOMNIA,2
ES,INTESTINAL OBSTRUCTION,2
ES,JOINT SWELLING,2
ES,LEFT VENTRICULAR DYSFUNCTION,2
ES,LIP DISORDER,2
ES,LYMPHADENOPATHY,2
ES,LYMPHOPENIA,2
ES,MATERNAL EXPOSURE DURING PREGNANCY,2
ES,MEDICATION ERROR,2
ES,MELAENA,2
ES,MYELODYSPLASTIC SYNDROME,2
ES,MYOCARDIAL INFARCTION,2
ES,MYOCARDIAL ISCHAEMIA,2
ES,NASAL CONGESTION,2
ES,OESOPHAGEAL ULCER HAEMORRHAGE,2
ES,OLIGURIA,2
ES,ORAL PAIN,2
ES,ORAL PRURITUS,2
ES,OSTEOARTHRITIS,2
ES,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,2
ES,PERIPHERAL SWELLING,2
ES,PERITONITIS,2
ES,PLATELET COUNT DECREASED,2
ES,PNEUMONIA BACTERIAL,2
ES,POISONING DELIBERATE,2
ES,PROCTALGIA,2
ES,RESPIRATORY SYMPTOM,2
ES,RESTLESSNESS,2
ES,SALIVARY HYPERSECRETION,2
ES,SKIN DEPIGMENTATION,2
ES,SKIN EROSION,2
ES,SKIN EXFOLIATION,2
ES,SOMNOLENCE,2
ES,SPINAL COLUMN STENOSIS,2
ES,SPINAL FRACTURE,2
ES,SQUAMOUS CELL CARCINOMA,2
ES,SUDDEN HEARING LOSS,2
ES,SYNCOPE,2
ES,THROMBOSIS,2
ES,THYROID NEOPLASM,2
ES,TRACHEOBRONCHITIS,2
ES,VASCULITIS,2
ES,VERTIGO,2
ES,VISUAL IMPAIRMENT,2
ES,WEIGHT DECREASED,2
ES,ABDOMINAL DISTENSION,1
ES,ABDOMINAL RIGIDITY,1
ES,ABDOMINAL SEPSIS,1
ES,ABDOMINAL WALL HAEMATOMA,1
ES,ACCIDENTAL EXPOSURE TO PRODUCT,1
ES,ACCIDENTAL OVERDOSE,1
ES,ACTIVATED PARTIAL THROMBOPLASTIN TIME RATIO DECREASED,1
ES,ACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,1
ES,ACUTE LEUKAEMIA,1
ES,ACUTE MYELOID LEUKAEMIA,1
ES,ACUTE RESPIRATORY FAILURE,1
ES,ADENOCARCINOMA OF COLON,1
ES,ADNEXA UTERI PAIN,1
ES,ADRENAL ATROPHY,1
ES,ADRENAL INSUFFICIENCY,1
ES,ALBUMINURIA,1
ES,ALICE IN WONDERLAND SYNDROME,1
ES,ANAL HAEMORRHAGE,1
ES,ANAPHYLACTOID REACTION,1
ES,ANGIOPATHY,1
ES,ANURIA,1
ES,AORTIC ARTERIOSCLEROSIS,1
ES,APALLIC SYNDROME,1
ES,ARTERIAL THROMBOSIS,1
ES,ARTERIOSCLEROSIS CORONARY ARTERY,1
ES,ARTHROPATHY,1
ES,ASPERGILLUS INFECTION,1
ES,ASPHYXIA,1
ES,ATELECTASIS,1
ES,ATRIAL FLUTTER,1
ES,ATRIOVENTRICULAR BLOCK,1
ES,ATROPHIC GLOSSITIS,1
ES,AUTOIMMUNE HEPATITIS,1
ES,BASAL CELL CARCINOMA,1
ES,BILIARY DRAINAGE,1
ES,BILIARY TRACT INFECTION,1
ES,BLADDER DIVERTICULUM,1
ES,BLADDER PAIN,1
ES,BLINDNESS,1
ES,BLINDNESS TRANSIENT,1
ES,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
ES,BLOOD PH DECREASED,1
ES,BLOOD PHOSPHORUS DECREASED,1
ES,BLOOD TRIGLYCERIDES INCREASED,1
ES,BLOOD UREA INCREASED,1
ES,BONE MARROW INFILTRATION,1
ES,BREAST ABSCESS,1
ES,BREAST PAIN,1
ES,BRONCHITIS,1
ES,BRONCHOPULMONARY ASPERGILLOSIS,1
ES,CAMPYLOBACTER GASTROENTERITIS,1
ES,CAMPYLOBACTER INFECTION,1
ES,CANDIDA INFECTION,1
ES,CAPILLARY LEAK SYNDROME,1
ES,CARCINOMA IN SITU OF SKIN,1
ES,CARDIAC FAILURE CHRONIC,1
ES,CARDIAC FAILURE CONGESTIVE,1
ES,CARDIOVASCULAR DISORDER,1
ES,CATARACT,1
ES,CEREBRAL ATROPHY,1
ES,CEREBRAL HAEMATOMA,1
ES,CEREBRAL HAEMORRHAGE,1
ES,CEREBRAL ISCHAEMIA,1
ES,CHOLANGITIS,1
ES,CHOLECYSTITIS,1
ES,CHOLECYSTITIS ACUTE,1
ES,CHOLURIA,1
ES,CHOREA,1
ES,CHRONIC GASTRITIS,1
ES,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
ES,CLOSTRIDIUM DIFFICILE INFECTION,1
ES,COGNITIVE DISORDER,1
ES,COLD SWEAT,1
ES,COLITIS ISCHAEMIC,1
ES,CONGENITAL ANOMALY,1
ES,CONJUNCTIVAL HAEMORRHAGE,1
ES,CONTRAINDICATION TO MEDICAL TREATMENT,1
ES,CONTUSION,1
ES,CORNEAL PERFORATION,1
ES,CORONARY ARTERY DISEASE,1
ES,CORONARY ARTERY THROMBOSIS,1
ES,CREATININE RENAL CLEARANCE DECREASED,1
ES,CUTANEOUS LUPUS ERYTHEMATOSUS,1
ES,CUTANEOUS SYMPTOM,1
ES,CYANOSIS,1
ES,CYSTITIS,1
ES,DEHYDRATION,1
ES,DELAYED MYELINATION,1
ES,DEMENTIA,1
ES,DEPRESSION,1
ES,DEREALISATION,1
ES,DERMATITIS,1
ES,DERMATITIS BULLOUS,1
ES,DEVICE BREAKAGE,1
ES,DEVICE RELATED INFECTION,1
ES,DIPLOPIA,1
ES,DISCOMFORT,1
ES,DISTURBANCE IN ATTENTION,1
ES,DIVERTICULITIS,1
ES,DIVERTICULUM,1
ES,DIVERTICULUM INTESTINAL,1
ES,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
ES,DRUG CROSS-REACTIVITY,1
ES,DRUG DEPENDENCE,1
ES,DRUG LEVEL BELOW THERAPEUTIC,1
ES,DRUG LEVEL DECREASED,1
ES,DRUG LEVEL INCREASED,1
ES,DRUG TITRATION ERROR,1
ES,DRY MOUTH,1
ES,DUCTUS ARTERIOSUS PREMATURE CLOSURE,1
ES,DUODENAL ULCER,1
ES,DUPUYTREN^S CONTRACTURE,1
ES,DYSAESTHESIA,1
ES,EAR PAIN,1
ES,EATING DISORDER,1
ES,ELECTROCARDIOGRAM QT PROLONGED,1
ES,EMBOLISM VENOUS,1
ES,EMPHYSEMA,1
ES,ENCEPHALITIS,1
ES,ENTERITIS,1
ES,EPIDERMAL NECROSIS,1
ES,EPIGASTRIC DISCOMFORT,1
ES,EPILEPSY,1
ES,ESCHERICHIA INFECTION,1
ES,EXPOSURE DURING PREGNANCY,1
ES,EXTRA DOSE ADMINISTERED,1
ES,EXTRAVASATION,1
ES,EYE HAEMORRHAGE,1
ES,EYE OEDEMA,1
ES,EYE PRURITUS,1
ES,EYE SWELLING,1
ES,EYELID FUNCTION DISORDER,1
ES,EYELID OEDEMA,1
ES,FACIAL PARALYSIS,1
ES,FALL,1
ES,FEELING ABNORMAL,1
ES,FIXED DRUG ERUPTION,1
ES,FLUID RETENTION,1
ES,FLUSHING,1
ES,FREEZING PHENOMENON,1
ES,GAIT INABILITY,1
ES,GALLBLADDER NEOPLASM,1
ES,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
ES,GASTRIC HAEMORRHAGE,1
ES,GASTRIC MUCOSAL LESION,1
ES,GASTRIC POLYPS,1
ES,GASTRIC ULCER PERFORATION,1
ES,GASTROINTESTINAL ULCER,1
ES,GENERALISED ERYTHEMA,1
ES,GENITAL PAIN,1
ES,GLAUCOMA,1
ES,GLOSSITIS,1
ES,GUILLAIN-BARRE SYNDROME,1
ES,GYNAECOMASTIA,1
ES,HAEMATOTOXICITY,1
ES,HAEMODYNAMIC INSTABILITY,1
ES,HAEMORRHAGE,1
ES,HAEMORRHOIDAL HAEMORRHAGE,1
ES,HALLUCINATION_ AUDITORY,1
ES,HEPATIC ENZYME INCREASED,1
ES,HEPATIC HAEMORRHAGE,1
ES,HEPATIC LYMPHOCYTIC INFILTRATION,1
ES,HEPATIC NECROSIS,1
ES,HEPATITIS ACUTE,1
ES,HEPATITIS TOXIC,1
ES,HEPATOCELLULAR INJURY,1
ES,HEPATORENAL FAILURE,1
ES,HERPES VIRUS INFECTION,1
ES,HODGKIN^S DISEASE,1
ES,HOT FLUSH,1
ES,HYPERCOAGULATION,1
ES,HYPERGLYCAEMIA,1
ES,HYPERPARATHYROIDISM,1
ES,HYPERTHYROIDISM,1
ES,HYPOGLYCAEMIC COMA,1
ES,HYPOPROTEINAEMIA,1
ES,HYPOTHYROIDISM,1
ES,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,1
ES,ILEUS PARALYTIC,1
ES,IMMUNOSUPPRESSION,1
ES,INCORRECT DOSAGE ADMINISTERED,1
ES,INCORRECT DRUG ADMINISTRATION DURATION,1
ES,INFECTIOUS MONONUCLEOSIS,1
ES,INFLUENZA LIKE ILLNESS,1
ES,INFUSION RELATED REACTION,1
ES,INJECTION SITE DISCOMFORT,1
ES,INJECTION SITE INFLAMMATION,1
ES,INJECTION SITE PRURITUS,1
ES,INJECTION SITE RASH,1
ES,INJECTION SITE WARMTH,1
ES,INTERNATIONAL NORMALISED RATIO INCREASED,1
ES,INTERVERTEBRAL DISC DEGENERATION,1
ES,INTERVERTEBRAL DISC PROTRUSION,1
ES,INTESTINAL HAEMORRHAGE,1
ES,INTESTINAL ISCHAEMIA,1
ES,INTESTINAL ULCER,1
ES,INTESTINAL ULCER PERFORATION,1
ES,INTRACARDIAC THROMBUS,1
ES,INTRAVENTRICULAR HAEMORRHAGE,1
ES,INTUSSUSCEPTION,1
ES,IRIDOCYCLITIS,1
ES,IRIS ADHESIONS,1
ES,IRON DEFICIENCY ANAEMIA,1
ES,KETOACIDOSIS,1
ES,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
ES,LACRIMATION INCREASED,1
ES,LACUNAR INFARCTION,1
ES,LARGE INTESTINE POLYP,1
ES,LEFT VENTRICULAR FAILURE,1
ES,LETHARGY,1
ES,LIP PRURITUS,1
ES,LIVER DISORDER,1
ES,LIVER FUNCTION TEST ABNORMAL,1
ES,LIVER TRANSPLANT,1
ES,LOCAL SWELLING,1
ES,LOSS OF CONSCIOUSNESS,1
ES,LUNG INFILTRATION,1
ES,LUPUS-LIKE SYNDROME,1
ES,MACULAR OEDEMA,1
ES,MACULE,1
ES,MALABSORPTION,1
ES,MALIGNANT MELANOMA,1
ES,MASTOCYTOSIS,1
ES,MEDICATION RESIDUE PRESENT,1
ES,MENINGOENCEPHALITIS HERPETIC,1
ES,MENINGOENCEPHALITIS VIRAL,1
ES,MERALGIA PARAESTHETICA,1
ES,MESENTERIC PANNICULITIS,1
ES,METRORRHAGIA,1
ES,MICTURITION FREQUENCY DECREASED,1
ES,MIGRAINE,1
ES,MIGRAINE WITH AURA,1
ES,MIXED LIVER INJURY,1
ES,MOBILITY DECREASED,1
ES,MOUTH HAEMORRHAGE,1
ES,MUCOSAL HAEMORRHAGE,1
ES,MUCOUS MEMBRANE DISORDER,1
ES,MULTI-ORGAN FAILURE,1
ES,MUSCLE CONTRACTIONS INVOLUNTARY,1
ES,MUSCLE FATIGUE,1
ES,MUSCULOSKELETAL CHEST PAIN,1
ES,MYOCARDITIS,1
ES,MYOSITIS,1
ES,NASAL OBSTRUCTION,1
ES,NASAL POLYPS,1
ES,NECROSIS,1
ES,NEOPLASM,1
ES,NEOPLASM MALIGNANT,1
ES,NEOPLASM PROGRESSION,1
ES,NEPHRITIS,1
ES,NEPHROTIC SYNDROME,1
ES,NERVOUSNESS,1
ES,NEURODERMATITIS,1
ES,NEUROENDOCRINE CARCINOMA,1
ES,NEUTROPENIC SEPSIS,1
ES,NEUTROPHILIA,1
ES,NODULAR REGENERATIVE HYPERPLASIA,1
ES,NON-CARDIAC CHEST PAIN,1
ES,NON-SMALL CELL LUNG CANCER,1
ES,OBSTRUCTIVE AIRWAYS DISORDER,1
ES,OCULAR DISCOMFORT,1
ES,OCULAR HYPERAEMIA,1
ES,OCULAR VASCULAR DISORDER,1
ES,OCULOGYRIC CRISIS,1
ES,OESOPHAGEAL HAEMORRHAGE,1
ES,OESOPHAGEAL PERFORATION,1
ES,OESOPHAGEAL ULCER,1
ES,OESOPHAGITIS,1
ES,OPTIC NEURITIS,1
ES,ORAL CANDIDIASIS,1
ES,ORAL DISORDER,1
ES,ORAL MUCOSA EROSION,1
ES,ORAL MUCOSAL ERUPTION,1
ES,OROPHARYNGEAL BLISTERING,1
ES,OSTEONECROSIS,1
ES,OSTEOPENIA,1
ES,OXYGEN SATURATION DECREASED,1
ES,PALLOR,1
ES,PALMOPLANTAR KERATODERMA,1
ES,PANCREATITIS,1
ES,PANNICULITIS,1
ES,PAPILLARY THYROID CANCER,1
ES,PARKINSONISM,1
ES,PARKINSON^S DISEASE,1
ES,PELVIC PAIN,1
ES,PELVIC VENOUS THROMBOSIS,1
ES,PENILE ERYTHEMA,1
ES,PEPTIC ULCER,1
ES,PEPTIC ULCER PERFORATION,1
ES,PERFORMANCE STATUS DECREASED,1
ES,PERICARDITIS,1
ES,PERINEURIAL CYST,1
ES,PERIODONTAL DISEASE,1
ES,PERIORBITAL CELLULITIS,1
ES,PERIORBITAL OEDEMA,1
ES,PERIPHERAL ISCHAEMIA,1
ES,PERIPHERAL VENOUS DISEASE,1
ES,PERSECUTORY DELUSION,1
ES,PETECHIAE,1
ES,PEYRONIE^S DISEASE,1
ES,PHARYNGEAL LESION,1
ES,PHOTOPHOBIA,1
ES,PHOTOSENSITIVITY REACTION,1
ES,PHYSICAL DISABILITY,1
ES,PLEURAL FIBROSIS,1
ES,PLEURISY,1
ES,PNEUMONIA INFLUENZAL,1
ES,PNEUMOTHORAX,1
ES,POLYNEUROPATHY,1
ES,POLYP,1
ES,PORTAL HYPERTENSION,1
ES,POSTOPERATIVE WOUND INFECTION,1
ES,PRESYNCOPE,1
ES,PRIAPISM,1
ES,PROCEDURAL COMPLICATION,1
ES,PROCTITIS,1
ES,PRODUCT QUALITY ISSUE,1
ES,PRODUCTIVE COUGH,1
ES,PROSTATE CANCER,1
ES,PRURITUS GENITAL,1
ES,PSYCHOGENIC SEIZURE,1
ES,PSYCHOMOTOR HYPERACTIVITY,1
ES,PULMONARY ALVEOLAR HAEMORRHAGE,1
ES,PULMONARY EMBOLISM,1
ES,PULMONARY HAEMORRHAGE,1
ES,PULMONARY MASS,1
ES,PULMONARY TOXICITY,1
ES,PURPURA,1
ES,RADIATION SKIN INJURY,1
ES,RADICULITIS CERVICAL,1
ES,RASH ERYTHEMATOUS,1
ES,RASH MORBILLIFORM,1
ES,RASH PAPULAR,1
ES,RED CELL DISTRIBUTION WIDTH INCREASED,1
ES,REGURGITATION,1
ES,RENAL CELL CARCINOMA,1
ES,RENAL CYST,1
ES,RENAL MASS,1
ES,RENAL NECROSIS,1
ES,RENAL NEOPLASM,1
ES,RESPIRATORY ACIDOSIS,1
ES,RESPIRATORY DISTRESS,1
ES,RETINAL DETACHMENT,1
ES,RETINOPATHY,1
ES,RETINOPATHY CONGENITAL,1
ES,RETROPERITONEAL LYMPHADENOPATHY,1
ES,RHEUMATOID FACTOR INCREASED,1
ES,RHINORRHOEA,1
ES,RIB FRACTURE,1
ES,ROTAVIRUS TEST POSITIVE,1
ES,SARCOIDOSIS,1
ES,SCAB,1
ES,SEDATION,1
ES,SEIZURE,1
ES,SENSATION OF FOREIGN BODY,1
ES,SENSORY LOSS,1
ES,SEPSIS,1
ES,SEROTONIN SYNDROME,1
ES,SHOCK,1
ES,SHOCK HAEMORRHAGIC,1
ES,SINUSITIS,1
ES,SKIN DISCOLOURATION,1
ES,SKIN DISORDER,1
ES,SKIN HYPERPIGMENTATION,1
ES,SKIN MASS,1
ES,SPINAL OSTEOARTHRITIS,1
ES,SPLENIC LESION,1
ES,SPUTUM CULTURE POSITIVE,1
ES,SQUAMOUS CELL CARCINOMA OF THE TONGUE,1
ES,STAPHYLOCOCCAL INFECTION,1
ES,STERNAL FRACTURE,1
ES,STRABISMUS,1
ES,STREPTOCOCCUS TEST POSITIVE,1
ES,STRESS,1
ES,SUBACUTE HEPATIC FAILURE,1
ES,SUPERIOR VENA CAVA SYNDROME,1
ES,SWELLING FACE,1
ES,SWOLLEN TONGUE,1
ES,SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA,1
ES,SYNOVIAL RUPTURE,1
ES,SYSTEMIC LUPUS ERYTHEMATOSUS,1
ES,TENDERNESS,1
ES,TENDON RUPTURE,1
ES,THROAT IRRITATION,1
ES,THROMBOTIC MICROANGIOPATHY,1
ES,TONGUE BLISTERING,1
ES,TONGUE DISCOLOURATION,1
ES,TONGUE DISORDER,1
ES,TONGUE PRURITUS,1
ES,TONIC CONVULSION,1
ES,TONSILLAR HYPERTROPHY,1
ES,TOOTH EROSION,1
ES,TRANSIENT ISCHAEMIC ATTACK,1
ES,TREMOR,1
ES,TYPE IV HYPERSENSITIVITY REACTION,1
ES,ULCER,1
ES,URETHRAL STENOSIS,1
ES,URINARY BLADDER POLYP,1
ES,URINARY RETENTION,1
ES,URINARY TRACT OBSTRUCTION,1
ES,VENA CAVA THROMBOSIS,1
ES,VENOUS INSUFFICIENCY,1
ES,VENTRICULAR SEPTAL DEFECT,1
ES,VIRAL RASH,1
ES,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
ES,VISION BLURRED,1
ES,VITAMIN D DEFICIENCY,1
ES,VITH NERVE PARALYSIS,1
ES,VITREOUS DETACHMENT,1
ES,VULVAL OEDEMA,1
ES,VULVAR EROSION,1
ES,VULVOVAGINAL SWELLING,1
ES,WHITE BLOOD CELL COUNT DECREASED,1
ES,WHITE BLOOD CELL COUNT INCREASED,1
ES,WHITE BLOOD CELLS URINE POSITIVE,1
ES,WOUND DEHISCENCE,1
ES,WOUND HAEMORRHAGE,1
ES,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
SE,HEPATIC FAILURE,13
SE,ACUTE KIDNEY INJURY,11
SE,BRAIN OEDEMA,9
SE,FATIGUE,8
SE,TOXICITY TO VARIOUS AGENTS,7
SE,AGITATION,6
SE,DIARRHOEA,6
SE,GAIT DISTURBANCE,6
SE,DEATH,5
SE,PYREXIA,5
SE,VOMITING,5
SE,ASTHENIA,4
SE,BLOOD GLUCOSE ABNORMAL,4
SE,HEADACHE,4
SE,PRURITUS,4
SE,SPEECH DISORDER,4
SE,ABDOMINAL PAIN UPPER,3
SE,ANAEMIA,3
SE,ANGIOEDEMA,3
SE,CARDIAC FAILURE,3
SE,DIZZINESS,3
SE,DRUG ABUSE,3
SE,DRUG INEFFECTIVE,3
SE,DYSPNOEA,3
SE,INTENTIONAL SELF-INJURY,3
SE,JAUNDICE,3
SE,LIVER INJURY,3
SE,OVERDOSE,3
SE,PRODUCT USE ISSUE,3
SE,REYE^S SYNDROME,3
SE,SYNCOPE,3
SE,ALTERED STATE OF CONSCIOUSNESS,2
SE,AMMONIA INCREASED,2
SE,CONVULSION,2
SE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
SE,DRUG-INDUCED LIVER INJURY,2
SE,ELECTROCARDIOGRAM QT PROLONGED,2
SE,FLUID RETENTION,2
SE,GASTRIC ULCER,2
SE,HYPERAMMONAEMIA,2
SE,MUSCLE SPASMS,2
SE,NAUSEA,2
SE,OESOPHAGITIS HAEMORRHAGIC,2
SE,RASH,2
SE,SEIZURE,2
SE,SUICIDAL IDEATION,2
SE,SWELLING FACE,2
SE,TRANSFUSION,2
SE,ABDOMINAL DISCOMFORT,1
SE,ABDOMINAL HERNIA,1
SE,ABDOMINAL HERNIA OBSTRUCTIVE,1
SE,ABDOMINAL PAIN,1
SE,ACUTE PRERENAL FAILURE,1
SE,AGEUSIA,1
SE,ALANINE AMINOTRANSFERASE INCREASED,1
SE,ALOPECIA,1
SE,ANAEMIA POSTOPERATIVE,1
SE,ANASTOMOTIC LEAK,1
SE,ANOSMIA,1
SE,ANXIETY,1
SE,APHASIA,1
SE,ARRHYTHMIA,1
SE,ASPARTATE AMINOTRANSFERASE INCREASED,1
SE,BACK PAIN,1
SE,BALANCE DISORDER,1
SE,BLOOD CORTISOL DECREASED,1
SE,BLOOD CREATININE INCREASED,1
SE,BLOOD PRESSURE INCREASED,1
SE,C-REACTIVE PROTEIN INCREASED,1
SE,CAPILLARY LEAK SYNDROME,1
SE,CEREBROVASCULAR ACCIDENT,1
SE,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
SE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
SE,CIRCULATORY COLLAPSE,1
SE,COLITIS,1
SE,CONDITION AGGRAVATED,1
SE,CONFUSIONAL STATE,1
SE,CONSTIPATION,1
SE,CONTRAINDICATED DRUG ADMINISTERED,1
SE,COUGH,1
SE,CROHN^S DISEASE,1
SE,DEPRESSED MOOD,1
SE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
SE,DYSPEPSIA,1
SE,DYSSTASIA,1
SE,EPILEPSY,1
SE,EPISTAXIS,1
SE,ERYTHEMA,1
SE,FEBRILE NEUTROPENIA,1
SE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
SE,GASTRIC HAEMORRHAGE,1
SE,GASTRIC ULCER PERFORATION,1
SE,GASTRITIS HAEMORRHAGIC,1
SE,HALLUCINATION_ VISUAL,1
SE,HEMIPLEGIA,1
SE,HEPATITIS,1
SE,HYPERHIDROSIS,1
SE,HYPERSENSITIVITY,1
SE,HYPERTENSION,1
SE,HYPOACUSIS,1
SE,HYPOAESTHESIA,1
SE,HYPOCALCAEMIA,1
SE,HYPOCOMPLEMENTAEMIA,1
SE,HYPOPHYSITIS,1
SE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
SE,INSOMNIA,1
SE,INTENTIONAL OVERDOSE,1
SE,INTERVERTEBRAL DISC PROTRUSION,1
SE,INTRAVENTRICULAR HAEMORRHAGE,1
SE,LEUKOCYTOSIS,1
SE,LIP SWELLING,1
SE,LOSS OF CONSCIOUSNESS,1
SE,MELAENA,1
SE,MEMORY IMPAIRMENT,1
SE,MIGRAINE,1
SE,MITOCHONDRIAL CYTOPATHY,1
SE,MUSCLE TIGHTNESS,1
SE,MUSCULOSKELETAL STIFFNESS,1
SE,NAIL DISORDER,1
SE,NAIL HYPERTROPHY,1
SE,NECROTISING COLITIS,1
SE,NEPHROPATHY TOXIC,1
SE,NEUROPATHY PERIPHERAL,1
SE,OEDEMA,1
SE,OEDEMA PERIPHERAL,1
SE,OLIGURIA,1
SE,OROPHARYNGEAL PAIN,1
SE,PAIN,1
SE,PAIN IN EXTREMITY,1
SE,PARAESTHESIA,1
SE,PERICARDIAL EFFUSION,1
SE,PHARYNGEAL HYPOAESTHESIA,1
SE,PHARYNGITIS,1
SE,PHOTOSENSITIVITY REACTION,1
SE,PLEURAL EFFUSION,1
SE,PNEUMONITIS,1
SE,POST PROCEDURAL HAEMORRHAGE,1
SE,PRODUCT SUBSTITUTION ISSUE,1
SE,PRODUCT USE IN UNAPPROVED INDICATION,1
SE,PUBIS FRACTURE,1
SE,PULMONARY EMBOLISM,1
SE,PULMONARY OEDEMA,1
SE,RENAL FAILURE ACUTE,1
SE,RESPIRATORY DISORDER,1
SE,RESPIRATORY FAILURE,1
SE,SEPSIS,1
SE,SEPTIC ARTHRITIS STAPHYLOCOCCAL,1
SE,SKIN DISORDER,1
SE,SKIN HYPERTROPHY,1
SE,SOMNOLENCE,1
SE,STREPTOCOCCAL INFECTION,1
SE,SWELLING,1
SE,THERAPEUTIC RESPONSE CHANGED,1
SE,THROAT IRRITATION,1
SE,TREMOR,1
SE,VISION BLURRED,1
SE,WOUND INFECTION,1
SE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
CH,ACUTE KIDNEY INJURY,16
CH,HEAT STROKE,15
CH,EXPOSURE DURING PREGNANCY,12
CH,RENAL FAILURE ACUTE,9
CH,ABDOMINAL PAIN UPPER,8
CH,RENAL IMPAIRMENT,8
CH,VOMITING,8
CH,WEIGHT DECREASED,8
CH,COMA,7
CH,HEPATOCELLULAR INJURY,7
CH,MANIA,7
CH,MULTIPLE ORGAN DYSFUNCTION SYNDROME,7
CH,MUSCULAR WEAKNESS,7
CH,AGRANULOCYTOSIS,6
CH,ANHIDROSIS,6
CH,ASTHENIA,6
CH,ATAXIA,6
CH,DRUG LEVEL INCREASED,6
CH,FALL,6
CH,PYREXIA,6
CH,SOMNOLENCE,6
CH,DECREASED APPETITE,5
CH,DIZZINESS,5
CH,DRUG INEFFECTIVE,5
CH,DYSPNOEA,5
CH,FOETAL EXPOSURE DURING PREGNANCY,5
CH,PNEUMONIA,5
CH,PNEUMONIA ASPIRATION,5
CH,SHOCK,5
CH,SUICIDE ATTEMPT,5
CH,ABORTION INDUCED,4
CH,ABORTION SPONTANEOUS,4
CH,CEREBROVASCULAR ACCIDENT,4
CH,CONFUSIONAL STATE,4
CH,DIARRHOEA,4
CH,FOETAL GROWTH RESTRICTION,4
CH,GAIT DISTURBANCE,4
CH,GASTROINTESTINAL HAEMORRHAGE,4
CH,HYPOAESTHESIA,4
CH,INTENTIONAL OVERDOSE,4
CH,MATERNAL EXPOSURE DURING PREGNANCY,4
CH,OVERDOSE,4
CH,PAIN,4
CH,PARAESTHESIA,4
CH,RENAL FAILURE,4
CH,TACHYCARDIA,4
CH,TOXICITY TO VARIOUS AGENTS,4
CH,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
CH,COLITIS,3
CH,DYSPEPSIA,3
CH,ELECTROCARDIOGRAM QT PROLONGED,3
CH,HAEMATEMESIS,3
CH,HYPOHIDROSIS,3
CH,HYPOKALAEMIA,3
CH,HYPOMAGNESAEMIA,3
CH,HYPOTENSION,3
CH,INFLAMMATION,3
CH,INFLUENZA LIKE ILLNESS,3
CH,MELAENA,3
CH,RASH MACULO-PAPULAR,3
CH,RHABDOMYOLYSIS,3
CH,SEIZURE,3
CH,SLEEP DISORDER,3
CH,SPINAL FRACTURE,3
CH,TUBULOINTERSTITIAL NEPHRITIS,3
CH,VISION BLURRED,3
CH,ABDOMINAL PAIN,2
CH,AGGRESSION,2
CH,ALANINE AMINOTRANSFERASE INCREASED,2
CH,ANAEMIA,2
CH,ANAPHYLACTIC REACTION,2
CH,ANGIOEDEMA,2
CH,ANTIPHOSPHOLIPID SYNDROME,2
CH,ASPARTATE AMINOTRANSFERASE INCREASED,2
CH,ASPIRATION BRONCHIAL,2
CH,BLOOD CREATININE INCREASED,2
CH,BLOOD POTASSIUM INCREASED,2
CH,BLOOD PRESSURE DECREASED,2
CH,COGNITIVE DISORDER,2
CH,CONSTIPATION,2
CH,CORROSIVE GASTRITIS,2
CH,DEPRESSED LEVEL OF CONSCIOUSNESS,2
CH,DISTURBANCE IN ATTENTION,2
CH,DRUG ABUSE,2
CH,DYSPNOEA EXERTIONAL,2
CH,EXTRADURAL HAEMATOMA,2
CH,EYE PAIN,2
CH,HAEMORRHAGE,2
CH,HAEMORRHAGE INTRACRANIAL,2
CH,HEADACHE,2
CH,HYPERKALAEMIA,2
CH,HYPERLACTACIDAEMIA,2
CH,HYPOCALCAEMIA,2
CH,HYPONATRAEMIA,2
CH,HYPOREFLEXIA,2
CH,INJECTION SITE ERYTHEMA,2
CH,INJECTION SITE PAIN,2
CH,LEUKOPENIA,2
CH,LOSS OF CONSCIOUSNESS,2
CH,METABOLIC ACIDOSIS,2
CH,MULTI-ORGAN FAILURE,2
CH,MYALGIA,2
CH,NEPHROTIC SYNDROME,2
CH,PAIN IN EXTREMITY,2
CH,PALPITATIONS,2
CH,PANCREATITIS,2
CH,PANCYTOPENIA,2
CH,PARAPLEGIA,2
CH,PERIPHERAL ARTERY THROMBOSIS,2
CH,PERIPHERAL ISCHAEMIA,2
CH,PHARYNGITIS,2
CH,POISONING,2
CH,POTENTIATING DRUG INTERACTION,2
CH,PRODUCT USE ISSUE,2
CH,RESPIRATORY ACIDOSIS,2
CH,SEPSIS,2
CH,SEROTONIN SYNDROME,2
CH,SKIN NECROSIS,2
CH,SPINAL PAIN,2
CH,TACHYPNOEA,2
CH,TENDON RUPTURE,2
CH,TOOTH LOSS,2
CH,TOXIC EPIDERMAL NECROLYSIS,2
CH,VENTRICULAR EXTRASYSTOLES,2
CH,ABDOMINAL FAT APRON,1
CH,ABNORMAL BEHAVIOUR,1
CH,ABORTION,1
CH,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,1
CH,ACCIDENTAL OVERDOSE,1
CH,ACCIDENTAL POISONING,1
CH,ACUTE RESPIRATORY FAILURE,1
CH,AFFECT LABILITY,1
CH,AGEUSIA,1
CH,ALVEOLITIS,1
CH,AMNESIA,1
CH,ANTICOAGULATION DRUG LEVEL INCREASED,1
CH,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
CH,ANXIETY,1
CH,APHASIA,1
CH,APRAXIA,1
CH,ARACHNOID CYST,1
CH,ARTERIAL SPASM,1
CH,ARTHRALGIA,1
CH,BACK PAIN,1
CH,BACTERIAL INFECTION,1
CH,BALANOPOSTHITIS,1
CH,BLADDER CANCER,1
CH,BLOOD GLUCOSE INCREASED,1
CH,BLOOD PRESSURE IMMEASURABLE,1
CH,BONE DENSITY DECREASED,1
CH,BRONCHOSPASM,1
CH,CALCULUS URINARY,1
CH,CARDIOPULMONARY FAILURE,1
CH,CELLULITIS,1
CH,CEREBELLAR SYNDROME,1
CH,CEREBRAL HAEMATOMA,1
CH,CEREBRAL HAEMORRHAGE,1
CH,CEREBRAL MICROANGIOPATHY,1
CH,CEREBRAL VASOCONSTRICTION,1
CH,CHOLESTATIC LIVER INJURY,1
CH,COMPARTMENT SYNDROME,1
CH,CONGENITAL MEGACOLON,1
CH,CONTUSION,1
CH,DEATH,1
CH,DECEREBRATE POSTURE,1
CH,DELUSION,1
CH,DEPRESSION,1
CH,DERMATITIS,1
CH,DEVICE RELATED INFECTION,1
CH,DISINHIBITION,1
CH,DIVERTICULITIS,1
CH,DIVERTICULITIS INTESTINAL HAEMORRHAGIC,1
CH,DIVERTICULUM INTESTINAL,1
CH,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
CH,DRUG HYPERSENSITIVITY,1
CH,DRUG INTOLERANCE,1
CH,DRUG PRESCRIBING ERROR,1
CH,DRUG SCREEN FALSE POSITIVE,1
CH,DRUG SCREEN POSITIVE,1
CH,DYSGEUSIA,1
CH,DYSPHAGIA,1
CH,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
CH,ELEVATED MOOD,1
CH,ENERGY INCREASED,1
CH,ENURESIS,1
CH,EOSINOPHILIA,1
CH,EPILEPSY,1
CH,ERYTHEMA,1
CH,ESCHERICHIA URINARY TRACT INFECTION,1
CH,EUPHORIC MOOD,1
CH,EXERCISE TOLERANCE DECREASED,1
CH,EXTENSOR PLANTAR RESPONSE,1
CH,EXTRAPYRAMIDAL DISORDER,1
CH,EYE MOVEMENT DISORDER,1
CH,FASCIAL RUPTURE,1
CH,FATIGUE,1
CH,FEMUR FRACTURE,1
CH,FLIGHT OF IDEAS,1
CH,FOETAL DEATH,1
CH,FOOT DEFORMITY,1
CH,GASTRIC HAEMORRHAGE,1
CH,GASTRITIS,1
CH,GASTROINTESTINAL DISORDER,1
CH,GASTROINTESTINAL NECROSIS,1
CH,GASTROOESOPHAGEAL REFLUX DISEASE,1
CH,GENERAL PHYSICAL HEALTH DETERIORATION,1
CH,GENERALISED TONIC-CLONIC SEIZURE,1
CH,GRAFT VERSUS HOST DISEASE,1
CH,GRAND MAL CONVULSION,1
CH,GRANDIOSITY,1
CH,HAEMATOMA,1
CH,HAEMOCHROMATOSIS,1
CH,HAEMORRHAGIC ANAEMIA,1
CH,HAND FRACTURE,1
CH,HENOCH-SCHONLEIN PURPURA,1
CH,HEPATIC ENZYME ABNORMAL,1
CH,HEPATIC FAILURE,1
CH,HEPATITIS CHOLESTATIC,1
CH,HYDROCEPHALUS,1
CH,HYPERAESTHESIA,1
CH,HYPERAMYLASAEMIA,1
CH,HYPERBILIRUBINAEMIA,1
CH,HYPERCAPNIA,1
CH,HYPERREFLEXIA,1
CH,HYPERSENSITIVITY VASCULITIS,1
CH,HYPERTENSION,1
CH,HYPERTHERMIA,1
CH,HYPERTONIA,1
CH,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
CH,IMPRISONMENT,1
CH,IMPULSIVE BEHAVIOUR,1
CH,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
CH,INCORRECT DOSE ADMINISTERED,1
CH,INFECTION,1
CH,INJECTION SITE DRYNESS,1
CH,INJECTION SITE PLAQUE,1
CH,INJECTION SITE URTICARIA,1
CH,INTERNATIONAL NORMALISED RATIO INCREASED,1
CH,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
CH,IRRITABILITY,1
CH,JOINT DISLOCATION,1
CH,LACTIC ACIDOSIS,1
CH,LARGE FOR DATES BABY,1
CH,LARGE INTESTINE POLYP,1
CH,LETHARGY,1
CH,LIGAMENT RUPTURE,1
CH,LIMB INJURY,1
CH,LIP SWELLING,1
CH,LOGORRHOEA,1
CH,LOSS OF PROPRIOCEPTION,1
CH,LUNG INFILTRATION,1
CH,MALAISE,1
CH,MEDICATION ERROR,1
CH,MENISCUS OPERATION,1
CH,MENTAL DISORDER,1
CH,MENTAL STATUS CHANGES,1
CH,METASTASES TO ABDOMINAL WALL,1
CH,METASTASES TO BONE,1
CH,MIOSIS,1
CH,MOBILITY DECREASED,1
CH,MONONEUROPATHY,1
CH,MOUTH ULCERATION,1
CH,MULTIPLE SCLEROSIS RELAPSE,1
CH,MUSCLE HAEMORRHAGE,1
CH,MUSCLE INJURY,1
CH,MUSCLE RIGIDITY,1
CH,MUSCLE SPASMS,1
CH,MUSCULOSKELETAL STIFFNESS,1
CH,MYDRIASIS,1
CH,MYELOMALACIA,1
CH,NAUSEA,1
CH,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
CH,NEONATAL TACHYPNOEA,1
CH,NEPHROGENIC DIABETES INSIPIDUS,1
CH,NEUROPATHY PERIPHERAL,1
CH,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
CH,NUCHAL RIGIDITY,1
CH,OBSTRUCTIVE AIRWAYS DISORDER,1
CH,OEDEMATOUS PANCREATITIS,1
CH,OPTIC NEUROPATHY,1
CH,ORTHOSTATIC HYPOTENSION,1
CH,OVARIAN CYST,1
CH,PAINFUL RESPIRATION,1
CH,PALLOR,1
CH,PANCREATITIS NECROTISING,1
CH,PATENT DUCTUS ARTERIOSUS,1
CH,PERIODONTITIS,1
CH,PERIPHERAL SWELLING,1
CH,PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED,1
CH,PERSISTENT DEPRESSIVE DISORDER,1
CH,PERSONALITY CHANGE,1
CH,PHIMOSIS,1
CH,PHOTOPHOBIA,1
CH,POLYARTHRITIS,1
CH,POST PROCEDURAL HAEMORRHAGE,1
CH,PREMATURE BABY,1
CH,PRESYNCOPE,1
CH,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
CH,PRURITUS GENERALISED,1
CH,PSYCHOMOTOR HYPERACTIVITY,1
CH,PSYCHOTIC BEHAVIOUR,1
CH,PULMONARY GRANULOMA,1
CH,PULMONARY MASS,1
CH,PULMONARY SARCOIDOSIS,1
CH,PULSE ABSENT,1
CH,PUPILLARY DISORDER,1
CH,RADIUS FRACTURE,1
CH,RASH ERYTHEMATOUS,1
CH,RASH GENERALISED,1
CH,REBOUND EFFECT,1
CH,REFLEXES ABNORMAL,1
CH,RESPIRATORY FAILURE,1
CH,RESPIRATORY GAS EXCHANGE DISORDER,1
CH,RETINAL DETACHMENT,1
CH,RHEUMATOID ARTHRITIS,1
CH,SCLERAL DISCOLOURATION,1
CH,SENSATION OF HEAVINESS,1
CH,SENSORY DISTURBANCE,1
CH,SINUSITIS,1
CH,SKIN INFECTION,1
CH,SOMATIC SYMPTOM DISORDER,1
CH,SPEECH DISORDER,1
CH,SPINAL EPIDURAL HAEMATOMA,1
CH,SPONDYLITIS,1
CH,STAPHYLOCOCCAL SEPSIS,1
CH,STEATOHEPATITIS,1
CH,STEVENS-JOHNSON SYNDROME,1
CH,STOMATITIS,1
CH,SUBARACHNOID HAEMORRHAGE,1
CH,SUBDURAL HAEMORRHAGE,1
CH,SURGERY,1
CH,SYNCOPE,1
CH,SYNOVITIS,1
CH,SYSTEMIC LUPUS ERYTHEMATOSUS,1
CH,TACHYPHRENIA,1
CH,TALIPES,1
CH,TORSADE DE POINTES,1
CH,TREMOR,1
CH,TRISOMY 21,1
CH,ULCER,1
CH,UNDERDOSE,1
CH,UPPER MOTOR NEURONE LESION,1
CH,URINARY INCONTINENCE,1
CH,URTICARIA,1
CH,UVEITIS,1
CH,VERTIGO,1
CH,VITAMIN D DEFICIENCY,1
CH,WHITE BLOOD CELL COUNT DECREASED,1
CH,WOUND,1
TW,DRUG ERUPTION,4
TW,PYREXIA,4
TW,AGGRESSION,3
TW,DEPRESSION,3
TW,PNEUMONIA,3
TW,SUICIDAL IDEATION,3
TW,AGITATION,2
TW,CONDITION AGGRAVATED,2
TW,CONSTIPATION,2
TW,COUGH,2
TW,DELUSION,2
TW,DIZZINESS,2
TW,DYSPNOEA,2
TW,ERYTHEMA,2
TW,EYELID OEDEMA,2
TW,LOSS OF CONSCIOUSNESS,2
TW,MOUTH ULCERATION,2
TW,PARANOIA,2
TW,RHINITIS,2
TW,UPPER RESPIRATORY TRACT INFECTION,2
TW,ABDOMINAL PAIN,1
TW,ABDOMINAL WALL CYST,1
TW,ACUTE RESPIRATORY FAILURE,1
TW,AGRANULOCYTOSIS,1
TW,ALTERED STATE OF CONSCIOUSNESS,1
TW,ANAEMIA,1
TW,ANAL ABSCESS,1
TW,ANAL EROSION,1
TW,ANAL POLYP,1
TW,ANGIOEDEMA,1
TW,ASPARTATE AMINOTRANSFERASE INCREASED,1
TW,ATRIAL FIBRILLATION,1
TW,BACK PAIN,1
TW,BACTERAEMIA,1
TW,BLISTER,1
TW,BLOOD PRESSURE DIASTOLIC DECREASED,1
TW,BLUE TOE SYNDROME,1
TW,BRONCHOSPASM,1
TW,CARBUNCLE,1
TW,CARDIAC FAILURE CONGESTIVE,1
TW,CELLULITIS,1
TW,CHEST PAIN,1
TW,CHILLS,1
TW,CHRONIC KIDNEY DISEASE,1
TW,CONJUNCTIVITIS,1
TW,CYTOMEGALOVIRUS INFECTION,1
TW,DECREASED APPETITE,1
TW,DEHYDRATION,1
TW,DELIRIUM,1
TW,DERMATITIS,1
TW,DERMATITIS BULLOUS,1
TW,DERMATITIS DIAPER,1
TW,DEVICE RELATED INFECTION,1
TW,DIABETIC KETOACIDOSIS,1
TW,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
TW,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
TW,DRUG WITHDRAWAL SYNDROME,1
TW,DYSPEPSIA,1
TW,EMPYEMA,1
TW,ENCEPHALOMALACIA,1
TW,ENTEROCOLITIS INFECTIOUS,1
TW,ERYTHEMA MULTIFORME,1
TW,EYE PAIN,1
TW,FIXED ERUPTION,1
TW,FUNGAEMIA,1
TW,FURUNCLE,1
TW,GASTROENTERITIS,1
TW,GENITAL PAIN,1
TW,HEADACHE,1
TW,HEPATITIS,1
TW,HISTIOCYTOSIS HAEMATOPHAGIC,1
TW,HYDROCEPHALUS,1
TW,HYPERNATRAEMIA,1
TW,ILEUS,1
TW,IMPULSE-CONTROL DISORDER,1
TW,INFECTION,1
TW,INFLUENZA,1
TW,LEUKOPENIA,1
TW,LIP EROSION,1
TW,LIP ULCERATION,1
TW,LIPASE INCREASED,1
TW,LIVER ABSCESS,1
TW,MYALGIA,1
TW,NEUTROPENIA,1
TW,NUCHAL RIGIDITY,1
TW,OLIGURIA,1
TW,ORAL PAIN,1
TW,PAIN IN EXTREMITY,1
TW,PANCYTOPENIA,1
TW,PARENT-CHILD PROBLEM,1
TW,PENILE ULCERATION,1
TW,PEPTIC ULCER,1
TW,PEPTIC ULCER PERFORATION,1
TW,PERITONITIS,1
TW,PERSONALITY DISORDER,1
TW,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
TW,PNEUMOMEDIASTINUM,1
TW,PNEUMONIA ASPIRATION,1
TW,PNEUMONIA PNEUMOCOCCAL,1
TW,PNEUMONIA STREPTOCOCCAL,1
TW,PSYCHOMOTOR HYPERACTIVITY,1
TW,PSYCHOTIC DISORDER,1
TW,PULMONARY TUBERCULOSIS,1
TW,RASH,1
TW,RENAL FAILURE,1
TW,RESPIRATORY FAILURE,1
TW,ROSEOLOVIRUS TEST POSITIVE,1
TW,SCHIZOPHRENIA,1
TW,SEIZURE,1
TW,SEPTIC SHOCK,1
TW,SERRATIA BACTERAEMIA,1
TW,SHOCK,1
TW,SHUNT INFECTION,1
TW,SKIN BURNING SENSATION,1
TW,SKIN EROSION,1
TW,SKIN EXFOLIATION,1
TW,SOLILOQUY,1
TW,STEVENS-JOHNSON SYNDROME,1
TW,SUICIDE ATTEMPT,1
TW,SUSPECTED PRODUCT CONTAMINATION,1
TW,SWELLING FACE,1
TW,THROMBOCYTOPENIA,1
TW,UPPER GASTROINTESTINAL HAEMORRHAGE,1
TW,URINARY RETENTION,1
TW,URINARY TRACT INFECTION,1
TW,URTICARIA,1
TW,VENTRICULAR FIBRILLATION,1
TW,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
TH,PERIORBITAL OEDEMA,3
TH,PRURITUS,3
TH,EYELID OEDEMA,2
TH,HEPATITIS,2
TH,STEVENS-JOHNSON SYNDROME,2
TH,CELLULITIS,1
TH,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
TH,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
TH,GASTRITIS,1
TH,HYPERSENSITIVITY,1
TH,LYMPHADENOPATHY,1
TH,LYMPHOCYTOSIS,1
TH,NAUSEA,1
TH,PYREXIA,1
TH,RASH MACULO-PAPULAR,1
TH,TOXIC EPIDERMAL NECROLYSIS,1
TH,URINARY RETENTION,1
TH,VOMITING,1
TR,DRUG HYPERSENSITIVITY,35
TR,ANGIOEDEMA,32
TR,THERAPEUTIC PRODUCT CROSS-REACTIVITY,21
TR,NECROTISING COLITIS,16
TR,DRUG INEFFECTIVE,14
TR,URTICARIA,12
TR,TOXIC EPIDERMAL NECROLYSIS,10
TR,INTENTIONAL OVERDOSE,7
TR,SUICIDE ATTEMPT,7
TR,VANISHING BILE DUCT SYNDROME,7
TR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,6
TR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,6
TR,DYSPNOEA,6
TR,HYPOTENSION,6
TR,NO THERAPEUTIC RESPONSE,6
TR,POST PROCEDURAL HAEMORRHAGE,6
TR,RHINORRHOEA,6
TR,COMA,5
TR,FORCED EXPIRATORY VOLUME DECREASED,5
TR,WHEEZING,5
TR,GASTRIC PERFORATION,4
TR,HYPERSENSITIVITY,4
TR,KOUNIS SYNDROME,4
TR,PRURITUS,4
TR,TACHYCARDIA,4
TR,TRANSAMINASES INCREASED,4
TR,COUGH,3
TR,DEPRESSED LEVEL OF CONSCIOUSNESS,3
TR,DYSTONIA,3
TR,EXTRAPYRAMIDAL DISORDER,3
TR,OCULOGYRIC CRISIS,3
TR,TOXICITY TO VARIOUS AGENTS,3
TR,ABDOMINAL PAIN UPPER,2
TR,ANAPHYLACTIC SHOCK,2
TR,FEEDING INTOLERANCE,2
TR,FIXED ERUPTION,2
TR,FLUSHING,2
TR,GAZE PALSY,2
TR,INTESTINAL PERFORATION,2
TR,PAIN,2
TR,POISONING,2
TR,RASH MACULO-PAPULAR,2
TR,RENAL FAILURE,2
TR,RENAL IMPAIRMENT,2
TR,SINUS TACHYCARDIA,2
TR,SKIN LESION,2
TR,TORTICOLLIS,2
TR,AQUAGENIC WRINKLING OF PALMS,1
TR,ASPIRATION,1
TR,ASTHENIA,1
TR,BACK PAIN,1
TR,BENIGN VAGINAL NEOPLASM,1
TR,BLINDNESS UNILATERAL,1
TR,BLOOD CREATININE INCREASED,1
TR,BLOOD PRESSURE INCREASED,1
TR,BLOOD UREA INCREASED,1
TR,CHEST PAIN,1
TR,CHOLESTASIS,1
TR,CONDITION AGGRAVATED,1
TR,DEEP VEIN THROMBOSIS,1
TR,DEPRESSION,1
TR,DERMATITIS BULLOUS,1
TR,DIARRHOEA,1
TR,DISORIENTATION,1
TR,DRUG ABUSE,1
TR,DRUG DEPENDENCE,1
TR,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
TR,ENDOMETRIAL HYPERPLASIA,1
TR,EYE DISORDER,1
TR,FACE OEDEMA,1
TR,FACIAL PARESIS,1
TR,FALL,1
TR,FIXED DRUG ERUPTION,1
TR,GASTROINTESTINAL HAEMORRHAGE,1
TR,HAEMATOCHEZIA,1
TR,HEADACHE,1
TR,HEMIPARESIS,1
TR,HYPERACUSIS,1
TR,HYPOAESTHESIA ORAL,1
TR,IMPATIENCE,1
TR,INFLUENZA LIKE ILLNESS,1
TR,INJECTION SITE ERYTHEMA,1
TR,INJECTION SITE PRURITUS,1
TR,INJECTION SITE REACTION,1
TR,INJECTION SITE SWELLING,1
TR,JAUNDICE,1
TR,LIP OEDEMA,1
TR,LIP SWELLING,1
TR,LYMPHADENOPATHY,1
TR,MALAISE,1
TR,MEMORY IMPAIRMENT,1
TR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
TR,MUSCLE HAEMORRHAGE,1
TR,NASAL CONGESTION,1
TR,NEUROPATHY PERIPHERAL,1
TR,OVERDOSE,1
TR,PAIN OF SKIN,1
TR,PANCREATIC NEOPLASM,1
TR,PHARYNGEAL ERYTHEMA,1
TR,PRODUCT USE ISSUE,1
TR,PURPURA,1
TR,PYREXIA,1
TR,RASH,1
TR,RASH ERYTHEMATOUS,1
TR,RHEUMATOID ARTHRITIS,1
TR,SKIN NECROSIS,1
TR,SLEEP DISORDER,1
TR,SPEECH DISORDER,1
TR,STEVENS-JOHNSON SYNDROME,1
TR,TONSILLAR HAEMORRHAGE,1
TR,TOOTH ABSCESS,1
TR,TOOTHACHE,1
TR,URINARY TRACT INFECTION,1
TR,UTERINE POLYP,1
TR,VASCULITIS,1
TR,VERTIGO,1
UG,ABORTION SPONTANEOUS,2
UG,BLOOD CREATININE INCREASED,2
UG,TUBERCULOSIS,2
UG,UTERINE HAEMORRHAGE,2
UG,ANAEMIA,1
UG,BACK PAIN,1
UG,BRONCHOPNEUMONIA,1
UG,BRONCHOPULMONARY ASPERGILLOSIS,1
UG,CARDIAC MURMUR,1
UG,DIABETES MELLITUS,1
UG,EXOMPHALOS,1
UG,HYPERGLYCAEMIA,1
UG,MYCOBACTERIUM TEST POSITIVE,1
UG,NEPHROPATHY TOXIC,1
UG,PRURITUS GENERALISED,1
UG,PULMONARY TUBERCULOSIS,1
UG,RASH,1
UG,SEPSIS,1
UG,SHOCK,1
UG,TUMOUR HAEMORRHAGE,1
UG,VENTRICULAR SEPTAL DEFECT,1
UA,STEVENS-JOHNSON SYNDROME,5
UA,ANGINA UNSTABLE,2
UA,ANAEMIA,1
UA,FEBRILE NEUTROPENIA,1
UA,GASTRODUODENAL HAEMORRHAGE,1
UA,LEUKOPENIA,1
UA,RENAL FAILURE,1
GB,MALAISE,339
GB,DYSPNOEA,320
GB,DIZZINESS,290
GB,VOMITING,271
GB,NAUSEA,236
GB,DIARRHOEA,221
GB,FATIGUE,217
GB,HEADACHE,205
GB,ACUTE KIDNEY INJURY,204
GB,RASH,201
GB,ARTHRALGIA,176
GB,PAIN,176
GB,INSOMNIA,171
GB,ABDOMINAL PAIN,168
GB,CONFUSIONAL STATE,167
GB,PAIN IN EXTREMITY,159
GB,PRURITUS,158
GB,PARAESTHESIA,149
GB,PYREXIA,144
GB,SWELLING FACE,140
GB,ANXIETY,136
GB,HAEMATEMESIS,134
GB,MYALGIA,134
GB,DECREASED APPETITE,133
GB,LIP SWELLING,130
GB,GASTROINTESTINAL HAEMORRHAGE,128
GB,MELAENA,122
GB,COUGH,116
GB,ABDOMINAL PAIN UPPER,115
GB,DEPRESSION,114
GB,OVERDOSE,114
GB,INTENTIONAL OVERDOSE,108
GB,SOMNOLENCE,103
GB,SYNCOPE,103
GB,HYPERHIDROSIS,102
GB,LETHARGY,97
GB,FEELING ABNORMAL,96
GB,PERIPHERAL SWELLING,96
GB,TREMOR,95
GB,PALPITATIONS,94
GB,ASTHENIA,91
GB,UPPER GASTROINTESTINAL HAEMORRHAGE,91
GB,HYPERSENSITIVITY,87
GB,TOXICITY TO VARIOUS AGENTS,87
GB,LOSS OF CONSCIOUSNESS,86
GB,CHEST DISCOMFORT,85
GB,CONDITION AGGRAVATED,83
GB,SUICIDAL IDEATION,82
GB,TINNITUS,81
GB,VISION BLURRED,80
GB,HYPOTENSION,78
GB,FALL,76
GB,URTICARIA,76
GB,DYSPEPSIA,75
GB,BACK PAIN,74
GB,CHEST PAIN,74
GB,GASTRITIS,73
GB,WHEEZING,72
GB,GASTRIC ULCER,66
GB,SUICIDE ATTEMPT,66
GB,TACHYCARDIA,66
GB,HYPOAESTHESIA,65
GB,CHILLS,63
GB,MUSCULOSKELETAL STIFFNESS,63
GB,CONSTIPATION,62
GB,GAIT DISTURBANCE,62
GB,RENAL FAILURE ACUTE,62
GB,ANAPHYLACTIC REACTION,61
GB,ANGIOEDEMA,61
GB,ERYTHEMA,61
GB,MUSCULAR WEAKNESS,61
GB,BLISTER,60
GB,MOUTH ULCERATION,59
GB,BALANCE DISORDER,58
GB,LIVER FUNCTION TEST ABNORMAL,58
GB,SWOLLEN TONGUE,57
GB,ABDOMINAL DISCOMFORT,56
GB,MUSCLE SPASMS,56
GB,DISTURBANCE IN ATTENTION,55
GB,ABDOMINAL DISTENSION,54
GB,CIRCULATORY COLLAPSE,53
GB,SEPSIS,53
GB,AGITATION,52
GB,ALOPECIA,52
GB,OROPHARYNGEAL PAIN,52
GB,SWELLING,50
GB,WEIGHT DECREASED,49
GB,CARDIAC ARREST,48
GB,MIGRAINE,48
GB,TENDONITIS,48
GB,EYE SWELLING,47
GB,HYPERTENSION,47
GB,VERTIGO,47
GB,BRADYCARDIA,46
GB,SKIN EXFOLIATION,46
GB,ALANINE AMINOTRANSFERASE INCREASED,45
GB,DISORIENTATION,45
GB,DRUG INTOLERANCE,45
GB,DYSPHAGIA,45
GB,HAEMOGLOBIN DECREASED,45
GB,DEPRESSED MOOD,44
GB,PANCYTOPENIA,44
GB,RECTAL HAEMORRHAGE,44
GB,RENAL IMPAIRMENT,44
GB,BURNING SENSATION,43
GB,DEATH,43
GB,DYSGEUSIA,43
GB,RASH ERYTHEMATOUS,43
GB,DYSARTHRIA,42
GB,LOWER RESPIRATORY TRACT INFECTION,42
GB,HALLUCINATION,41
GB,PNEUMONIA,41
GB,DUODENAL ULCER,40
GB,EPISTAXIS,40
GB,LYMPHADENOPATHY,40
GB,FAECES DISCOLOURED,39
GB,JOINT SWELLING,39
GB,ORAL PAIN,39
GB,PALLOR,39
GB,RASH GENERALISED,39
GB,DEHYDRATION,38
GB,DRUG HYPERSENSITIVITY,38
GB,DRUG INEFFECTIVE,38
GB,ANAEMIA,37
GB,ASTHMA,37
GB,EYE PAIN,37
GB,MUSCLE TWITCHING,37
GB,STEVENS-JOHNSON SYNDROME,37
GB,DRY EYE,36
GB,DRY MOUTH,36
GB,RENAL FAILURE,36
GB,GASTROOESOPHAGEAL REFLUX DISEASE,35
GB,HEPATIC FUNCTION ABNORMAL,35
GB,HOT FLUSH,35
GB,LOCAL SWELLING,35
GB,VISUAL IMPAIRMENT,35
GB,APHASIA,34
GB,PHARYNGEAL OEDEMA,34
GB,DEEP VEIN THROMBOSIS,33
GB,HYPONATRAEMIA,33
GB,PRURITUS GENERALISED,33
GB,CONVULSION,32
GB,PERSONALITY CHANGE,32
GB,PRODUCT USE ISSUE,32
GB,RASH MACULAR,32
GB,SKIN BURNING SENSATION,32
GB,UNRESPONSIVE TO STIMULI,32
GB,URINARY RETENTION,32
GB,AMNESIA,31
GB,BLOOD PRESSURE DECREASED,31
GB,ERECTILE DYSFUNCTION,31
GB,LIMB DISCOMFORT,31
GB,TUBULOINTERSTITIAL NEPHRITIS,31
GB,HYPERACUSIS,30
GB,INFLUENZA LIKE ILLNESS,30
GB,SEIZURE,30
GB,THROAT TIGHTNESS,30
GB,AGGRESSION,29
GB,EYELID OEDEMA,29
GB,SLEEP DISORDER,29
GB,STRESS,29
GB,ABNORMAL BEHAVIOUR,28
GB,CONTUSION,28
GB,EMOTIONAL DISTRESS,28
GB,HIATUS HERNIA,28
GB,INFECTION,28
GB,MEMORY IMPAIRMENT,28
GB,NEUROPATHY PERIPHERAL,28
GB,PULMONARY OEDEMA,28
GB,RASH PRURITIC,28
GB,TEARFULNESS,28
GB,BLOOD CREATININE INCREASED,27
GB,COMA SCALE ABNORMAL,27
GB,MENTAL IMPAIRMENT,27
GB,NEUTROPENIA,27
GB,NIGHTMARE,27
GB,PETECHIAE,27
GB,SELF INJURIOUS BEHAVIOUR,27
GB,WHITE BLOOD CELL COUNT INCREASED,27
GB,ACUTE MYOCARDIAL INFARCTION,26
GB,GINGIVAL BLEEDING,26
GB,HYPERKALAEMIA,26
GB,INCORRECT DOSE ADMINISTERED,26
GB,JAUNDICE,26
GB,MOOD ALTERED,26
GB,PANIC ATTACK,26
GB,WITHDRAWAL SYNDROME,26
GB,ATAXIA,25
GB,EXPOSURE DURING PREGNANCY,25
GB,GASTRIC ULCER PERFORATION,25
GB,HAEMORRHAGE,25
GB,INTERNATIONAL NORMALISED RATIO INCREASED,25
GB,IRRITABILITY,25
GB,MOOD SWINGS,25
GB,PULMONARY EMBOLISM,25
GB,THROAT IRRITATION,25
GB,ATRIAL FIBRILLATION,24
GB,COGNITIVE DISORDER,24
GB,DRUG PRESCRIBING ERROR,24
GB,NEUTROPHIL COUNT INCREASED,24
GB,NIGHT SWEATS,24
GB,OEDEMA PERIPHERAL,24
GB,SNEEZING,24
GB,URINARY TRACT INFECTION,24
GB,VENTRICULAR FIBRILLATION,24
GB,ABNORMAL DREAMS,23
GB,CRYING,23
GB,DRY SKIN,23
GB,DUODENAL ULCER HAEMORRHAGE,23
GB,DUODENITIS,23
GB,DYSPNOEA EXERTIONAL,23
GB,EPILEPSY,23
GB,ERYTHEMA MULTIFORME,23
GB,FEELING HOT,23
GB,RESTLESSNESS,23
GB,TENDON PAIN,23
GB,DEAFNESS,22
GB,HYPERSOMNIA,22
GB,INTESTINAL DIAPHRAGM DISEASE,22
GB,OESOPHAGITIS,22
GB,PRODUCT USE IN UNAPPROVED INDICATION,22
GB,ABNORMAL WEIGHT GAIN,21
GB,DISCOMFORT,21
GB,HEPATIC STEATOSIS,21
GB,MOBILITY DECREASED,21
GB,MUSCLE ATROPHY,21
GB,MYOCARDIAL INFARCTION,21
GB,NASOPHARYNGITIS,21
GB,NEUTROPENIC SEPSIS,21
GB,PHOTOPHOBIA,21
GB,SCAR,21
GB,SEDATION,21
GB,ANGER,20
GB,ANURIA,20
GB,BLOOD CREATINE PHOSPHOKINASE INCREASED,20
GB,CELLULITIS,20
GB,DYSKINESIA,20
GB,ECZEMA,20
GB,FOETAL DEATH,20
GB,HAEMATOCHEZIA,20
GB,TOXIC EPIDERMAL NECROLYSIS,20
GB,APNOEA,19
GB,ARTHRITIS,19
GB,BLOOD PRESSURE INCREASED,19
GB,DERMATITIS EXFOLIATIVE,19
GB,DRUG WITHDRAWAL SYNDROME,19
GB,DRUG-INDUCED LIVER INJURY,19
GB,DUODENAL ULCER PERFORATION,19
GB,GROIN PAIN,19
GB,HEMIPARESIS,19
GB,JOINT CREPITATION,19
GB,LACTIC ACIDOSIS,19
GB,PAIN OF SKIN,19
GB,CEREBROVASCULAR ACCIDENT,18
GB,COLD SWEAT,18
GB,DERMATITIS,18
GB,FOETAL EXPOSURE DURING PREGNANCY,18
GB,GASTROINTESTINAL DISORDER,18
GB,MENTAL DISORDER,18
GB,PNEUMONITIS,18
GB,PULMONARY CONGESTION,18
GB,ACCIDENTAL OVERDOSE,17
GB,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,17
GB,DYSPHONIA,17
GB,FEELING COLD,17
GB,MICTURITION URGENCY,17
GB,ORTHOSTATIC HYPOTENSION,17
GB,PHOTOSENSITIVITY REACTION,17
GB,SCRATCH,17
GB,SKIN LESION,17
GB,TACHYPNOEA,17
GB,VITREOUS FLOATERS,17
GB,ALCOHOL POISONING,16
GB,ARTHROPATHY,16
GB,BLOOD ALKALINE PHOSPHATASE INCREASED,16
GB,CARDIOMEGALY,16
GB,COMPLETED SUICIDE,16
GB,DEPRESSED LEVEL OF CONSCIOUSNESS,16
GB,ELECTROCARDIOGRAM QT PROLONGED,16
GB,HALLUCINATIONS_ MIXED,16
GB,HEAD DISCOMFORT,16
GB,HOSTILITY,16
GB,JOINT STIFFNESS,16
GB,METABOLIC ACIDOSIS,16
GB,MUSCULOSKELETAL PAIN,16
GB,NEURALGIA,16
GB,QUALITY OF LIFE DECREASED,16
GB,ALCOHOL INTERACTION,15
GB,CATARACT,15
GB,CONJUNCTIVAL HYPERAEMIA,15
GB,DERMATITIS ALLERGIC,15
GB,DYSURIA,15
GB,EOSINOPHILIA,15
GB,HAEMATURIA,15
GB,HEART RATE INCREASED,15
GB,HYPOKALAEMIA,15
GB,IMPLANT SITE EXTRAVASATION,15
GB,IMPLANT SITE INFECTION,15
GB,MACROPHAGES INCREASED,15
GB,ONYCHOMYCOSIS,15
GB,PARAESTHESIA ORAL,15
GB,PSYCHOMOTOR HYPERACTIVITY,15
GB,RHABDOMYOLYSIS,15
GB,RHEUMATOID ARTHRITIS,15
GB,SMALL INTESTINAL OBSTRUCTION,15
GB,SPEECH DISORDER,15
GB,WOUND DEHISCENCE,15
GB,AGEUSIA,14
GB,BREAST PAIN,14
GB,CHROMATURIA,14
GB,DRUG LEVEL INCREASED,14
GB,FLUSHING,14
GB,FORMICATION,14
GB,GINGIVITIS,14
GB,HALLUCINATION_ VISUAL,14
GB,INHIBITORY DRUG INTERACTION,14
GB,MUCOSAL INFLAMMATION,14
GB,OEDEMA,14
GB,PERIPHERAL COLDNESS,14
GB,PURULENT DISCHARGE,14
GB,RESPIRATORY FAILURE,14
GB,SKIN REACTION,14
GB,THIRST,14
GB,THROMBOCYTOPENIA,14
GB,WEIGHT INCREASED,14
GB,ABNORMAL FAECES,13
GB,ACTIVITIES OF DAILY LIVING IMPAIRED,13
GB,BLOOD BILIRUBIN INCREASED,13
GB,BLOOD ETHANOL INCREASED,13
GB,BLOOD UREA INCREASED,13
GB,BRONCHOSPASM,13
GB,CARDIAC FAILURE,13
GB,CHOLECYSTITIS ACUTE,13
GB,COAGULOPATHY,13
GB,DISSOCIATION,13
GB,FAECAL INCONTINENCE,13
GB,FEAR,13
GB,FIBROSIS,13
GB,HIP FRACTURE,13
GB,HYPERGLYCAEMIA,13
GB,HYPOAESTHESIA ORAL,13
GB,IMPAIRED GASTRIC EMPTYING,13
GB,INFLAMMATION,13
GB,INTENTIONAL SELF-INJURY,13
GB,ISCHAEMIC STROKE,13
GB,LIP ULCERATION,13
GB,NASAL CONGESTION,13
GB,NEPHROLITHIASIS,13
GB,OESOPHAGEAL ULCER,13
GB,ORAL MUCOSAL BLISTERING,13
GB,PELVIC PAIN,13
GB,PRESYNCOPE,13
GB,PSYCHOTIC DISORDER,13
GB,RASH MACULO-PAPULAR,13
GB,RECTOCELE,13
GB,SKIN DISORDER,13
GB,SUBDURAL HAEMATOMA,13
GB,SUDDEN DEATH,13
GB,UPPER RESPIRATORY TRACT INFECTION,13
GB,VISUAL ACUITY REDUCED,13
GB,ASCITES,12
GB,BILIARY SEPSIS,12
GB,BONE PAIN,12
GB,COLITIS MICROSCOPIC,12
GB,CREATININE RENAL CLEARANCE ABNORMAL,12
GB,GASTROINTESTINAL ULCER,12
GB,LYMPHOEDEMA,12
GB,OSTEOARTHRITIS,12
GB,PEPTIC ULCER,12
GB,PERITONITIS,12
GB,POLLAKIURIA,12
GB,PSORIASIS,12
GB,REACTION TO EXCIPIENT,12
GB,RESPIRATORY DEPRESSION,12
GB,SENSORY DISTURBANCE,12
GB,SKIN INFECTION,12
GB,SKIN ULCER,12
GB,STAPHYLOCOCCAL INFECTION,12
GB,SUBSTANCE ABUSE,12
GB,TOOTH LOSS,12
GB,ULCER,12
GB,VAGINAL HAEMORRHAGE,12
GB,VASODILATATION,12
GB,ACUTE LEFT VENTRICULAR FAILURE,11
GB,ANAL HAEMORRHAGE,11
GB,APLASTIC ANAEMIA,11
GB,ASPARTATE AMINOTRANSFERASE INCREASED,11
GB,DRUG DOSE OMISSION,11
GB,FEMUR FRACTURE,11
GB,HAEMOPTYSIS,11
GB,HYPERCHOLESTEROLAEMIA,11
GB,HYPOGLYCAEMIA,11
GB,HYPOTHERMIA,11
GB,HYPOXIA,11
GB,IRRITABLE BOWEL SYNDROME,11
GB,MICROCYTIC ANAEMIA,11
GB,MOVEMENT DISORDER,11
GB,NECK PAIN,11
GB,PANCREATITIS ACUTE,11
GB,PANIC REACTION,11
GB,PRODUCTIVE COUGH,11
GB,RENAL TUBULAR NECROSIS,11
GB,RESPIRATORY ARREST,11
GB,RESTLESS LEGS SYNDROME,11
GB,STOMATITIS,11
GB,TREATMENT NONCOMPLIANCE,11
GB,URINE OUTPUT DECREASED,11
GB,AMYLASE INCREASED,10
GB,ANAPHYLACTIC SHOCK,10
GB,APATHY,10
GB,BEDRIDDEN,10
GB,BONE MARROW FAILURE,10
GB,BREAST CANCER,10
GB,CANDIDA INFECTION,10
GB,CARDIAC DISORDER,10
GB,COLITIS,10
GB,COMA,10
GB,COORDINATION ABNORMAL,10
GB,DIARRHOEA HAEMORRHAGIC,10
GB,EAR DISCOMFORT,10
GB,ERUCTATION,10
GB,EYELID PTOSIS,10
GB,FACE OEDEMA,10
GB,FACIAL NERVE DISORDER,10
GB,FACIAL PARESIS,10
GB,FEELING DRUNK,10
GB,GAMMA-GLUTAMYLTRANSFERASE INCREASED,10
GB,GLOSSODYNIA,10
GB,GOUT,10
GB,HEPATIC FAILURE,10
GB,HEPATITIS ACUTE,10
GB,INVASIVE DUCTAL BREAST CARCINOMA,10
GB,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,10
GB,MEDICATION ERROR,10
GB,MUSCULOSKELETAL DISCOMFORT,10
GB,MYOCLONUS,10
GB,OROPHARYNGEAL BLISTERING,10
GB,PAIN IN JAW,10
GB,PLATELET COUNT DECREASED,10
GB,POLYURIA,10
GB,PRESCRIBED OVERDOSE,10
GB,PRODUCT SUBSTITUTION ISSUE,10
GB,PULMONARY FIBROSIS,10
GB,PURPURA,10
GB,RASH PAPULAR,10
GB,RENAL DISORDER,10
GB,SINUSITIS,10
GB,SKIN ATROPHY,10
GB,TACHYPHRENIA,10
GB,TENSION,10
GB,URINARY INCONTINENCE,10
GB,VARICELLA,10
GB,ABASIA,9
GB,ALVEOLITIS ALLERGIC,9
GB,ANORGASMIA,9
GB,APHONIA,9
GB,ARRHYTHMIA,9
GB,BRAIN OEDEMA,9
GB,CHOLELITHIASIS,9
GB,CONTRAINDICATED DRUG PRESCRIBED,9
GB,DRUG ADMINISTRATION ERROR,9
GB,EUPHORIC MOOD,9
GB,FEBRILE NEUTROPENIA,9
GB,FOOD REFUSAL,9
GB,GASTRIC ULCER HAEMORRHAGE,9
GB,HAIR GROWTH ABNORMAL,9
GB,HELICOBACTER INFECTION,9
GB,HEPATITIS,9
GB,HEPATOTOXICITY,9
GB,INJURY,9
GB,LIBIDO DECREASED,9
GB,LIVER DISORDER,9
GB,PANCREATITIS,9
GB,PSYCHOMOTOR SKILLS IMPAIRED,9
GB,REFLEXES ABNORMAL,9
GB,RESPIRATORY DISORDER,9
GB,SEROTONIN SYNDROME,9
GB,SKIN HAEMORRHAGE,9
GB,SOCIAL PROBLEM,9
GB,STAPHYLOCOCCAL SCALDED SKIN SYNDROME,9
GB,TRANSIENT ISCHAEMIC ATTACK,9
GB,UNEVALUABLE EVENT,9
GB,WHITE BLOOD CELL COUNT DECREASED,9
GB,ABDOMINAL TENDERNESS,8
GB,ABULIA,8
GB,ACUTE CORONARY SYNDROME,8
GB,BACTERAEMIA,8
GB,BLEPHAROSPASM,8
GB,BODY TEMPERATURE DECREASED,8
GB,BONE DENSITY DECREASED,8
GB,BREATH ODOUR,8
GB,C-REACTIVE PROTEIN INCREASED,8
GB,CACHEXIA,8
GB,CHRONIC KIDNEY DISEASE,8
GB,COAGULATION TIME PROLONGED,8
GB,DEAFNESS BILATERAL,8
GB,DECREASED ACTIVITY,8
GB,EYE DISORDER,8
GB,FIBROMYALGIA,8
GB,GASTRIC HAEMORRHAGE,8
GB,GINGIVAL DISORDER,8
GB,GINGIVAL RECESSION,8
GB,GLOMERULAR FILTRATION RATE DECREASED,8
GB,HAEMORRHAGE INTRACRANIAL,8
GB,HEARING IMPAIRED,8
GB,HEPATIC ENZYME INCREASED,8
GB,HEPATIC NECROSIS,8
GB,HYPOPHAGIA,8
GB,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,8
GB,INTERVERTEBRAL DISC PROTRUSION,8
GB,INTRA-ABDOMINAL HAEMORRHAGE,8
GB,IRREGULAR BREATHING,8
GB,MASS,8
GB,MEAN CELL VOLUME INCREASED,8
GB,MUCOSAL ULCERATION,8
GB,MULTIPLE SCLEROSIS,8
GB,MYOCARDIAL ISCHAEMIA,8
GB,NECROSIS,8
GB,NECROTISING ULCERATIVE GINGIVOSTOMATITIS,8
GB,NEGATIVE THOUGHTS,8
GB,OCULAR HYPERAEMIA,8
GB,PARANOIA,8
GB,PEMPHIGOID,8
GB,PERIORBITAL OEDEMA,8
GB,PERIPHERAL ISCHAEMIA,8
GB,PLEURAL EFFUSION,8
GB,PSEUDODEMENTIA,8
GB,RENAL TUBULAR ACIDOSIS,8
GB,RHINITIS,8
GB,SHOCK,8
GB,SKIN WRINKLING,8
GB,SMALL INTESTINAL HAEMORRHAGE,8
GB,SPINAL CORD COMPRESSION,8
GB,SUPRAVENTRICULAR TACHYCARDIA,8
GB,TEETH BRITTLE,8
GB,TRIGGER FINGER,8
GB,WOUND,8
GB,WOUND INFECTION,8
GB,ABNORMAL CLOTTING FACTOR,7
GB,ABNORMAL LOSS OF WEIGHT,7
GB,ABORTION SPONTANEOUS,7
GB,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,7
GB,ALVEOLAR RHABDOMYOSARCOMA,7
GB,ANGINA PECTORIS,7
GB,ARTHRITIS BACTERIAL,7
GB,BLOOD GLUCOSE INCREASED,7
GB,BLOOD LACTATE DEHYDROGENASE INCREASED,7
GB,BLOOD SODIUM DECREASED,7
GB,BONE MARROW INFILTRATION,7
GB,BRUXISM,7
GB,CARPAL TUNNEL SYNDROME,7
GB,CONGENITAL TERATOMA,7
GB,CONSCIOUSNESS FLUCTUATING,7
GB,DISTURBANCE IN SEXUAL AROUSAL,7
GB,DUODENAL ULCER REPAIR,7
GB,DYSPAREUNIA,7
GB,EAR SWELLING,7
GB,EXTRAPYRAMIDAL DISORDER,7
GB,FOOD INTOLERANCE,7
GB,GENERALISED TONIC-CLONIC SEIZURE,7
GB,GENITAL BURNING SENSATION,7
GB,GRIP STRENGTH DECREASED,7
GB,HUNGER,7
GB,HYPERREFLEXIA,7
GB,HYPERVENTILATION,7
GB,HYPOTONIA,7
GB,INFLUENZA,7
GB,INTESTINAL PERFORATION,7
GB,KETOACIDOSIS,7
GB,LIP DISCOLOURATION,7
GB,LIP EXFOLIATION,7
GB,LOCKED-IN SYNDROME,7
GB,LOOSE TOOTH,7
GB,MOUTH SWELLING,7
GB,MUSCLE SPASTICITY,7
GB,MYDRIASIS,7
GB,MYOSITIS,7
GB,NASAL INFLAMMATION,7
GB,NERVOUS SYSTEM DISORDER,7
GB,PAROTID GLAND ENLARGEMENT,7
GB,PHARYNGITIS,7
GB,PROTHROMBIN TIME PROLONGED,7
GB,PRURITUS GENITAL,7
GB,PYROGLUTAMATE INCREASED,7
GB,RHINORRHOEA,7
GB,SENSORY LOSS,7
GB,SKIN DISCOLOURATION,7
GB,STRIDOR,7
GB,THINKING ABNORMAL,7
GB,TONGUE OEDEMA,7
GB,TOOTHACHE,7
GB,VAGINAL ULCERATION,7
GB,VULVOVAGINAL DRYNESS,7
GB,ABDOMINAL PAIN LOWER,6
GB,ADVERSE EVENT,6
GB,ALCOHOL ABUSE,6
GB,BLINDNESS,6
GB,BLOOD POTASSIUM DECREASED,6
GB,CARDIOTOXICITY,6
GB,CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE,6
GB,CHONDROCALCINOSIS PYROPHOSPHATE,6
GB,COELIAC DISEASE,6
GB,COLITIS ULCERATIVE,6
GB,COMPLEX PARTIAL SEIZURES,6
GB,CORONARY ARTERY OCCLUSION,6
GB,CYANOSIS,6
GB,DELIRIUM,6
GB,DRUG ABUSE,6
GB,DRUG ERUPTION,6
GB,DUODENOGASTRIC REFLUX,6
GB,DYSPHEMIA,6
GB,EAR INFECTION,6
GB,EROSIVE DUODENITIS,6
GB,EXTREMITY CONTRACTURE,6
GB,EYE DISCHARGE,6
GB,EYE IRRITATION,6
GB,FACIAL PARALYSIS,6
GB,FEELING OF BODY TEMPERATURE CHANGE,6
GB,FLATULENCE,6
GB,FOLLICULITIS,6
GB,GAIT INABILITY,6
GB,GAMBLING DISORDER,6
GB,HAEMODYNAMIC INSTABILITY,6
GB,HAND DEFORMITY,6
GB,HEART RATE DECREASED,6
GB,HEART VALVE INCOMPETENCE,6
GB,HYPERAESTHESIA,6
GB,IMMUNE THROMBOCYTOPENIC PURPURA,6
GB,INCONTINENCE,6
GB,INCORRECT DOSAGE ADMINISTERED,6
GB,INCORRECT DRUG ADMINISTRATION DURATION,6
GB,INTENTIONAL PRODUCT MISUSE,6
GB,IRON DEFICIENCY ANAEMIA,6
GB,JEJUNAL ULCER PERFORATION,6
GB,LEFT VENTRICULAR DYSFUNCTION,6
GB,LIVER INJURY,6
GB,LOWER LIMB FRACTURE,6
GB,MATERNAL EXPOSURE DURING PREGNANCY,6
GB,NEUROLOGICAL SYMPTOM,6
GB,NEUTROPHIL COUNT ABNORMAL,6
GB,NEUTROPHILIA,6
GB,OCULOGYRIC CRISIS,6
GB,OEDEMA MOUTH,6
GB,ORAL MUCOSAL EXFOLIATION,6
GB,OSTEONECROSIS,6
GB,PERICARDIAL EFFUSION,6
GB,PETIT MAL EPILEPSY,6
GB,PLATELET COUNT INCREASED,6
GB,PLEURAL DISORDER,6
GB,PLEURITIC PAIN,6
GB,POLYMENORRHAGIA,6
GB,PRESCRIBED UNDERDOSE,6
GB,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,6
GB,PROTEINURIA,6
GB,RESPIRATORY DISTRESS,6
GB,SARCOMA,6
GB,SCAB,6
GB,SINUS BRADYCARDIA,6
GB,SPINAL DISORDER,6
GB,SPONTANEOUS PENILE ERECTION,6
GB,STUBBORNNESS,6
GB,SUBCUTANEOUS ABSCESS,6
GB,SUPERINFECTION,6
GB,TENDON DISORDER,6
GB,TONGUE BLISTERING,6
GB,TONGUE COATED,6
GB,TONGUE DISCOLOURATION,6
GB,TONGUE ULCERATION,6
GB,TONSILLITIS,6
GB,URETHRITIS NONINFECTIVE,6
GB,URINE FLOW DECREASED,6
GB,VASCULITIC RASH,6
GB,VOMITING PROJECTILE,6
GB,VULVOVAGINAL CANDIDIASIS,6
GB,YELLOW SKIN,6
GB,ABDOMINAL RIGIDITY,5
GB,ADENOIDITIS,5
GB,AGRANULOCYTOSIS,5
GB,AKATHISIA,5
GB,ANAPHYLACTOID REACTION,5
GB,ANTI-TRANSGLUTAMINASE ANTIBODY,5
GB,APPARENT DEATH,5
GB,ARTERIOSCLEROSIS,5
GB,AXILLARY PAIN,5
GB,BETA HAEMOLYTIC STREPTOCOCCAL INFECTION,5
GB,BLADDER PAIN,5
GB,BLOOD CREATININE ABNORMAL,5
GB,BODY TEMPERATURE INCREASED,5
GB,CARDIOVASCULAR DISORDER,5
GB,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,5
GB,CLUMSINESS,5
GB,DEAFNESS CONGENITAL,5
GB,DECREASED INTEREST,5
GB,DEPRESSION SUICIDAL,5
GB,DISCOLOURED VOMIT,5
GB,DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT,5
GB,DRUG DISPENSING ERROR,5
GB,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,5
GB,DRY THROAT,5
GB,DYSTONIA,5
GB,EMOTIONAL DISORDER,5
GB,ENCEPHALITIS,5
GB,EXFOLIATIVE RASH,5
GB,EXTRASYSTOLES,5
GB,EYE PRURITUS,5
GB,FACIAL PAIN,5
GB,FEEDING DISORDER,5
GB,FOREIGN BODY SENSATION IN EYES,5
GB,GASTRIC DISORDER,5
GB,GASTRITIS EROSIVE,5
GB,GASTROINTESTINAL MUCOSAL DISORDER,5
GB,HAEMATOMA,5
GB,HEART RATE IRREGULAR,5
GB,HERPES ZOSTER,5
GB,HYPOKINESIA,5
GB,HYPOMANIA,5
GB,INCORRECT PRODUCT FORMULATION ADMINISTERED,5
GB,INJECTION SITE BRUISING,5
GB,INTERCEPTED MEDICATION ERROR,5
GB,LACRIMATION INCREASED,5
GB,LACTOSE INTOLERANCE,5
GB,LEUKOPENIA,5
GB,LIP BLISTER,5
GB,LOSS OF CONTROL OF LEGS,5
GB,MANIA,5
GB,MONOPLEGIA,5
GB,MUCOUS STOOLS,5
GB,MUSCLE INJURY,5
GB,NEPHROCALCINOSIS,5
GB,NEPHROPATHY TOXIC,5
GB,NEUTROPHIL COUNT DECREASED,5
GB,NUCHAL RIGIDITY,5
GB,OESOPHAGEAL CANCER METASTATIC,5
GB,OSTEOMYELITIS,5
GB,OSTEONECROSIS OF JAW,5
GB,PANCREATIC CARCINOMA,5
GB,PAROSMIA,5
GB,PENIS DISORDER,5
GB,PERITONITIS BACTERIAL,5
GB,PNEUMOCYSTIS JIROVECII PNEUMONIA,5
GB,POLYMYALGIA RHEUMATICA,5
GB,POSTURING,5
GB,PROCTALGIA,5
GB,PROCTITIS,5
GB,PSYCHOTIC BEHAVIOUR,5
GB,RECTAL ABSCESS,5
GB,RECTAL SPASM,5
GB,RENAL PAPILLARY NECROSIS,5
GB,RESPIRATORY TRACT OEDEMA,5
GB,SCREAMING,5
GB,SERUM FERRITIN ABNORMAL,5
GB,SPONDYLITIS,5
GB,STATUS EPILEPTICUS,5
GB,STRESS FRACTURE,5
GB,SUPERFICIAL VEIN PROMINENCE,5
GB,TENDON INJURY,5
GB,TOOTH ABSCESS,5
GB,TRAUMATIC LUNG INJURY,5
GB,UPPER LIMB FRACTURE,5
GB,URETERIC OBSTRUCTION,5
GB,URINE ODOUR ABNORMAL,5
GB,VASOSPASM,5
GB,VIITH NERVE PARALYSIS,5
GB,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,4
GB,ACIDOSIS,4
GB,ACNE,4
GB,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,4
GB,ADRENAL INSUFFICIENCY,4
GB,ANTIPSYCHOTIC DRUG LEVEL INCREASED,4
GB,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,4
GB,BLOOD CHOLESTEROL INCREASED,4
GB,BLOOD COPPER DECREASED,4
GB,BLOOD GLUCOSE DECREASED,4
GB,CARDIAC FAILURE CONGESTIVE,4
GB,CARDIAC FUNCTION TEST ABNORMAL,4
GB,CEREBRAL HAEMORRHAGE,4
GB,CERULOPLASMIN DECREASED,4
GB,CHAPPED LIPS,4
GB,CONTRAINDICATED DRUG ADMINISTERED,4
GB,CONTRAINDICATED PRODUCT ADMINISTERED,4
GB,DELUSION,4
GB,DIABETIC KETOACIDOSIS,4
GB,DIVERTICULITIS,4
GB,DROOLING,4
GB,DUODENAL PERFORATION,4
GB,DYSCHROMATOPSIA,4
GB,ECCHYMOSIS,4
GB,ELECTROLYTE IMBALANCE,4
GB,EMBOLISM VENOUS,4
GB,EMPHYSEMA,4
GB,ENCEPHALOPATHY,4
GB,ERYTHRODERMIC PSORIASIS,4
GB,EXERCISE TOLERANCE DECREASED,4
GB,EYE HAEMORRHAGE,4
GB,EYE INFECTION,4
GB,GASTRODUODENITIS,4
GB,GASTROINTESTINAL INFLAMMATION,4
GB,GENITAL HAEMORRHAGE,4
GB,GENITAL TRACT INFLAMMATION,4
GB,HEPATIC CONGESTION,4
GB,HYPEREMESIS GRAVIDARUM,4
GB,HYPERVIGILANCE,4
GB,HYPOMAGNESAEMIA,4
GB,IDIOSYNCRATIC DRUG REACTION,4
GB,IMPAIRED SELF-CARE,4
GB,INFUSION RELATED REACTION,4
GB,JAUNDICE CHOLESTATIC,4
GB,LARGE INTESTINE PERFORATION,4
GB,LUNG DISORDER,4
GB,LUPUS-LIKE SYNDROME,4
GB,MIGRAINE WITH AURA,4
GB,MULTI-ORGAN DISORDER,4
GB,MULTIPLE ORGAN DYSFUNCTION SYNDROME,4
GB,NERVOUSNESS,4
GB,OXYGEN SATURATION DECREASED,4
GB,PAPILLOEDEMA,4
GB,PENILE BLISTER,4
GB,PEPTIC ULCER PERFORATION,4
GB,PHARYNGEAL ERYTHEMA,4
GB,PHARYNGEAL PARAESTHESIA,4
GB,POISONING DELIBERATE,4
GB,POLYARTHRITIS,4
GB,POST PROCEDURAL HAEMORRHAGE,4
GB,RASH PUSTULAR,4
GB,RED BLOOD CELL SEDIMENTATION RATE INCREASED,4
GB,RENAL FAILURE CHRONIC,4
GB,RENAL FUNCTION TEST ABNORMAL,4
GB,RETCHING,4
GB,RIB FRACTURE,4
GB,SALIVARY HYPERSECRETION,4
GB,SELF-INJURIOUS IDEATION,4
GB,SEPTIC SHOCK,4
GB,SKIN SENSITISATION,4
GB,SKIN TIGHTNESS,4
GB,SYSTEMIC LUPUS ERYTHEMATOSUS,4
GB,THERAPEUTIC RESPONSE UNEXPECTED,4
GB,TRISMUS,4
GB,TROPONIN INCREASED,4
GB,VESTIBULAR ATAXIA,4
GB,VULVOVAGINAL DISCOMFORT,4
GB,X-RAY LIMB ABNORMAL,4
GB,ACCIDENTAL DEATH,3
GB,ACCIDENTAL EXPOSURE TO PRODUCT,3
GB,ACUTE PSYCHOSIS,3
GB,ACUTE RESPIRATORY DISTRESS SYNDROME,3
GB,AORTIC ANEURYSM RUPTURE,3
GB,APHTHOUS STOMATITIS,3
GB,APPLICATION SITE SCAR,3
GB,ARTERIOSCLEROSIS CORONARY ARTERY,3
GB,ATYPICAL FEMUR FRACTURE,3
GB,AUTISM,3
GB,AUTOIMMUNE HEPATITIS,3
GB,BACTERIAL INFECTION,3
GB,BARRETT^S OESOPHAGUS,3
GB,BLOOD CREATINE INCREASED,3
GB,BLOOD PRESSURE INADEQUATELY CONTROLLED,3
GB,BLOOD PRESSURE SYSTOLIC DECREASED,3
GB,BODY TEMPERATURE FLUCTUATION,3
GB,BRADYPHRENIA,3
GB,BRAIN INJURY,3
GB,CEREBRAL INFARCTION,3
GB,CEREBRAL ISCHAEMIA,3
GB,CROHN^S DISEASE,3
GB,DENTAL CARIES,3
GB,DEREALISATION,3
GB,DERMATITIS CONTACT,3
GB,DIPLOPIA,3
GB,DISEASE PROGRESSION,3
GB,DRUG DEPENDENCE,3
GB,DUODENITIS HAEMORRHAGIC,3
GB,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,3
GB,EPICONDYLITIS,3
GB,ERYTHEMA NODOSUM,3
GB,FLUID OVERLOAD,3
GB,FOOD AVERSION,3
GB,FOOD CRAVING,3
GB,FREQUENT BOWEL MOVEMENTS,3
GB,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,3
GB,GENERAL PHYSICAL HEALTH DETERIORATION,3
GB,GINGIVAL BLISTER,3
GB,GINGIVAL PAIN,3
GB,GRANULOMA,3
GB,HAEMODIALYSIS,3
GB,HAEMORRHOIDS,3
GB,HALLUCINATION_ AUDITORY,3
GB,HEAD BANGING,3
GB,HELICOBACTER TEST POSITIVE,3
GB,HICCUPS,3
GB,HYDRONEPHROSIS,3
GB,HYPERCALCAEMIA,3
GB,HYPERPROLACTINAEMIA,3
GB,HYPERTHERMIA,3
GB,HYPOCALCAEMIA,3
GB,HYPOTHYROIDISM,3
GB,IMMUNOSUPPRESSION,3
GB,IMPAIRED HEALING,3
GB,IMPAIRED WORK ABILITY,3
GB,INDUCED LABOUR,3
GB,INTESTINAL OBSTRUCTION,3
GB,JOINT EFFUSION,3
GB,LUNG CONSOLIDATION,3
GB,MALIGNANT NEOPLASM PROGRESSION,3
GB,MENINGISM,3
GB,MENORRHAGIA,3
GB,MENSTRUATION IRREGULAR,3
GB,METRORRHAGIA,3
GB,MOUTH HAEMORRHAGE,3
GB,MULTIPLE SCLEROSIS RELAPSE,3
GB,MUSCLE RIGIDITY,3
GB,NECROTISING FASCIITIS,3
GB,NEUROLEPTIC MALIGNANT SYNDROME,3
GB,OBESITY,3
GB,OBSESSIVE-COMPULSIVE DISORDER,3
GB,OLIGOHYDRAMNIOS,3
GB,ORAL DISCOMFORT,3
GB,ORAL DISORDER,3
GB,OVARIAN CYST,3
GB,PATHOLOGICAL FRACTURE,3
GB,PEMPHIGUS,3
GB,PHARYNGITIS STREPTOCOCCAL,3
GB,PLATELET AGGREGATION DECREASED,3
GB,PNEUMONIA ASPIRATION,3
GB,POST PROCEDURAL COMPLICATION,3
GB,POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME,3
GB,PRODUCT PHYSICAL ISSUE,3
GB,PRODUCT QUALITY ISSUE,3
GB,PROSTATE CANCER,3
GB,PULMONARY HYPERTENSION,3
GB,PYELONEPHRITIS,3
GB,REACTION TO DRUG EXCIPIENTS,3
GB,RED BLOOD CELL COUNT DECREASED,3
GB,RENAL PAIN,3
GB,RESPIRATORY TRACT INFLAMMATION,3
GB,RESTING TREMOR,3
GB,RHEUMATOID FACTOR INCREASED,3
GB,SCROTAL ULCER,3
GB,SELF-MEDICATION,3
GB,SEXUAL DYSFUNCTION,3
GB,SHOCK HAEMORRHAGIC,3
GB,SKIN IRRITATION,3
GB,SKIN TEXTURE ABNORMAL,3
GB,SLUGGISHNESS,3
GB,SPLENOMEGALY,3
GB,SUBDURAL HAEMORRHAGE,3
GB,SUDDEN CARDIAC DEATH,3
GB,SUNBURN,3
GB,TEMPERATURE INTOLERANCE,3
GB,TOOTH DISORDER,3
GB,TRANSAMINASES INCREASED,3
GB,TREATMENT FAILURE,3
GB,UPPER RESPIRATORY TRACT CONGESTION,3
GB,URETERAL DISORDER,3
GB,URETHRAL HAEMORRHAGE,3
GB,UROGENITAL HAEMORRHAGE,3
GB,VAGINAL DISCHARGE,3
GB,VASCULITIS,3
GB,VERTIGO LABYRINTHINE,3
GB,VISUAL FIELD DEFECT,3
GB,WOUND DECOMPOSITION,3
GB,WOUND HAEMATOMA,3
GB,WOUND SECRETION,3
GB,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,3
GB,ABDOMINAL ABSCESS,2
GB,ABDOMINAL SYMPTOM,2
GB,ABSCESS,2
GB,ABSCESS LIMB,2
GB,ACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,2
GB,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,2
GB,ADRENAL HAEMORRHAGE,2
GB,ADVERSE DRUG REACTION,2
GB,ALANINE AMINOTRANSFERASE ABNORMAL,2
GB,ALLODYNIA,2
GB,AMMONIA INCREASED,2
GB,ANAL INCONTINENCE,2
GB,ANKYLOSING SPONDYLITIS,2
GB,APPENDICITIS,2
GB,APPLICATION SITE ERYTHEMA,2
GB,APPLICATION SITE PAIN,2
GB,APPLICATION SITE SWELLING,2
GB,APPLICATION SITE VESICLES,2
GB,AREFLEXIA,2
GB,ASPHYXIA,2
GB,ATELECTASIS,2
GB,ATRIAL FLUTTER,2
GB,AUTISM SPECTRUM DISORDER,2
GB,AUTOPHOBIA,2
GB,AZOTAEMIA,2
GB,BASAL CELL CARCINOMA,2
GB,BENIGN INTRACRANIAL HYPERTENSION,2
GB,BILIARY CIRRHOSIS PRIMARY,2
GB,BLOOD CHOLESTEROL ABNORMAL,2
GB,BLOOD POTASSIUM INCREASED,2
GB,BONE NEOPLASM,2
GB,BURSITIS,2
GB,C-REACTIVE PROTEIN ABNORMAL,2
GB,CARDIO-RESPIRATORY ARREST,2
GB,CARDITIS,2
GB,CATHETER SITE RELATED REACTION,2
US,DRUG INEFFECTIVE,7431
US,PAIN,3970
US,NAUSEA,3554
US,FATIGUE,3396
US,HEADACHE,3362
US,DRUG HYPERSENSITIVITY,2346
US,DIARRHOEA,2272
US,DIZZINESS,2246
US,ANXIETY,2062
US,VOMITING,1991
US,DYSPNOEA,1942
US,MALAISE,1807
US,ARTHRALGIA,1773
US,PAIN IN EXTREMITY,1587
US,FEELING ABNORMAL,1531
US,DEPRESSION,1527
US,INSOMNIA,1497
US,RASH,1447
US,ABDOMINAL DISCOMFORT,1422
US,INJURY,1418
US,BACK PAIN,1413
US,ASTHENIA,1380
US,FALL,1309
US,PRURITUS,1244
US,ABDOMINAL PAIN UPPER,1232
US,WEIGHT DECREASED,1154
US,ABDOMINAL PAIN,1139
US,DRUG DOSE OMISSION,1137
US,PYREXIA,1137
US,SOMNOLENCE,1102
US,GAIT DISTURBANCE,1032
US,PULMONARY EMBOLISM,1021
US,COUGH,1008
US,CONDITION AGGRAVATED,999
US,PRODUCT USE ISSUE,986
US,CONSTIPATION,985
US,MUSCLE SPASMS,976
US,HYPOAESTHESIA,974
US,DEEP VEIN THROMBOSIS,940
US,INJECTION SITE PAIN,933
US,PARAESTHESIA,904
US,CHEST PAIN,884
US,OVERDOSE,883
US,EMOTIONAL DISTRESS,872
US,DEATH,870
US,HYPERSENSITIVITY,865
US,DYSPEPSIA,863
US,NASOPHARYNGITIS,854
US,DRUG EFFECT INCOMPLETE,848
US,INCORRECT DOSE ADMINISTERED,848
US,DECREASED APPETITE,835
US,COMPLETED SUICIDE,823
US,INTENTIONAL PRODUCT MISUSE,807
US,WEIGHT INCREASED,807
US,HYPERTENSION,773
US,URTICARIA,773
US,TOXICITY TO VARIOUS AGENTS,732
US,PNEUMONIA,725
US,TREMOR,719
US,SINUSITIS,711
US,PERIPHERAL SWELLING,702
US,MYALGIA,695
US,URINARY TRACT INFECTION,669
US,ANAEMIA,648
US,MIGRAINE,644
US,THERAPEUTIC RESPONSE UNEXPECTED,643
US,INFLUENZA LIKE ILLNESS,633
US,ALOPECIA,612
US,MEMORY IMPAIRMENT,610
US,ERYTHEMA,603
US,BLOOD PRESSURE INCREASED,598
US,VISION BLURRED,596
US,DYSGEUSIA,593
US,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,587
US,HYPERHIDROSIS,577
US,PRODUCT QUALITY ISSUE,576
US,GASTROOESOPHAGEAL REFLUX DISEASE,549
US,MUSCULAR WEAKNESS,542
US,GASTROINTESTINAL HAEMORRHAGE,539
US,DYSPHAGIA,535
US,FLUSHING,531
US,OROPHARYNGEAL PAIN,529
US,INJECTION SITE ERYTHEMA,528
US,CONFUSIONAL STATE,513
US,HYPOTENSION,512
US,ACUTE KIDNEY INJURY,507
US,CHILLS,506
US,GENERAL PHYSICAL HEALTH DETERIORATION,506
US,BALANCE DISORDER,505
US,JOINT SWELLING,505
US,DEHYDRATION,494
US,ARTHRITIS,473
US,MUSCULOSKELETAL PAIN,465
US,MULTIPLE SCLEROSIS RELAPSE,461
US,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,457
US,INFLUENZA,452
US,MUSCULOSKELETAL STIFFNESS,449
US,SWELLING,448
US,PALPITATIONS,446
US,CONTUSION,443
US,THROAT IRRITATION,442
US,INTENTIONAL PRODUCT USE ISSUE,441
US,BURNING SENSATION,433
US,CEREBROVASCULAR ACCIDENT,430
US,UNEVALUABLE EVENT,429
US,BRONCHITIS,425
US,CHEST DISCOMFORT,424
US,INJECTION SITE BRUISING,417
US,PSORIASIS,417
US,DRY MOUTH,410
US,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,408
US,GASTRIC DISORDER,404
US,ABDOMINAL DISTENSION,402
US,HOT FLUSH,402
US,DRUG EFFECT DECREASED,399
US,DRUG INTOLERANCE,396
US,RHEUMATOID ARTHRITIS,396
US,UTERINE PERFORATION,393
US,EXTRA DOSE ADMINISTERED,390
US,OEDEMA PERIPHERAL,388
US,NEUROPATHY PERIPHERAL,387
US,POOR QUALITY DRUG ADMINISTERED,384
US,VISUAL IMPAIRMENT,382
US,NECK PAIN,376
US,EXPIRED PRODUCT ADMINISTERED,373
US,HEART RATE INCREASED,372
US,INFECTION,366
US,SEIZURE,365
US,SWELLING FACE,362
US,STRESS,359
US,HAEMORRHAGE,358
US,INTENTIONAL OVERDOSE,353
US,SUICIDAL IDEATION,342
US,LOSS OF CONSCIOUSNESS,336
US,DEVICE ISSUE,334
US,PRE-EXISTING CONDITION IMPROVED,331
US,ASTHMA,325
US,RENAL FAILURE,322
US,DRY SKIN,321
US,BLOOD GLUCOSE INCREASED,318
US,OSTEOARTHRITIS,315
US,UPPER RESPIRATORY TRACT INFECTION,315
US,WHITE BLOOD CELL COUNT DECREASED,313
US,EPISTAXIS,312
US,IRRITABILITY,311
US,MOBILITY DECREASED,309
US,FEELING HOT,302
US,BONE PAIN,300
US,RHINORRHOEA,300
US,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,296
US,ANHEDONIA,293
US,THROMBOSIS,291
US,PRODUCT TASTE ABNORMAL,286
US,NERVOUSNESS,283
US,MYOCARDIAL INFARCTION,281
US,CHOLECYSTITIS CHRONIC,277
US,SUICIDE ATTEMPT,277
US,GASTROINTESTINAL DISORDER,273
US,INJECTION SITE REACTION,272
US,SYNCOPE,272
US,AMNESIA,271
US,HAEMOGLOBIN DECREASED,269
US,INJECTION SITE PRURITUS,268
US,DEPRESSED MOOD,266
US,PRODUCT USE IN UNAPPROVED INDICATION,266
US,ORAL DISCOMFORT,265
US,SLEEP DISORDER,261
US,ARTHROPATHY,258
US,PRODUCT PHYSICAL ISSUE,258
US,NASAL CONGESTION,257
US,ACCIDENTAL EXPOSURE TO PRODUCT,255
US,FLATULENCE,255
US,TINNITUS,255
US,OSTEOPOROSIS,253
US,HEPATIC ENZYME INCREASED,252
US,POLLAKIURIA,251
US,CHOLELITHIASIS,249
US,LIP SWELLING,249
US,TACHYCARDIA,248
US,SEPSIS,247
US,NIGHT SWEATS,245
US,INCORRECT DRUG ADMINISTRATION DURATION,241
US,PELVIC PAIN,241
US,LOCAL SWELLING,237
US,DISCOMFORT,235
US,DEVICE DISLOCATION,233
US,FEAR,233
US,CRYING,232
US,DISTURBANCE IN ATTENTION,232
US,DRUG WITHDRAWAL SYNDROME,232
US,LETHARGY,232
US,RENAL DISORDER,232
US,CARDIAC ARREST,231
US,DYSPHONIA,230
US,HAEMATOCHEZIA,230
US,INJECTION SITE SWELLING,230
US,RASH PRURITIC,230
US,AGITATION,229
US,BLISTER,228
US,VERTIGO,227
US,DISEASE PROGRESSION,226
US,MULTIPLE SCLEROSIS,224
US,PANIC ATTACK,224
US,RECTAL HAEMORRHAGE,224
US,INJECTION SITE HAEMORRHAGE,223
US,MENORRHAGIA,222
US,NEPHROLITHIASIS,221
US,GALLBLADDER DISORDER,218
US,HALLUCINATION,216
US,SKIN DISCOLOURATION,216
US,EYE SWELLING,215
US,ROAD TRAFFIC ACCIDENT,215
US,GASTRIC ULCER,210
US,CELLULITIS,209
US,DIABETES MELLITUS,209
US,INTERVERTEBRAL DISC PROTRUSION,209
US,STOMATITIS,208
US,DRUG ADMINISTRATION ERROR,205
US,SLEEP APNOEA SYNDROME,205
US,WRONG TECHNIQUE IN DRUG USAGE PROCESS,205
US,ATRIAL FIBRILLATION,203
US,HERPES ZOSTER,201
US,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,200
US,DYSURIA,200
US,ADVERSE DRUG REACTION,199
US,BLOOD CHOLESTEROL INCREASED,199
US,ACTIVITIES OF DAILY LIVING IMPAIRED,196
US,WHEEZING,196
US,NO ADVERSE EVENT,195
US,MENTAL DISORDER,193
US,CATARACT,191
US,VAGINAL HAEMORRHAGE,191
US,RENAL FAILURE ACUTE,189
US,ADVERSE EVENT,188
US,SPEECH DISORDER,188
US,CARDIAC FAILURE CONGESTIVE,186
US,RESPIRATORY FAILURE,186
US,PLATELET COUNT DECREASED,185
US,POOR QUALITY SLEEP,185
US,THROMBOPHLEBITIS SUPERFICIAL,185
US,UNDERDOSE,184
US,GASTRITIS,183
US,FOREIGN BODY,182
US,MALIGNANT NEOPLASM PROGRESSION,182
US,THROMBOCYTOPENIA,181
US,EYE PAIN,180
US,TYPE 2 DIABETES MELLITUS,180
US,OEDEMA,178
US,BONE DISORDER,177
US,CONVULSION,177
US,CARDIAC DISORDER,176
US,FIBROMYALGIA,175
US,MENTAL STATUS CHANGES,173
US,GLOSSODYNIA,172
US,HYPOKALAEMIA,172
US,MOOD SWINGS,172
US,LIMB DISCOMFORT,171
US,THERAPY CESSATION,170
US,ACNE,169
US,DRUG EFFECT DELAYED,169
US,ABDOMINAL PAIN LOWER,168
US,EAR INFECTION,168
US,THERAPEUTIC RESPONSE DECREASED,168
US,NEUTROPENIA,166
US,ANAPHYLACTIC REACTION,165
US,DRY EYE,165
US,RASH ERYTHEMATOUS,165
US,ABASIA,164
US,PAIN IN JAW,164
US,PLEURAL EFFUSION,164
US,HYPOAESTHESIA ORAL,163
US,ULCER,162
US,ACCIDENTAL OVERDOSE,161
US,MATERNAL EXPOSURE DURING PREGNANCY,161
US,SCAR,160
US,DYSSTASIA,158
US,RASH GENERALISED,158
US,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,157
US,CARDIO-RESPIRATORY ARREST,157
US,INFLAMMATION,157
US,NEURALGIA,156
US,RETCHING,156
US,JOINT STIFFNESS,155
US,INTERVERTEBRAL DISC DEGENERATION,154
US,NIGHTMARE,153
US,DYSARTHRIA,152
US,FLUID RETENTION,152
US,SKIN EXFOLIATION,152
US,LYMPHADENOPATHY,151
US,UPPER GASTROINTESTINAL HAEMORRHAGE,151
US,EXPOSURE DURING PREGNANCY,149
US,ORAL PAIN,149
US,METABOLIC ACIDOSIS,148
US,PRODUCTIVE COUGH,148
US,WITHDRAWAL SYNDROME,146
US,GASTRIC HAEMORRHAGE,144
US,HYPERSOMNIA,144
US,SWOLLEN TONGUE,144
US,COGNITIVE DISORDER,143
US,CYSTITIS,142
US,IRRITABLE BOWEL SYNDROME,142
US,PRURITUS GENERALISED,142
US,GENITAL HAEMORRHAGE,141
US,JOINT INJURY,141
US,OSTEONECROSIS OF JAW,141
US,BLOOD CREATININE INCREASED,140
US,DISORIENTATION,140
US,FOOT FRACTURE,140
US,PROCEDURAL PAIN,140
US,BLOOD PRESSURE DECREASED,139
US,STAPHYLOCOCCAL INFECTION,139
US,URINARY INCONTINENCE,139
US,FEELING COLD,138
US,PSORIATIC ARTHROPATHY,138
US,VIRAL INFECTION,137
US,CROHN^S DISEASE,134
US,EMOTIONAL DISORDER,134
US,PANCREATITIS,134
US,RENAL IMPAIRMENT,134
US,PRODUCT SUBSTITUTION ISSUE,133
US,ANGER,132
US,FEELING JITTERY,132
US,HAEMORRHOIDS,132
US,CHOLECYSTECTOMY,131
US,DRUG ABUSE,131
US,ABNORMAL DREAMS,130
US,CARPAL TUNNEL SYNDROME,130
US,EAR PAIN,130
US,INJECTION SITE MASS,130
US,LIMB INJURY,130
US,PHARYNGEAL OEDEMA,130
US,RASH MACULAR,130
US,RIB FRACTURE,130
US,THROAT TIGHTNESS,130
US,IMPAIRED HEALING,129
US,LIVER DISORDER,129
US,RESTLESS LEGS SYNDROME,129
US,RESTLESSNESS,129
US,HOSPITALISATION,128
US,TOOTHACHE,128
US,ABNORMAL BEHAVIOUR,127
US,APHASIA,127
US,MUSCULOSKELETAL DISCOMFORT,127
US,SINUS DISORDER,127
US,SKIN DISORDER,126
US,SURGERY,126
US,VISUAL ACUITY REDUCED,126
US,FUNGAL INFECTION,125
US,HAEMATURIA,125
US,HEAD INJURY,125
US,BLOOD POTASSIUM DECREASED,124
US,MEDICATION ERROR,124
US,SPINAL OSTEOARTHRITIS,124
US,TREATMENT NONCOMPLIANCE,124
US,TRANSIENT ISCHAEMIC ATTACK,123
US,ALANINE AMINOTRANSFERASE INCREASED,122
US,ATELECTASIS,122
US,IMPAIRED WORK ABILITY,121
US,DEVICE DIFFICULT TO USE,120
US,RESPIRATORY ARREST,120
US,TOOTH DISORDER,120
US,MOVEMENT DISORDER,119
US,HYPONATRAEMIA,117
US,MOOD ALTERED,117
US,OSTEOPENIA,117
US,VITAMIN D DEFICIENCY,117
US,HYPOTHYROIDISM,116
US,OCULAR HYPERAEMIA,116
US,CHROMATURIA,115
US,COLITIS,115
US,AGGRESSION,114
US,DIPLOPIA,114
US,BACK DISORDER,113
US,DIVERTICULITIS,113
US,HAEMATEMESIS,113
US,LIGAMENT SPRAIN,113
US,DEVICE MALFUNCTION,112
US,EYE IRRITATION,112
US,CENTRAL NERVOUS SYSTEM LESION,110
US,FAECES DISCOLOURED,110
US,HIATUS HERNIA,110
US,MUSCLE TIGHTNESS,110
US,MUSCULOSKELETAL CHEST PAIN,110
US,URINARY RETENTION,110
US,WHITE BLOOD CELL COUNT INCREASED,110
US,DYSPNOEA EXERTIONAL,109
US,HYPOXIA,109
US,DYSKINESIA,107
US,ASPARTATE AMINOTRANSFERASE INCREASED,106
US,CHOKING,106
US,EYE DISORDER,106
US,LACRIMATION INCREASED,106
US,ABORTION SPONTANEOUS,105
US,DRUG DEPENDENCE,105
US,SEASONAL ALLERGY,105
US,PRODUCT ADHESION ISSUE,104
US,HAEMOPTYSIS,103
US,MUSCLE TWITCHING,103
US,EATING DISORDER,102
US,FOETAL EXPOSURE DURING PREGNANCY,102
US,OSTEOMYELITIS,102
US,BODY HEIGHT DECREASED,101
US,LUNG DISORDER,101
US,MIDDLE INSOMNIA,101
US,PULMONARY MASS,101
US,RED BLOOD CELL COUNT DECREASED,101
US,SINUS CONGESTION,101
US,LABORATORY TEST ABNORMAL,100
US,LOCALISED INFECTION,100
US,BLINDNESS,99
US,CHOLECYSTITIS,99
US,LIVER FUNCTION TEST ABNORMAL,99
US,PANCYTOPENIA,99
US,COMA,98
US,PRODUCT ODOUR ABNORMAL,98
US,TENDONITIS,97
US,CORONARY ARTERY DISEASE,96
US,HEPATIC STEATOSIS,96
US,LACERATION,96
US,OXYGEN SATURATION DECREASED,96
US,SCIATICA,96
US,STEVENS-JOHNSON SYNDROME,96
US,BREAST CANCER,95
US,DRUG SCREEN POSITIVE,95
US,HYPOACUSIS,95
US,PRESYNCOPE,95
US,SNEEZING,95
US,ANGIOEDEMA,94
US,COELIAC DISEASE,94
US,MICTURITION URGENCY,94
US,REACTION TO DRUG EXCIPIENTS,94
US,INJECTION SITE RASH,93
US,MENTAL IMPAIRMENT,93
US,GASTROENTERITIS VIRAL,92
US,HEMIPARESIS,92
US,OVARIAN CYST,92
US,BLOOD URINE PRESENT,91
US,EMBEDDED DEVICE,91
US,HEPATIC FAILURE,91
US,INTENTIONAL DRUG MISUSE,91
US,METASTASES TO BONE,91
US,PRESCRIBED OVERDOSE,91
US,SEPTIC SHOCK,91
US,SKIN BURNING SENSATION,91
US,SKIN LESION,91
US,WOUND,91
US,ARRHYTHMIA,90
US,COAGULOPATHY,90
US,COLITIS ULCERATIVE,90
US,EXOSTOSIS,90
US,HYPERGLYCAEMIA,90
US,NEOPLASM PROGRESSION,90
US,RASH PAPULAR,90
US,BILIARY DYSKINESIA,89
US,CHRONIC KIDNEY DISEASE,89
US,COLD SWEAT,89
US,SKIN ULCER,89
US,THINKING ABNORMAL,89
US,THIRST,89
US,TOOTH INFECTION,89
US,DEVICE BREAKAGE,88
US,EYE PRURITUS,87
US,INJECTION SITE URTICARIA,87
US,MEDICAL DEVICE DISCOMFORT,87
US,DYSMENORRHOEA,86
US,KIDNEY INFECTION,86
US,PARAESTHESIA ORAL,86
US,PULMONARY OEDEMA,86
US,UNRESPONSIVE TO STIMULI,86
US,ACUTE HEPATIC FAILURE,85
US,FEBRILE NEUTROPENIA,85
US,RESPIRATORY TRACT CONGESTION,85
US,ROTATOR CUFF SYNDROME,85
US,ATRIAL SEPTAL DEFECT,84
US,SENSORY DISTURBANCE,84
US,BRADYCARDIA,83
US,DEPRESSED LEVEL OF CONSCIOUSNESS,83
US,HYPOPHAGIA,83
US,INFLAMMATORY BOWEL DISEASE,83
US,MALABSORPTION,83
US,MENSTRUATION IRREGULAR,83
US,RESPIRATORY DISTRESS,83
US,ULCER HAEMORRHAGE,83
US,TUBULOINTERSTITIAL NEPHRITIS,82
US,WRONG DRUG ADMINISTERED,82
US,BLOOD GLUCOSE DECREASED,81
US,CARDIOMEGALY,81
US,FEMUR FRACTURE,81
US,PSYCHOLOGICAL TRAUMA,81
US,ANGINA PECTORIS,80
US,DEAFNESS,80
US,DECREASED INTEREST,80
US,DRUG PRESCRIBING ERROR,80
US,HEART RATE IRREGULAR,80
US,LOWER LIMB FRACTURE,80
US,PRODUCT LABEL ISSUE,80
US,INCREASED APPETITE,79
US,NEOPLASM MALIGNANT,79
US,PHARYNGITIS STREPTOCOCCAL,79
US,DIVERTICULUM,78
US,ERUCTATION,78
US,HYPERLIPIDAEMIA,78
US,INTESTINAL OBSTRUCTION,78
US,LEUKOPENIA,78
US,TOXIC EPIDERMAL NECROLYSIS,78
US,UPPER LIMB FRACTURE,78
US,ANKLE FRACTURE,77
US,ENDOMETRIOSIS,77
US,HEAD DISCOMFORT,77
US,HYPERKALAEMIA,77
US,METRORRHAGIA,77
US,RESPIRATORY TRACT INFECTION,77
US,GOUT,76
US,HAEMATOCRIT DECREASED,76
US,LEUKOCYTOSIS,76
US,MATERNAL EXPOSURE TIMING UNSPECIFIED,76
US,NERVOUS SYSTEM DISORDER,76
US,SPINAL COLUMN STENOSIS,76
US,DENTAL CARIES,75
US,ERECTILE DYSFUNCTION,75
US,INJECTION SITE WARMTH,75
US,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,75
US,MUSCLE SPASTICITY,75
US,MUSCULOSKELETAL DISORDER,75
US,PLASMA CELL MYELOMA,75
US,RESPIRATORY DISORDER,75
US,BURSITIS,74
US,HIP FRACTURE,74
US,INITIAL INSOMNIA,74
US,PHOTOPHOBIA,74
US,TENDERNESS,74
US,TOOTH ABSCESS,74
US,BLOOD TRIGLYCERIDES INCREASED,73
US,CEREBRAL HAEMORRHAGE,73
US,FEELING DRUNK,73
US,HYPOKINESIA,73
US,INCREASED TENDENCY TO BRUISE,73
US,IRON DEFICIENCY ANAEMIA,73
US,MASS,73
US,MULTIPLE FRACTURES,73
US,PULMONARY HYPERTENSION,73
US,AGEUSIA,72
US,HUNGER,72
US,ILL-DEFINED DISORDER,72
US,LIVER INJURY,72
US,LYMPHOCYTE COUNT DECREASED,72
US,PELVIC VENOUS THROMBOSIS,72
US,MUSCLE STRAIN,71
US,PREGNANCY WITH CONTRACEPTIVE DEVICE,71
US,ENCEPHALOPATHY,70
US,INJECTION SITE INDURATION,70
US,OBESITY,70
US,PRODUCT COATING ISSUE,70
US,PRODUCT PACKAGING ISSUE,70
US,PSYCHOMOTOR HYPERACTIVITY,70
US,CYST,69
US,HEART RATE DECREASED,69
US,LUNG INFECTION,69
US,NERVE COMPRESSION,69
US,NERVE INJURY,69
US,PRODUCT DIFFICULT TO SWALLOW,69
US,DRUG ADMINISTERED AT INAPPROPRIATE SITE,68
US,HAEMATOMA,68
US,MITRAL VALVE INCOMPETENCE,68
US,SKIN IRRITATION,68
US,ACUTE MYOCARDIAL INFARCTION,67
US,BACK INJURY,67
US,COORDINATION ABNORMAL,67
US,FEAR OF DISEASE,67
US,GENERALISED TONIC-CLONIC SEIZURE,67
US,HAEMORRHAGIC ANAEMIA,67
US,ASCITES,66
US,FULL BLOOD COUNT DECREASED,66
US,HERNIA,66
US,MOUTH ULCERATION,66
US,PHOTOSENSITIVITY REACTION,66
US,PRODUCT COLOUR ISSUE,66
US,TOOTH FRACTURE,66
US,CLOSTRIDIUM DIFFICILE INFECTION,65
US,FEEDING DISORDER,65
US,GASTRIC ULCER HAEMORRHAGE,65
US,GLAUCOMA,65
US,LACTIC ACIDOSIS,65
US,PREMATURE BABY,65
US,PSYCHOTIC DISORDER,65
US,ACUTE RESPIRATORY FAILURE,64
US,BIPOLAR DISORDER,64
US,DEFORMITY,64
US,DRUG-INDUCED LIVER INJURY,64
US,GALLBLADDER INJURY,64
US,IMPAIRED DRIVING ABILITY,64
US,INFUSION RELATED REACTION,64
US,JOINT RANGE OF MOTION DECREASED,64
US,MEDICAL DEVICE PAIN,64
US,SEDATION,64
US,ELECTROCARDIOGRAM QT PROLONGED,63
US,HYPERCALCAEMIA,63
US,INCORRECT PRODUCT STORAGE,63
US,INTERNAL HAEMORRHAGE,63
US,PNEUMOTHORAX,63
US,SPINAL FRACTURE,63
US,TEMPERATURE INTOLERANCE,63
US,TREATMENT FAILURE,63
US,APPLICATION SITE PAIN,62
US,CONGENITAL ANOMALY,62
US,DEVICE EXPULSION,62
US,DISABILITY,62
US,ECZEMA,62
US,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,62
US,PERICARDIAL EFFUSION,62
US,SOMNAMBULISM,62
US,CANDIDA INFECTION,61
US,EXPIRED DRUG ADMINISTERED,61
US,FOOT DEFORMITY,61
US,SPINAL PAIN,61
US,APPLICATION SITE ERYTHEMA,60
US,BLADDER DISORDER,60
US,CONCUSSION,60
US,HYSTERECTOMY,60
US,ORAL HERPES,60
US,PNEUMONITIS,60
US,PRODUCT SIZE ISSUE,60
US,RHABDOMYOLYSIS,60
US,TRICUSPID VALVE INCOMPETENCE,60
US,WRIST FRACTURE,60
US,BLOOD BILIRUBIN INCREASED,59
US,BLOOD COUNT ABNORMAL,59
US,BONE LESION,59
US,BRAIN INJURY,59
US,EAR DISCOMFORT,59
US,FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT,59
US,LARGE INTESTINE POLYP,59
US,SNORING,59
US,SPINAL DISORDER,59
US,BASAL CELL CARCINOMA,58
US,HYPOGLYCAEMIA,58
US,NOCTURIA,58
US,PNEUMONIA ASPIRATION,58
US,VENTRICULAR SEPTAL DEFECT,58
US,CARDIAC MURMUR,57
US,CATAPLEXY,57
US,DRUG TOLERANCE,57
US,DYSPAREUNIA,57
US,MENISCUS INJURY,57
US,RENAL TUBULAR NECROSIS,57
US,THYROID DISORDER,57
US,VITAMIN D DECREASED,57
US,ANORECTAL DISCOMFORT,56
US,BEDRIDDEN,56
US,JAUNDICE,56
US,JOINT DISLOCATION,56
US,LUNG INFILTRATION,56
US,PARANOIA,56
US,PATENT DUCTUS ARTERIOSUS,56
US,POST PROCEDURAL HAEMORRHAGE,56
US,TOOTH LOSS,56
US,UPPER-AIRWAY COUGH SYNDROME,56
US,DIABETIC KETOACIDOSIS,55
US,FREQUENT BOWEL MOVEMENTS,55
US,HANGOVER,55
US,PALLOR,55
US,PERIPHERAL COLDNESS,55
US,SINUS TACHYCARDIA,55
US,CHOLECYSTITIS ACUTE,54
US,CONJUNCTIVITIS,54
US,DEVICE FAILURE,54
US,LIVER FUNCTION TEST INCREASED,54
US,METASTASES TO LIVER,54
US,NEUTROPHIL COUNT DECREASED,54
US,SINUS HEADACHE,54
US,SLUGGISHNESS,54
US,BLOOD ALKALINE PHOSPHATASE INCREASED,53
US,DERMATITIS,53
US,INCONTINENCE,53
US,MELAENA,53
US,OESOPHAGITIS,53
US,PULMONARY INFARCTION,53
US,SCOLIOSIS,53
US,SYSTEMIC LUPUS ERYTHEMATOSUS,53
US,UTERINE LEIOMYOMA,53
US,BLOOD PRESSURE ABNORMAL,52
US,BODY TEMPERATURE INCREASED,52
US,DRUG SCREEN FALSE POSITIVE,52
US,GASTROENTERITIS,52
US,INCORRECT ROUTE OF DRUG ADMINISTRATION,52
US,ISCHAEMIC STROKE,52
US,LOWER GASTROINTESTINAL HAEMORRHAGE,52
US,PRODUCT USE COMPLAINT,52
US,RENAL CYST,52
US,ABSCESS,51
US,APHONIA,51
US,CEREBRAL INFARCTION,51
US,DELIRIUM,51
US,GROIN PAIN,51
US,LARYNGITIS,51
US,LIBIDO DECREASED,51
US,OESOPHAGEAL PAIN,51
US,PRESCRIBED UNDERDOSE,51
US,SMALL INTESTINAL OBSTRUCTION,51
US,SPINAL COMPRESSION FRACTURE,51
US,ARTERIOSCLEROSIS,50
US,BREAST PAIN,50
US,EPIGASTRIC DISCOMFORT,50
US,EUPHORIC MOOD,50
US,HAIR COLOUR CHANGES,50
US,IMPAIRED GASTRIC EMPTYING,50
US,MENSTRUAL DISORDER,50
US,BLOOD SODIUM DECREASED,49
US,CARDIAC FAILURE,49
US,CONTRAINDICATED PRODUCT ADMINISTERED,49
US,DRY THROAT,49
US,EYE INFECTION,49
US,GASTROINTESTINAL PAIN,49
US,HEPATIC CIRRHOSIS,49
US,INTERVERTEBRAL DISC DISORDER,49
US,JOINT EFFUSION,49
US,LUMBAR SPINAL STENOSIS,49
US,MUCOSAL INFLAMMATION,49
US,MUSCLE ATROPHY,49
US,PAIN OF SKIN,49
US,BLINDNESS UNILATERAL,48
US,DEVICE RELATED INFECTION,48
US,EMBOLISM ARTERIAL,48
US,FACIAL PAIN,48
US,FLANK PAIN,48
US,GINGIVAL BLEEDING,48
US,LOWER RESPIRATORY TRACT INFECTION,48
US,METASTASES TO SPINE,48
US,PERONEAL NERVE PALSY,48
US,QUALITY OF LIFE DECREASED,48
US,RENAL PAIN,48
US,SCREAMING,48
US,AFFECT LABILITY,47
US,ANKYLOSING SPONDYLITIS,47
US,ENERGY INCREASED,47
US,GAIT INABILITY,47
US,HEARING IMPAIRED,47
US,IMMUNE SYSTEM DISORDER,47
US,MEDICAL DEVICE COMPLICATION,47
US,OPTIC NEURITIS,47
US,OSTEOSCLEROSIS,47
US,SENSORY LOSS,47
US,SKIN FISSURES,47
US,ADVERSE REACTION,46
US,CARDIOVASCULAR DISORDER,46
US,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,46
US,DECREASED ACTIVITY,46
US,DUODENAL ULCER,46
US,EYELID OEDEMA,46
US,GINGIVAL PAIN,46
US,HAIR TEXTURE ABNORMAL,46
US,INTERNATIONAL NORMALISED RATIO INCREASED,46
US,LYMPHOEDEMA,46
US,PRODUCT FORMULATION ISSUE,46
US,SENSATION OF FOREIGN BODY,46
US,VAGINAL DISCHARGE,46
US,BLOOD PRESSURE FLUCTUATION,45
US,DERMATITIS CONTACT,45
US,DISEASE RECURRENCE,45
US,EMPHYSEMA,45
US,ENURESIS,45
US,FEELING OF BODY TEMPERATURE CHANGE,45
US,HAND FRACTURE,45
US,MENINGITIS ASEPTIC,45
US,PARALYSIS,45
US,POST-TRAUMATIC STRESS DISORDER,45
US,BLOOD TESTOSTERONE DECREASED,44
US,DECUBITUS ULCER,44
US,HEPATOMEGALY,44
US,SPLENOMEGALY,44
US,TRANSAMINASES INCREASED,44
US,AMENORRHOEA,43
US,ANAPHYLACTIC SHOCK,43
US,BACTERIAL INFECTION,43
US,CARDIOMYOPATHY,43
US,DEVICE USE ERROR,43
US,HYPERAESTHESIA,43
US,INJECTION SITE DISCOLOURATION,43
US,INTERNAL INJURY,43
US,INTRACRANIAL VENOUS SINUS THROMBOSIS,43
US,KNEE ARTHROPLASTY,43
US,MADAROSIS,43
US,MANIA,43
US,NODULE,43
US,PREGNANCY,43
US,PROSTATE CANCER,43
US,PROTEINURIA,43
US,RENAL INJURY,43
US,SECRETION DISCHARGE,43
US,SEROTONIN SYNDROME,43
US,WALKING AID USER,43
US,WEIGHT FLUCTUATION,43
US,ATAXIA,42
US,BRUXISM,42
US,NAIL DISORDER,42
US,OSTEOLYSIS,42
US,PULMONARY FIBROSIS,42
US,APPLICATION SITE PRURITUS,41
US,ARTHROPOD BITE,41
US,BLOOD CREATINE PHOSPHOKINASE INCREASED,41
US,BLOOD IRON DECREASED,41
US,BOWEL MOVEMENT IRREGULARITY,41
US,DRUG DISPENSING ERROR,41
US,FORMICATION,41
US,INJECTION SITE NODULE,41
US,INTESTINAL PERFORATION,41
US,MOTOR DYSFUNCTION,41
US,NASAL DISCOMFORT,41
US,POST PROCEDURAL COMPLICATION,41
US,PULMONARY CONGESTION,41
US,SKIN INFECTION,41
US,URINE OUTPUT DECREASED,41
US,ACUTE RESPIRATORY DISTRESS SYNDROME,40
US,ADRENAL INSUFFICIENCY,40
US,EXPOSED BONE IN JAW,40
US,MULTIPLE ALLERGIES,40
US,MUSCLE DISORDER,40
US,PANCREATITIS ACUTE,40
US,PHARYNGITIS,40
US,POLYP,40
US,PROSTATIC SPECIFIC ANTIGEN INCREASED,40
US,SKIN CANCER,40
US,TONGUE DISCOMFORT,40
US,ACIDOSIS,39
US,ELECTROCARDIOGRAM ABNORMAL,39
US,ELECTROLYTE IMBALANCE,39
US,GLYCOSYLATED HAEMOGLOBIN INCREASED,39
US,HIP ARTHROPLASTY,39
US,ORAL CANDIDIASIS,39
US,SCAB,39
US,SUPRAVENTRICULAR TACHYCARDIA,39
US,TENDON RUPTURE,39
US,VENTRICULAR EXTRASYSTOLES,39
US,ANAL PRURITUS,38
US,APATHY,38
US,APNOEA,38
US,BLOOD DISORDER,38
US,BLOOD MAGNESIUM DECREASED,38
US,GRIP STRENGTH DECREASED,38
US,HYPERKERATOSIS,38
US,LUNG NEOPLASM MALIGNANT,38
US,MAJOR DEPRESSION,38
US,MELANOCYTIC NAEVUS,38
US,METASTASES TO LUNG,38
US,ONYCHOMYCOSIS,38
US,ORAL MUCOSAL BLISTERING,38
US,PELVIC INFLAMMATORY DISEASE,38
US,PURULENT DISCHARGE,38
US,SPINAL OPERATION,38
US,TOOTH EXTRACTION,38
US,URINE ODOUR ABNORMAL,38
US,BLOOD POTASSIUM INCREASED,37
US,BRONCHOSPASM,37
US,CORONARY ARTERY OCCLUSION,37
US,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,37
US,LIP DRY,37
US,ORAL DISORDER,37
US,OSTEONECROSIS,37
US,SKIN HAEMORRHAGE,37
US,TACHYPNOEA,37
US,TONGUE DISORDER,37
US,VITREOUS FLOATERS,37
US,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,36
US,COMPLICATION OF DEVICE REMOVAL,36
US,COMPRESSION FRACTURE,36
US,CYANOSIS,36
US,DIABETIC NEUROPATHY,36
US,ECCHYMOSIS,36
US,EYELID PTOSIS,36
US,FURUNCLE,36
US,GASTROINTESTINAL SOUNDS ABNORMAL,36
US,HYDRONEPHROSIS,36
US,MYDRIASIS,36
US,PAROSMIA,36
US,PATHOLOGICAL FRACTURE,36
US,THERAPEUTIC RESPONSE CHANGED,36
US,ABDOMINAL TENDERNESS,35
US,BONE LOSS,35
US,FAILURE TO THRIVE,35
US,GINGIVAL SWELLING,35
US,GLUCOSE TOLERANCE IMPAIRED,35
US,HEPATOTOXICITY,35
US,ILEUS,35
US,INTENTIONAL SELF-INJURY,35
US,LEFT VENTRICULAR HYPERTROPHY,35
US,MALIGNANT MELANOMA,35
US,MOUTH SWELLING,35
US,PERSONALITY CHANGE,35
US,THROMBOTIC THROMBOCYTOPENIC PURPURA,35
US,VARICOSE VEIN,35
US,VIRAL UPPER RESPIRATORY TRACT INFECTION,35
US,ABNORMAL FAECES,34
US,APHTHOUS ULCER,34
US,APPARENT DEATH,34
US,BLOOD CALCIUM DECREASED,34
US,BLOOD TEST ABNORMAL,34
US,BLOOD UREA INCREASED,34
US,BREAST CANCER METASTATIC,34
US,CHOKING SENSATION,34
US,DYSGRAPHIA,34
US,DYSPHORIA,34
US,EJECTION FRACTION DECREASED,34
US,HALLUCINATION_ AUDITORY,34
US,HEPATIC ENCEPHALOPATHY,34
US,HYPERCHOLESTEROLAEMIA,34
US,IMPLANT SITE PAIN,34
US,INFERTILITY FEMALE,34
US,KOUNIS SYNDROME,34
US,NEOPLASM,34
US,ORTHOSTATIC HYPOTENSION,34
US,OTITIS MEDIA,34
US,SKIN ATROPHY,34
US,SYNOVIAL CYST,34
US,CLOSTRIDIUM DIFFICILE COLITIS,33
US,DELUSION,33
US,GLOSSITIS,33
US,HAEMORRHAGE INTRACRANIAL,33
US,HEPATIC LESION,33
US,HEREDITARY ANGIOEDEMA,33
US,HYPERTHYROIDISM,33
US,INCREASED UPPER AIRWAY SECRETION,33
US,NASAL DRYNESS,33
US,PANIC REACTION,33
US,PLEURISY,33
US,PROCTALGIA,33
US,RENAL FAILURE CHRONIC,33
US,SALIVARY HYPERSECRETION,33
US,THERAPY NON-RESPONDER,33
US,VENA CAVA THROMBOSIS,33
US,ACCIDENT,32
US,APPLICATION SITE IRRITATION,32
US,FOOD ALLERGY,32
US,HAIR DISORDER,32
US,HYPOCALCAEMIA,32
US,HYPOVOLAEMIA,32
US,INJECTION SITE PAPULE,32
US,MASTICATION DISORDER,32
US,METASTASES TO CENTRAL NERVOUS SYSTEM,32
US,ODYNOPHAGIA,32
US,PERICARDITIS,32
US,POLYURIA,32
US,PRODUCT PREPARATION ERROR,32
US,SHOCK,32
US,SKIN REACTION,32
US,SPONDYLOLISTHESIS,32
US,SQUAMOUS CELL CARCINOMA,32
US,VISUAL FIELD DEFECT,32
US,BACTERAEMIA,31
US,BARRETT^S OESOPHAGUS,31
US,C-REACTIVE PROTEIN INCREASED,31
US,CARDIAC FLUTTER,31
US,DEMENTIA,31
US,DERMATITIS ACNEIFORM,31
US,DRUG ERUPTION,31
US,DRUG LEVEL INCREASED,31
US,HEPATITIS,31
US,MOUTH HAEMORRHAGE,31
US,NEPHROPATHY,31
US,PETECHIAE,31
US,PLATELET COUNT INCREASED,31
US,PRODUCT COMMINGLING,31
US,PRODUCT CONTAINER ISSUE,31
US,PROSTATOMEGALY,31
US,UTERINE HAEMORRHAGE,31
US,BLINDNESS TRANSIENT,30
US,BLOOD GLUCOSE ABNORMAL,30
US,BONE DENSITY DECREASED,30
US,BRAIN OEDEMA,30
US,ENDODONTIC PROCEDURE,30
US,EYE DISCHARGE,30
US,EYE HAEMORRHAGE,30
US,FISTULA,30
US,FOREIGN BODY IN RESPIRATORY TRACT,30
US,FRUSTRATION,30
US,GINGIVITIS,30
US,GOITRE,30
US,INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS,30
US,INJURY ASSOCIATED WITH DEVICE,30
US,INTENTIONAL UNDERDOSE,30
US,KYPHOSIS,30
US,MACULAR DEGENERATION,30
US,MEDICATION RESIDUE PRESENT,30
US,ONYCHOCLASIS,30
US,RHINITIS ALLERGIC,30
US,SEXUAL DYSFUNCTION,30
US,TENDON PAIN,30
US,ALTERED STATE OF CONSCIOUSNESS,29
US,APPENDICECTOMY,29
US,APPLICATION SITE RASH,29
US,ARTERIOSCLEROSIS CORONARY ARTERY,29
US,CHEILITIS,29
US,EAR DISORDER,29
US,HEPATIC CYST,29
US,INTESTINAL HAEMORRHAGE,29
US,JUGULAR VEIN THROMBOSIS,29
US,NON-CARDIAC CHEST PAIN,29
US,OBSESSIVE-COMPULSIVE DISORDER,29
US,PLEURITIC PAIN,29
UM,BACK PAIN,1
UM,CELLULITIS,1
UM,CONTRAINDICATED PRODUCT ADMINISTERED,1
UM,FEAR,1
UM,FEELING HOT,1
UM,PARANOIA,1
UM,STAPHYLOCOCCUS TEST POSITIVE,1
UM,SURGERY,1
UM,TREMOR,1
UY,CARDIOVASCULAR DISORDER,1
UY,COUGH,1
UY,DISEASE PROGRESSION,1
UY,DRUG INEFFECTIVE,1
UY,EJECTION FRACTION DECREASED,1
UY,INFLUENZA,1
UY,NAUSEA,1
UY,PYREXIA,1
UY,RESPIRATORY TRACT INFECTION,1
UY,VOMITING,1
VE,ARTHRALGIA,4
VE,DRUG-INDUCED LIVER INJURY,4
VE,PAIN IN EXTREMITY,4
VE,PYREXIA,4
VE,VOMITING,4
VE,HEADACHE,3
VE,DEPRESSION,2
VE,DIARRHOEA,2
VE,DIZZINESS,2
VE,DYSPNOEA,2
VE,FATIGUE,2
VE,PAIN,2
VE,ABASIA,1
VE,ABDOMINAL PAIN UPPER,1
VE,ANGINA PECTORIS,1
VE,ANGIOEDEMA,1
VE,BLOOD CHOLESTEROL INCREASED,1
VE,BLOOD GROWTH HORMONE INCREASED,1
VE,BLOOD TRIGLYCERIDES INCREASED,1
VE,BRADYCARDIA,1
VE,BRONCHITIS,1
VE,BULIMIA NERVOSA,1
VE,CAESAREAN SECTION,1
VE,CATARACT,1
VE,CERVIX DISORDER,1
VE,CHEST PAIN,1
VE,CHILLS,1
VE,CHOLELITHIASIS,1
VE,CHOLESTATIC LIVER INJURY,1
VE,CONDITION AGGRAVATED,1
VE,CONVULSION,1
VE,DECREASED APPETITE,1
VE,DIABETES MELLITUS INADEQUATE CONTROL,1
VE,DISCOMFORT,1
VE,EYE DISORDER,1
VE,EYE HAEMORRHAGE,1
VE,FEELING ABNORMAL,1
VE,FOOD INTOLERANCE,1
VE,GASTRITIS,1
VE,HAEMOGLOBIN DECREASED,1
VE,HEPATOCELLULAR INJURY,1
VE,HERNIA,1
VE,HERNIAL EVENTRATION,1
VE,HYPERHIDROSIS,1
VE,IMMUNOSUPPRESSION,1
VE,INFLUENZA,1
VE,INJECTION SITE PAIN,1
VE,INSULIN-LIKE GROWTH FACTOR INCREASED,1
VE,MALAISE,1
VE,MASS,1
VE,MATERNAL EXPOSURE DURING PREGNANCY,1
VE,MIXED LIVER INJURY,1
VE,MOBILITY DECREASED,1
VE,MUSCULOSKELETAL DISCOMFORT,1
VE,MUSCULOSKELETAL PAIN,1
VE,MYALGIA,1
VE,NEEDLE ISSUE,1
VE,NERVE COMPRESSION,1
VE,OSTEOPOROSIS,1
VE,PERIPHERAL SWELLING,1
VE,PNEUMONIA,1
VE,PNEUMONITIS,1
VE,POLYDIPSIA,1
VE,PRODUCT USE ISSUE,1
VE,RASH,1
VE,RESPIRATORY ARREST,1
VE,RESPIRATORY SYMPTOM,1
VE,RESPIRATORY TRACT INFECTION,1
VE,RHEUMATOID ARTHRITIS,1
VE,SPINAL COLUMN INJURY,1
VE,SPINAL FRACTURE,1
VE,SWELLING,1
VE,TINNITUS,1
VE,TOXIC EPIDERMAL NECROLYSIS,1
VE,URTICARIA,1
VE,VISUAL ACUITY REDUCED,1
VE,VISUAL IMPAIRMENT,1
VE,VITREOUS FLOATERS,1
VN,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,2
VI,DRUG EFFECT INCOMPLETE,1
